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ABSTRACT
Dietary iron (Fe) overload, originally referred to as Bantu Visceral Siderosis, is an Re­
loading condition that is still prevalent in rural populations of sub-Saharan Africa. The 
better known Fe loading disease, hereditary haemochromatosis (HFI) is frequently 
complicated by hepatocellular carcinoma (HCC) and, in rare instances this occurs in the 
absence of cirrhosis. The latter, together with recent evidence that dietary Fe overload in 
the Black African carries an increased risk for HCC, suggests that excessive hepatic iron 
may itself be carcinogenic. The aim of the study was to determine if Fe alone could induce 
HCC in experimental rat models and, if so, to investigate possible mechanisms of 
hepatocarcinogenesis. 360 Wistar albino rats (Rattus norvegicus) were divided into 6 
groups. The first group, the control animals, was designated C group. Groups 2 - 6  were 
Fe-fed alone or in combination with other chemicals: group 2 Fe alone (Fe group), group 3 
(Fe + V) vitamins A & E supplementation [50 mg all trans-retinol (vitamin A) and 500 mg 
a-tocopherol (vitamin E) per kg diet], group 4 (Fe - V) received a diet totally devoid of 
vitamins A & E, group 5 (Fe + ASA) received 20 mg aspirin (ASA) per day, group 6 (Fe + 
Cu) received 300 mg/kg diet of copper sulphate (CuS04) supplementation for 12 months 
followed by 3% copper hydroxide carbonate [CuC0 3 »Cu(0 H)2]. Fe-fed rats were 
originally given 2% carbonyl iron (Cl) up to 8 months. This was increased to 2.5% up to 
12 months, followed by 0.5% ferrocene (dicyclopentadienyl iron) {ad libitum). The rats 
were monitored for 36 months and were sacrificed periodically and the blood and liver 
analysed. The following tests were performed: serum Fe, histological hepatic Fe grading, 
liver Fe concentration (LIC), Superoxide radical (*“02), Total Antioxidant Status (TAS), 
Glutathione peroxidase (GPx), Superoxide dismutase (SOD), Catalase (CAT), Vitamin C, 
Oxygen Radical Absorbance Capacity (ORAC), Malondialdehyde (MDA), FOX II assay 
for lipid hydroperoxides, 8-isoprostane (8-IP), 4-hydroxynonenal (4-HNE) 
immunohistochemistry, 8-hydroxy-2’-deoxyguanosine (80HdG) immunohistochemistry, 
liver 80HdG concentration (ELISA), Fluorimetric Analysis of DNA Unwinding (FADU), 
Ames mutagenicity test, Pulse Field Gel Electrophoresis (PFGE), AST, ALT,AFP and 
liver histology. Serum Fe reached a plateau after 16 months of Fe feeding. Serum Fe in the 
Fe-loading group was 2.5 times higher than the control group (p<0.05). At 12 months, 
hepatic Fe grading was 2+. When Cl was substituted with ferrocene, Fe-loading was 4+ at
v
16 months. At 32 months LIC in the Fe groups was 19.8 + 6.9 mg/g w.wt (33 times above 
the control group). Fe overload led to the generation of Reactive Oxygen Species (ROS). 
'”02 was 2-2.5 times higher in the Fe-fed groups than the control (p>0.05). Antioxidant 
levels (AO) were statistically significant but at different time-points. AO enzymes operated 
in a dynamic equilibrium and with a compensatory mechanism. The total lipid-soluble AO 
was 25% that of the total aqueous-soluble AO in the liver (p<0.05 at 12 months). The FOX 
II assay was found to be a better biomarker of lipid peroxidation (LPO) compared to MDA 
and 8-IP. LPO occurred as an early event of oxidative stress induced by Fe, and this was 
also detected immunohistochemically. Adducts of DNA oxidative damage i.e. 80HdG 
were detected in the Fe-overloaded groups. Furthermore, liver 80HdG concentration was 
significantly raised after 12 months (p<0.05). DNA strand-breaks were observed by PFGE 
in the early days of the study. In addition, DNA unwinding was observed and found to be 
significant between 12 and 20 months in the Fe-loaded groups (p<0.05). Mutagens were 
demonstrated in the liver in the Fe-loaded groups. The C group remained negative 
throughout with an average reversion frequency of 330 colonies. The Fe-loaded groups had 
twice this value between 20 and 24 months (p<0.05). Liver damage, assessed by AST and 
ALT levels, commenced after 16 months of Fe-overloading (p<0.05). 26% of Fe- 
overloaded livers examined histologically between 20 and 32 months had iron-free foci 
(IFF) that stained positive for GST-71. Histologically, neoplastic changes such as IFF were 
present in all the Fe-fed groups. Multiple IFF was detected in one liver from the Fe + V 
group. Inclusions resembling Mallory bodies were identified. Others, such as hamartomata, 
von Meyenburg complexes and Gandy-Gamma bodies, were observed. The presence of fat, 
focal fat and micro-steatosis was identified. In addition, hepatocellular adenoma was a 
borderline case in one liver from the Fe group. HCC was present in the liver of one rat in 
the Fe group. The tumour was 2 cm in diameter and arose in a liver without cirrhosis or 
fibrosis. AO vitamins and ASA were unable to prevent these histological events. Copper 
did not show any synergy histologically as a possible co-carcinogen. This study is the first 
to demonstrate the development of HCC in an animal model of haemochromatosis. Dietary 
Fe alone may be carcinogenic through a mechanism that involves the generation of 
reactive oxygen species, LPO, oxidative DNA damage, DNA strand breaks and unwinding, 
and mutagenesis.
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Chapter 1: Introduction
1.0 DIETARY IRON OVERLOAD AND HEPATOCELLULAR CARCINOMA
1.1 Historical and Clinical perspectives
Dietary iron overload was first described by Strachan in 1929 (Strachan, 1929). This iron 
loading condition occurs in parts of sub-Saharan Africa (where as many as 10% of the 
adult population may be affected) and was previously referred to as Bantu visceral 
siderosis. Following necropsy analysis of 876 Blacks from southern and central Africa, 
Strachan concluded that haemochromatosis (a disorder that interferes with iron metabolism 
and results in excess iron deposits throughout the body) was a common disease in Black 
Africans and that the major cause of the iron overload was the diet. Although these 
findings were greeted with scepticism, the high prevalence of this condition and its cause 
was later confirmed in a number of studies (Higginson et al., 1953; Walker, 1953; 
Bothwell et al., 1960, 1962, 1964; Buchanan 1966, 1967, 1969; MacPhail et al., 1979a, 
1979b; Gordeuk et al., 1986; Friedman et al., 1990; Gordeuk 1992b; Moyo et al., 1998; 
Mandishona et al., 1998).
Iron overload in southern African blacks was later thought to result from some metabolic 
defect caused by chronic malnutrition (Gillman and Gillman, 1951). However, very high 
dietary intake of iron was subsequently confirmed to be the reason, with most of the iron 
being derived from the iron drums and pots used in brewing traditional alcoholic 
beverages, which were consumed in large quantities by the blacks (Bothwell et al., 1964). 
The bulk of the iron was deposited in the liver and the mononuclear-macrophage system 
(Bothwell et al., 1965). Consequences of this iron deposition are micronodular cirrhosis, 
ascorbic acid deficiency, and osteoporosis (Bothwell et al., 1960). Recent evidence has
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suggested the possibility that dietary iron overload may be caused by an interaction 
between the increased dietary iron and a gene distant from the HLA linked iron-loading 
locus responsible for the hereditary iron loading disease, hereditary haemochromatosis 
(HH). There is as yet no evidence to support this hypothesis, however (Gordeuk, 1992a).
A revision of the South African Liquor Laws in 1963 was followed by far reaching 
changes in the drinking habits of urban black South Africans that eventually led to a 
considerable decline in the prevalence and severity of iron overload in urban dwellers, and 
hence a lessening of interest in research into this condition (MacPhail et al., 1979a). 
However, interest in dietary iron overload was revived when this disease was shown to be 
still prevalent in rural populations in sub-Saharan Africa (Gordeuk et al., 1986).
The recognition that dietary iron overload is an important public health problem in sub- 
Saharan Africa raised the question of its possible association with other common diseases 
in Black Africans, including hepatocellular carcinoma (HCC). Although this malignancy 
occurs frequently throughout sub-Saharan Africa (Kew, 1992), no causal association 
between iron overload and HCC in Black Africans has previously been proved (Paterson et 
al., 1985). However, an association between the two conditions was reported in a number 
of earlier publications (Kew, 1981; Gordeuk et al., 1996; Moyo et al., 1998). Furthermore, 
in 1998 Mandishona et al. reported a statistically significant association between dietary 
iron overload and HCC, giving a relative risk for developing HCC of 10.6 and a population 
attributable risk of 29%, and suggesting a significant role for this disorder in the aetiology 
and pathogenesis of HCC (Mandishona et al., 1998).
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HCC is regarded as one of the major malignant diseases in the word today. Among the 
reasons for this are its high incidence in several of the world’s most populous regions, its 
grave prognosis, and the fact that a number of potentially preventable risk factors for the 
tumour have been identified. The peculiar geographical distribution of HCC, as well as 
time trends in its occurrence and the effects of migration on its incidence, implicated 
environmental carcinogens in the aetiology and pathogenesis of the tumour. Men are more 
likely than are women to develop HCC, and its prevalence generally increases with 
increasing age, except in black Africans where there is a shift towards younger age groups 
(Kew, 1994). Major risk factors for the tumour are persistent infection with hepatitis B or 
C viruses, repeated exposure to the mycotoxin, aflatoxin, and cirrhosis, whatever its cause. 
In addition, dietary iron overload is an important risk factor in sub-Saharan Africa. The 
risk posed by dietary iron overload should be seen in the context that most of the 
conventionally recognised toxic effects of alcohol on the liver are uncommon in Black 
Africans with dietary iron overload (the home brewed beer has an alcohol content of 3%) 
and with HCC (Friedman et al., 1990). Friedman (1990) and others have, however, found 
portal fibrosis or cirrhosis in a higher proportion of subjects with hepatocellular iron grades 
3+ or 4+ than in subjects with lower iron grades. This observation is consistent with the 
belief that iron overload is a cause or a co-factor in the development of portal fibrosis and 
cirrhosis in black Africans.
The best known of the iron loading diseases is hereditary haemochromatosis (HH). In
patients with HH an inborn error of metabolism leads to the absorption of excessive
quantities of iron from diets with normal iron content. The condition occurs predominantly
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in populations of Northern European origin. The mutant gene mainly responsible for this 
condition is closely linked to the HLA-A locus on chromosome 6. A candidate gene 
originally called HLA-H, but now renamed HFE, encodes a 343 amino acid HMC class 1 
protein, and 83% of subjects affected with HH are homozygous for two mutations in the 
gene, C282Y (substitution of tyrosine for cysteine at position 282) and H63D (the 
substitution of aspartate for histidine at position 63)(Feder et al., 1996). The C282Y 
mutation is closely related to HH, with between 83% (Feder et al., 1996) and 100% of 
clinically affected individuals being homozygous (C282Y/C282Y) for this mutation 
(Jazwinska et al., 1996). However, the implication of the H63D mutation is less clear. A 
small number of patients with HH have been identified as either compound heterozygotes 
(C282Y/H63D) or as homozygotes for H63D (H63D/H63D). H63D heterozygotes have 
hepatic iron concentrations significantly higher than control subjects, but lower than 
C282Y homozygotes. Most importantly, there is no biochemical or histological evidence 
of liver disease, and there are no clinical manifestations in the H63D heterozygotes. The 
exact mechanisms by which mutations in the HFE gene lead to increased intestinal iron 
absorption in the face of an elevated body iron content are unknown. Recent studies have 
shown that HFE associates with the transferrin receptor (TfR) and may thus play some role 
in regulating the entry of iron into cells (Anderson, 2001). This capability is lost in C282Y 
mutant HFE. Powell (2002) has speculated that the ability of intestinal crypt cells to take 
up iron from plasma transferrin (Tf) (a means of signalling the intestine of the body iron 
levels and hence body iron requirement) may be defective in HH patients. Consistent with 
this belief is the observation that the mucosal epithelium in HH contains remarkably little 
iron in comparison with patients having other forms of iron overload, despite comparable
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degrees of systemic iron loading in all of these iron loading diseases. Furthermore, in HH 
the excess iron is preferentially deposited in the hepatocytes. In contrast, iron deposition in 
dietary iron overload is in the Kupffer cells and macrophages, as well as hepatocytes.
HH is frequently complicated by HCC formation, with relative risks of between 100 and 
over 200 being calculated (Niederau et al., 1985). The longer the patient survives the more 
likely is this complication. The vast majority of patients with HH who develop HCC have 
cirrhosis, and it was originally believed that cirrhosis, and not iron per se, was the cause of 
the malignant transformation. However, about 30 patients have recently been reported to 
develop HCC in the absence of cirrhosis (Blumberg et al., 1988; Leone et al., 2000; Pellise 
et al., 2001), suggesting that excessive iron itself may be hepatocarcinogenic.
1.2 Putative mechanisms of iron-induced carcinogenesis
The putative mechanisms of iron-related carcinogenesis involve iron’s role in oxidative 
injury and in cell growth. Iron has been shown to cause lipid peroxidation (LPO) and 
oxidant stress in experimental dietary overload and patients with HH. This observation is 
supported by a growing number of studies showing increased products of LPO in the liver 
of iron-overloaded animals (Houglum et al., 1990; Paradis et al., 1997a; Marmunti et al., 
1998). The formation of sufficient reactive oxygen species (ROS) leads to an impairment 
of basic immune defences, such as antigen-specific immune responses, cytotoxic T-cell 
proliferation and function, and enhancement of suppressor T-cell activity. These alterations 
in T-cell function may lead to impaired immune surveillance against cancer.
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One possible argument against iron’s role as a carcinogen has been the few reports of 
cancers arising after iron depletion (Fracanzani et al., 2001). However, the carcinogenic 
effects of most toxins are known to occur as long as 20 years after exposure. It can 
therefore be hypothesized that the generation of ROS, lysosomal and DNA damage, or 
other mechanisms are irreversibly underway before iron depletion occurs, and that the 
eventual toxin removal does not stop what is already an inevitable process (Mallory and 
Kowdley, 2001).
Many questions about the role of iron in hepatocarcinogenesis remain to be answered. 
Moreover, laboratory evidence supporting iron’s role as a carcinogen has yet to be 
conclusively shown. The purpose of this study is to develop an animal model of dietary 
iron overload and to investigate the putative mechanisms of iron-induced HCC, including 
whether iron is directly carcinogenic or induces HCC only indirectly by causing chronic 
necroinflammatory hepatic disease in the form of cirrhosis or fibrosis.
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2.0 RESEARCH HYPOTHESIS
It is believed that iron (Fe) overloaded individuals may be susceptible to LPO, mediated by 
Fe according to the “Fenton” or “Haber-Weiss” reaction, with the resultant effect being the 
production of excessive quantities of ROS. These oxygen species induce DNA strand 
breaks and may increase the rate of DNA unwinding, with consequent mutagenic and 
carcinogenic activity.
The suggested hypothesis is that the generation of ROS as a result of Fe overload, LPO, 
oxidative DNA damage including strand breaks, unwinding, and mutagenesis, are major 
steps in the pathogenesis of Fe induced HCC.
2.1 AIMS OF THE STUDY
The aims of the study were to ascertain:
i. if HCC develops in Fe overloaded rats, and to investigate the mechanism(s) 
of this occurrence, including whether excess hepatic iron was directly or 
indirectly carcinogenic.
ii. if Fe overload leads to an increased generation of ROS and, if so, their 
involvement in hepatocarcinogenesis.
iii. the involvement of LPO and oxidative DNA damage in mutagenesis.
iv. if DNA strand breaks and DNA unwinding are part of the 
hepatocarcinogenic process.
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In order to elucidate the mechanism(s) by which dietary Fe overload causes HCC in an 
experimental animal model, the following criteria were adhered to in this study: (1) iron 
exposure leading to iron overload was planned to occur over at least half the animals life 
span, (2) the route of exposure was analogous to that in humans (i.e. per os by diet, gavage, 
water-drinking), (3) exposure was directed to the whole body rather than specific sites, and 
(4) appropriate controls were included in the experiment.
2.2 EXPERIMENTAL DESIGN
In the study, 6 groups each made up of 60 Wistar albino rats were established. The first 
group, the control group, was designated C group. Groups 2 to 6 were fed Fe as described 
below. Group 2 was designated Fe group. Group 3 (Fe + V group) received vitamins A and 
E supplementation [50 mg all trans-retinol (vitamin A) and 500 mg a-tocopherol (vitamin 
E) per kg diet], in addition to iron. Group 4 (Fe - V group) received a diet totally devoid of 
vitamins A and E (but supplemented with iron). Group 5 (Fe + ASA group) received 20 
mg acetyl salicylic acid (aspirin) per day in addition to the iron diet. Group 6 (Fe + Cu) 
received 300 mg/kg wt CuSCL for 12 months, followed by 3% copper hydroxide carbonate 
[CuC0 3*Cu(0 H)2] together with iron supplementation.
The rats were studied for 3 years. Five rats from each group were sacrificed every 4 mo for 
2 years. Thereafter, sacrifice depended on the health status of the animal. Rats were 
initially anaesthetized with 0.1 ml/100 g wt Anaket and Chinazin (4:1). Blood was sampled 
by cardiac puncture. Blood sampling was always done between 0700 hr and 0900 hr. Rats 
were then euthanased and their livers harvested under aseptic conditions. One portion of
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the liver was snap frozen in liquid nitrogen (and then stored at -70°C) and the other placed 
in 10% buffered formalin. In cases of unexpected death, the liver was harvested.
2.3 SUBJECTS AND DIET
2.3.1 Subjects
The Wistar albino rat (Rattus norvegicus) was selected for the study based on its higher 
growth and survival rate compared to the Fischer 344 and the Sprague Dawley rats (Figure
1).
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Figure 1 Growth Curves of 3 types of commonly used experimental rats (Harlan, 2000).
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Eighty female and 40 male Wistar albino rats weighing 120-140 g were crossed to raise 
360, largely male pups. Wistar albino rats received humane care in accordance with the 
guidelines of the Animal Ethics Committee of the University of the Witwatersrand. Rats 
were housed in plastic cages with stainless steel tops in the animal unit of the Medical 
School of the University of the Witwatersrand where room temperature, humidity and 
ventilation were controlled according to international standards. Animals were maintained 
at a 12-hour light-cycle. Ethical approval was obtained from the Animal Ethics Screening 
Committee of the University of the Witwatersrand for this study (AESC No. 2000/90/3 & 
AESC No. 2002/54/3). Rats were purchased from Elarlan Olac Ltd, Bicester, UK.
2.3.2 Diet
Weanling rats were fed (ad libitum) the standard chow diet (AIN-93G Formulation, 
manufactured by EPOL, South Africa), supplemented initially with 2% pentacarbonyl iron 
(Cl) according to the protocol of Plummer et al. (1997). Cl and the subsequently used 
ferrocene were obtained from Sigma (Germany). The control group (C) received the 
standard chow diet. Pups were weaned at 6 weeks and continued to receive the iron 
supplementation or control diet. Because of the relatively ineffective iron loading at 8 
months Cl was increased to 2.5%. However, hepatic Fe loading was still poor at 12 months 
and the 2.5% Cl supplementation was finally replaced with 0.5% dicyclopentadienyl iron 
(ferrocene) at this point.
2.3.2.1 Cl
Cl (C9Fe2C>9) is commonly referred to as iron powder. It is manufactured using the
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carbonyl decomposition process, with the resultant iron appearing as uniform microscopic 
spheres with only traces of carbon, oxygen and nitrogen. Cl is of high purity with superior 
electromagnetic properties. Typically, Cl is used as a catalyst, radar absorbing material, 
precision electronic component, animal feed, multivitamin complexes and iron 
supplements.
2.3.2.1 Ferrocene
Ferrocene was first synthesized in 1951. The sandwich structure of ferrocene (shown 
below) was first predicted from its image resonance (IR) and nuclear magnetic resonance 
(NMR), and confirmed by X-ray crystallography.
The uses of ferrocene range from being a biochemical and analytical chemical to other 
industrial applications such as diesel oil improvement, gasoline anti-knocking agent, 
fertilizers etc. It is also used as an ingredient of antibiotics and blood tonic preparations 
(Madinaveitta, 1965) and for anticancer treatment [investigated in animals (Kovjazin et al., 
2003)]. Furthermore, some ferrocene analogues have been postulated to totally restore the 
activity of chloroquine against chloroquine-resistant parasites (Domarle et al., 1998). 
Finally, its potential use in human anti-malarial therapy has also been investigated 
(Domarle et al., 1998). Twelve types of novel ferrocenyl sugars with anti-malaria 
properties towards P. falciparum and anti-cancer properties in mouse cancer cell FM3A 
have been synthesized (Itoh et al., 2000).
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Ferrocene metabolism
The mechanisms present in the intestine which regulate the absorption of iron are 
apparently arranged to deal only with ions of this metal. They fail to operate when 
presented with compounds containing ferrocene nucleus from which the iron cannot be 
ionized without disrupting the very stable molecule. The physical and chemical properties 
of ferrocene are more akin to those of aromatic hydrocarbons, such as benzene and 
naphthalene, than to those of ion salts, however chelated these salts may be. This is 
reflected in the behaviour of the ferrocenes in the animal body. Like the lower 
homologues of benzene, the ferrocenes with small aliphatic substitutes are well absorbed 
when given by mouth. The higher homologues of ferrocene, like those of benzene, fail to 
be absorbed (Madinaveitia, 1965). Once ferrocenes are absorbed in the body they continue 
to behave as benzoid compounds. Like benzoic acid and benzene sulphonic acids, the 
sulphonated ferrocenes and the ferrocene carboxylic acids are eliminated in the urine, 
presumably un-degraded, though perhaps conjugated. The mechanisms present in the 
kidney which normally prevent iron passing into the urine do not recognise the metal as 
such when it is presented to them as a ferrocene derivative (Madinaveitia, 1965).
The fate of the absorbed iron has been examined in detail in ferrocene itself, and in some 
less-toxic and well absorbed ferrocarbnons, especially in dineopentyl ferrocene 
(Madinaveitia, 1965). In mice and rats the yellow ferrocenes could be seen in the stomach 
and duodenum during the first few hours after ingestion. The intestine was stained yellow 
until just below the point at which it is joined to the bile duct. This may indicate that, like 
many other water-insoluble substances, the ferrocenes are absorbed with the help of the
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bile acids. Ferrocene was not present in the bile of guinea-pigs dosed with dineopentyl 
ferrocene.
Toxicity of ferrocenes
The toxicity of ferrocenes is of a different type from that of iron salts, and it is thought to 
be the result of the ferrocene nucleus and not to the iron they contain. The toxicity of some 
ferrocenes to mice increased when they were given by mouth as solutions in oils. These 
ferrocenes are yellow compounds in fat. The fat of mice that received a single dose of 
dineopentyl ferrocene corresponding to lg/kg of iron was discoloured. The benzene 
extractable iron of the homogenized carcass of the animals increased reaching a maximum 
of 2.3 mg of iron per 20 g mouse the day after dosing and then decreased. The toxicity of 
dineopentyl and probably of other ferrocenes also depends both on the amount of fat and 
ferrocene given. The mechanism by which the fats increase the toxicity of ferrocenes has 
not been elucidated. Animals receiving lethal doses of water-soluble ferrocenes die in 
convulsions after dosing. It is possible that some insoluble ferrocenes are metabolised to 
toxic water-soluble compounds still containing the intact ferrocene nucleus. Water- 
insoluble ferrocenes act more slowly, but with similar symptoms (Madinaveitia, 1965).
Mutagenicity and genotoxicity of ferrocene
Ferrocene was negative in a bacterial mutation assay (pre-incubation), using S. 
typhimurium strains TA98, TA100, TA1535, and TA1537 with and without metabolic 
activation systems from induced rat and hamster livers (Haworth S et al., 1983). It was also 
negative for the plate incorporation test using S. typhimurium strains TA 97, TA98,
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TA100, TA102, TA1535, TA 1537 and TA1538 (Dunkel et al., 1999). Ferrocene was 
further found to be negative in a sex-linked recessive lethal D. melanogaster assay after 
feeding (Zimmering et al., 1985). In a mouse lymphoma L5178Y TK +/' mutation assay in 
the presence of liver S9 mix, ferrocene was found negative (Dunkel et al., 1999). Lastly, 
ferrocene was negative for a chromosome aberration assay using Chinese Hamster ovary 
(CHO)(GaIloway et al., 1985). However, ferrocene was positive in the following assays: 
(a) a sex-linked recessive lethal assay in D. melanogaster after injection (Zimmering et al., 
1985), (b) a heritable translocation assay in D. melanogaster after injection (Zimmering et 
al., 1985), (c) a mouse lymphoma L5178Y TK +/' mutation assay in the absence of liver S9 
mix (Dunkel et al., 1999 and (d) a sister chromatid exchange (SCE) assay in CHO cells, 
with and without metabolic activation (Galloway et al., 1985). No data from genotoxicity 
studies in intact mammals has been found.
Yeary et al. (1969) showed that oral doses of 300 and 1000 mg/kg b.wt for 3 months 
resulted in a high level of haemosiderosis in dogs. However, cirrhosis observed in dogs, 
was considered by the authors to be the effect of the hydrocarbon moiety. Cirrhosis has so 
far not been reported in any rat study using ferrocene.
Nielsen and Heinrich (1993) studied the metabolism of 3,5,5-trimethylhaxanoyl-ferrocene 
(TMH-ferrocene), an analogue of ferrocene, in experimental rats. The bioavailability of 
iron from TMH-ferrocene (48% whole body retention from a 5mg Fe dose) was twice as 
high as ferrocene and 6 times higher than (TMH)2-ferrocene and ferrous sulphate. In 
contrast to well-known iron salts, the intestinal absorption of TMH-ferrocene iron was
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independent of the dose (1 or 5 mg Fe) and similar in iron deficient and iron-loaded rats, 
indicating that the body’s iron stores do not regulate the intestinal absorption of TMH- 
ferrocene. After intestinal absorption, TMH-ferrocene iron in the portal blood is 
transported to the liver independently from transferrin. The iron is released from the 
hydrocarbon moiety within the liver. Depending on the body’s iron stores, TMH-ferrocene 
iron is then incorporated preferentially into haemoglobin (iron-deficient state) or added to 
iron stores in the liver. A transient storage of ferrocene iron in fat tissues has been 
observed after oral administration of ferrocene but not TMH-ferrocene. As a result of the 
high bioavailability of ferrocene, chronic feeding of this compound results in a rapid and 
progressive iron overloading in rats. For example Nielsen et al. (1993) obtained hepatic 
iron of 16.9 mg/g w.w after 10 weeks of feeding rats a diet containing 0.5% TMH- 
ferrocene.
The biochemical and the biophysical properties of ferrocene were investigated by Ward et 
al. (1991) using experimental animals. Male Wistar rats were fed a chow diet with total 
iron intake of 5 mg/day for 6 weeks. High hepatic iron was predominantly located in the 
lysosomes. Hepatic iron loading was 7.24 + 1.97 mg Fe/g tissue. Ferritin and haemosiderin 
were isolated from the livers of the ferrocene-loaded rats and their iron stores consisted 
mainly of ferrihydrite. Free-radical-mediated damage in the iron-loaded livers was inferred 
from the significant depletion of a-tocopherol in both the livers and subcellular hepatic
lysosomal fraction, which inversely correlated with the increasing iron content and was 
associated with increased fragility of the lysosomal membranes. In addition, male
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C57BL/61bg mice fed a diet containing 0.04-0.2% w/w ferrocene (less than half the 
amount used in the present study) for 115 days developed severe hepatic siderosis 
accompanied by a 15-fold induction of non-haem iron content, compared with control mice 
receiving a diet with normal amounts of iron. The ferrocene treatment led to significant 
increases in hepatocellular necrosis as measured by plasma alanine aminotransferase 
(ALT) levels. Histological assessment of hepatic fibrosis revealed mild increases in 
collagen deposition localized with accumulations of hemosiderin, primarily in centrilobular 
hepatocytes. Hepatic fibrosis was confirmed by measurement of hepatic hydroxyproline 
content that was increased 4-fold in ferrocene-fed mice compared to the controls. Hepatic 
siderosis was accompanied by significant increases in hepatic malondialdehyde (MDA) 
content, suggesting the ferrocene-induced iron burden initiated LPO in vivo (Valerio and 
Petersen, 2000).
Dullman et al. (1992) fed female Wistar rats with 0.5%TMH-ferrocene for 56 weeks. First 
signs of liver damage, such as necrosis of single hepatocytes and mild fibrosis, began at a 
liver iron concentration of 14.7 + 1.4 mg/g w.w. With increasing iron loading, focal 
necrosis of hepatocytes and iron-burdened macrophages occurred, and significant 
perisinusoidal as well as portal fibrosis developed. Cirrhosis could not be induced in this 
animal model, however. In the present study 0.5% ferrocene was added to the chow diet. 
This corresponds to 39 mg Fe per day (calculated on an average of 20 g chow diet 
consumption per rat) and is well below the LD5o value of 440mg. In addition, ferrocene has 
88.7% absorption and 27.4% whole body retention (Nielsen and Heinrich, 1993).
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2.4 METHODS
A battery of assays was employed to cover iron overload, ROS, antioxidants, LPO, DNA 
changes, liver disease, tumour markers and HCC. Methods are outlined below.
SER U M  IRON  
HISTOLOGICAL GRADING  
LIVER IRON CONTENT ( LIC)
SUPERO XIDE  FREE RADICAL f 0 2)
TOTAL ANTIOXIDANT STATUS (TAS)
GLUTATHIONE PERO X IDASE  (GPx)
SUPERO XIDE  D ISM U TASE ( SOD)
CATALASE
OXYGEN RAD ICAL A B SO R B A N C E  CAPACITY (ORAC)
MALONDIALDEHYDE (MDA)
FOX II A SSA Y  FOR LIPID HYDROPEROXIDES
4-HYDROXYNONENAL (4-HNE) 
IMMUNOHISTOCHEMISTRY
8-HYDROXYDEOXYGUANOSINE (80HdG) 
IMM UNOHISTOCHEMISTRY
LIVER 80HdG
FLUORIMETRIC ANALYS IS  OF DNA UNWINDING
(FADU)
A M ES  MUTAGENICITY TEST
PULSED  FIELD GEL ELECTRO PH O RESIS  (PFGE)
COMM ET A SSA Y
ASPARTATE A M IN O TRA N SFERASE(AST )
ALANINE AM IN O TRA N SFERASE  (ALT)
ALPHA FETO PROTEIN (AFP)
LIVER HISTOLOGY
Figure 2 METHODS USED FOR THIS STUDY
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3.0 TRACE ELEMENTS
Trace elements are those that occur in human and animal tissues in milligram per kilogram 
amounts. Similarly, requirement is expressed in milligrams per day. An element is 
considered essential when a deficiency produces impairment of function and when 
restoration of physiological amounts of that element alone prevents or alleviates the 
impairment. In absolute deficiency, death occurs. In excess, a marginal toxic response 
occurs, followed in severe instances by a fatal toxic response. Biochemical functions of 
iron and other trace metals and signs of deficiencies in humans are known.
3.1 CHARACTERISTICS OF IRON AND COPPER IN TRACE ELEMENT 
FUNCTION
Four main characteristics of trace element function are well understood. These are: 
specificity, homeostasis, interactions and amplification.
3.1.1 Specificity
Trace elements are essential and specific in their functions in vivo. They cannot be 
replaced by chemically similar elements. The essential trace elements interact with electron 
donor atoms such as nitrogen, sulphur, and oxygen, the types of interaction depending on 
bond types and configurational preferences. Certain trace elements (e.g., Fe, Cu, Mo) are 
stable in more than one valance state, which allows for biological oxidation-reduction 
functions, whereas others (e.g., Zn"‘) are stable in a single state only, which allows for 
more of a conformation or substrate-binding role (Stadtman, 1990).
18
Chapter 3: Trace Elements
3.1.2 Homeostasis
Mechanisms that ensure optimal body distribution of an element over a range of intakes 
constitute a system of homeostatic regulation of the element. The amount of trace element 
absorbed generally decreases with increasing concentration in the intestinal lumen and 
associated tissues. Active transport mechanisms involving absorption by specific metal 
binders and feedback inhibition have been postulated for iron, zinc and copper (Pena et al., 
1999).
The principal excretory route for elimination of most trace metals is in the faeces. Faecal 
excretion reflects dietary intake, homeostatic regulatory mechanisms, gastrointestinal 
absorption and endogenous metal secretion into the intestines. Relatively small amounts of 
trace metals are excreted through urine. Other minor routes include loss through hair, nails, 
skin cell desquamation and sweat. Menstrual iron loss and seminal zinc loss are also minor 
but can be significant in certain circumstances.
3.1.3 Interactions
A high concentration of one trace element can interfere with the metabolism of other trace 
elements present in normal or marginal amounts. Alternatively, the effect of a toxic trace 
element may be ameliorated by another "protective" trace element. Large amounts of zinc 
in diet interfere with intestinal Cu absorption, and result in Cu deficiency despite otherwise 
adequate Cu intake. Cu deficiency, in turn, is known to provoke iron deficiency and 
anaemia (Owen, 1973).
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3.1.4 Amplification
Very small amounts of trace elements are required for optimal performance of the whole 
organism. The absence of small amounts of trace elements (e.g., Fe) can result in overt 
clinical abnormalities (e.g., anaemia). The basis of this amplification of trace element 
action is that trace elements are constituents of, or interact with, enzymes and hormones 
that regulate the metabolism of much larger amounts of biochemical substrates.
3.2 FUNCTIONS AND METABOLISM OF IRON (Fe)
Fe, the most important essential trace element, represents 55 and 45 mg/kg of the body 
weight in adult healthy men and women, respectively. Normally about 60-70% of total 
body Fe is present in haemoglobin in circulating erythrocytes. Myoglobin, cytochrome, 
and other Fe-containing enzymes comprise a further 10%, and the remaining 20-30% is 
stored as ferritin. Although Fe bound to transferrin (Tf) is less than 0.1% (~ 3mg) of the 
total body Fe, it is dynamically the most important Fe pool with the highest rate of 
turnover (Finch et al., 1982). The metabolism of Fe resembles in many aspects that of 
other trace elements. Normally, very small quantities are present in most cells of the body, 
in plasma, or in other extracellular fluids. The body rigorously conserves its Fe stores.
Figure 3 illustrates the pathways of Fe metabolism and the daily rates of exchange between 
the various Fe compartments. Approximately 2.5g of Fe are contained within erythrocytes 
(RBCs) or their precursors in the bone marrow. A plasma Fe transport protein called 
apotransferrin, which has two Fe-binding sites per molecule, accomplishes transport of Fe 
from one organ to another. Each of these sites can bind one Fe3+ together with one ion of
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HCO3 '. The apotransferrin-Fe3+ complex is called Tf. Approximately 2.5 mg of Fe are 
normally present in plasma.
Figure 3 Pathway o f iron metabolism showing sites where HFE may play a role. 
The basic components o f iron influx and efflux are shown in intestinal, erythroid, 
reticuloendothelial (RE), and parenchymal cells. Tf, transferrin; Cp, ceruloplasmin; 
Fe, iron; Heph, hephaestin; FT, ferritin; Hb, haemoglobin; HC, haemochromatosis. 
(Anderson and Powell, 2000).
A major pathophysiological feature o f haemochromatosis is an increase in intestinal iron 
absorption. It is predicted that mutations in genes important for intestinal iron transit would 
ameliorate the haemochromatosis phenotype. This is indeed the case, and HFE  knockout 
mice carrying mutations in the gene for the brush border iron transporter DMT1 show 
reduced levels o f hepatic iron accumulation. DMT1 is the major molecule facilitating the
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uptake of dietary iron by the epithelial cells of the proximal small intestine (Figure 
3)(Fleming et al., 1997). Mice defective in DMT1 (mk) have a profound microcytic, 
hypochromic anaemia. The demonstration by Levy and colleagues (Levy et al., 2000) that 
deletion of the HFE gene cannot correct the mk phenotype shows that DMT1 is the major 
route of entry into intestinal epithelial cells in haemochromatosis.
The intestinal epithelial cell is a polarized cell and iron must traverse not only the apical 
membrane but the basolateral membrane as well. Insight into this iron efflux step, have 
come from the cloning of the gene mutant in sla mice (Vulpe et al., 1999), another mouse 
strain with an inherited anaemia. The affected gene has been named Hephaestin and it 
bears significant homology to the copper-containing plasma protein ceruloplasmin, which 
has been known to play a role in iron release from tissues. HFE knockout mice carrying 
the sla mutation show considerably reduced hepatic iron levels, indicating that hephaestin 
plays an important role in iron loading. However, since the block of absorption is not 
complete, alternative basolateral iron transfer pathways appear to be operating. It would be 
expected that disruption of the newly identified basolateral iron transporter IREG1 (or 
ferroprotein 1) (McKie et al., 2000) would also ameliorate the iron overloading phenotype 
of HFE knockout mice (Anderson and Powell, 2000).
Ferritin is the major Fe storage compound. It is a spherical molecule consisting of an 
apoferritin shell and an interior ferric oxyhydroxide (FeOOH)x crystalline core. The 
apoferritin shell is composed of 24 subunits or monomers. Pores on the surface permit 
ingress and egress of molecules such as Fe2+, ascorbic acid, and flavin mononucleotide.
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The FeOOH core crystal may contain as many as 4000 Fe atoms, although it usually 
contains 2000 or less. Release of Fe from ferritin is probably non-enzymatic and may 
involve rapid reduction by reduced flavin mononucleotide or other reducing substances. 
The resultant Fe2+ leaves the crystal and diffuses out through a pore of the ferritin shell. 
Thus, ferritin is both a very efficient Fe trap and a readily available source of Fe for 
metabolic requirements.
Ferritin is found in nearly all cells of the body. In hepatocytes and in the macrophage 
system of the bone marrow and other organs, ferritin provides a reserve of Fe readily 
available for the formation of haemoglobin and other haem proteins. In healthy men, the 
total body content of stored Fe, mostly as ferritin, is approximately 800mg; in healthy 
women it ranges from 0-200mg. Minute quantities of ferritin are also present in serum in 
concentrations proportional to the total body stored Fe. Liver injury results in release of 
relatively large amounts of ferritin into plasma.
Haemosiderin, the other form of stored Fe, is aggregated, partially deproteinized ferritin. In 
contrast to ferritin, haemosiderin is insoluble in aqueous solutions. Fe is only slowly 
released from haemosiderin. Like ferritin, haemosiderin normally is found predominantly 
in cells of liver, spleen, and bone marrow. Tissue Fe normally amounts to approximately 8 
mg. Tissue Fe diminishes early in the course of Fe deficiency. Numerous cellular enzymes 
and coenzymes require Fe, either as an integral part of the molecular structure or as a co­
factor.
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3.2.1 Physiology
A well balanced diet provides 10-15 mg of Fe daily, mostly in the form of haemoglobin 
and myoglobin in meat. About 1 mg of Fe is absorbed each day. Absorption occurs 
principally in the duodenum. Haem is absorbed directly; inorganic Fe is absorbed in the 
ferrous state.
Both ferritin and Tf are present in the absorptive cells of the intestinal mucosa, and it is 
believed that they operate to regulate Fe absorption. When body Fe stores are high, the 
ferritin content of mucosal epithelium is also high and the Tf content is low. Fe that enters 
mucosal cells is trapped in ferritin and lost when the mucosa cell is sloughed into the 
intestinal lumen. This mechanism reduces Fe absorption when body stores of Fe are 
already increased. Conversely, with Fe deficiency, the mucosal cell content of apoferritin 
is diminished, the Tf (and apotransferrin) content is increased, and Fe absorption is 
accelerated.
The major pathway of Fe metabolism (Figure 3) is a virtually closed cycle in which Fe 
passes from the plasma Tf to the RBC precursors in the bone marrow, where it is 
incorporated into haemoglobin. These cells then enter the circulation as mature RBCs, 
where they remain for about 120 days before they are metabolically "worn out" and are 
engulfed by phagocytes, particularly in the spleen. The Fe is released from the 
haemoglobin and returns to the plasma Tf, thus completing one cycle and beginning 
another.
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Each day about 1-2 mg of Fe absorbed from the intestinal tract enters this cycle to 
compensate for the 1-2 mg of Fe lost each day from the body. With each menstrual cycle 
women lose about 40 - 80 ml of blood, which is equivalent to 20 - 40 mg of Fe. This loss 
must be made up by increased absorption of Fe by intestinal mucosa. Similarly, about 600- 
900 mg of Fe is lost as a consequence of each pregnancy.
3.2.2 Fe acquisition, transport and storage
Because of Fe’s virtual insolubility and potential toxicity under physiological conditions, 
specialized molecules for the acquisition, transport and storage of Fe in a soluble, nontoxic 
forms have evolved to meet the cellular and organismal Fe requirements. Thus, under 
normal circumstances these physiological Fe-complexing agents leave body fluids and 
cells with extremely low concentrations of "free Fe". Nevertheless, the existence of a short­
lived Fe-containing intermediate within the cell is a possibility. Although the nature of this 
intermediate pool of chelatable or transient Fe remains elusive, the size of this pool is 
maintained by sophisticated control mechanisms that co-ordinately regulate cellular Fe 
uptake and storage.
In vertebrates Fe is transported within the body between sites of absorption, storage and 
use by the plasma glycoprotein, Tf, which binds Fe tightly but reversibly. Tf is recognised 
by specific cell membrane receptors that are crucial for cellular Fe acquisition. After its 
intracellular release from Tf-receptor complexes, Fe enters functional compartments or is 
stored in ferritin. The daily turnover of Tf Fe is of the order of 30 mg. Normally about 
80% of this Fe is transported to the bone marrow in humans (and also to the spleen in
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rodents), for haemoglobin synthesis, in developing erythroid cells (Figure 3). From these 
sites, reticulocytes are released into the circulation where, within 24 hrs, they lose Tf 
receptors, mitochondria, ribosomes, and all the other components of haemoglobin 
synthesis and develop into mature erythrocytes that circulate in the blood for about 120 
days (in humans). Senescent erythrocytes are phagocytized by the cells of the monocyte- 
macrophage (reticuloendothelial) system, where the haem moiety is split from 
haemoglobin and catabolized. The liberated Fe is released back to plasma Tf at a rate that 
normally matches the rate of Fe transport for erythropoiesis. Although this well-maintained 
dynamic equilibrium of Tf Fe is reasonably well understood, all of the mechanisms and 
controls involved in the release of Fe from reticuloendothelial cells have not been defined. 
The remaining 5 mg of the daily plasma Fe turnover is exchanged with the nonerythroid 
tissue i.e. the liver. About 1 mg of dietary Fe is absorbed per 24 hrs and net organismal Fe 
balance is maintained by a daily loss of approximately 1 mg through nonspecific 
mechanisms (mostly cell desquamation). In summary, there are two important features of 
organismal Fe metabolism. First, Fe turnover is virtually an internal event in the body; and 
second, most of the Fe turnover is used for the synthesis of haem by erythroid cell.
3.2.3 Iron Overload
Traditionally, haemosiderosis indicated Fe overload without overt associated tissue injury 
and haemochromatosis implied Fe overload with injury to involved organs as manifested 
by cellular degradation and fibrosis. In current usage, however, haemochromatosis is a 
generic term for Fe overload, irrespective of evidence of tissue injury. Fe overload most 
commonly results from chronic excessive absorption of Fe from diet. HH is a disorder of
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Fe overload as a result of an inborn error of Fe metabolism. The precise mechanism is 
unknown. Iron overload is rarely the result of repeated blood transfusions or protracted 
ingestion of Fe supplements. Sideroblastic anaemia is a group of Fe-loading disorders of 
unknown cause. In a hereditary type of this disorder, there is deficiency of 8-amino- 
levulinic acid synthetase in RBC precursors. Fe accumulates in mitochondria because of 
this metabolic bottleneck.
3.2.3.1 Fe overload in experimental animals
The development of methods for producing Fe overload in rats has provided a valuable 
tool for the investigation of the role of Fe in disease processes, such as hepatic fibrosis and 
cirrhosis (Roberts et al., 1993; Mackinnon et al., 1995). One of the simplest of these 
methods is the addition of Cl to the diet (Bacon et al., 1983; Pietrangelo et al., 1990; 
Britton et al, 1990; Britton et al., 1994; Tector et al., 1995). Effective Fe loading is 
achieved quickly by adding 3% Cl to the diet of mother rats shortly after they give birth, 
and to the diet of the offspring after weaning. By the age of 10 weeks, offspring have Fe 
deposition in 75 - 100 % of hepatocytes (grade III -IV siderosis). However, during the 
loading period rats suffer from diarrhoea and their growth rate is severely retarded, so that 
at age 10 weeks they weigh approximately 35% less than controls. Various modifications 
of the feeding regimen have been used, such as addition of 2% or 2.5% Cl to the diet, or 
addition of 3% for the first month, then reducing this to 2.5%. However, there are no 
published reports demonstrating any advantages of one regimen over another.
In a study by Plummer et al. (1997), four pregnant Porton rats were assigned to receive
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0, 0.5, 1.0, or 2.0% by weight of Cl. The allocated diets were commenced 2 days after the 
rats gave birth, thereby initiating Fe supplementation to the offspring via breast milk. 
When the offspring were 3 weeks old, they were separated from their mothers and caged 
according to sex. They continued to receive the Fe supplementation until they were 32 
weeks old. At weeks 8, 16, 24, and 32, liver biopsies were performed on all rats. Rats not 
receiving supplementation showed only a small (approx. 2 fold) increase in hepatic Fe 
content from the age of 8-32 weeks, and none of the livers showed excess stainable Fe. 
Male rats tend to reach a plateau of hepatic Fe content by 8-16 weeks, whereas female rats 
continued to load over the whole 32 weeks period. Females had a higher hepatic Fe content 
than males by a factor of 2.8. Fe loading scores in the biopsies taken suggested that rats 
tend to reach their maximum loading by 16 weeks. No fibrosis was apparent in any of the 
livers. At the highest dose of Fe, the weight of female rats was lower by an average of 
14%, and of males by 19%, compared with the corresponding controls. The researchers 
were of the opinion that levels of 2% Cl in the diet gives grade III-IV Fe loading, while 
having only a moderate effect on growth rate. The gastrointestinal toxicity of Fe is 
presumably less with 2% dietary Fe than with 3%, which caused a greater degree of growth 
retardation. In conclusion, 2% Cl supplementation was suitable for maximum Fe loading 
within 16-32 weeks with little adverse effects.
rload at the ultrastructural level
load is examined at the ultrastructural level, Fe-loaded cells have abundant 
lysosomes that contain Fe stored in the form of ferritin and haemosiderin 
994). Peters and co-workers (Peters et al., 1976; Seymour et al., 1978) have
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proposed that Fe overload results in an acquired lysosomal storage disease. The 
accumulation of Fe in lysosomes increases their fragility and damages the cell. These 
investigators observed that the activities of several lysosomal enzymes, including N-acetyl- 
glucosaminidase (NAGA) and acid phosphatase (ACP), are increased in liver biopsies of 
patients with Fe-overload (Peters et al., 1976). These increases may result from lysosomal 
proliferation and distension (Peters et al., 1985). When lysosomal fragility was determined 
in homogenates of these biopsies, there was a reduction in latent (membrane-enclosed) 
NAGA activity without a change in latent ACP activity, suggesting that there may be two 
populations of lysosomes in the Fe-loaded livers: one population rich in NAGA, which 
becomes more fragile, and the other rich in ACP, which is relatively unaffected. In patients 
with HH who had their Fe stores normalized by phlebotomy, the NAGA latency returned 
to normal, indicating that the increased lysosomal fragility was Fe-dependent (Seymour et 
al., 1978). Although it is not known if the lysosomal fragility observed in vitro reflects the 
situation in vivo, suggestive evidence is provided by a study in thalassaemic patients in 
which elevated serum NAGA levels were correlated with the degree of Fe overload (as 
assessed by serum ferritin levels) (Frigerio et al., 1984). Stal et al. (1990) performed 
ultrastructural studies on liver biopsies from patients with HH and observed that the 
lysosomal volume density in hepatocytes is increased and is correlated with the degree of 
Fe overload. Lysosomal volume density normalized following Fe removal by phlebotomy.
One mechanism that may contribute to the increased lysosomal fragility found in Fe 
overload is LPO. It has been shown that ferritin, and especially haemosiderin, are increased 
in liver biopsies from patients with Fe overload (about 10- to 100-fold, respectively) (O’ 
Connell et al., 1986).
29
Chapter 3: Trace Elements
Both ferritin and haemosiderin can stimulate LPO in vitro at acidic pH without the need for 
a reducing element (O’ Connell et al., 1985). Since lysosomes are an acid organelle 
compartment, it is possible that intra-lysosomal LPO initiated by ferritin occurs in Fe 
overload. Haemosiderin is about 20% as potent as ferritin in stimulating LPO in vitro. On 
this basis, it has been suggested that conversion of ferritin to haemosiderin may have a 
relatively cytoprotective effect by reducing the ability of Fe to stimulate LPO (O’ Connell 
et al., 1986). However, in Fe overload, because the total amount of haemosiderin increases 
disproportionately, its potential role in toxicity cannot be ruled out.
Myers et al. (1991) studied the structure, physicochemical properties, and pH of hepatic 
lysosomes in rats with dietary Fe overload (Figure 4). Lysosomal Fe content was increased 
drastically, and the lysosomes were enlarged, and more fragile. Lysosomal membrane from 
the Fe-loaded group had evidence of increased LPO [measured as thiobarbituric acid 
reactive substance (TBARs)], and their fluidity was decreased. It was concluded that iron- 
catalyzed peroxidation of lysosomal membrane lipids is likely the mechanism of these 
structural, physicochemical, and functional disturbances.
t fragility 
+ volume 
i  pH
T fluidity
i lipid peroxidation
Figure 4. Changes in hepatic lysosomes after iron or copper overload
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3.3 TRANSFERRIN (Tf)
Plasma Tf belongs to a family of related Fe-binding proteins including lactoferrin (Lf), 
which is found both intracellularly and in secretions such as milk, tears, and semen. These 
proteins have a molecular weight of 80 kDa and share a high degree of sequence 
homology. Tf functions to transport Fe between sites of absorption, storage and use. 
Immature erythroid cells are major consumers of Tf-Fe. The membrane-bound Tf 
homologue, melanotransferrin, can transport Fe ‘complexed’ to low-molecular-weight 
ligands into the cell (Beer et al., 1997). The physiological relevance of this process is 
unknown. Although Tf has bacteriostatic activity (Linder and Hazegh-Azam, 1996), the 
physiological significance of this antibacterial activity is unclear.
3.3.1 Molecular properties
The Tfs are monometric glycoproteins (~ 6% carbohydrate) consisting of two homologous 
domains, each of which contains one high-affinity Fe(III)-binding site. Although the 
carbohydrate moiety does not seem to be required for Tf function, a partial loss of terminal 
sialic residues is a distinctive finding in alcoholism. Tf binds two atoms of Fe(III) with 
high affinity. The binding of Tf to Fe is a pH dependent process, a property that is involved 
in the physiological mechanism of Fe release from the protein. X-ray crystallographic 
studies of both human Lf and rabbit Tf indicate that the Fe atom is surrounded by four 
protein ligands, the phenolate oxygen of two tyrosine residues, an imidazole nitrogen of a 
histidine residue, and a carboxylate oxygen of an aspartic acid residue. These protein 
ligands occupy four of the six octahedral sites around each Fe atom, leaving two cis 
positions to be filled by water and or an anion (Borjigin et al., 1999).
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The anion is bicarbonate and is bound in a bidentate mode, occupying a pocket between 
the Fe atom, an arginine side chain, and the N-terminus of helix 5 (Bull et al., 1993a). 
Serum Tf is a bilobular molecule (Casareno et al., 1998), the two lobes having a high 
degree of internal homology. These bilobular molecules have one Fe-binding site per lobe 
and a pseudo two-fold axis linking the two lobes of the molecule. A similar folding pattern 
is observed in each lobe, consistent with duplication of a primordial gene coding for a 40 
kDa monoferric Tf. Binding and release of Fe by Tf are accompanied by dramatic 
conformational changes in the protein. In the absence of Fe, the two domains involved in 
binding are widely separated and assume an "open" configuration. On the other hand, 
insertion of Fe brings the two domains of the binding cleft close towards the metal, and Tf 
assumes a "closed" configurational state.
Although it has long been believed that the two Fe binding sites of Tf are equivalent and 
independent, this is not the case. Electron spin resonance and absorption spectroscopy 
studies comparing the two binding sites of the N- and C- terminal domains provide 
convincing evidence that the two sites are not identical. Furthermore, the two sites exhibit 
differences with respect to the effect of pH on the stability of Fe binding and their affinity 
for Fe at a constant pH. Fe binding to the site in the N-terminal domain is both more acid- 
labile and of a lower affinity than the binding to the site in the C-terminal domain 
(association constants of 6.8 x 1019 and 4 x 1020, respectively, for the 2 sites of human Tf at 
pH 7.4). Tf in plasma is only about 30% saturated with Fe. It is therefore predicted from 
the thermodynamics and kinetics of Fe binding that all four species of Tf will be present 
i.e. Fe-free apotransferrin, fully saturated diferric Tf, and the two monoferric Tfs
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containing Fe in either the N-terminal or C-terminal domain binding sites. Chelly et al. 
(1993) found that all four species of Tf in normal human serum elicit a redistribution of 
iron to the C-terminal site, suggesting that a low molecular weight serum substance causes 
the preferential binding of Fe to the N-terminal site. There is no evidence that would 
suggest a functional significance for the difference in the two Fe binding sites of Tf or for 
the distribution of Fe between the sites in normal human plasma. Reticulocytes and 
hepatocytes in vitro remove Fe equally well from either of the Tf Fe-binding sites.
3.4 METAL-INDUCED TOXICITY
The liver is an important organ of Fe and Cu deposition in overload conditions, and 
elevated hepatic concentrations of these metals can result in hepatocellular injury. Two 
main hypotheses have been postulated: the oxidative injury hypothesis and the lysosomal 
injury hypothesis. A third hypothesis involving lipocytes activation and cytokine 
expression has recently evolved (Arezzini et al., 2003).
3.5 THE OXIDATIVE INJURY HYPOTHESIS
The oxidative injury hypothesis postulates that Fe and Cu overload can result in the 
formation of oxyradicals in the liver, with resultant damage to cellular constituents and 
impairment of hepatocellular function.
3.5.1 Oxyradicals formation by Fe and Cu
Abundant evidence now exists from in vitro experiments that both Fe and Cu can, when 
these metals are available in a redox-active form, catalyze the production of oxyradicals
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(Halliwell et al., 1989). Two important radicals that can result from these reactions are 
lipid radicals and *OH. One type of reaction promoted by Fe and Cu that leads to the 
formation of lipid radicals is the decomposition of preformed lipid hydroperoxides 
(LOOH). Ferrous (Fe2+) ions or cuprous (Cu+) ions can react with LOOH to form alkoxyl 
radicals (LOO*). Details of this are discussed under the section on ROS. However, the net 
reaction is:
Mn + h 2o 2 ----- > M(n+1) + ’OH
1Xo+
M(n+1) + “*o2 ----- > M n + o2
H20 2 + ~'o2 ----- > ’OH + OH- + 0 2
M  catalyst
* Where Mn is a transition metal i.e. Fe or Cu.
Spin-trapping experiments have confirmed that *OH radicals are produced in the livers of 
experimental animals after administration of Fe or Cu (Burkitt et al., 1991; Kadiiska et al., 
1992; Kadiiska et al., 1995). The ’OH is extremely reactive and can attack many cell 
constituents, including lipids, nucleic acids, carbohydrates and proteins. Furthermore, the 
polyunsaturated fatty acids (PUFAs) of membrane phospholipids are particularly 
susceptible to oxidative attack.
3.5.2 Fe and Cu in LPO and oxidative stress
After the initiation of LPO by *OH, a number of by-products, including conjugated dienes, 
LOOH, thiobabituric acid-reactants (TBA-reactants), malondialdehyde (MDA), and 
4-hydroxynonenal (HNE) are formed. MDA and HNE, which are reactive aldehydes, can 
react with proteins and the resulting adducts then serve as markers of LPO. In recent times
34
Chapter 3: Trace Elements
isoprostanes have been recognized as suitable markers of oxidative stress (Delanty et al., 
1996; Reilly et al., 1997). High concentrations of the metals in the liver seem to be 
required to produce LPO, suggesting that the normal storage and excretion pathways have 
to be overwhelmed before Fe or Cu is available to catalyze oxyradical production.
Although oxyradicals have the potential to cause damage to lipids, proteins, carbohydrates, 
and DNA, cells contain protective mechanisms in the form of antioxidants (including 
vitamins), scavenging enzymes, and repair processes that counteract the effects of 
oxyradical production. The net effect of this cellular function depends on the balance 
between radical production and cytoprotective agent response.
3.6 SUBCELLULAR ORGANELLE DAMAGE
3.6.1 Lysosomal Injury Hypothesis
Accumulation of Fe and Cu in lysosomes is a common feature of Fe and Cu overload. It is 
generally considered that sequestration of Fe or Cu within lysosomes serves a protective 
role by removing the redox-active metal from the cytoplasm and by providing a route for 
removal from the liver through lysosome-mediated biliary excretion (La Russo, 1989). The 
lysosomal injury hypothesis proposes that excess accumulation of Fe or Cu within the 
lysosomes can lead to lysosomal fragility, impaired lysosomal function, and eventually 
cellular injury through the release of hydrolytic enzymes and stored metals into the 
cytoplasm.
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3.6.2 Mitochondria
Table 1 The effect of Iron or Copper Overload In Vivo on hepatic mitochondria.
Metal Observation
Iron Overload Lipid peroxidation
Impaired oxidative metabolism
Decreased cytochrome c oxidase 
2*Decreased Ca sequestration 
2+
Decreased Ca release
Decreased content of reduced pyrimidine nucleotides
Copper Overload
Lipid peroxidation
Impaired oxidative metabolism
Decreased cytochrome oxidase
Table l summarizes the effects of Fe and Cu overload on hepatic mitochondria in 
experimental animals. Mitochondrial oxidative metabolism is susceptible to metal-induced 
impairment. In normal mitochondria, electron transport is tightly coupled to the 
phosphorylation of adenosine diphosphate (ADP). Thus, in the absence of ADP, the rate of 
oxygen consumption is low, while with ADP present the rate of oxygen consumption is 
increased. Normal mitochondria, therefore, have a high respiratory control ratio (RCR). 
Hepatic mitochondria from Fe-loaded rats show significant decreases in the state 3 
respiratory rate and in the RCR at moderate degrees of hepatic Fe overload. At hepatic Fe 
concentrations at which oxidative metabolism is decreased, evidence of conjugated diene 
formation indicative of mitochondrial LPO is evident. Similar damage to the mitochondrial 
respiration chain in association with LPO has been observed in rats with Cu overload 
(Sokol et al., 1993). These studies suggest that chronic hepatic Fe or Cu overload in vivo 
results in an inhibitory defect in the mitochondrial electron transport chain. Similar defects 
in oxidation are produced in vitro by metal-induced peroxidation of normal mitochondria.
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The effect of both Fe and Cu overload on mitochondrial respiration results primarily from 
a decrease in cytochrome c oxidase activity. Cytochrome oxidase is functionally dependent 
on intact cardiolipin, a mitochondrial phospholipid that contains a high percentage of 
PUFA. Thus, it is likely that LPO damages cardiolipin, which may impair cytochrome 
oxidase activity. Alternatively, direct peroxidative injury to the protein subunits of 
cytochrome oxidase might occur concomitantly with mitochondrial LPO in Fe overload. 
The impairment in mitochondrial oxidative capacity caused by Fe or Cu overload could 
have a deleterious effect on the energy state of the liver. Consistent with this possibility, 
chronic dietary Fe-overload in rats results in a substantial decrease in hepatic ATP 
concentrations (Pietrangelo et al., 1995b). This decrease in hepatic ATP levels may disturb 
hepatocellular function and compromise cellular integrity.
Chronic Fe overload in rats also results in impaired calcium sequestration by hepatic 
mitochondria (Britton et al., 1991), which occurs in parallel with a decrease in substrate 
oxidation. Since mitochondrial calcium sequestration depends on the maintenance of the 
mitochondrial transmembrane potential, it is likely that the defect in substrate oxidation is 
at least in part responsible for the altered mitochondrial calcium sequestration. 
Furthermore, an increase in mitochondrial permeability may play a role in decreasing 
calcium sequestration (Britton, 1996).
3.6.3 Endoplasmic Reticulum (ER)
Hepatic microsomal LPO has been found in vivo in rats with chronic dietary Fe overload, 
when the hepatic content exceeded a certain threshold (Bacon et al., 1986). In addition,
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decreases in mitochondrial cytochrome P-450, aminopyrine demethylase activity, and 
cytochrome b5 were associated with microsomal LPO in the model. Although this finding 
does not prove direct causality, it seems likely that the loss of these cytochromes was the 
result of peroxidative damage. It has been demonstrated in vitro that Fe-induced 
peroxidation in hepatic microsomes causes a reduction in cytochrome P-450 (Waller et al., 
1983). Bonkovsky et al. (1984) measured antipyrine clearance and hepatic cytochrome P- 
450 concentrations in patients with various types of Fe overload. Although the number of 
patients studied was very small and some variations existed between the groups, no 
differences were found between Fe-loaded patients and controls. Another microsomal 
function that is sensitive to the damaging effects of peroxidation is calcium sequestration 
(Waller et al., 1983). Chronic Fe overload in rats results in an impairment in hepatic 
microsomal calcium sequestration, and this may alter calcium homeostasis and contribute 
to cell injury.
3.6.4 Plasma membrane
Little data are available concerning the effects of Fe or Cu overload on liver plasma 
membrane. At a mild degree of Fe overload in rats, there is a decrease in the content of 
unsaturated fatty acids in the phospholipids of the plasma membrane fraction. Similar 
changes are also seen in the mitochondrial membranes, and these changes in membrane 
composition are consistent with the occurrence of LPO. It is possible that some enzymes in 
the plasma membrane of the hepatocytes may be inhibited by Fe or Cu overload, since it 
has been shown that some thiol-rich enzymes (such as Na+, K+- ATPase) in plasma 
membranes of heart cells are sensitive to Fe (Link et al., 1994).
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3.6.5 Hepatic DNA damage
Patients with long-standing HH with cirrhosis are at increased risk of developing HCC. 
Accordingly, it has been proposed that HCC in these patients may be a consequence of Fe- 
induced oxidative damage to hepatic DNA, combined with the replicative stimulus 
provided by the nodular regeneration of cirrhosis. Fe salts have been shown to produce 
DNA strand breaks when incubated in vitro with purified DNA or with isolated rat liver 
mitochondria or nuclei (Imlay et al., 1988; Hruszkewycz, 1988). In addition, it has been 
demonstrated that endogenous Fe plays a key role in the DNA damage produced by 
hydrogen peroxide in mammalian cells, because pre-treatment with Fe chelating agents 
diminishes this damage (Mello et al., 1984). It is thought that some Fe is bound to DNA in 
vivo and that this Fe, in the presence of *~02 and H2O2, can catalyze the formation of "site- 
directed" *OH radicals that cause DNA damage (Halliwell et al., 1990). LPO products in 
the presence of Fe can also produce DNA damage in vitro through a mechanism that may 
also involve *OH radicals (Park et al., 1992).
The first evidence that chronic Fe overload in vivo results in damage to hepatic DNA was 
provided by studies that showed an increased number of strand breaks in hepatic DNA 
from Fe-loaded rats (Edling et al., 1990). The induction of strand breaks in DNA has been 
associated with both initiation and promotion events in chemically induced carcinogenesis 
(Walles et al., 1984; Hartley et al., 1985). Increased oxidative damage in hepatic DNA has 
been demonstrated in acyl hydrocarbon {Ah) - responsive mice after a single subcutaneous 
injection of Fe dextran (Faux et al., 1992). Oxidative DNA was evaluated using 8- 
hydroxydeoxyguanosine (80HdG) as a marker. It has been demonstrated that DNA
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templates containing 80HdG are misread both at the modified base and at adjacent 
residues, which could result in oxidative mutagenesis (Kuchino et al., 1987; Wood et al., 
1990). In addition to producing DNA damage, Fe can cause the transformation of cells. 
Repeated intraperitoneal injections of rats with the Fe chelate ferric nitrilotriacetate 
(FeNTA) resulted in renal adenocarcinoma with metastasis to the liver and lung (Okada et 
al., 1983). Exposure of cultured rat epithelial cells to a high concentration of iron 
nitrilotriacetate (FeNTA) resulted in the appearance of some cells that showed 
morphological transformation, grew in soft agar, and induced metastatic carcinoma when 
injected in newborn rats. This suggests that oxidative damage to DNA catalyzed by 
FeNTA may play a key role in the rapid neoplastic transformation of these cells (Yamada 
etal., 1990).
Little information is available concerning DNA damage in patients with Fe overload. In a 
study on hepatic DNA samples from 6 patients with HH, "bulky" DNA lesions were 
detected that contained 2 to 50 base modifications per 100 million nucleotides. 
Surprisingly, the levels of 80HdG were not raised in these samples, suggesting that these 
"bulky" DNA lesions may be a more sensitive indicator of Fe-induced DNA damage 
(Carmichael et al., 1995).
Ionic Cu in the presence of H2O2 or reducing agents can cause DNA damage in vitro 
(Aruoma et al., 1991). Cu overload in rats results in increased levels of 80HdG in hepatic 
DNA, indicative of oxidative damage. In Long Evans Cinnamon (LEC) rats, long-term 
administration of Cu could lead to chronic hepatitis, increased levels of 80HdG in hepatic
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DNA, and HCC (Masuda et al., 1988). Administration of penicillamine (Cu-chelating 
agent) to LEC rats could prevent these effects. This suggests that the development of HCC 
in these animals might be related to Cu-induced oxidative DNA damage. In patients with 
Wilson disease (WD), “bulky” lesions of hepatic DNA have been reported, without 
increase in 80HdG content (Carmichael et al., 1995). HCC is rarely seen in WD, perhaps 
because the usual clinical course of the disease does not allow sufficient time for it to 
develop.
Evidence exists of oxidative injury to hepatic DNA in animals with Fe and Cu overload. 
This damage might be an important step leading to carcinogenesis, especially when 
coupled with a regenerative stimulus provided by cirrhosis. Although hepatic DNA 
damage has been detected in patients with HH or WD, it is not known if this is the result of 
an oxidative process.
3.6.6 Iron Induced Hepatocarcinogenesis
The main clinical, biologic, and pathologic features of HCC complicating 
haemochromatosis are similar to those of other HCCs (Deugnier et al., 1993b). Iron free 
foci (IFF) defined as clear-cut sublobular nodules of hepatocytes free of iron or either 
significantly less iron than the surrounding parenchyma were found in 7.6% of 185 patients 
with uncomplicated haemochromatosis and in 83% of haemochromatosis patients with 
HCC (Deugnier et al., 1992, 1993a). Evidence from experimental (Hirota and Williams, 
1979) and clinical (Deugnier et al., 1993a) data, points to the possible involvement of IFF 
as an early step toward HCC. Cirrhosis is no longer thought to be a prerequisite for the
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development of HCC in haemochromatosis livers and therefore, iron could be a (co) 
carcinogenic factor. Although there is some evidence of the promoting effect of iron on 
tumour cell growth in vivo (Thompson et al., 1991) and in vitro (Bergeron et al., 1985), a 
direct carcinogenic effect of iron has not been documented in rats. Oxidative stress has 
been suggested as a possible mechanism of iron-induced HCC. Excessive oxidative stress 
as seen in iron overload may cause DNA alterations including point mutations, deletion, 
additions or chromosomal translocations. Moreover, environmental toxins such as iron 
may alter the methylation status of DNA. These events may lead to potential mutagenic 
effects (Pogribny et al., 1995) and activation of oncogenes and inactivation of tumour 
suppressor genes. The mutation frequency of the p53 tumour suppressor gene in HH was 
60% A:T to G:C and 40% A:T to T:A mutations in one study (Vautier et al., 1999). This 
mutation spectrum suggests that etheno-deoxyguanine or etheno-deoxyadenine DNA 
adducts may be responsible for the DNA damage. These DNA modifications are produced 
by the reaction with LPO products in the livers of HH patients (Nair et al., 1998).
Figure 5 Mechanisms of hepatotoxicity induced by Fe or Cu overload.
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3.7 COPPER (Cu)
3.7.1 BIOCHEMISTRY AND PHYSIOLOGY
The major functions of Cu metalloproteins involve oxidative-reduction reactions. Most 
known Cu-containing enzymes bind and react directly with molecular oxygen. Cu is an 
integral component of many metalloenzymes, including ceruloplasmin, cytochrome c 
oxidase, superoxide dismutase, dopamine-P-hydroxylase, ascorbate oxidase, lysyl oxidase 
and tyrosinase (Linder and Hazegh-Azam, 1996).
A number of pathological conditions have been attributed to the loss of cuproenzyme 
activity. Failure of pigmentation has been attributed to depressed tyrosinase activity 
required in the first step in the biosynthesis of melanin. A variety of connective tissue 
cross-linking defects (cardiac, vascular, and skeletal) may be caused by a loss of lysyl 
oxidase activity (Owen, 1982; Strain, 1994). Ataxia may result from depressed cytochrome 
c oxidase activity of motor neurons. Depressed dopamine-9-hydroxylase activity can result 
in abnormal catecholamine conversions. Furthermore, Cu plays an important role in Fe 
metabolism. Cu deficiency impairs Fe absorption, and anaemia accompanies severe Cu 
deficiency. Ceruloplasmin, the major Cu-containing protein in plasma, has a ferroxidase 
activity that oxidizes ferrous Fe to the ferric state prior to its binding by plasma Tf 
(Owen, 1973).
3.7.1.1 Metabolism
Cu absorption is maximal in the duodenum and may be absorbed from the stomach. Within 
the intestinal mucosa cells, Cu can react with metallothionein, a sulfhydryl-rich protein
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group that binds Cu through the formation of mercaptide bonds. Other metal ions, 
particularly zinc and cadmium, compete with Cu for sulfhydryl-binding sites, which 
explain the antagonism of these metals toward Cu absorption (Rojas et al., 1996). The 
amount of Cu absorbed from the intestine is between 50% and 80% of ingested Cu 
(Johnson and Milne, 1991). Factors affecting Cu levels include gender (women absorb a 
greater percentage than men), the amount ingested, the chemical form, and certain dietary 
constituents. The latter include other trace elements, sulfate, various amino acids, fibre, 
and phytates. Cu absorption may be impaired in patients with diffuse diseases affecting the 
small bowel such as sprue, lymphosarcoma, and scleroderma. Absorbed Cu is rapidly 
transported to the liver where it is stored, mostly as metallothionein-like cuproprotein. Cu 
is released from the liver, mainly as ceruloplasmin, a multifunctional cuproprotein that 
accounts for 60% to more than 80% of the total Cu in the plasma. Cu may be transported to 
cells for incorporation into Cu-containing enzymes by several identified transport 
mechanisms. These include ceruloplasmin, transcuprein, Cu-albumin, and Cu-amino acid 
complexes. The movement of Cu within the cell and its incorporation into cuproproteins 
may be regulated by both glutathione and metallothionein (Anon, 1991). The liver is the 
key organ in the homeostatic regulation of Cu metabolism. Cu is stored in the liver and 
incorporated and released as ceruloplasmin to maintain blood levels. Intestinal absorption 
mechanisms and regulation of biliary excretion also have major roles in regulating of Cu 
homeostasis (Sternlieb, 1980).
Cu is excreted primarily in the faeces as unabsorbed dietary Cu and from the biliary and
gastrointestinal secretions. Biliary Cu excretion ranges from 0.5 to 1.3 mg/day. Cu losses
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in the urine and sweat amount to less than 3% of dietary intake. Menstrual losses of Cu are 
minor: 0.1 to 0.8 mg per menstrual period. Estrogens increase serum Cu concentrations, 
probably by increasing hepatic ceruloplasmin synthesis. Serum Cu concentration is 
normally higher in women than men. Testosterone and progesterone administration has 
also been reported to increase plasma Cu levels (Mehta et al., 1989).
During infections or inflammatory stress, serum Cu concentrations rise because of the 
acute-phase action of interleukin-1 (Rafter, 1994). Elevated serum Cu concentrations are 
seen in portal cirrhosis, biliary tract disease, and hepatitis, probably because excess Cu, 
which would normally be excreted in the bile, is retained in the circulation. 
Hypocupraemia has been observed in haemolytic jaundice, haemochromatosis, and some 
types of cirrhosis because of the inability of the damaged liver to synthesize ceruloplasmin.
3.7.1.2 Cu Homeostasis
Cu ions are involved in a unique chemistry as a result of their ability to adopt distinct 
redox states, either oxidized [Cu(II)] or in the reduced state [Cu(I)]. Consequently, Cu ions 
serve as important catalytic cofactors in redox chemistry for proteins that carry out 
fundamental biological functions that are required for growth and development. Cu- 
requiring proteins are involved in a variety of biological processes and deficiencies in these 
enzymes, or alterations in their activities, often cause disease states or pathophysiological 
conditions as shown in Table 2.
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Table 2 Disease states or pathophysiological conditions associated with copper.
Common Name
(Cu containing substances)
Biological Function Consequence of Deficiency or Defects
Cu/Zn SOD Free radical detoxification Oxidative damage of cell components
Cytochrome c oxidase Electron transport in the 
mitochondria
S y m p t o m s  of  d e f i c i e n c y  of  A T P :m y o p a th y ,  a tax ia , 
s e iz u re s
Lysyl oxidase Cross linking of collagen and 
elastin
Connective tissue symptoms; vascular rapture 
and torsion,
Loose skin and joints, emphysema,
Dopamin-9-hyroxylase Catecholoamine production Hypothalamic imbalance: hypothermia, 
Hypotension, dehydration, somnolence
Tyrosinase, Melanin production Depigmentation
Peptidylglycine Bioactivation of Peptide Probable widespread effects through malfunction
Monooxygenase hormones of several peptide hormones
Ceruloplasmin Ferroxidase, Cu transport Anemia
Clotting Factor, V, VIII Blood clotting Bleeding tendency
Angiogenin, Induction of blood vessel Defective blood vessel development
Metallothionein Cu -  sequestration Cu toxicity
Prion protein Normal function currently 
unknown; Cu binding 
properties suggest 
potential role in Cu uptake
Altered sleep pattern and circadian rhythm in 
mice, Creutzfeld Jacob disease, Kuru, 
Gerstmann-Straussler-Scheinker disease 
Fatal familial insomnia
P-amyloid precursor 
protein
Normal function currently 
unknown
Familial Alzheimer's disease,
Hephaestin, Iron egress from intestines Sex-linked anaemia
Cu is also a potent cytotoxin when allowed to accumulate in excess of cellular needs. In 
addition to the generation of ROS, Cu may manifest its toxicity by displacing other metal 
cofactors from their natural ligands in key cellular signalling proteins. For example, the 
replacement of Zn(II) by Cu(II) in the zinc-finger DNA binding domain of the human
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3.7.1.3 Cu uptake and absorption
Organisms must have uptake mechanisms to absorb Cu from nutrients, transport Cu across 
biological membranes, and deliver it to Cu-requiring proteins. However, precise regulatory 
mechanisms must be in place to prevent the accumulation of Cu ions to toxic levels. The 
importance of maintaining this critical balance is underscored by the existence of two well- 
characterised human genetic diseases in Cu transport, Menkes and Wilson Disease (WD) 
(Bull and Cox, 1993b). In mammals, dietary Cu is absorbed across the mucosal membrane 
in cells that line the stomach and the small intestines. Exactly how this occurs is currently 
unknown. It has been proposed that Cu diffuses through the mucous layer that covers the 
intestinal wall (Linder, 1991). However, given the exquisite care with which copper is 
guided into and within yeast cells it seems unlikely that diffusion alone will account for 
this process.
3.7.1.4 Post intestinal mucosal cell transport
The pathway of Cu through the baso-lateral membrane has been identified through 
studying Menkes disease. Menkes disease is characterized by progressive neurological 
impairment and death in infancy. The entrapment of Cu in intestinal cells, kidney and 
vascular endothelial cells in the blood-brain barrier in Menkes patients leads to Cu 
deficiency, as ascertained by defects in the activities of many Cu-dependant proteins. The
oestrogen receptor renders this protein defective in binding to its cognate target DNA
sequences in v i tr o , thereby potentially interfering with its role in hormone-dependent
signal transduction in  v iv o  (Predki and Sarkar 1992).
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isolation of the Menkes disease gene (ATP7A) showed that this gene encodes a membrane 
associated P-type ATPase (Chelly et a l, 1993).
3.7.1.5 Cu in circulation
In the portal blood and systemic circulation Cu is bound to albumin and histidine. Exactly 
how albumin and histidine relinquish Cu to organs and tissues is currently unclear. 
However, it is possible that the bound Cu is handed off to the hCtrl Cu transporter, either 
directly or indirectly. The predominant Cu-containing protein in mammalian serum is 
ceruloplasmin, a glycosylated multi-Cu ferroxidase synthesized primarily in the liver and 
that carries >95% of the total serum Cu. Ceruloplasmin coordinates 7 Cu atoms that are 
incorporated during its biosynthesis and maturation in the secretory pathway (Sato and 
Gitlin, 1991). Although it is not yet established whether ceruloplasmin is involved in Cu 
m obilization  from the serum , the absence o f ceru loplasm in  in patients in 
aceruloplasminemia, a genetic disorder of ceruloplasmin deficiency, has not yet been 
shown to alter Cu levels in the peripheral tissues examined (Harris et a l, 1998).
It has been proposed that excess Cu is stored in the vacuoles to prevent toxicity. The role 
of putative Cu chaperones for targeting Cu to the vacuole and their mechanism of action is 
unknown. Furthermore, the mechanism by which Cu ions are delivered from the plasma 
membrane transporters to the Cu chaperones without releasing free Cu ions into the cytosol 
remains unclear.
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3.8 CLINICAL SIGNIFICANCE
Cu deficiency in infants has been observed in prematurity, malnutrition, malabsorption, 
chronic diarrhoea, hyperalimentation, and prolonged feeding with low-Cu total-milk diets. 
The susceptibility of premature infants to Cu deficiency is related to their low stores of 
liver and spleen Cu (which accumulates rapidly during the last trimester of gestation) and 
the probability of longer feeding exclusively on milk formulae. A deficit in protein 
nutrition is sufficient to impair Cu transport and storage and may also be a causal factor. 
Signs of Cu deficiency include (1) neutropenia and hypochromic anaemia in the early 
stages, both of which are responsive to oral Cu but not iron; (2) osteoporosis and various 
bone and joint abnormalities that reflect deficient Cu-dependent cross-linking of bone 
collagen and connective tissue; (3) decreased pigmentation of the skin and general pallor, 
which are attributed to tyrosine-required melanin synthesis; and (4) in the later stage, 
possible neurological abnormalities (hypotonia, apnea, psychomotor retardation), probably 
caused by cytochrome c oxidase deficit. Long-term hyperalimentation with infusates 
deficient in trace minerals has been shown to produce Cu deficiency in both infants and 
adults. Observed signs are those usually associated with Cu deficiency, including lowered 
plasma Cu and ceruloplasmin, anaemia, etc. Cu deficiency has also been associated with 
Zn therapy for sickle cell disease and treatment with Cu-chelating agents such as 
penicillamine. Low levels of serum Cu contribute to an increased risk of coronary heart 
disease through instability of heart rhythm and hyperlipidemia. Experimental animals fed 
Cu-deficient diets and human subjects fed diets believed to be marginal in Cu have 
exhibited many signs closely related to coronary heart disease. These include abnormal 
electrocardiograms, hypercholesterolaemia, glucose intolerance, and hypertension.
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3.8.1 Menkes’ syndrome
An extreme form of Cu deficiency is seen in Menkes' syndrome, an X-linked genetic 
defect in Cu transport and storage. Clinical manifestations occur early in life and include 
kinky or twisted, brittle steely hair (attributed to loss of Cu-catalyzed disulfide bond 
formation), depigmentation, and vascular defects. The affected infants are Cu-deficient, 
and have low serum, hepatic, and cerebral Cu concentrations, low ceruloplasmin levels, 
and little or no cytochrome c oxidase activity in nerve tissues. Symptoms usually appear by 
three months of age, with death occurring by five years of age. Affected infants exhibit a 
build up of copper in the duodenal mucosal tissue as a result of defective Cu absorption. 
Red cell Cu is not decreased, and neutropenia and anaemia, two usual signs of Cu 
deficiency, do not appear.
3.8.2 Wilson disease (WD)
WD (hepatolenticular degeneration) is a genetically determined Cu accumulation disease 
that usually presents between 6 and 40 years of age. Disease symptoms include 
neurological disorders, cirrhosis, and Kayser-Fleischer rings (green-brown discoloration) 
in the cornea caused by Cu deposition. Cu accumulates in the liver, brain, kidney, and 
cornea. The haemolysis, necrosis, and other cellular damage that occur may be caused by 
LPO, a known effect of Cu toxicity. Urinary Cu excretion is increased. The hepatic 
synthesis of ceruloplasmin is decreased, which results in a low serum concentration of this 
enzyme (<20 mg/dl). Serum Cu is generally decreased because of low ceruloplasmin 
concentrations. Thus, the simultaneous measurements of serum Cu, ceruloplasmin, and 
urinary Cu are useful in the diagnosis of this disease.
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4.0 THE CHEMISTRY OF FREE RADICAL REACTIONS
4.0.1 The Definition and Reactions of Free Radicals
Free radicals are formed from molecules by breaking a bond such that each fragment keeps 
one electron. Free radicals may also be formed by collision of the non-radical species by a 
reaction between a radical and a molecule, which must then produce a radical since the 
total number of electrons is odd (Aruoma, 1998). Radical ions are positively or negatively 
charged free radicals, e.g. a protonated amine radical (H3N"1"), or the superoxide radical 
anion (*”0 2 ).
Even though a species is an ion depending on the number of its electrons in relation to the 
number of protons, all species with unpaired electrons in their outer orbital are free 
radicals, independent of the number of protons. Several chemical reactions are inhibited by 
the fission of the two-electron bond. The bond may be cleaved symmetrically, producing 
free radicals (Eq.l), or asymmetrically, when ions are formed (Eq.2).
A:B - —> A- + B+ (1)
A:B - —> A f + B+ (2)
Chemical substances may be converted into free radicals by irradiation (i.e. X-ray or UV), 
or by additives called inhibitors. It has long been known that ionizing radiation produces 
free radicals in biological systems, and these play a major role in the aetiology of radiation 
injuries. In addition, free radicals may be formed in aerobic organisms, including humans, 
in the course of physiological and pathological processes or by exogenous agents (Del 
Maestro, 1980).
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Free radical reactions are, in general, chain reactions. In the course of these reactions, free 
radicals are formed during the initiation step(s). These enter into reactions in the course of 
several propagation steps, during which the number of free radicals is conserved until they 
are eventually destroyed in a termination process.
Free radicals of importance in living organisms include hydroxyl (*OH), superoxide ('“Ch), 
nitric oxide (NO*), thyl (RS*) and peroxyl (ROO*). Peroxynitrite (ONOCT), hypochlorous 
acid (HOC1), hydrogen peroxide (H2O2), singlet oxygen (*Ag) (often written as '0 2 ) and 
ozone (O3) are not free radicals, but can easily lead to a free radical reaction.
4.0. 2 Radicals of Molecular Oxygen: Physical and Chemical Properties.
Radicals formed from molecular oxygen are a serious hazard for both living and nonliving 
matter. The biradical property of oxygen allows it to act as an initiator and to participate in 
additive reactions. Nevertheless, it is basically a weak oxidant as a result of its free 
electron with parallel spin. Reactive intermediates of oxygen are generated by reduction or 
excitation. Reactive intermediates formed in the course of excitation and reduction, are not 
invariably free radicals (e.g. delta singlet oxygen or H2O2). Nevertheless, they resemble 
free radicals in their reactivity and importance. These are called “reactive oxygen 
intermediates” (ROI’s).
4.0. 3 Reduction
In the course of the complete tetravalent (four-electron) reduction of oxygen, water is 
formed. If it undergoes sequential univalent (one-electron) reduction, reactive
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intermediates are formed. The ’ O2, H2O2 and the *OH are such intermediates. These may 
damage biological systems. According to the quantum reduction mechanical concept of 
spin restriction, univalent reduction is more likely to occur in vivo. In living organisms 
therefore, oxidative enzymes (i.e. cytochrome oxidase) have developed, which circumvent 
the law of spin restriction and catalyze divalent and tetravalent reduction of oxygen, so that 
only small amounts of ROIs are formed. Cytochrome oxidase catalyzes the tetravalent 
reduction of oxygen and it is responsible for the bulk of the total oxygen consumption in 
the course of cellular metabolism. Nevertheless, ROIs are formed in small amounts during 
cellular metabolism, but the defence systems are able to neutralize them under normal 
conditions. Additionally, ROI’s are formed during autooxidation of different chemical 
compounds, more readily via univalent reduction of O2 (Miller et al., 1990). For example, 
during autooxidation o f hydroquinones, leukoflavins, catecholam ines, thiols, 
tetrahydropterins, or oxyhaemoglobin, ‘”02 are formed. Furthermore, ROI’s are generated 
during enzymatic processes (e.g. of xanthine oxidase), in subcellular organelles (i.e. 
mitochondria, chloroplast), or during cell functions of phagocytes or thrombocytes.
4.0.4 Excitation
*02 is formed if one of the unpaired electrons of molecular oxygen is transferred via 
energy absorption to a higher energy orbital and its spin is inverted. '(>2 exists in two 
states, i.e. as delta singlet oxygen A '0 2  in which the newly paired electrons occupy the 
same orbital, and sigma singlet E 102 in which the electrons of opposite spins are in 
different orbitals. The excess energy of 'C>2 may be spent through thermal decomposition, 
light emission, or chemical reaction (as indicated by chemiluminescence) (Klebanoff, 
1980; McCord et al., 1978).
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4.0.5 Reactions in which ROI’s are Formed
'“02 may be found during autooxidation of various compounds, in the mitochondrial 
respiratory pathway, if the members of the cycle are reduced and react with oxygen, in 
chloroplast, and in connection with phagocyte function and reduced nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase function (Rossi et al., 1985). The reactivity of 
*“02 is limited. Its importance lies in its ability to oxidize transition metal complexes and 
organic substrates, to bind to metals, and to be transformed into other ROIs. In acid media, 
such as the vacuole of the phagocyte or the micro-environment of cell membranes, * “02 is 
protonated into the perhydroxy radical (H O2” ’). The cell surface, containing polyanions, 
attract H+ ions. H 0 2“ ’ is a stronger oxidant than *“02 and is cytotoxic.
H2O2 is formed either by the divalent reduction of molecular oxygen catalysed, for 
example, by glucose oxidase or from *”0 2  catalyzed by the enzyme superoxide dismutase 
(SOD) (Fridovich, 1989). During the Harber Weiss reaction of *”02 and H2O2 the 
extremely reactive *0H radical is produced.
O2 + H2O2 --------■> O2 + *0H + OH
This reaction, however, proceeds very slowly in living organisms and thus significant 
amounts o f ’OH are not formed. The reactions are accelerated by metal catalysis, resulting 
in a Fenton-type reaction where significant amounts of *OH may be produced.
*“0 2 + * Mn+1 -------> Mn + 0 2
Mn + H20 2 --------> Mn+I + *0H + OH”
H2O2 + H2O2 --------> O2 + *0H + OH
* Where M  is a transition metal, i.e. Fe or Cu.
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By analogy with the Fenton reaction, hydroperoxide may participate in the reaction instead 
of H2O2.
Fe2+ + ROOH ------ > Fe3+ + RO* + OH”
The alkoxy radical RO* is only slightly less reactive than the 'OH radical, and may damage 
biological systems excessively, either itself or the *OH produced as a result of internal
hydrogen atom transfer. 0 2 may be formed in the following reactions:
H2O2 + •~o2 + H+ ------ > 'o2 + H20 2 (1)
-O 2 + H20 2 metal ^ 'o 2 + *0H + OH- (2)
o c r + h2o2 ------ > '0 2 + c r  + H2O2 (3)
* o2 + ’OH ------ > 'o 2 + OH' (4)
0 0
2 - o 2 + 73 l 0 
-
1 O - O - C - R ____ > 2 '0 2 + 2RC02~ * (5)
Reaction (1) is an analogue of the spontaneous dismutation of *”02- Spontaneous 
dismutation is the same as the SOD-catalyzed reaction, but is a nonenzymatic reaction and 
is much slower. Reaction (2) is a variant of the Fenton reaction. Reaction (3) occurs in the 
course of the function of the granulocyte myeloperoxidase -  H2O2 -  halide system. '0 2 
may be formed during the interaction of *”02 + *0H (reaction 4) and of ’”02 and diacyl 
peroxides (reaction 5) (Badway and Karnovsky, 1980; Fantone et al., 1982).
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4.1 REACTIVE OXYGEN SPECIES (ROS) INVOLVED IN IRON OVER - 
LOAD
4.1.1 Superoxide radical (*”02)
The * O2 is an oxygen-centered radical with selective reactivity. This species is produced 
by a number of enzyme systems, by autooxidation reactions, and by non-enzymatic 
electron transfers that univalently reduce molecular oxygen. In aqueous solution, ' ”02 can 
oxidize ascorbic acid. It can also reduce certain iron complexes, such as cytochrome c and 
ferric-ethylenediaminetetraacidic acid (Fe3+-EDTA). SOD accelerates the dismutation of 
’“O2, converting it to H2O2 and O2 (Fridovich, 1989; Richter et al., 1977). Some ’”02 is 
made deliberately. For example, the phagocytes (neutrophils, monocytes, macrophages, 
eosinophils) generate large amounts of ’”02 as part of their killing mechanism (Babior and 
Woodman 1990; Weiss 1989). When this essential defence mechanism goes wrong, 
several diseases are accompanied by excessive phagocyte activation, leading to tissue 
damage, to which ROS and reactive nitrite species (RNS) are contributory factors (Babior 
and Woodman 1990; Eze, 1993). Neutrophils have the function of recognizing foreign 
particles such as bacteria, either because bacteria have an unusual surface or, more often, 
because antibodies are bound to them. Enzymes like SOD seem to have specifically 
evolved to make *”02 exist in the plasma membrane of neutrophils. Although normally 
inactive, this enzyme is activated when neutrophils encounter a foreign particle. The 
enzyme takes NADPH from the neutrophil cytosol, oxidizes it to NADP+, and passes 
electron onto O2, hence reducing O2 to ‘”02 outside the cell (Rossi et al., 1985; Klebanoff, 
1980). Activation of the enzyme occurs at the point of contact particle, and this piece of 
membrane is then used to engulf the particle, forming a phagocytic vacuole. The
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importance of the production of ‘ O2 in humans is shown by chronic granulomateous 
disease (CGD) (Cumutte and Babior, 1987), a collective name given to inborn disorders in 
which the membrane-bound NADPH oxidase is inactive.
*”02 production is activated when foreign particles touch the neutrophil surface and some 
*”02 escapes into the extracellular fluid. Yet extracellular fluids have little superoxide 
dismutase activity. Thus, excessive production of *'02 and H0C1 by activated phagocytes 
can impose an oxidative stress on the surrounding tissues, and this happens in several 
human diseases.
4.1.2 Hydrogen peroxide (H2O2)
H2O2 is not a free radical. It can cross membranes and slowly oxidize a number of 
compounds. H2O2 can be formed in vivo when *'02 dismutates and also by many oxidase 
enzymes, including monamine and amino acid oxidases. Xanthine oxidase converts 
hypoxanthine to xanthine and xanthine to urate, O2 being simultaneously reduced to both 
’“O2 and H2O2 (Granger, 1988). Levels of xanthine oxidase are normally low in human 
tissues, but they may increase after injury, such as trauma or ischaemia (Buckley, 1994).
Some metabolic roles of H2O2 are known, and others have been proposed. H2O2 can 
regulate gene expression: one mechanism is by (directly or indirectly) displacing an 
inhibitory subunit from the cytoplasmic gene transcription factor NF-kB (Schreck et al., 
1992), at least in some cell types (Brennan and O’Neill, 1995). The activated factor then 
migrates to the nucleus and causes expression of multiple genes. Other peroxides (such as
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lipid peroxides) do the same (Collins, 1993). H2O2 at low (micromolar) levels also seems 
to be poorly reactive. However, higher levels of H2O2 can attack several cellular energy- 
producing systems. For example, it inactivates the glycolytic enzyme glyceraldehyde-3- 
phosphate dehydrogenase. H2O2 also forms the 'OH in the presence of transition metal ions 
and O2, and can facilitate this reaction (Miller et al., 1990).
4.1.3 Hydroxyl radical (’OH)
Much of the toxicity of ’“O2 and H2O2 involves formation of *OH. The 'OH radical is a 
highly reactive oxygen-centered radical with an estimated half-life in cells of only 10‘9 
seconds. One feature of the 'OH (and other radicals) is that it gives rise to another radical. 
Thus, when it reacts with a molecule, the result is the formation of another radical species. 
The resulting species usually has lower reactivity than the *OH. 'OH radicals attack all 
proteins, DNA, PUFAs in membranes and many other biological molecules. In the case of 
'OH generation by Fenton type chemistry, the extent of 'OH formation is largely 
determined by the availability and location of the metal ion catalyst. In an in vitro study in 
which the technique of gas chromatography with selected ion monitoring (GC/MS/SIM) 
was used to compare the role of Cu and Fe ions in promoting damage to DNA by H2O2, Cu 
ions were significantly more reactive in causing DNA damage in the presence of H2O2 than 
were equimolar Fe ions (Aruoma et al., 1991).
The availability of “free” Fe and Cu in vivo is controlled. Fe ions are absorbed from the 
gut and are transported to iron-requiring cells by the protein Tf in an attempt to keep the Fe 
pool as small as possible. 'OH generation can take place when the homeostasis is altered.
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For example Cu and Fe ions released into perfusates can cause ischaemia / reperfusion 
injury (Chevion et al., 1993). Using electron spin resonance (ESR) spin trapping system, 
Ramos et al. (1992) detected *OH as the a-hydroxyethyl spin trapping adduct of 4-pyridyl- 
1-oxide-n-terbutylnitrone formed from phorbol-12-myristate-13-acetate-stimulated human 
neutrophils and monocytes without the addition of supplemental Fe. In systems that lacked 
myeloperoxidase, it was necessary to add Fe to detect *OH adduct. Thus, human 
neutrophils and monocytes can generate *OH through a myeloperoxidase-dependent 
mechanism (Ramos et al., 1995) that could have microbicidal implications.
4.1.4 Peroxyl radicals (ROO‘)
These radicals are formed during LPO chain reactions, such as the oxidation of 
polyunsaturated fats and unsaturated fatty acids. LPO may be initiated by any species that 
has sufficient reactivity to abstract a hydrogen atom from a PUFA side chain (such as those 
of arachidonic acid and linolenic acid) in membrane lipids. Arachidonic acid is a precursor 
of prostaglandins and leukotriens. It contains a number of methylene-interrupted double 
bonds that are particularly prone to hydrogen atom abstraction. Although the mechanism 
and the biological significance of LPO have been extensively reviewed (Dix and Aitkens 
1993; Esterbauer et al., 1993), delineation of LPO as a major pathway in most 
degenerative diseases would depend on adequate standardization and control of 
measurement conditions (Auroma, 1996). The link between DNA damage, faulty repair of 
DNA, protooncogene activation, and the ability of some of the end products of LPO to act 
as promoters o f carcinogenesis has been widely discussed (Cheeseman, 1993).
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The end products of LPO could have profound effects on vascular function because of their 
ability to mimic or antagonize the actions of some of the stereospecific products formed by 
cyclooxygenase and lipoxygenase enzymes. For example, the F2-isoprostanes are 
generated by peroxidation of arachidonic acid via the generation of ROO* isomers that 
undergo endoxyclization to prostaglandin-like compounds. Their formation in vivo appears 
to be enhanced under conditions of oxidative stress (Nourooz-Zadeh et al., 1995; Morrow 
and Roberts, 1996).
Oxidation of low density lipoprotein (LDL) is a free-radical-mediated process that results 
in numerous structural and functional changes (Esterbuaer et al., 1993). The initiation of 
LDL oxidation occurs by the peroxidation of the PUFA in LDL. Oxidation of LDL is 
initiated by ROS that abstract H* from a double bond in PUFA, followed by molecular 
rearrangement that leads to the formation of conjugated double bonds that are commonly 
referred to as conjugated dienes (CD) (Esterbauer FI et al., 1993). Cholesterol in LDL can 
be oxidized to oxysterols, such as 7-keto cholesterol. The propagation phase is followed by 
a decomposition phase, in which there is cleavage of double bonds resulting in the 
formation of aldehydes such as MDA and 4-HNE, and hexanol, that can crosslink with 
amino groups on apo B-100.
Changes in the protein moiety of LDL also occur during oxidation (Parthasarathy and 
Rankin, 1992). The aldehydic products of LDL oxidation are diffusible cytotoxins 
(Chisolm, 1991). Oxidation is followed by an increase in the negative charge of LDL, 
possibly resulting from derivatization of positively charged amino groups through the
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formation of Schiffs base with aldehydes. Furthermore, the apo-B protein undergoes 
oxidative scission leading to fragmentation.
4.2 FREE RADICALS GIVE RISE TO FREE RADICALS -  LPO
Lipids are readily oxidized both in vivo and in vitro, for example, by the peroxidized lipids 
present in age pigments. The parallel spin of molecular oxygen prevents the direct addition 
of the electron pair to another molecule and thus prevents chemical bond formation. For a 
bond to be formed, spin reversal must occur. Since spin reversal takes a long time in 
comparison to the half-life of activated complexes, molecular oxygen is a relatively weak 
oxidant, and autooxidation of lipids in living organisms is a relatively slow process. 
Nevertheless, if lipids are activated to free radicals R* via removal of hydrogen (mediated 
by a free radical initiator), they enter into reactions with molecular oxygen more readily. A 
ROO’ is formed during the reaction and this process is called LPO. PUFA are especially 
liable to peroxidation since the C-H bond of their so- called a-methylene carbon next to 
the double bond is weak, and thus they may be regarded as partially activated. Therefore, 
as the initial step of LPO, hydrogen is removed from this carbon atom (the hydrogen of a -  
methylene carbon atom is also called allylic hydrogen) (Del M aestro, 1980).
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I. Initiation and formation of metastabie intermediate products
x- + -  ch2- ch= ch- ch2- ch = ch- ch2-
h
Alkyl radical
XH + - C H 2-C H  =  C H -C H '-C H  =  C H -C H 2-
Alkyl radical, isomer Alkyl radical, isomer
■ CH2— CH =  CH —CH =  CH —CH—CH2 — and -C H 2-C H -C H -C H -C H -C H -C H 2-
1“ h
and -C H 2-C H -C H  =  CH-CH =  C H -C H 2- 
0-0'
ch2- ch= ch- ch= ch- ch 
] 0-0
R' + -C I-b -C H = C H -C H = C H -C H -C H 2-  and —CH2—CH—CH=CH —CH=CH —CH2—+ R'
I
0 -0 H 0 -0 H
(1 ) 
(2a)
12b)
(3)
t i l
II. Catalysis and propagation
-C H 2-C H  =  C H -C H = C H -C H -C H 2-
Alkoxy radical 0 —OH
-C H 2-C H  =  C H -C H  =  C H -C H -C H 2 
I0'
J.R H
- ch2- ch= ch- ch= ch-  ch2 ♦ R'I
OH
III. Fragmentation and termination
+ Spontaneously or 
metal catalyzed
'OH 
|  .RH
HOH + R'
Alkoxy radical
— CH2-C H = C H  —CH —CH=CH — 
I
O'
Aldehyde
-'OH
Alkyl radical
-C H 2- C H = C - C H  ♦ *CH =  CH —
0 — CH2 — CH =  CH — CH —CH =  CH —
0 — CH =  CH —
(5)
( 6 )
(7)
( 8 )
(9)
Figure 6 Phases of Lipid Peroxidation (After Demopoulos et al., 1980).
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Figure 6 shows the process of LPO:
1. During initiation a free radical substance (X* in Figure 6) reacts with a fatty acid chain 
containing one or more multiple bonds (R with two multiple bonds). 2. (a) A radical centre 
is formed next to the double bond (a-methylene carbon) after the free radical initiator has 
abstracted a hydrogen atom and thereby ceased to be a free radical (XH). At the same time 
an alkyl radical R* is formed from the lipid, (b) Several configurational changes follow the 
initiation almost immediately and massive electron transfers occur: (i) transfer of the free 
electron to other C atoms; (ii) this moves the double bonds closer, leading to the formation 
of conjugated double bonds, (iii) Some double bonds adopt the trans configuration, instead 
of the cis configuration characteristic of fatty acids.
3. The oxygen is added to the R’ and a ROO* is formed.
4. ROO*s abstract hydrogen from the nearby molecules (RH, which may be other 
unsaturated fatty acids, proteins, antioxidants, or nucleic acids) and thus the metastable 
hydroperoxides (ROOH) are formed.
5-6. ROOFI are capable of spontaneous decomposition to 'OH and alkoxyl radicals RO*. 
As a result of metal catalysis, RO*, ROO' and 'OH or hydrogen ions are formed.
7. With the abstraction of hydrogen from neighbouring molecules RH, the RO’ and 'OH 
are terminated, but further radicals are formed from the molecules losing their hydrogens.
8. RO’ may undergo further oxidation or may be fragmented by continuous free radical 
attack on their a-methylene carbon atoms. In this way bis-hydroperoxides (i.e. two OOH 
groups on single fatty acids) may be formed and the fatty acid is decomposed into 
aldehydes and alkyl radical fragments.
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9. Alkyl radicals may react with the surrounding radicals, e.g. RO*, and thus the process is 
terminated as a result of the formation of O-bonded bridges between the molecules, or C-C 
bonds may be formed with another alkyl radical.
Initiation may thus start a chain reaction that, if uncontrolled by defence mechanisms, may 
lead to extensive damage to surrounding molecules. Autooxidation of lipids eventually 
leads to the formation of new C-C bonds. Since lipids are membrane constituents, it is 
easy to see what extent to which cross-linking may damage the membranes (Figure 7).
Disulphide 
crosslinking
Free
radical
damage
Malondialdehyde Fotty acid
released from oxidation
oxidized fatty acids
Figure 7 Free radical induced damage. MDA, one of the products of LPO, facilitates 
cross-linking. Free radical may also produce protein-protein cross-links, amino acid 
oxidation, a fissure of protein fibres. (Freeman and Crapo, 1982)
Autooxidation is considerably accelerated by the presence of transition metals (i.e. Fe and 
Cu) that enhance the degradation of metastable hydroperoxides (Figure 6, Eqs. 5,6). Lipids 
that are readily oxidized promote the metal-catalyzed oxidation, in the presence of O2 or 
more inert cellular components like proteins or nucleic acids (Figure 6, Eqs. 7,9). 
Autooxidation is a very slow circumscribed process under physiological conditions.
Transmembrane
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Under pathological conditions, however, it is accelerated, becomes more extensive, and 
may damage all basic biomolecules (Demopoulos et al, 1980; Slater, 1984). The meta­
stable lipid peroxides formed during LPO, MDA, and other stable end products of LPO, 
e.g. 2-alkenals and 4-hydroxyl-2-alkenals, may reach more distant parts of the cell or other 
cells and tissues as a result of their relative stability. Thus, LPO may also damage cells or 
tissues that are not directly exposed to peroxidative damage (Petkai, 1980; Pryor, 1982).
Previous studies using much higher amounts of dietary Fe in male rats, formed a strong 
correlation between Fe intake and LPO (Dresow et al., 1995; Inan et a l, 1998; Dougherty 
et al., 1981). In a study on Fe overload that compared 200 and 30,000 pg/g dietary Fe as 
Cl in male rats, Dabbagh AJ et al. (1994) reported substantial hepatic LPO, and depletion 
of endogenous antioxidants, including vitamin E.
4.3 PATHOLOGICAL FREE RADICAL REACTIONS
Uncontrolled, abnormal radical reactions occurring in the cell are called pathological free 
radical reactions. Radicals generated under physiological conditions, when control 
mechanisms fail for some reason, may also elicit such reactions. In addition, exogenous 
agents and physical interactions with ionizing radiation, UV, or plastic implants may cause 
these reactions.
4.4 FREE RADICAL DAMAGE
4.4.1 Damage of Enzymes and Proteins Caused By Free Radicals
Polymerization, breakage of polypeptide chains, and changes in the amino acid structure
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may occur in proteins and enzymes exposed to LPO in aqueous solutions. Proteins 
containing unsaturated fatty acid and sulphur containing amino acids (tryptophan, tyrosine, 
phenylalanine, histidine, methionine, cysteine) are mostly sensitive to the modification of 
the amino acid structure (Freeman et al., 1982). Because proteins are membrane 
constituents, their damage explains the membrane-damaging effect of free radicals, while 
the loss of the specific activity of the enzymes may also have severe consequences.
Some of the important membrane proteins are phospholipid dependent. Their active 
configuration is generated via interaction of the hydrophobic parts of the polypeptide chain 
and the fatty acid parts of the special membrane phospholipids. Na+,K+ -ATPase, succinyl 
dehydrogenase and cytochrome oxidase are among these enzymes that are damaged. 
Understandably, LPO triggered by free radical reactions, inactivates these enzymes, 
(Demopoulos, 1980).
4.4.2 Damage of the Cell Membrane and the Subcellular Organelle
Biomembranes and subcellular organelles are the chief targets of LPO-induced damage. 
Mitochondrial and microsomal membranes contain relatively more PUFA in their 
phospholipids than the plasma membrane and are, therefore, more susceptible to 
peroxidation. Substances generating free radicals damage various subcellular structures 
selectively. Damage of the lysosome membranes may lead to intracellular catabolism. 
Lysosomes contain relatively less PUFA compared with the mitochondria and microsomes, 
and therefore, they are less susceptible to oxidative injury (Tappel, 1973).
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4.4.3 Fluorescent Molecular Damage and Lipofuscin Pigments
Lipofuscin pigments accumulate in human and animal tissue as a result of aging. These are 
lipid-protein complexes resulting from the peroxidation of the PUFAs of subcellular 
membranes and correspond to the so-called residual body, the end product of lysosomal 
digestion. This conjugated imine structure (RN=CH-CH=CH-NH-R), having fluorescent 
chromophore properties, is an indictor of the cross-linking reactions of LPO (Freeman et 
al., 1982: Holland et al., 1982). MDA may be present in lipofuscin either in the Schiff base 
form, or in the polymerized form. Ceroid, having a structure similar to lipofuscin also 
accumulates during normal aging, as a result of pathological processes (Vistnes'eT al., 
1983).
4.4.4 Free Radical Damage of Nucleic acids and Their Components
Free radical damage to the DNA of living organisms may be the result of breakage of the 
main chains or of a strand, degradation of bases, or cleavage of hydrogen bonds. All 
components of nucleic acids may be exposed to free radical damage, which either becomes 
permanent or may be repaired by special mechanisms. Unrepaired damage in bases may 
lead to mutation, while damage in the pentose part may result in chain breakage. Histones 
with high arginine and lysine content have been found to be good 'OH radical scavengers 
with a possible role of protecting DNA against pathological free radical reactions 
(Nakayama et al., 1984; Zs-Nagy and Floyd, 1984).
4.4.5 Connection Between LPO and Tissue Damage
LPO may proceed in a controlled form without causing total cell damage. But it may also
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lead to tissue damage, either reversible or irreversible. In the latter case it causes the death 
of the cells. Reversibility is the result of cellular antioxidant protection. Lysosomal enzyme 
release invariably causes cell damage, but cell death is the result of intracellular Ca 
accumulation caused by the failure of the microsomal Ca 2+ pump. LPO may not only be 
the cause of cell damage, but may also be the result of tissue damage caused by some other 
factors. It is thus hard to judge in some disease states whether cell damage as a result of 
LPO is primary, or whether LPO is secondary to cellular damage. Antioxidants are 
inactivated in the damaged tissue, and metals stored in the cells (mostly Fe and Cu) are 
released. These may then promote LPO (Younes and Siegers, 1984).
4.5 FREE RADICAL REACTIONS AND MUTAGENESIS
Free radical reactions can induce mutation of DNA either directly or indirectly. 
Mutagenesis, however, is not always harmful. Deficiency in the repair mechanism may be 
secondary to DNA damage caused by free radicals. The mutagenic effect of free radicals 
on bacteria has been proved experimentally, and a similar effect of activated phagocytes 
has been found in cell cultures (Moody and Hassan, 1982). Three types of antimutagens 
have been distinguished, depending upon their mechanism.
1. Desmutagens, that inactivate or kill mutagens.
2. Inhibitors of the metabolism of substances needing metabolic activation for their 
mutagenic action.
3. Antimutagens proper, which inhibit the mutagenic effect at the cellular level.
Although the antimutagenic effects of antioxidants have been repeatedly described, the 
results have been contradictory.
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4.6 FREE RADICAL REACTIONS AND CARCINOGENESIS
The majority of tumours are caused by environmental factors. Although environmental 
chemical carcinogens are of diverse structure, they act almost without exception by way of 
free radical mechanisms: they are either free radicals themselves, or are converted to free 
radicals when activated, or they induce pathological free radicals reactions indirectly. 
Three types of anticarcinogenic protective mechanisms are known: (a) prevention of the 
formation of active forms; (b) stimulation of carcinogen detoxifying systems; and (c) 
mechanisms acting after interaction with targets.
Endogenous carcinogens and mutagens (i.e. MDA) are produced in aging as a result of 
LPO. Some stable diffusible products of LPO can damage the genetic material, thus 
playing a role in the initiation and promotion of tumours. Chemicals can also cause 
chromosomal damage (similarly to membrane active substances) in an indirect way by 
activating the respiratory burst of phagocytes and by inducing peroxisome proliferation 
leading to LPO (Cerutti, 1985). Mitochondrial univalent leakage and the disturbed balance 
of the protective mechanisms acting against it may constitute another link between aging, 
mutagenesis and carcinogenesis.
4.7 CELLULAR ENZYMATIC DEFENCE (AGAINST RADICALS OF 
MOLECULAR OXYGEN)
4.7.1 Antioxidant defence of the Intracellular Space
The chief mechanism protecting cells in vivo against oxygen toxicity and LPO is the 
maintenance of low oxygen tension in the tissues (approx. 26Mm Hg). Thus, the formation
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o f '“02 and other LPO-inducing ROIs is kept under control (Hornby and Crivello, 1983) 
and SOD enzymes mediate the removal of '“02. The therapeutic potential of SOD has 
stimulated the production of an authentic human SOD (HSOD) by gene technology 
(Wheeler et al., 2001).
SODs are metalloproteins containing Mn, Fe or Cu + Zn (MnSOD, FeSOD, CuZnSOD) 
and are ubiquitous in the cells of aerobic organisms. All subunits are composed of 151 
amino acids and contain an atom of Cu and Zn each. Both subunits are bound by a 
disulphide bridge, and lose their enzyme activity through its dissolution. The molecule has 
a bullet-shaped spatial structure and the external Cu atoms form the active catalytical 
centre. Zn plays no role in the enzyme activity. FeSOD is found in prokaryotes, MnSOD in 
both eukaryotes and prokaryotes, while CuZnSOD in eukaryotes. The mitochondria of 
eukaryotes contain only MnSOD, whereas the cytosol also contains MnSOD, in addition to 
CuZnSOD. SOD catalyses the reaction
*“0 2 + 2H+ --------> H20 2 + 0 2
H2O2 may thus be formed not only during the divalent reduction of O2 but by SOD activity. 
For instance, MnSOD may transform *“02 produced during mitochondrial metabolism into 
H2O2, which means that permanent production of small amounts of H2O2 in cells is 
removed by catalase (CAT), a haem enzyme, and by various peroxidases [i.e. selenium 
glutathione peroxidase (SeGPx)]. CAT is found in peroxisomes and catalyses the reaction
H2O2 --------- > H2O + l/ 2  O2
At low molecular H2O2 concentrations, CAT is relatively unreactive. Its peroxisomal
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localization also suggests that other defence systems may also be responsible for the 
removal of H2O2. Thus peroxidases catalyze the reaction and thereby decompose H2O2 
utilizing reducing agents.
SeGPx can remove not only H2O2 but also LOOH. Thus, it functions later than vitamin E. 
It does not prevent the formation of hydroperoxides, but degrades them once they are 
formed. At low H2O2 concentration SeGPx provides the main line of defence, whereas at 
higher toxic levels of H2O2, CAT also starts functioning. SOD and peroxidase or SOD 
and CAT may jointly fulfil the role of a terminal oxidase, catalyzing the reduction of *"02 
to water (McCord and Fridovich, 1978). A selenium-independent glutathione peroxidase 
(SeiGPx) has been isolated, which cannot metabolise H2O2 but only organic peroxides. The 
role of SeGPx is probably in protection against LPO (Holland et al., 1982).
The cellular enzymes described (with the exception of SeGPx and SeiGPx, which attack 
lipid peroxides) remove ROIs directly, thereby inhibiting LPO, which is kept at a 
minimum level. The cellular vitamin antioxidants (C,A,E,K) and thiol-containing 
compounds, ubiquinone, urates, glucose etc. constitute the second line of defence, in 
addition to their participation in the first line via their scavenger activity.
The third line of cellular defence is the decomposition of the end products of LPO (i.e. the 
alkenes, alcohols, epoxides and aldehydes) produced in the degradation of lipid peroxides. 
It has been shown that enzymes that have so far been thought to have the primary function 
of metabolizing xenobiotics, have the capability of metabolizing LPO products. Possibly
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this activity also belongs to their primary functions. For instance, epoxide hydrolase and 
aldehyde reductase have been shown to metabolize peroxidation products, while 
cytochrome P-450 monooxidases have been found to metabolize endogenous lipids and 
prostaglandins. Cytochrome P-450 has multiple functions. It may participate in the defence 
mechanisms against LPO; it may be damaged during LPO, and it may be the source of *“02 
formation. The protective enzymes are mutually interdependent. For example, *“02 inhibits 
CAT and other haeme-containing peroxidases, and SOD provides protection against this 
inhibitory effect. Similarly, two of the three SODs are inactivated by H2O2, while CAT and 
peroxidase provide protection against this inactivation (Fridovich, 1983).
4.7.2 Antioxidant Defence of the Extracellular Space
A very low level of the enzymes participating in cellular defence can be detected in the 
extracellular space. They probably get there by passive diffusion from the interior of the 
cells. Therefore, the defence of the extracellular space against free radical reactions is 
much weaker. In addition only a small fraction of the low serum SOD activity is the result 
of CuZnSOD. Its greatest part is accounted for by a high molecular weight tetrameric SOD 
(CuZnSOD - a dimer) that also contains Cu (four atoms) and probably the same amount of 
Zn. It was believed earlier that this tetrameric SOD only occurs in the extracellular space, 
as indicated by its glycoprotein structure characteristic of most plasma proteins, but not 
found intracellularly. It was, therefore called, extracellular SOD (EC-SOD). However, EC- 
SOD has also been detected in cells. Apart from a few exceptions, it occurs in much 
smaller amounts intracellularly than CuZnSOD and MnSOD. The SOD activity in the 
extracellular space is low in spite of the presence of EC-SOD. This probably reflects a
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“compromise” between the necessary defence of the extracellular space against destructive 
ROIs (e.g. the microbicidal and cytolytic function of phagocytes) and the chemotactic 
activity triggered by *”02 (Marklund, 1984). Ceruloplasmin is a ferroxidase; it oxidizes Fe 
(II) to Fe (III), thereby inhibiting the metal catalysis of LPO. It probably also acts as a 
direct scavenger of *”02. These properties make ceruloplasmin one of the antioxidants of 
the extracellular space. Tf is also believed to be another circulatory antioxidant. As 
opposed to ceruloplasmin, which is invariably saturated with Cu, Tf is saturated with Fe 
only in pathological states. Its antioxidant activity depends on its Fe-free fraction only 
because it is an Fe chelator. An antioxidant action has been attributed to urate and glucose 
in the extracellular space (Sagone Jr et al., 1983).
4.8 CONTROL OF FREE RADICAL REACTIONS
4.8.1 Control and Defence against Free Radical Reactions in Biological Systems
Molecular structures of vital importance, like the cell membrane, DNA and proteins, have 
constituents that are very sensitive to radical reactions, such as the a-methylene carbon 
atom of PUFAs, as well as the allylic hydrogen and the thymidine base.
4.8.2 Control by Membrane Structure
Free radicals formed during electron transport are kept under control by the enzymes and 
carriers of the transport chain, which are bound to the membrane and are closely packed 
together. The PUFAs of the membrane are localized in its hydrophobic region, far from the 
site of electron transport, which takes place in the hydrophillic region. Thus, the protection 
of PUFA is inherent in the membrane structure. This defence may be damaged if the cell
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membrane or mitochondria are injured, giving rise to pathological free radical reactions. 
PUFAs of the membrane phospholipids are “packed” by cholesterol. Hydrogen bonds in 
membranes also provide protection against free radicals. However, hydrophobic chemical 
pathogens (e.g. CC1, DDT, halothane and some carcinogenic substances) can penetrate the 
hydrophobic region and initiate free radical reactions.
4.8.3 Control by Specific Molecular Structure
Some normally occurring free radicals are under control because they are intermediates 
formed during reactions of enzyme-substrate complexes. As a result of their'fixed 
localization and short half-life, they have little chance to interact with other substances. 
The rate of radical reactions is influenced by the amount of membrane unsaturated fatty 
acids and the degree of their unsaturation. These in turn, depend to a lesser extent on the 
fat content of the diet and, predominantly, on genetic factors (Demopoulos, 1973).
4.8.4 Control by Scavengers and Antioxidants
Substances interacting with free radicals and thereby inhibiting free radical reactions are 
called scavengers. These must reach their target at the right time and in the right 
concentrations. Synthetic scavengers used for therapy must be of low toxicity. Also, the 
scavenger radical formed during the interaction of the scavenger with the toxic radical 
intermediates should be less reactive or have a longer half-life than the radical they attack. 
Scavengers show a high degree of selectivity in their reactions with free radicals, which are 
stoichiometric reactions. They should therefore be applied in proper doses (Slater, 1984). 
Scavengers and antioxidants may be enzymes or vitamins.
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Lately, antioxidants have been reported to have a tumour promoter and mutagenic effect 
and radiosensitizing ability. These opposing effects of antioxidants (i.e. carcinogen- 
anticarcinogen) may be accounted for by the dose as well as endogenous factors (i.e. lipid 
peroxides, which have a role in the control of cell division). For example PUFAs in low 
concentrations stimulate mitosis. However, at higher concentrations they produce larger 
amounts of lipid peroxides and have an antimitotic effect. The balance between ROIs and 
the protective systems such as enzyme / vitamin antioxidants acting against them, play an 
important role in carcinogenesis.
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5.0 VITAMINS
5.0.1 Definition
Vitamins are organic compounds required in trace amounts (microgram or milligram 
quantities per day) in the diet, of humans and other animals and are needed for health and 
reproduction. They can be synthesized chemically or isolated from certain plants. Some 
synthetic analogues and derivatives of vitamins have been designed to serve as inhibitors 
(e.g. methotrexate as an antifolate), as have others that substitute part of the natural vitamin 
(e.g. 8-ethylriboflavin and riboflavin). Only small amounts of vitamins are required for 
their function: they often have catalytic (coenzymatic) roles, in contrast to the relatively 
large amounts of such macronutrients as protein, lipid and carbohydrate.
Vitamins are one of the most essential factors that affect the health and development of 
humans. The deficiency of a single vitamin is relatively uncommon. However, it can occur 
as a result of an inborn error of metabolism or as a result of unusual restriction of dietary 
intake. More frequently seen are complex deficiencies that arise as a result of food fads, as 
complications of certain diseases, especially those affecting food absorption, as a result of 
massive loss of blood or haemodialysis, or as a consequence of the use of certain drugs. On 
the other hand, excessive use of vitamins is sometimes encountered.
5.1 VITAMIN A
5.1.1 Chemistry and Source
The two natural forms of vitamin A, retinal and 3-hydroretinol (A2) are C l5- isoprenoid 
alcohols that have a substituted /?-ionone and 3-dehydro-/?-ionone ring, respectively, as 
shown in Figure 8.
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Figure 8 Vitaminic forms of A(, A2 and P-carotene. R=CH2OH for retinol, CHO for 
retinals and C 02H for retinoic acids.
Vitamin A is sensitive to oxygen and UV light. Vitamin A] predominates, especially as 
long chain fatty acid esters, in the liver of mammals and saltwater fish (e.g., in cod liver), 
whereas the biologically less active vitamin A2 is found in fresh water fish oils. The 
structure of the most common and effective provitamin A, /2-carotene, is given in Figure 8.
5.1.2 Requirement and Daily Allowance
Studies in humans indicate that 500 to 600 pg of retinol, or considerably more /2-carotene, 
is the minimum requirement for adults to maintain an adequate blood concentration and to 
prevent deficiency symptoms (National Research Council, 1989). Greater intakes are 
necessary to produce significant liver storage. The recommended daily allowance (RDA) is 
1000 R.E. (retinol equivalents) for adult males and 800 R.E. for females. Based on animal 
studies, the American Institute of Nutrition-93 (AIN-93) fixed vitamin A for laboratory 
rodents at 4000 IU (= 400 R.E) (Reeves PG et al., 1993).
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5.1.3 Absorption, Transport and Metabolism
The emulsification to micelles by bile salts enhances the uptake of various forms of 
vitamin A and provitamin A by mucosal cells of the small intestine. Absorption of the free 
retinol is followed by re-esterification with long-chain fatty acids within the mucosal cells. 
Retinyl esters, in association with chylomicrons, then pass via the lymphatic system to the 
liver and are stored in a lipoglycoprotein complex. Retinol associated with plasma retinol­
binding protein is released from hepatocytes to form, with circulating pre-albumin, a 
molecular aggregate of sufficient size to avoid loss through glomerular filtration. Small 
amounts are stored in the kidney and lung tissues. However, storage of vitamin A is mainly 
hepatic, and the liver can store requirements for approximately 2 years for an adult.
5.1.4 Functions
The best-understood physiological function of vitamin A is its participation as retinal in 
vision. Other forms (retinol and retinoic acid) are necessary for growth of bones, testicular 
and ovarian functions, embryonic development and for regulation of growth and 
differentiation of epithelial tissues. Retinol and retinoic acid may act as cofactors in 
biochemical reactions.
5.1.5 Deficiency
Degenerative changes in the eye or skin are commonly observed in vitamin A deficiency 
(Wilson, 1991). Poor dark adaptation or “night blindness (nyctalopia)” is an early 
symptom, followed by degenerative changes in the retina. Associated skin changes include 
dryness, roughness, papular eruptions and follicular hyperkeratosis.
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5.1.6 Excess
Toxic effects occur with hypervitaminosis A, either as a result of ingestion of excess 
vitamin or as a side effect of inappropriate therapy (Campbell et al., 1980; Wilson, 1991). 
One of the most important factors affecting the toxicity of vitamin A is the form in which it 
is administered, and symptoms can appear more readily after administrating aqueous 
emulsions rather than oily solutions. Hypervitaminosis can occur when the liver storage of 
retinol and its esters exceeds 10,000 IU/g of tissue, a level 10 times the estimated RDA for 
adult males, or if plasma vitamin A levels exceed 140 pg/dl. Moderately high doses taken 
for protracted periods result in chronic toxic effects which can lead to a fattwliver. 
Administration of doses up to three-fold the RDA for several years result in hepatotoxicity 
(Geubel et al., 1991). However, no mutagenicity was found with the Ames test (Bagdon et 
al., 1960; Heywood et al., 1985). In addition, tumorigenicity of /3-carotene was not found 
during a 2-year study period in animals, and in carcinogenicity studies in mice, vitamin A 
was without discernible tumorigenicity (Diplock, 1995).
5.2 VITAMIN E
5.2.1 Chemistry and Source
(^•a-tocopherol is the most biologically active form of vitamin E. Units of vitamin E are 
based on this. This group is made up of 8 related natural compounds that are 
biosynthesized in plants and are abundant in vegetable oils. The chemical structure of 
vitamin E and its related compounds are shown in Figure 9.
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Tocopherois, R -
R' R’
a c h 3 c h 3
0 c h 3 h Tocotrienols, R =
qh3 ch3Y H CH3
6 H H
Figure 9 Vitaminic forms of E
At room temperature, members of this group are viscous oils. They are soluble in lipid 
solvents and insoluble in water, stable in acid and heat in the absence of oxygen, but are 
degraded in alkaline solutions and by UV light.
5.2.2 Requirement and Allowance
The requirement for vitamin E is related to the PUFA content of cellular structures, and 
this depends on the nature and amount of dietary fat, which affects such structures. Hence, 
the minimum adult requirement for vitamin E is uncertain but is probably not more than 3- 
4 mg (4.5-6 IU) for (5-a-tocopherol per day (National Research Council, 1989). When 
vitamin E activity of tocopherois and tocotrienols in mixed diets is calculated, an estimated 
range of 7-13 mg of a-tocopherol equivalents (10-20 IU) can be expected. This intake 
maintains plasma concentrations of total tocopherois within the reference interval of 0.5-
1.2 mg/dl, which also ensures an adequate concentration in all tissues. The requirement for 
rodents is 75 IU/kg diet as indicated in the AIN-93G report (Reeves et al., 1993).
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5.2.3 Absorption, Transport and Metabolism
Twenty to 80 percent of dietary vitamin E absorbed from the gastrointestinal tract 
(duodenum) requires the presence of dietary fat, bile salts and normal pancreatic function 
for effective absorption. Most tocopherols enter the blood stream through the lymph, where 
the tocopherol is associated with chylomicrons and very low-density lipoproteins. The 
vitamin is stored in most tissues, with the largest amount stored in adipose tissues. Up to 4 
years’ requirement can be stored. The rapid exchange of tocopherols occurs between the 
erythrocyte membranes and plasma lipoproteins. Only a small fraction of physiological 
amounts administered appear in urine. Large doses of Fe may increase the" daily 
requirement of vitamin E. Vitamin E may facilitate absorption, hepatic storage, utilization 
and reduction of toxicity of vitamin A. Even though it is thought that large doses of 
vitamin A may even deplete vitamin E stores, evidence from 2319 participants in the 
“Carotene and Retinol Efficiency Trial” given 30 mg /?-carotene/day (50-60 times the 
RDA) and 25,000 IU retinol/day (25 times the RDA) for up to 6 years showed no evidence 
of decreased vitamin E (Goodman et al., 1994). In the present study 10 times the vitamin E 
RDA for rodents was given.
5.2.4 Functions
Vitamin E is considered an essential nutritional element, although its exact function is 
unknown. Vitamin E best serves as an antioxidant for unsaturated fatty acyl moieties of 
lipids within membranes. Oxidative damage of polyunsaturated fatty acyl parts of 
membrane phospholipids can occur as a result of H2O2 production by flavoprotein 
oxidases. Concurrently, this can lead to free radical damage and vitamin E can serve as an
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antioxidant interrupting the initiation step of the LPO reaction. It may also act as a co­
factor in some enzyme systems. A potential role for vitamin E in the prevention or 
treatment of cancer has been suggested. However, efficacy has not been proven.
5.2.5 Deficiency and Excess
Signs of deficiency include irritability, oedema, and haemolytic anaemia. Deficiency 
symptoms rarely occur in children or adults except in cases of severe malabsorption, for 
example, in cystic fibrosis. Toxic responses to high intake of vitamin E in which 
competition for absorption may increase requirements for other fat-soluble vitamins, 
notably D and K, have been recognised in animals. This problem appears to occur in 
humans who already have limited quantities of vitamin K. In general, relatively high doses 
of vitamin E (e.g., 300 mg/day) appear to be tolerated. The toxicity of vitamin E is low, 
and animal studies have shown that vitamin E is not mutagenic, carcinogenic, or 
teratogenic (Diplock, 1995).
5.2.6 Vitamin E and Fibrogenesis
The effect of vitamin E supplementation on hepatic fibrogenesis in chronic dietary Fe 
overload was investigated by Brown et al. (1997). Dietary supplementation with a- 
tocopherol acetate resulted in 1 .2 -2  and 2-2.5 fold increases in both hepatic and plasma 
a-tocopherol levels in the vitamin supplemented group compared to the control. Vitamin E 
supplementation caused a significant reduction of TBARs. Histologically, fibrosis was 
mild in the Fe group and no bridging fibrosis was observed. The results demonstrate 
dissociation between LPO and collagen production and suggest that the profibrogenic
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action of the Fe in this model is mediated through effects that cannot be completely 
suppressed by vitamin E.
5.2.7 Vitamin E, Oxidative Stress and LPO
MDA and cytosolic aldehyde dehydrogenase (ALDH) levels were examined in rat liver 
tissues after feeding different levels of vitamin E and or selenium and PUFAs for 12-38 
weeks. MDA production was significantly increased by vitamin E deficiency or by high 
levels of polyunsaturated fat intake, but not selenium deficiency. ALDH increased upon 
increased production of MDA after 12-16 weeks. However, ALDH activity was suppressed 
after 38 weeks of feeding on the vitamin E deficient diet. The results indicate that hepatic 
cytosolic ALDH may be involved in the metabolism of MDA during a relatively short­
term in vivo LPO increase, but that ALDH activity becomes suppressed after more severe 
in vivo LPO has been produced (Hye-Sung, 1994).
The protective effect of vitamin E and cobalt was examined by Inan et al. (1998). Results 
of the 3-week study on 38 male Wistar rats showed that in vivo cobalt, in addition to 
vitamin E (100 mg/kg b.wt 3x weekly), could function as a potent antioxidant in the 
amelioration of Fe-induced LPO. In the liver, cobalt and vitamin E reduced LPO levels by 
50%. Fe overload however, caused a 70% decrease in cytochrome c oxidase activity, 
leading to reduced ATP synthesis. Accordingly, increased ATP demand caused ATP 
degradation to hypoxanthine and the formation of several new ROS. The concentration of 
hypoxanthine in the liver was found to be 3-4 fold higher than in the controls. However, 
because vitamin E is an inhibitor of LPO, its action as an antioxidant resulted in a decrease
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of hypoxanthine. Furthermore, vitamin E protected the liver tissue from the presence of 
extensive granuloma formation in Fe- overloaded liver tissue more efficiently than cobalt.
5.3 VITAMIN C
5.3.1 Chemistry and Source
L-Ascorbic acid (vitamin C), shown in Figure 10, is a white crystalline solid that is readily 
soluble in water. It is reversibly oxidized to dehydroascorbic acid (ascorbone) (Figure 10), 
and the dehydro form is more readily degraded than the reduced form. Some mammals, 
including humans lack L-gulonolactone oxidase, the enzyme that catalyzes the formation 
of 2-keto-L-gulonolactone, which spontaneously tautomerizes to L-ascorbic acid. The best 
source of vitamin C is in citrus fruits, berries, melons, tomatoes, green pepper, raw 
cabbage, and leafy green vegetables. Losses during processing, especially with heat and 
aerobic conditions, can be considerable.
OH OH
L-Ascorbic acid Dehydroascorbic acid
Figure 10 L-Ascorbic and dehydroascorbic acids 
5.3.2 Requirement and Allowance
An RDA of 60 mg seems adequate to maintain near saturation of tissues in the adult male, 
with a body pool of about 1.5 g. An RDA of 40 to 45 mg is suggested for children.
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5.3.3 Absorption, Transport and Metabolism
Absorption of vitamin C occurs readily, mostly from the stomach, where some of the 
ascorbic acid is converted to the dehydro form. At physiological pH, the uncharged 
dehydroascorbic acid passes across cell membranes faster than the monoanionic L- 
ascorbate. Passive diffusion of vitamin C may largely account for entry into some cells 
such as leukocytes and erythrocytes, but an active transport mechanism may also be 
operative. The half-life for vitamin C in humans is about 16 days. Ascorbate, 
dehydroascorbic acid, and lesser amounts of a number of catabolites are present in the 
urine.
5.3.4 Iron and Vitamin C
Ascorbic acid is known to enhance the availability and absorption of iron from non-heme 
iron sources (Hallberg L, 1981). Vitamin C achieves this effect in the small intestine by 
helping to convert dietary iron from the ferric state (Fe3+) to the more soluble ferrous state 
(Fe2+), and by binding to ferric iron (Fe3+) to form soluble complexes (Bendich & Cohen, 
1990). When body iron stores are low, the enhancing effect of vitamin C on non-haem iron 
absorption is markedly higher than when iron stores are high. It is well known that in the 
presence of redox-active iron, ascorbic acid acts as a pro-oxidant in vitro and might 
contribute to the formation of hydroxyl radical, which eventually may lead to lipid, DNA 
or protein oxidation (Samuni et al., 1983). Thus, ascorbic acid supplementation in 
individuals with high iron and or bleomycin-detectable iron (BDI) in some preterm infants 
could be deleterious because it may cause oxidative damage to biomolecules (Minetti et 
al., 1992; Berger et al., 1995; Halliwell, 1996; Herber et al., 1996). However, no pro­
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oxidant effect was observed on ascorbic acid supplementation on DNA damage in presence 
or absence of iron (Herbert et al., 2000).
5.3.5 Functions
The most clearly established and critical functional role for ascorbic acid is that of a
cofactor for protocollagen hydroxylase, the enzyme responsible for hydroxylation of prolyl
2+and lysyl residues within nascent peptides in connective tissue protein. Absorption of Fe 
is enhanced by simultaneous ingestion of the vitamin.
5.3.6 Deficiency and excess
Protracted deficiency of vitamin C leads to scurvy. Infantile scurvy, also known as 
Barlow’s disease, exhibits a bayonet-rib syndrome. Some scorbutic patients may develop 
anaemia, display radiological changes characteristic of osteoporosis, or die suddenly from 
heart failure. Large doses of ascorbic acid have generally been considered to be non-toxic 
and free of adverse effects except for gastrointestinal symptoms that are experienced by 
some subjects (Dallman, 1990; Campbell et al., 1980). However, more serious adverse 
effects have been observed and are suspected to be potential hazards. Acute, sub-acute, 
chronic, and sub-chronic toxicity of vitamin C is infrequent and is well tolerated without 
side effects (Hanck, 1982). High ascorbic acid intake has no effect on Fe absorption in 
healthy Fe-replete subjects, which repudiates suggestions that Fe overload could be a 
consequence of high ascorbate intake (Cook, 1984). It appears that the regulation of body 
Fe stores is unaffected by any increased availability of Fe from the diet that might be 
caused by the effect of excess ascorbate on Fe. Vitamin C has virtually no adverse effect 
even in patients with hemochromatosis.
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Many reports indicate that ascorbic acid added to cells in culture increases the rate of 
mutagenesis (Rivers, 1989). Detailed reports exist of increased DNA repair, and 
chromosome aberrations in cells cultured in media that included ascorbate (Driscoll et al., 
1999; Mure and Rossman, 2001). However, these effects were shown only in cultures that 
contained Fe3+ or Cu2+, and when steps were taken to ensure low concentrations of these 
metals in the culture medium, no detrimental effect on DNA was observed. In such in vitro 
systems, the mutagenic effect of ascorbate can probably be attributed to the generation of 
oxygen-derived free radicals driven by ascorbate and metal ions. Efficient free radical­
scavenging systems protect DNA in vivo from such effects, and intracellular concentrations 
of ascorbate, and metals (that are efficiently sequestrated on binding proteins), are so low 
and unlikely to be harmful.
5.4 VITAMINS AS ANTIOXIDANTS
Antioxidants may act at different phases of LPO. They may: (a) inhibit the initiation 
process by abstracting the allylic hydrogen from the cr-methylene carbon atom (e.g. 
vitamin E); (b) inhibit the formation of hydroperoxides by chain breakers (e.g. vitamins E 
& C); (c) degrade the hydroperoxides formed without producing radicals by inhibiting the 
metal catalysis and accelerating the decomposition of hydroperoxides (e.g. penicillamine); 
(d) and remove the free radical by scavenger activity (e.g. vitamins E & A) (Hornsby et al., 
1983). Individual antioxidants may act by one or more of the above-mentioned 
mechanisms. Whether a substance behaves as an antioxidant or prooxidant (facilitating 
peroxidation) depends on its concentration and on the environment in which it acts. 
Suppose that a free radical X* is formed in a cell and attacks cell constituent A:
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A’s hydrogen atom is abstracted and paired with X’s single electron. This leads to further 
damaging reactions. Alternatively, antioxidant Z with a scavenger action may capture the 
unpaired electron of X* and the resultant molecule XZ may become reactive. The same 
scavenger molecule Z may, under different conditions, be activated to Z’ after having 
accepted the single electron of X* and may even be more reactive than X*, causing even 
greater damage. Therefore, in using synthetic scavengers it is an important requirement 
that the scavenger radical product of the reaction should be less reactive than the radical to 
be removed. At the same time, reactions in complex in vivo systems are not completely 
predictable. For example, Cu if added to PUFA, facilitates autooxidation. Flowever, Cu- 
complexes in tissues generally but not invariably, behave as antioxidants. Vitamin C is a 
prooxidant at low concentrations in the presence of trace amounts of transition metals (Cu/ 
Fe) (either free or chelates) and reduces the metals, thereby promoting the metal catalysis 
of LPO. At high concentrations, however, when there are sufficient binding sites, vitamin 
C is an antioxidant.
5.4.1 Water-soluble Radical Scavenging Antioxidants
Vitamin C acts as a water-soluble antioxidant, acting against aqueous radicals formed in 
whole blood. In a study by Niki et al. (1990), when whole blood alone was incubated at 
37°C in air, neither antioxidants were consumed nor did oxidation proceed appreciably. 
However, as soon as the water soluble-radical initiator, 2,2’-azobis(amidinopropane) 
dihydrochloride was added, the consumption of water-soluble antioxidants was observed. 
Vitamin C was consumed most rapidly, followed by bilirubin, uric acid and plasma 
vitamin E. As plasma antioxidants were consumed, LOOH formation was observed.
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Vitamin E on the other hand was only slowly consumed at the initial stage (Frei et al., 
1989). These results suggest that vitamin C operates as the first line of the plasma 
antioxidant defence system against ROS. Water-soluble antioxidants are capable of 
scavenging only free, aqueous radicals and cannot scavenge lipophilic radicals within the 
membranes or the lipoproteins. Therefore, once the aqueous radicals attack lipids, for 
example, and the oxidation proceeds within the lipid layer, or when the oxidation is 
induced by the lipophilic radicals formed initially within the lipophilic interior, the water 
soluble antioxidants can no longer suppress the oxidation efficiently.
Vitamin C can act synergistically with vitamin E (McCay, 1985; Niki, 1987). It has been 
observed in fact that vitamin C acts as an efficient antioxidant with vitamin E in the 
oxidation of LDL and phospholipid liposomal membranes induced by lipophilic radicals 
(Sato et al., 1990), although vitamin C by itself is not a good antioxidant in the absence of 
vitamin E. Vitamin C reduces nitroxide radical almost instantaneously in homogenous 
solutions. However, the rate of their interactions becomes less as the nitoxide radical goes 
deeper into the interior of the membrane (Takahashi et al., 1988). These results suggest 
that vitamin E is located near the surface of LDL and membranes.
Vitamin C is a strong reducing agent. It is unstable, readily losing its hydrogen atoms. It 
may act as an antioxidant by interrupting the LPO chain reaction and losing a hydrogen 
atom as it reacts with the ROO* and produces the more stable monodehydroascobate. 
Additionally, it may also have a direct *”02 and *OH scavenger action. When vitamin C 
interacts with ROIs, the product is a mixture of monodehydroascobate and
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dehydroascobinic acid, depending on whether one or two hydrogen atoms are removed 
(Dormandy, 1983; Pottathil et al, 1981).
5.4.2 Lipid-Soluble Radical Scavenging Antioxidants
Vitamin E is known to be an important, lipophilic radical scavenging antioxidant (Burton 
et al., 1985). It scavenges not only lipophilic radicals within the lipid compartment but also 
aqueous radicals attacking membranes from outside. Antioxidant activities of lipophilic 
radical scavengers depend not only on their chemical activities toward oxygen radicals, but 
also on physical factors such as the local concentration and the mobility of antioxidants 
within the specific microenvironment. Furthermore, the antioxidant activity of a- 
tocopherol in membranes is much less than that in solutions, and it decreases as the oxygen 
radical goes deeper into the membrane interior (Takahashi et al., 1989). Apparently, the 
mobility of a-tocopherol is markedly restricted, at least vertically, in membranes. The 
main lipid phase antioxidant activity of vitamin E in the cell membrane occurs through 
hydrogen donation to hydroperoxides. Thus, the formation of hydroperoxides is prevented, 
the chain reaction is terminated, and the extension of the pathological free reaction is 
prevented. In addition, it also scavenges ’Ch. The phytyl side chain of vitamin E is not 
involved in its antioxidant action (Hornsby et al., 1983).
In a study done by Ibrahim et al. (1997), male Swiss-Webster mice fed on vitamin E- 
deficient fish oil diet for 4 weeks had significantly higher levels of TBARs, conjugated 
dienes, and protein carbonyls. The levels of TBARs were further increased by Fe 
supplem entation. Significantly lower concentrations o f a-tocopherol and higher
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glutathione (GSH) were found in the liver of mice fed on fish oil and vitamin E, than the 
other groups. Dietary fat or vitamin E and Fe did not alter the activities of Se-GSH 
peroxidase, non-Se-GSH peroxidase, catalase, and glutathione reductase. In addition, 
dietary fat or vitamin E and Fe did not affect the level of ascorbic acid. These results 
suggest that vitamin E protects not only lipid-soluble compounds, but also water-soluble 
constituents, against oxidative damage.
High levels of dietary vitamin E, however, do not replace cellular glutathione peroxidase 
(GPX1) protection from acute oxidative stress. In a study with GPX1 knockout mic?~and 
wild type mice, dietary vitamin E levels had no apparent effect on the histopathology. High 
levels of vitamin E intake, up to 100-fold daily nutritional needs, could not prevent the 
GPX1 or the wild type mice from paraquat lethality or substantially prolong their survival 
time. Supplementing a-tocopherol acetate at 7500 mg/kg resulted in a decrease in the 
survival of the wild type mice after the paraquat injection. Although vitamin E is 
considered safe at large oral dosages, megavitamin E doses may act as a prooxidant when 
free radicals are continuously generated, as under these experimental conditions. Despite 
the potent inhibition of hepatic LPO, high levels of dietary vitamin E did not replace the 
protection of GPX1 against the paraquat-induced lethality or the diquat-induced plasma 
ALT level increase in mice (Cheng et al., 1999).
Vitamin A plays a role in the differentiation of the epithelial tissue and in growth, and may 
have anticarcinogenic action. Its anticarcinogenic and antioxidant actions may be related to 
its unsaturated fatty acid content, which provides an alternative pathway for LPO. It is also
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a 1 C>2 scavenger, and its metal chelating property contributes to its potential antioxidant and 
anticarcinogenic actions.
5.5 VITAMIN ANTIOXIDANTS IN CANCER PREVENTION
Early epidemiological studies indicated that a diet rich in yellow vegetables is associated 
with decreased risk of cancer (MacLennan et al., 1977; Hirayama, 1979). Peto et al. (1981) 
hypothesized that the beta-carotene present in these vegetables might be responsible for the 
observed decreased in cancer rates. Since then, more than 100 case-control and cohort 
studies have examined the association between the intake of vitamins and the risk of 
developing cancer.
The Chinese Cancer Prevention Study tested the effects of four combinations of vitamins, 
using one-half replicate of a 2x4 factorial experimental design, among 29,548 adults aged 
40-69 years residing in Linxian, China. During the follow-up 2127 deaths occurred, 
including 792 cancer deaths, and 1298 incident cases of cancer. Only one of the 
combinations resulted in a slightly lower incidence of cancer (Blot et al., 1993). In the 
Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study, 29,133 Finnish male smokers, 
aged 50-69 yrs, were given 20 mg P-carotene daily, p-carotene had little or no effect on the 
incidence of cancers (ABCPS, 1994). The Physicians' Health Study randomly assigned 
22,071 healthy US male physicians, aged 40-84 yrs, to P-carotene (50 mg on alternate 
days) or placebo. After treatment and follow-up of 12 yrs, 2566 incident cases of cancer 
occurred. Supplementation with P-carotene had no effect on cancer incidence (Hennekens 
et al., 1996). Similar results were obtained in the P-Carotene and Retinol Efficiency Trial
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(CARET) testing a combination of (3-carotene (30 mg daily) and vitamin A (25,000 IU 
daily) (Omenn et al., 1996; Greenburg et al., 1994).
Adverse effects of P-carotene in cancer prevention studies have been reported (DeLuca and 
Ross, 1996; Albanes, 1999; ABCPS Group, 1994). The conundrum here is that P-carotene 
itself may act as an anticarcinogen, but its oxidized products at high concentrations may 
facilitate carcinogenesis (Wang and Russell, 1999). In a recent study, researchers found 
that vitamins A and E appeared to prevent cancer cells from self-destruction through 
apoptosis (Salganik, 1999; Greenburg et al., 1994). Twenty studies examined the relation 
between blood levels of vitamin E or a-tocopherol and cancer risk (Knekt, 1991; Knekt et 
al., 1991). About one-third of the blood-based studies observed significantly lower levels 
of vitamin E in prediagnostic specimens of subjects who eventually went on to develop 
cancer (total cancer, as well as various site-specific cancers), as compared with controls.
As data in support of or against the use of vitamins as antioxidants continue to increase, it 
may be worthwhile investigating the antioxidant properties of other chemical compounds 
that are capable of trapping ROIs and equally safe for medication. One such compound is 
acetylsalicylic acid (aspirin). The unsaturated double bonds in the benzene ring, does 
suggest that aspirin may have antioxidant properties.
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6.0 SALICYLATES
Salicylates are classified into two groups; acetylated and nonacetylated. Acetylsalicylic 
acid (ASA) or aspirin is the most important salicylic acid of ester derivatives. Salicylic 
acid and its derivatives are absorbed rapidly from the stomach and intestines by passive 
diffusion of undissociated molecules (Cohen, 1976). In addition, food significantly 
prolongs the mean gastric residence time of aspirin as well as the time to reach peak 
salicylate concentrations.
0
Figure 11 Molecular structure of aspirin
6.0.1 Distribution
The distribution of the acetyl group of aspirin is different from that of the salicyl moiety. 
The labile acetyl group is bound to a variety of proteins, glycoproteins, and lipids of the 
liver and other organs (Rainsford et al., 1983). With salicylates the fraction bound to 
albumin decreases with increasing total salicylate concentration (Windorfer et al., 1978). 
At low therapeutic salicylate concentrations in plasma (100 pg/ml), about 90% is bound, 
while at higher concentrations (400 pg/ml), only about 76% of the salicylate is bound 
(Wosilait, 1976). The protein binding of salicylates is also influenced by age and disease. 
Salicylates are present in breast milk and the peak concentration of salicylate in milk is 2% 
to 5% of the peak maternal plasma salicylate concentrations.
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6.0. 2 Metabolism
Aspirin is absorbed and rapidly hydrolysed (in the bowel wall and liver) to salicylic acid. 
Salicylic acid is eliminated from the body by: 1) renal excretion of salicylic acid; 2) 
conjugation with glycine to form salicyluric acid (SU); 3) conjugation with glucuronic 
acid to form salicyl phenolic glucuronide (SPG), salicyl acyl glucuronide (SAG), 
salicyluric acid phenolic glucuronide (SUPG); 4) oxidation to gentisic acid (GA) and 5) 
the formation of gentisuric acid from either SU (through microsomal oxidation) or GA (via 
glycine conjugation). 2,3-dihydrobenzoic acid has been identified in urine and plasma 
following the ingestion of aspirin.
6.0. 3 Elimination
After a small dose of aspirin (i.e., 300 mg or less) about 90% is excreted as SU and SPG 
(Tsuchiya and Levy, 1972). However, after moderate doses, when the amount of 
salicylates in the body is more than about 600 mg, the maximum rate of formation of SU, 
SUPG, and SPG are reached. The amount of salicylic acid in the body increases non- 
linearly with increasing dosage. When the amount of salicylate increases from 250 mg 
(equivalent of one aspirin tablet) to 10 g, the time required for the first 50% of the dose to 
be removed from the body increases from 3 to 20 hours.
6.0. 4 Excretion
Renal excretion of salicylate is through a balance of glomerular filtration, active proximal 
tubular secretion, passive tubular secretion, and passive tubular absorption. The excretion 
of salicylic acid is markedly pH-dependant: as the urinary pH changes from 5 to 8, the
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amount of free ionized salicylate excreted increases from 2% to 3% of the total salicylate 
dose to more than 80% (Smith et ah, 1946). There are several reports of circadian rhythms 
in the urinary excretion of salicylate, with excretion being faster after the drug is ingested 
between 7:00 and 11:00pm (Reinberg et ah, 1975). This increase may in part be related to 
the circadian changes in urinary pH or the increased clearance of salicylate during bed rest 
or prolonged supination (Levy, 1967).
6.0. 5 Drug Interactions
Published drug interactions with aspirin do not include an interaction with Fe and its 
products, although gastrointestinal bleeding may have a negative effect on Fe absorption. 
In addition, reduced Fe levels may be the result of haemoglobin loss.
6.0. 6 Mechanism of action
Injury triggers the production of prostaglandins, hormone-like molecules that causes fever 
and inflammation. Because of the prostaglandins, the nerve endings that are involved 
amplify and bring about recognition of pain. Prostaglandins H2 synthetase (PGHS) is the 
enzyme that synthesizes prostaglandins, and aspirin blocks the production of 
prostaglandins.
6.1 ASPIRIN -  ANTIOXIDANT ACTIVITY AND LPO.
The hydroxylation of aromatic compounds such as aspirin by ROS has been demonstrated
by Richmond e t  a l. (1981). In v itro  studies have also shown that the effect of aspirin on
free radical reactions is metal dependent. Aspirin is able to form metal complexes similar
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to SA, which are able to react with highly reactive *0H radicals (Grootveld and Halliwell, 
1986). The efficiency of this aspirin-*OH-radical-scavenger depends on its binding affinity 
for metal ions (Gutteridge, 1984; Kirkova et al., 1992).
Studies carried out on Wistar rats with varying aspirin doses of 300 mg/kg/d - 500 mg/kg/d 
(Kirkova et al., 1995) showed that LPO, measured by MDA production in aspirin-treated 
rats, was not significantly different from the control. This is contrary to the possible 
antioxidant capacity demonstrated by Gutteridge (1984). However, against the background 
knowledge of significant MDA production in liver homogenates after Fe(II)-induction, the 
effects of aspirin may have been hidden. The lack of significant changes in the H2O2- 
induced MDA production in the erythrocytes of aspirin-treated rats could also be ascribed 
to the high endogenous Fe level in these preparations. Gunther et al. (1991), reported after 
a 5-day oral treatment with 700 mg/kg salicylic acid, that the endogenous MDA level was 
not changed in the erythrocyte but slightly increased in the liver. On the contrary, it is 
known that MDA is one of the products of the enzymic oxidation of arachidonic acid, 
particularly of thromboxane biosynthesis (Hamberg et al., 1975) and that aspirin leads to 
irreversible inactivation of cyclooxygenase. Hence a decrease in MDA could be expected 
after aspirin treatment (Rang and Dale, 1987).
6.2 ASPIRIN AND LIVER PLASMA MEMBRANE
The lipid composition in the cell membrane primarily defines its fluidity, and 
modifications affect important cellular functions such as ion-transport, neurotransmitter 
release and the activity of membrane-bound enzymes (Spector and Yosek, 1985). Although
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some studies suggest that ASA stabilizes lysosomal membranes, others found ASA 
ineffective in stabilizing rat liver lysosomes. Omer et al. (1990) studied the effect of ASA 
on liver membranes, and membrane-bound enzymes. Their results showed that chronic oral 
administration of ASA at 50 mg/kg had no effect on cholesterol and phospholipid levels. 
However, significantly higher cholesterol and phospholipid levels were obtained in the 
group that received 200 mg/kg. Furthermore, raised levels of liver membrane 
phospholipids and cholesterol may be involved in the development of liver injury through 
the peroxidation of PUFAs.
6.3 ASPIRIN AND LIVER
High serum levels of ASA cause liver cell damage. However, the mechanisms remain 
obscure. Takashi et al. (1998) studied the effect of ASA on rat liver tissue. AST, ALT and 
direct bilirubin (D-bil) were not significantly increased at low doses. However, at a higher 
dose of 150mg/kg body wt. per o.s. daily for 3 weeks, the level of y- 
glutamyltranspeptidase (y-GTP) was significantly higher than that of the controls and liver 
damage was observed. In addition, mitochondria isolated (after 7 days) had a larger 
diameter than the controls. Although the mitochondrial change was not significant, it may 
be linked to the uncoupling of oxidative phosphorylation observed in the mitochondria 
isolated from ASA-treated rats (Tomoda et al., 1992).
6.4 ASPIRIN AGAINST CANCER
Most studies done on the anti-cancer potential of aspirin relate to colorectal cancer. 
However, few or no studies have been done in relation to aspirin and liver cancer. It is
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believed that the explanation for aspirin’s anti-tumour effect is that it blocks production of 
substances that may be required for tumour growth (Marcus, 1995) and this may be 
explored in this study.
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7.0 BIOMARKERS OF OXIDATIVE STRESS
7.0.1 Introduction
Epidemiological studies focusing on chronic diseases and antioxidants have in the past 
relied primarily on antioxidant nutrients. This approach, however, is in essence using 
estimates from exposure to a selected group of nutrients for actual oxidative status. 
Emphasis is now being placed on developing functional biomarkers of oxidative stress 
status that integrate the effect of exposure to oxidants with the full range of oxidant 
protective mechanisms in vivo. Such biomarkers being studied include lipids, DNA and 
protein oxidative products.
7.1 BIOMARKERS OF LPO
Oxidation of lipids has been extensively studied and there are more biomarkers available 
for lipid oxidation than for DNA and protein combined.
7.1.1 Thiobarbituric acid-reactive substances (TBARs)
TBARs are one of the earliest markers used in human and animal studies (Buege and Aust, 
1978). The assay of TBARs is a simple spectrophotometric assay that measures the 
chromogen produced by the reaction of thiobarbituric acid (TBA) with MDA, an end 
product of LPO. This is an easy method but non-specific because of other substances such 
as aldehydes reacting with TBA (Handelman and Pryor, 1999). The latter has rendered this 
approach obsolete. A modified version of this method uses HPLC to separate the MDA- 
TBA adduct from other interfering chromogens. This improves the specificity, sensitivity 
and reproducibility (Wong et al., 1987). TBARs can be measured in tissue but are
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generally measured in plasma. Plasma MDA has been reported to respond to alterations in 
antioxidant nutrients (Dixon et al., 1998).
7.1.2 Breath hydrocarbons
The measurement of breath hydrocarbons is another commonly used non-invasive 
approach for investigating LPO in vivo (Knutson et al., 2000). Pentane and ethane, which 
are formed from peroxidation of (n-6) and (n-3) fatty acids, respectively, are volatile 
compounds released into the breath. Potential errors involve contamination with ambient- 
air pentane and ethane (Knutson et al., 2000). In a recent study (Allard et al., 1994),'levels 
of breath pentane were higher in smokers (an oxidatively stressed group) than in non- 
smokers. Breath hydrocarbon levels were reduced in smokers on p-carotene 
supplementation.
7.1.3 LDL oxidation
The oxidative modification of LDL is thought to enhance atherogenicity. For this reason, 
susceptibility of LDL to induce oxidative stress ex vivo has been used as a possible bio­
marker of oxidative defence, at least in the LDL particle itself. Lipid-soluble antioxidants 
are known to be located in LDL in vivo. LDL susceptibility should therefore reflect the 
antioxidant defence system, particularly as it related to lipid substrates and lipid-soluble 
antioxidant compounds. This assay involves challenge to exogenous oxidants. For 
example, Cu is commonly used to induce oxidation and is followed by measuring of lag 
time before oxidation. Consistency of vitamin E to resistance to oxidation has been shown 
(Jialal et al., 1995). In interpreting results based on LDL oxidation, antioxidant efficacy
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and the choice of inducing agents used for both metal ion-dependent (i.e.. cupric ions) 
oxidation and metal ion-independent [e.g. 2 ,2 ’-azobis(2 -amidinopropane)dihydrochloride 
or AAPH] oxidation should be taken into account (Gaziano et al., 1995).
7.1.4 F2 isoprostanes
F2 isoprostanes are produced by free-radical induced peroxidation of arachidonic acid 
(Morrow et al., 1990). These compounds are formed in phospholipids and are cleaved and 
released into the circulation, before excretion into urine as free isoprostanes (Roberts and 
Morrow, 1997). The most abundant F2 isoprostane is 8-isoprostaglandin F2a (8-iso-PGF2a), 
which has been suggested to be a promising marker of oxidative injury (Sodergren et al., 
2000).
Urine is often considered a better matrix than serum for quantifying isoprostane status. 
Aspirin, for example, suppresses 8-isoprostane in serum (Reilly et al., 1996) but not in 
urine samples stored for any length of time, and such samples are generally considered 
inappropriate for isoprostane analysis. For urine samples, standardization of isoprostane 
concentration by creatinine should be considered.
One possible limitation to the use of isoprostanes in epidemiologic studies is that typical 
laboratory analysis depends on gas chromatography /mass spectroscopy (GC/MS) methods 
that are time consuming and therefore expensive for a large sample size. However, GC/MS 
methods have excellent specificity and sensitivity (Handelman and Pryor, 1999). 
Immunological assays, although available, may sacrifice specificity because of possible
1 0 2
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cross-reactions with other prostanoids. Studies of the modulation of isoprostanes are 
available. For example, Reilly et al. (1996) reported that vitamin C administration for 5 
days at 2 g daily to heavy smokers significantly reduced 8-iso-PGF2a in urine. However, 
vitamin E had no effect at either 100 or 800 IU/day.
7.1.5 Ferrous Xylenol orange (FOX) assay
This method is simple and sensitive. Additionally, it is said to give highly reproducible 
results for biological samples. It is reported to outperform the iodometric assay, and other 
assays in terms of simplicity and reproducibility. Finally, very small quantities only of 
samples are required for this assay (Wolff, 1994).
7.1.6 Other related assays
Oxygen radical absorbance capacity (ORAC)(Cao et al., 1993) and total ROO‘-trapping 
(TRAP)(Wayner et al., 1985) take into account the total antioxidant capacity of a system to 
scavenge or trap oxygen radicals. Assays such as ORAC allow investigators to use 
different reactive oxygen species generators to measure total antioxidant capacity of a 
sample under different conditions.
7.2 BIOMARKERS OF DNA OXIDATION
7.2.1 80HdG
This is one of the most common markers used in assessing oxidative DNA damage. This 
compound is sometimes referred to as 8-oxy-7-hydrodeoxyguanosine (8-oxodG). DNA can 
be oxidized to produce many oxidative products. However, oxidation of the C-8 of guanine
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is one of the more common oxidative events, and results in a mutagenic lesion that 
produces predominantly G-to-T transversion mutations. It has been suggested that 80HdG 
could be used as a possible approach to the assessment of the individual’s cancer risk as a 
result of oxidative stress (Kasai, 1997). 80HdG can be measured in human DNA samples 
(i.e. lymphocyte DNA, placental DNA etc) and urine. Several methods for quantifying this 
marker are available. High performance liquid chromatography (HPLC) with 
electrochemical detectors (HPLC/ECD) and CG/MS methods are the most widely used, 
although enzyme-linked immunosorbent assays (ELISA) techniques are also being 
employed (Santella, 1999). HPLC and ELISA methods were compared using placental 
tissue DNA. Values by both methods correlated well, but the ELISA values were higher 
than those determined by HPLC (Loft et al., 1994). This is possibly the result of cross­
reactivity with other compounds other than 80HdG.
The ready availability of urine makes it the preferred sample for epidemiological studies. 
Although convenient, urinary 80HdG also has limitations. 80HdG in the urine is a 
function not only of DNA oxidation (Loft et al., 1994), but also of excision repair. Urinary 
80HdG may be influenced by metabolic rate as well as renal integrity. These factors must 
be taken into consideration especially in intervention studies. Haegele et al. (2000), 
measured lymphocyte 80HdG by HPLC/ECD and urinary 80HdG by ELISA in a 14-day 
fruit and vegetable intervention trial. Results indicated that plasma lutein and |3- 
cryptoxanthin, both of which are xanthophyll carotenoids, were significantly inversely 
correlated with urinary isoprostane excretion (8-iso-PGF2a) and with 80HdG in 
lymphocyte DNA but not with urinary 80HdG. The authors noted the shortcomings
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with the ELISA as extreme variability in the pre-intervention urinary 80HdG values.
7.2.2 Antibodies to oxidized DNA
Serum antibodies to 5-hydroxymethyl-2’-deoxyuridine (HMdU), a product of thymine 
oxidation has been proposed as a possible biomarker of oxidized DNA. Frenkel et al. 
(1998) found that humans produce antibodies to this compound, and titres of anti-HMdU 
can be measured in a simple ELISA assay. This marker was evaluated in blood samples 
from 169 women with samples obtained 0.5- 6 years before diagnosis of breast, colon or 
rectal cancer. Anti-HMdU antibody level was significantly higher in the cases as compared 
to age-matched controls. Limited evidence suggests that dietary supplementation with ci- 
tocopherol (60 or 200 mg/d) can reduce levels of this biomarker (Hu et al., 1999).
7.2.3 Comet assay
The Comet assay, also referred to as the single-cell microgel electrophoresis or SCGE 
assay, was developed to detect DNA strand breaks. Breaks in the DNA allow supercoiled 
loops of DNA to relax and move out to form what looks under the conditions of the assay 
like a Comet with a tail. The proportion of the DNA in the tail is indicative of the extent of 
breaks. Modifications to the Comet assay have been developed that allow for the detection 
of oxidized DNA bases. An intermediate step has been introduced using edonuclease III, 
which induces breaks in the DNA at sites of oxidized pyrimidines (Collins et al., 1993). 
Pool-Zobel et al. (1997) used this modified Comet assay to demonstrate that 
supplementation of the diet with tomato, carrot or spinach products significantly reduced 
endogenous levels of strand breaks in lymphocyte DNA.
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7.3 BIOMARKERS OF PROTEIN OXIDATION
Biomarkers of protein oxidation are often applied when a battery of markers of oxidative 
stress status are being studied. Increased markers of protein oxidation have been associated 
with diseases such as Alzheimer’s disease, Parkinson’s disease, Duchenne muscular 
dystrophy, amyotrophic lateral sclerosis, rheumatoid arthritis and progeria (Stadtman and 
Berlett, 1998).
7.3.1 Protein carbonyls
The biomarker that is generally used to estimate protein oxidation is protein carbonytrThe 
conventional assay is a colorimetric procedure that involves dinitrophenylhydrazine 
(Levine et al., 1990). More recently an ELISA method has been developed (Winterbourn 
and Buss, 1999) that correlates well with the colorimetric assay.
Marangon et al. (1999) investigated the effects of oral supplementation with a-tocopherol 
and lipoic acid on various parameters of oxidative stress in 31 healthy subjects. Lipoic acid 
significantly decreased plasma carbonyl levels after 2 ,2 ’-azobis-(2 -methylpropion- 
amidine)-dihydrochloride (AAPH) induced oxidation, whereas a-tocopherol had no effect 
on plasma carbonyls. Both lipoic acid and a-tocopherol prolonged LDL lag time and 
decreased urinary F2 isoprostanes in their study.
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8.0 METHODS
8.1 SERUM / LIVER IRON DETERMINATION
8.1.1 Principle
Ferric Fe is dissociated from its carrier protein transferrin in an acid medium and 
simultaneously reduced to the ferrous form. The ferrous Fe is then complexed with a 
chromogen, to produce a blue chromophore that absorbs maximally at 595 nm (Ceriotti 
and Ceriotti, 1980).
i.
buffer
Transferrin (Fe3+)2 -----------> 2 Fe 3 + + Transferrin
ii.
Reducing agent
2 Fe 3+ ---------- > 2 Fe 2+
iii. 2 Fe 2+ + Chromogenous compound ----------> Ligand (blue chromophore)
8.1.2 Reagents
Sigma Serum Iron Kit was used that contained the following reagents:
A. Iron buffer reagent: hydroxylamine hydrochloride, 1.5% (w/v), in acetate buffer, 
pH 4.5 with surfactant added.
B. Iron colour reagent: ferrozine, 0.85% (w/v), in hydroxylamine hydrochloride 
solution with stabilizer added.
C. Fe standard: Fe, 500 pg/dl (89 pmoi/1) in hydroxylamine hydrochloride solution.
8.1.3 Sample Preparation for Liver Iron. [The method of Torrance and Bothwell 
(1968) was used].
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An acid solution was prepared as follows:
50 g TCA was dissolved in 200 ml ddl-bO (iron-free) in a 500 ml volumetric flask.
148.5 ml cone. HC1 was gently added and the volume made up to 500 ml. (The 
solution was stored in a dark bottle and was stable for 2 mo).
O.lg of tissue was weighed accurately and divided into 4 or more pieces. This was 
transferred into a test tube and 1.0 ml of acid solution was added. The tube was 
sealed with parafilm and incubated at 65°C for 20 hrs.
A 1:100 dilution of the supernatant (using the iron buffer reagent- hydroxylamine 
hydrochloride, from kit) was made and the tissue iron determined as described 
below. The concentration of tissue iron was corrected for dilution and weight. 
Results were expressed as pg/g wet wt.
8.1.4 Assay Procedure
The procedure was followed according to the manufacturer’s instructions. However, the 
sample and reagent volumes were modified as shown below.
Table 3 Serum and liver iron determination
Sample and Reagents Volume Remarks
Buffer lOOOpl
Sample / Standard / Blank lOOpl ddH-iO was used fnr hlank
Mixed and incubated at 37°C for 5 min
The in itia l abso rb a n ce  o f  th e  sa m p le /s ta n d a rd  
w as rea d  a t 560  n n t a g a in s t the b lank
Chromogen 40pl
M ix e d  a n d  in c u b a te d  f o r  5 m in  a t  37°C . The f in a l  a b so rb a n c e  w a s  r e a d  a g a in s t  b lank. The 
in itia l a b so r b a n c e  w a s  s u b tr a c te d  f r o m  f in a l  a b so rb a n c e  to  g iv e  SA f o r  sa m p le  a n d  sta n d a rd .
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8.1.5 Calculation
8 A  sample
Fe cone, of sample = -............. x Cone.standard
6 A  standard
8.2 ASCORBIC ACID DETERMINATION
8.2.1 Introduction
Ascorbic acid can be determined colorimetrically with 2,4-dinitrophenylhydrazine to form 
the red bis-hydrozone or with 2,4-dichlorophenolo-indophenoI that is reduced to a 
colourless form. Assessment of vitamin C status is generally done by measuring serum 
(plasma) and leukocyte levels of the vitamin. Urinary excretion and red cell concentrations 
have been found to be specific and useful indices of vitamin C status.
8.2.2 Principle
Ascorbic acid in plasma is oxidized by Cu (II) to form dehydroascorbic acid, which reacts 
with acidic 2,4-dinitrophenylhydrazine to form a red bis-hydrazone, which is measured at
5^20-
8.2.3 Reagents and Preparation
Metaphosphoric acid - H 3 P O 4  
H 2 S O 4
2,4-dinitrophenylhydrazine
Thiourea
CuS04
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1. Metaphosphoric acid (HP03) soln : 6.0g/dl (freshly prepared)
30.Og of HP03 in 500ml of dH20.
2. H2SO4 : 4.5 mol/1
250 ml H2SO4 was added slowly to 500ml cold water and made up to 1L 
Because considerable heat was generated, the flask was placed on ice.
3. H2S0 4 : 12 mol/1
650 ml H 2 S O 4  was added slowly to 300ml cold water and made up to a 
volume of 1L and refrigerated.
4. 2,4-Dinitrophenylhydrazine (2,4-DNPH) 2.0 g/dl in 4.5 mol H2SO4
10 g of 2,4-DNPH in H2SO4 was made up to a volume of 500 ml.
This was allowed to stand in a refrigerator overnight and then filtered.
5. Thiourea soln. 5.0 g/dl
5 g thiourea was added to a volume of 100 ml (Stable at 4°C for 1 min).
6 . CuS04 solQ: 0.6 g/dl
0.6 g of anhydrous CUSO4 in dH20  was made up to a volume of 100 ml.
7. Dinitrophenylhydrazine -thiourea-copper sulfate reagent (DTCS)
5 ml Thiourea soln. ]
5 ml CuS04 soln. ] } 4°C ( stable for 1 wk.)
100 ml 2,4-DNPH ]
8. Standards : - All ascorbic acid standards were prepared daily.
A) Ascorbic acid stock standard, 2.0 mmol/1 (In 6.0 g/dl freshly prepared HPO3)
1 1 0
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2.0 mmol/1 = ^
176.13
2.0 x 10'3 M = g
176.13
g = 176.13 x 2.0 x 10'3
= 352.26 x 10'3 
= 0.35g 
= 0.035g / dl
B) Working standard.
V, = M2V2
M,
V, = M2 x 10 ml
2
In seven 10 ml volumetric flasks, the following were pipetted:
0.0200 mmol/1 = 100.0 pi ] Stock ascorbic
0.0175 mmol/1 = 87.5 pi ] acid was used,
0.0150 mmol/1 = 75.0 pi ] and made
0.0100 mmol/1 = 50.0 pi ] up to 1 0 . 0  ml
0.0050 mmol/1 = 25.0 pi ] with freshly
0.0025 mmol/1 = 12.5 pi ] prepared HPO3
0.0010 mmol/1 = 5.0 pi ] soP.
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8.2.4 Assay Procedure
Table 4 Vitamin C determination
Sample and Reagents Volume Rem arks
Freshly prepared H 3P 0 4 500 pi
Sample / Standard / Blank 25 pi ddH.O was used for blank
Vortexed and centrifuged at 2500b for 10 min
Clear supernatant was pipetted 
into screw-capped tubes
480 pi
D T C S 160 pi T u bes w e r e  in c u b a te d  a t  3 7 °C f o r  3hrs
T u bes w e re  r e m o v e d  a n d  c h ille d  on  ice  
f o r  10  min.
Cold 12M H 2S 0 4 800pi T u bes w e re  c a p p e d  a n d  m ix e d  b y  
vo rtex in g .
The f in a l  a b so rb a n c e  a g a in s t  b la n k  w a s  r e a d  a t  5 2 0  nm.
8.2.5 Example of Spreadsheet and Calibration Curve
To correct for the dilution of plasma by HPCb, the concentration of vitamin C in the 
samples obtained from the standard curve was multiplied by 2 1  (dilution factor).
Sri. Abs. Cone. Mean Cone
y=3.5383x-0.0026 (mmol/l)
S1 0.005 0.0021
S2 0.005 0.0021
S3 0.010 0.0036
S4 0.022 0.0070
S5 0.036 0.0109
S6 0.038 0.0115
S7 0.041 0.0123
C1 0.020 0.0064
C3 0.006 0.0024
C5 0.019 0.0061
C4 0.002 0.0013
C5 0.014 0.0047
pmol/l
4.18
1 1 2
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Standard Curve for Vitamin C Analysis
0.08
0.07
0.06
0.05
0.04
0.03
0.02
0.01
0
0 0.005 0.01 0.015 0.02 0.025
Vit C Cone, (mmol/l)
8.3 SUPEROXIDE DISMUTASE (SOD) DETERMINATION
8.3.1 Introduction
The role of SOD is to accelerate the dismutation of the toxic superoxide (*T>2) radicals 
produced during oxidative energy processes to hydrogen peroxide and molecular oxygen.
( 02)2 + 2H -------> H2O2 + O2
8.3.2 Principle
This method employs xanthine and xanthine oxidase (XOD) to generate O2 radicals that 
react with 2-(4-Iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium chloride (I.N.T.) to 
form a red formazan dye. SOD activity is then measured by the degree of inhibition of this 
reaction.
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XOD
Xanthine > Uric acid + *“ 0 2 ...........................(1)
* oK
I.N.T. > Formazan d y e ....................................... (2)
OR
SOD
O f  + *“ 0 2 + 2H+ -----> 0 2 + H20 2 ...................(3)
SOD promotes reaction (3). Therefore reaction (2) is inhibited as a result of insufficient 
*“0 2. The degree of inhibition is directly proportional to the amount of SOD, and inversely 
proportional to the amount of formazan produced.
8.3.3 Reagents and Preparation
Randox Laboratories Ltd. SOD kit was used and the procedure followed according to the 
manufacturer’s instructions. The kit consisted of the following:
A. Mixed substrate made up of xanthine (0.05 mmol/1) and I.N.T. (0.025 mmol/1).
B. CAPS 40 mmol/1; pH 10.2 and EDTA 0.94 mmol/1
C. Xanthine oxidase (80 U/l)
D. SOD standard (5.3 mmol/1)
E. Sample diluent (0.01 mol/1 phosphate buffer, pH 7.0)
Preparation o f Various Standards
The Iyophilized standard (Std) was reconstituted to 10 ml and serial dilutions were 
prepared as follows:
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Vol. of Std. Soln Vol. of sample diluent
S6 Undiluted Std. -
S5 5ml ofS 6 5ml
S4 5ml of S5 5ml
S3 5ml of S4 5ml
S2 3ml of S3 6ml
SI — 5ml
Preparation o f Sample
180 pi of heparinized whole blood was used. Erythrocytes were washed 4 times using 1ml 
normal saline (0.9%) each time. Each wash was centrifuged at 3000 rpm for 10 min and 
the plasma aspirated off.
400 pi of cold ddfEO was then added to the washed cells. This was vortexed and allowed 
to stand for 15 min at 4°C. 10 pi of the lysate was then added to 490 pi of the phosphate 
buffer to achieve a 50-fold dilution factor (df) and a 30% - 60% inhibition of equation (2).
8.3.4 Assay Procedure.
The procedure was followed according to the manufacturer’s instructions with slight 
modifications. The reaction was carried out at 37°C. The absorbance was read against air 
blank at 505 nm.
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Table 5 SOD determination.
Sample and Reagents Volume Remarks
Diluted Sample / Control/ Sample 
diluent (blank)
25 pi
Mixed Substrate (Xanthine /I.N.T.) 850 pi
It was mixed well.
Xanthine Oxidase 125pl
This was well mixed, and t 
absorbance (Aj) was read at 30 s< 
min before reading the final absorl
ie timer started simultaneously. The initial 
jc. The reaction was allowed to proceed for 3 
>ance (A2) at 3:30 min.
8.3.5 Calculation
A2 - A1 
3
5A / min (standard or sample)
Sample diluent rate (SI rate) = rate of uninhibited reaction = 100%
Rates of all standard and diluted samples were converted into percentages of the sample 
diluent rate, and subtracted from 100% to give the percentage inhibition.
(<S4 std/m in  X  1 0 0 )
100 - -------------------------  = % inhibition
.............. (4)
(SA si/min )
A curve of percentage inhibition for each standard against Logio standard concentration of 
SOD U/ml was plotted. Using the percentage inhibition of the sample from equation (4), 
SOD concentration was obtained from the standard curve.
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SOD units/ml of whole blood = SOD units/ml from standard curve x 50 (df) 
Finally, SOD units /g haemoglobin was calculated using equation (5).
SOD units / ml
g haemoglobin
SOD units / g haemoglobin .................. (5)
8.3.6 Example of Spreadsheet and Calibration Curve
Sri. Final Abs Initial Abs8A=A2-A1 5A/min % Inhibition
100-
A2 A1 (d) (5Std x 100 
./ (5AS1/min)
S1 0.057 -0.016 0.073 0.024 21.51
S2 0.048 -0.01 0.058 0.019 37.63
S3 0.018 -0.018 0.036 0.012 61.29
S4 0.001 -0.023 0.024 0.008 74.19
S5 -0.011 -0.024 0.013 0.004 86.02
S6 -0.022 -0.028 0.006 0.002 93.55
C1 0.02 0.009 0.011 0.004 88.17
C2 0.031 -0.009 0.04 0.013 56.99
C3 0.022 -0.012 0.034 0.011 63.44
C4 0.025 -0.01 0.035 0.012 62.37
C5 0.021 -0.01 0.031 0.010 66.67
Log10
Cone.
Anti-Log Mean x
200(Df)=
z
Hb g/dl SOD/g Hb Mean SOD 
( z / Hb/ml)
-0.655 0.22
-0.178 0.66
0.122 1.33
0.423 2.65
0.724 5.30
0.045 1.11 221.8 13.9 1596
-0.243 0.57 114.4 12.5 915
-0.086 0.82 164.3 13.2 1244
-0.112 0.77 154.6 13.8 1121
-0.007 0.98 196.8 14.4 1367 1249
Calibration Curve for SOD for Wistar Rats at 4 mo Age / Iron Overloading
Log 10 Cone.
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8.4 GLUTATHIONE PEROXIDASE (GPx) DETERMINATION
8.4.1 Principle
Glutathione Peroxide (GPx) catalyses the oxidation of glutathione (GSH) by cumene 
hydroperoxide. In the presence of glutathione reductase (GR) and NADPH the oxidized 
glutathione (GSSG) is immediately converted to the reduced form with a concomitant 
oxidation of NADPH to NADP+. The decrease in absorbance as a result of the reaction is 
measured at 340 nm [Paglia and Valentine (1967); Kraus and Ganther (1980)].
2GSH + ROOH __ GPx__^ ROH + GSSG + H20
GSSG + NADP + H+ ___ NADP+ + 2GSH
Randox Laboratories Ltd. commercial kit was used and the procedure followed according 
to the manufacturer’s instruction.
8.4.2 Reagents in Kit
A. Glutathione (4.0 mmol/1)
B. Glutathione reductase (> 0.5 U/l)
C. NADPH (0.34 mmol/1)
D. Phosphate buffer (0.05 mol/1; pH 7.2)
E. EDTA (4.3 mmol/1)
F. Cumene hydroperoxide (0.18 mmol/1)
F. Diluting agent
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8.4.3 Sample Preparation
Heparinized whole blood (25 pi) was diluted with 625pi of the diluting agent. The assay 
was slightly modified for the rat’s blood sample, because the absorbance of the final 
reaction mixture could not be read on the Cobas Mira autoanalyzer. GPx was subsequently 
determined manually.
8.4.4 Assay Procedure 
Table 6 GPx determination
Sample and Reagents Volume Remarks
Diluted sample / Blank / Control 200 pi ddH20  was used as blank
ddH20
500 pi
The ddH2 0  and glutathione/ 
glutathione reductase reagent were 
mixed together before being added 
to the diluted blood sample.
Glutathione / glutathione 
reductase reagent 500 pi
Cumene hydroperoxide 40 pi
This was mixed and the timer started simultaneously. The initial absorbance 
(Al) at 340 nm was read after 1 min and the final absorbance (A2) read at 4 min.
8.4.5 Calculation
GPx concentration was calculated from the following formula:
U/l of haemolysate (diluted sample) = 8412 x 8A 340 nm / min (where 5A =A2-A1).
119
Chapter 8: Materials and Methods
8.4.6 Example of Spreadsheet and Calculations
Sri. In Abs Final Abs 8A 5Ab -SAbsBIk 5Abs/min [GPx]= 8412 x 26 Df Hb g/dl GPx Mean
A1 A2 A 2 - A 1 x 8Abs/min U/dl U/g Hb GPx
Contr 0.738 0.683 0.055 0.034 0.01133 95.3 2479 248
Std 0.764 0.700 0.064 0.043 0.01433 120.6 3135 313
Blk 0.671 0.657 0.014
C1 0.645 0.245 0.400 0.386 0.12867 1082.3 28141 2814 14.0 201.0
C2 0.650 0.266 0.384 0.370 0.12333 1037.5 26974 2697 13.0 207.5
C3 0.644 0.177 0.467 0.453 0.15100 1270.2 33026 3303 14.3 230.9
C4 0.566 0.179 0.387 0.373 0.12433 1045.9 27193 2719 14.9 182.5
C5 0.584 0.162 0.422 0.408 0.13600 1144.0 29745 2974 15.4 193.1 203.0
8.5 CATALASE DETERMINATION
8.5.1 Introduction
Catalase exhibits a dual function. Decomposition of H2O2 to give H2O and O2 [(catalytic 
activity eq. (1)], and oxidation of H donor eg. methanol, ethanol, fomic acid, phenol, with 
consumption of peroxide [peroxidic activity, eq.( 2 )].
2 H2O2
ROOH + AH2
catakse----.> 2 H20 + O2
catalase > h 2o ROH + A
( 1)
(2)
H2O2 and other ROS are increasingly recognized as toxic intermediates in a wide variety of 
pathological conditions. H2O2 is considered a key metabolite because of its relatively high 
stability, diffusion and involvement in cell signaling cascades. Safe disposal of H2O2 in 
cells is carried out by catalases and peroxidases. H2O2 being unmodified and passive can 
diffuse between cell compartments. Its toxicity is traced to the formation of *OH upon
1 2 0
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capture of an electron for instance, from Fe (II) or Cu (II). The *OH reacts immediately 
with almost all cellular compounds giving rise to alterations such as modified or disrupted 
proteins or nucleic acids. Thus, it is understandable why catalases are one of the most 
efficient enzymes known. It is so efficient that it cannot be saturated by H2O2 at any 
concentration.
8.5.2 Principle
The decomposition of H2O2 can be followed directly by the decrease in absorbance at 240 
nm (8240 = 0.00394 + 0.0002 liters mmol_1 mm ''). The difference in absorbance (5A24o) per 
unit time is a measure of catalase activity.
To avoid inactivation of the enzyme during the assay (usually 30 sec), or formation of 
bubbles in the cuvette resulting from liberated O2, it is necessary to use a relatively low 
H2O2 concentration (10 mM). The H2O2 concentration is critical in as much as there is 
direct proportionality between the substrate concentration and the rate of decomposition. 
The dependence of the H2O2 decomposition on the temperature is small, hence that 
measurements can be carried out between 0°C and 37°C. However, 20°C is recommended. 
The pH activity curve relative to Vo has a fairly broad pH optimum (pH 6.8 - 7.5): 
measurements were made at pH 7.0.
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8.5.3 Reagents and Preparation
A. Phosphate buffer, pH 7.0
a) 6.81 g K2P0 4 .......................................  1L (solution‘a ’)
b) 8.90 g Na2HP04.2H20 ..........................1L (solution ‘F)
c) ‘a ’ + ‘F  in ratio of 1:1.5 (v/v)................. (solution^’)
B. Preparation of 30 mM H20 2
0.170 ml 30 % H202, was added to soln. ‘c ’ and made up to 50 ml.
8.5.4 Sample Preparation
Venous blood in heparin, or citrate, was centrifuged at 800 g in 4 vol. of normal saline. 
The supernatant, buffy coats and upper 15% of the packed cells were removed by 
aspiration after each washing. Washing was done 4 times. A stock haemolysate was 
prepared containing * 5g Hb/100 ml by adding 4 parts by vol. of cold ddH20 to the blood 
sample. A 1:500 dilution of the concentrated haemolysate was prepared with phosphate 
buffer immediately before the assay was performed.
100 pi blood was washed with 400 pi normal saline (4 times).
40 pi (packed cells) + 160 pi cold H20 = 200 pi hemolysate
1:500 dilution of the haemolysate was made as ff:
10 pi (haemolysate) + 5 ml PO4 buffer solution ‘c’.
1 2 2
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8.5.5 Enzyme Stability
Catalase in intact erythrocytes and in concentrated haemolysates is stable for up to 6 days 
when kept at 2°C. However, there is a relatively rapid decline of activity in dilute 
haemolysate, which is more likely the result of decomposition of the enzyme into subunits, 
than to proteolytic changes. At a concentration of 1.2 mg Hb/ml the activity decreases by 
10-15% within 24 hrs; at a concentration of 0.06 mg Hb/ml the loss of activity is 10% after 
1 hr and 80-90% after 24 hr. Consequently, haemolysate samples should be analyzed 
within 5-10 min after dilution.
8.5.6 Assay Procedure
Table 7 Blood Catalase determination
Sample and Reagents Volume Remarks
X = 240 nm; Light path 10 
mm. Spectrophotometer was 
zeroed with air blank
Haemolysate 2000 pi In UV cuvette
30% H20 2 in P0 4 buffer 1000 pi The solution was mixed with a 
plastic paddle. The stopwatch 
was started immediately and the 
initial (Al) reading taken at 5 
sec. The final reading (A2) was 
made at 35 sec.
Test was repeated
8.5.7 Calculation
The decomposition of H20 2 initially takes about 30 sec. It follows that of a first order 
reaction with H20 2 concentration between 0.01 and 0.05 M. The rate constant (k) for the 
overall reaction is as follows:
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k = ( 1 /At) (In Si/S2) = (2.3 / A t) log S fS 2
For a time interval of 15 sec, the following relationship is obtained:
k =(2.3/15) ( log Aj/As) (sec -1)
To calculate khnl or klg Hb the following equation was used:
k l  ml = ka
klg Hb = k!m\ (1000/b)
= (2.3 /15) (a/b) (log A,/A2) (sec -1)
A] = A 240 at t = 0, A2 = A 240 at t = 15
a = dilution factor Hb cone, in blood or erythrocyte sediment (ms Hb/rnl)
Hb cone, in cuvette mg Hb/ml.
b = Hb content o f the blood (g/l)
i.e. AA = 0.450 - 4.00 ( log 0.450 ) = 0.05115
0.400
the following relationship holds: 
k = (2.3/Af) (\0 gA\IA2 )
= 0.1175 /At (sec'1)
8.5.8 Example of Spreadsheet and Calculation
Sri In. Ab1 Fi. Ab2 Ab1/Ab2 b=Log10 (2.3/30)*b Cat. Hb=c Df (500) [Cat]=zy Mean [Cat] Mean
Ab1/Ab2 /10-3 x 10-3=y x c=z x 10A -3 [Cat]
C1 0.537 0.419 1.282 0.108 0.00826 8.262 13.9 6950 57418.3
C2 0.545 0.429 1.270 0.104 0.00797 7.969 12.5 6250 49804.2
C3 0.553 0.434 1.274 0.105 0.00807 8.068 13.2 6600 53249.1
C4 0.519 0.435 1.193 0.077 0.00588 5.879 13.8 6900 40562.7
C5 0.511 0.432 1.183 0.073 0.00559 5.592 14.4 7200 40261.3 48259 48.3
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8 . 6  TOTAL ANTIOXIDANT STATUS 
8.6.1. Principle
2,2’-Azino-di-(3-ethylbenzthiazoline sulphonate) (ABTS®), when incubated with a 
peroxidase (metmyoglobin) and H2O2, produces the radical cation ABTS® +. The radical 
cation is a relatively stable blue-green colour that can be measured at 600 nm. However, 
antioxidants present in the sample will react with the cation free radical, thereby reducing 
its concentration and colour development. The level of antioxidants present in the sample
is therefore proportional to the chromogen produced.
HX-Fein + H20 2 -— > X [FeIV -  O] +
ABTS® + X [Felv -  O] ----- > ABTS® + +
HX-Fem = metmyoglobin
X -  [FeIV = O] = ferrylmyoglobin
H20
HX-Fem
8.6.2 Reagents in Kit
A. Phosphate buffered saline (80 mmol/1, pH 7.4)
B. Metmyoglobin (6.1 pmol/1)
C. ABTS® (610 6.1 pmol/1)
D. H20 2 (250 p.mol/1)
E. 6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox)
Randox Laboratories Ltd. TAS commercial kit was used and the test was carried out 
according to the manufacturer’s instructions.
8.6.3 Sample Preparation
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Freshly drawn heparinized plasma was used. Haemolysis was avoided.
8.6.3 Assay Procedure
Table 8  Serum Total Antioxidant Status
Sample and Reagents Volume Remarks
Diluted Sample / Blank / Control 20 pi ddH2 0  was used as blank
HX-Fem / ABTS® 1000 pi
Well mixed and initial 
absorbance (A 1) read at 600 
nm.
h 2o 2 200 pi
This was mixed and the timer started simultaneously. The final absorbance 
(A2) was read after 3 min. This reaction was performed at 37°C.
8.6.5 Calculation
TAS (mmol/1) = Factor x (5A Blk - 8A Sample), where 5A = A2 -  A1
Factor = Standard concentration
(5A Blk - 5A Standard)
8 .6 . 6  Example of Spreadsheet
Sri. Final Abs Initial Abs SAbs 5Blk - 5Abs TAS (mmol/l)
(1,65/8Blk-8Abstd)x6Blk-5AbT
Control 0.132 0.015
Std. 0.002 0.002 0.000 0.297 1.885
Blk 0.297 0.000 0.297 0.000 0.000
C1 0.163 0.005 0.158 0.139 0.772
C2 0.176 0.001 0.175 0.122 0.678
C3 0.152 0.003 0.149 0.148 0.822
C4 0.186 0.010 0.176 0.121 0.672
C5 0.206 0.012 0.194 0.103 0.572
Mean TAS 
(mmol/l)
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8.7 OXYGEN RADICAL ABSORBANCE CAPACITY (ORAC)
8.7.1 Introduction
Several methods have been developed to assess the total antioxidant capacities of various 
biological samples. However, these methods have their shortcomings. The ORAC assay 
depends on the properties of B- or R-phycoerythrin (PE). This assay is to date the only 
method that takes the reactive species (RS) reaction to completion and uses an “area under 
the curve” (AUC) technique for quantification, thus, combining both inhibition time and 
inhibition percentage of the RS action by antioxidants into a single quantity (Cao and 
Prior, 1999).
8.7.2 Principle
The ORAC assay depends on the detection of chemical damage to R-PE through the 
decrease in its fluorescence emission. Under appropriate conditions, the loss of PE 
fluorescence in the presence of RS is an index of oxidative damage of the protein. The 
inhibition against the loss of PE fluorescence in the ORAC assay is a measure of its 
antioxidant capacity against the RS.
8.7.3 Reagents and Preparation
Potassium hydrogen phosphate ( K 2 H P O 4 )
Sodium dihydrogen phosphate (Na^PO,})
B-Phycoerythrin (B-PE)
2.2’-Azobis-(2-amidinopropane) dihydrochloride (AAPH) 
6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox)
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A. 75 mM Phosphate buffer was prepared by dissolving 130.65 g K2HPO4 in 1L 
ddH20  (0.75 M), and 98.99 g NaH2P04 in another liter of ddH20  (0.75 M) 
separately. The 0.75 M K2HPC>4 and 0.75 M NaH2PC>4 were mixed in a ratio of 1:9 
to give a final concentration of 75 mM. The pH was adjusted to 7.0 and all 
solutions were stored at 4°C.
B. 68.0 mg/1 PE was prepared by dissolving 1 mg of PE in 14.7 ml ddH20.
C. 160 mM AAPH was prepared by dissolving 43.39 g AAPH in 1L ddH20.
D. 20 pM, 40 pM, 80 pM and 160 pM trolox standards were prepared by dissolving 
0.005 g/L, 0.01 g/L, 0.02 g/L and 0.04 g/L ddH20  respectively. Standards were 
aliquot into small vials and stored at -70°C.
8.7.4 Sample Preparation
a. Protein fraction: crude liver tissue extract was prepared by homogenizing liver 
tissue in phosphate buffer (1:4 w/v). The soluble fraction was obtained by a-two 
step centrifugation; first at 12,000 g for 10 min, followed by 100,000 g for 15 min. 
The supernatant, (approximately 0.5% w/v protein), was further diluted (1:25) to 
obtain 0.02% protein for the ORAC assay.
b. Non-protein fraction: the crude liver extract of 1:4 w/v was adjusted to 0.5% (5 g/1) 
protein concentration. Acetone was added at the ratio of 1:4 (liver extract : 
acetone). This was centrifuged at 4°C for 10 min and the supernatant was recovered 
for the ORAC assay.
c. Phosphate buffer and Trolox were used for blank and standard, respectively.
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8.7.5 Assay Procedure 
Table 9 ORAC determination
Sample and Reagents Volume Remarks
Phosphate buffer 1750 pi
PE 100 pi
The phosphate buffer and PE were 
preincubated at 37°Cfor 15min.
AAPH 50 pi
Sample / Standard / blank 100 pi The solution was vortexed.
Fluorescence was measured at: 
Ex=540; Em=565
Sample was read every 10 min until 
fluorescence of the last reading was 
5% that of the first.
8.7.6 Example of Spreadsheet and Calculation
A sample table, showing the calculation of trolox equivalent of the absorbance capacity of 
the antioxidants in the sample homogenate is shown below.
Mean(uM mM
60 90 120 140 160 180 200 f140/ f160/ f180/ f200/ P= ([Std] / Trolox Trolox
30min min min min min min min min 120 120 120 120 (0.5+If)x5 ps)xptxDf Units) Units
C1 13.1 8.1 5.8 4.5 3.6 2.9 2.5 2.2 0.800 0.644 0.556 0.489 14.94 10675
C2 13.1 11.0 8.4 6.7 5.6 4.8 4.3 3.8 0.836 0.716 0.642 0.567 16.31 11647
C3 14.2 9.0 6.7 5.3 4.4 3.8 3.3 3.0 0.830 0.717 0.623 0.566 16.18 11557 11293 11.29
160
uM 90.0 72.8 69.3 69.1 69.0 68.8 68.7 68.5 0.999 0.996 0.994 0.991 22.40
Where:
f A fraction of the previous and current time point
Df Dilution factor
[Std] = Standard concentration
(3s [3 of standard
Pt = P of test
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8 . 8  LIPID HYDROPEROXIDE (LOOH) DETERMINATION
8.8.1 Principle
Ferrous oxidation with xylenol orange (FOX VERSION II) is based on the principle of the 
rapid peroxide-mediated oxidation of the Fe2+ to Fe3+ under acidic conditions. The latter in 
the presence of xylenol orange, forms an Fe-xylenol orange complex that can be measured 
spectrophotometrically at 560 nm (Nourooz-Zadeh et al., 1994).
In this method, alkoxyl radicals generated in the ferrous oxidation step react rapidly with 
native lipid, generating further hydroperoxide in a chain reaction (Eqs. 1-4).
ROOH + Fe2+ ----> Fe3+ + RO* + OH' (1)
RO* + RH ----> ROH + R* (2 )
R* + o2 ----> ROO* (3)
ROO* + RH ----> ROOH + R* (4)
R* + BHT ----> RH + BT (5)
Inclusion of the chain-breaking antioxidant butylated hydroxytoluene (BHT) terminates the 
chain reaction. As shown in Eq.(5), BHT presumably repairs alkyl radicals produced by the 
reaction of alkoxyl radicals with unsaturated lipids [Eq. (2)]. Experimentally, BHT at a 
concentration of 4 mM was found to provide a firm endpoint when measuring 
phosphatidyl-choline and low-density lipoprotein peroxide content. The FOX reagent was 
further adopted for the measurement of LOOH by the addition of methanol (90%, v/v) in 
order to solubilize the lipid and BHT. Sorbitol was omitted in the FOX reagent as the high
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concentration of methanol (>25 M) in the revised method made the presence of sorbitol as 
an oxyl radical scavenger superfluous.
8.8.2 Reagents and Preparation
Xylenol orange (XO)
Ferrous ammonium sulfate [Fe(NH4)2(S04)2]
Butylated hydroxytoluene (BHT)
Sulphuric acid (H2S04)
Methanol. HPLC grade. (MeOH)
A. 250 mM H2SO4 was prepared by diluting 13.88 ml cone. H2SO4 (18 M) with 
ddH20  to 1L.
B. 4.4 mM BHT /MeOH was prepared by dissolving 0.97 g BHT in 1L HPLC 
grade MeOH.
C. Stock FOX solution: 1 mM XO / 2.5mM Fe(NH4)2(S0 4)2 in 250 mM H2S04 
was prepared by dissolving 0.76 g XO and 0.98 g Fe(NH4)2(S0 4)2 in 1L 250 
mM H2S04.
D. Working FOX II solution: 1 ml stock FOX II solution was added to 9 ml 
BHT/MeOH solution. This was freshly prepared before use.
E. The following concentrations of H2O2 were prepared using 30% Sigma H20 2 
which is equivalent to 8.82 M:
Stock standard 8.82 mM H2O2 was prepared by diluting 1ml 30% H2O2 (8.82 
M) to 1L. Thereafter, the following standards were prepared:
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4.4 jo.1 of stock standard was made up to 10 ml =3.9 pM
8.8 pi u = 7.81 pM
17.5 pi 66 = 15.62 pM
35.0 pi “ = 31.25 pM
70.0 pi 66 ^ 62.50 pM
8.8.3 Assay Procedure
Table 10 Serum LPO determination
Sample and Reagents Volume Remarks
Plasma / Blank (H20)/ Std 50 pi 1.5 ml microfuee vials were
used and work done in
duplicate
Working F O X  II reagent
950 pi The so lu tio n  w a s  v o r te x e d
It was then incubated at room 
temp, for 30 min
M ic ro fu g e  v ia ls  w e re  c e n tr ifu g e d  a t  
1 2 ,0 0 0  g  f o r  5  min. to  re m o ve  a ll  
f lo c c u la te d  m a te r ia ls
Absorbance of supernatant was read at 
560 nm.
8.8.4 Calculation
The concentrations of the samples were calculated from the calibration curve.
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8.8.5 Example of Spreadsheet and Calibration Curve
Mean Ab Cone. pM
S1 0.009 3.9
S2 0.025 7.8
S3 0.052 15.6
S4 0.113 31.3
S5 0.260 62.5
C1 0.173 43.0
C2 0.197 48.5
C3 0.279 37.6
C4 0.211 31.8
C5 0.118 30.2
Mean Cone.
38.2
c
c
o
CDw
ooc0
A
La
o
to
•Q<
0.3
0.25
0.2
0.15
0.1
0.05
0
-0.05
Cone, of H202 / umol/l
Calibration Curve for Lipid Peroxidation
y = 0.0043x-0.0117 
R!  = 0.9967
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8.9 MALONDIALDEHYDE (MDA) DETERMINATION
8.9.1 Introduction
LPO is a well-established mechanism of cellular injury in both plants and animals, and 
used as an indicator of oxidative stress in cells and tissues. Lipid peroxides are unstable, 
and they decompose to form a complex series of compounds, including reactive carbonyl 
compounds. PUFA peroxides generate MDA and 4-HNE upon decomposition. The 
measurement of MDA and 4-HNE has been used as an indicator of LPO.
8.9.2 Principle
BIOXYTECH® LPO-586™ (OXIS, USA) kit was used and the manufacturer’s instruction 
followed accordingly.
This assay is based on the reaction of a chromogenic reagent, N-methyl-2-phenylindole 
with MDA and 4-hydroxy-alkenals at 45°C. One molecule of MDA reacts with two 
molecules of N-methyl-2-phenylindole to yield a stable chromophore with maximal 
absorbance at 586 nm.
O r r ^ r r ON Ph Ph N
max = 586nm
MDA : R = OH
4-hydroxy-alcenal : R = hydroxyalkyl
Figure 12 Structure of MDA
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8.9.3. Reagents and Preparation
A. 10.3 mM N-methyl-2-phenylindole, in acetonitrile
B. 10 mM 1,1,3,3-Tetramethoxypropane in 20mM Tris-HCL, pH 7.4 (MDA Standard)
C. Methanol, 100% HPLC grade
D. 37% HCI
E. Standard preparation:
The standard concentration of 10 mM stock was diluted 1/100 (v/v) with ddf^O before 
further dilutions as indicated below.
Final concentration of standard (pM) 0.5 1.0 1.5 2.0 2.5 3.0
Volume of 100 pM standard (pi) 0 5.0 10 15 20 25
Volume of ddH20  (pi) 200 195 190 185 180 175
8.9.4 Assay Procedure
The procedure was followed according to the manufacturer’s instructions as shown below. 
ddH20  was used as a blank.
Table 11 MDA determination.
Sample and Reagent
Volume
Remarks
Sample / Standard / Blank 200 pi Microfuge tubes were used
N-methyl-2-phenylindole, in acetonitrile 650 pi The solution was gently vortexed
37% HCI 150 pi The solution was mixed well and 
‘stoppered’.
Tubes were incubated at 45°C for 60 
min
Turbid samples were centrifuged at 15,000 g for 10 min to obtain a clear supernatant. 
Supernatant was transferred into a cuvette and the absorbance read at 586 nm.
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8.9.5 Calculation
A calibration curve of absorbance of standards against standard concentration was plotted. 
The concentrations of the various samples were read from the standard curve.
8.9.6 Example of Spreadsheet and Calibration Curve
Sri. Abs. Blk Abs - Blk Cone. M ean Cone. Cone *5
pM pM
S1 0 0.0
S2 0.068 0.5
S3 0.131 1.0
S4 0.189 1.5
S5 0.252 2.0
S6 0.351 2.5
C1 0.118 0.106 0.012 0.117
C2 0.091 0.030 0.061 0.480
C3 0.081 0.037 0.044 0.354
C4 0.096 0.027 0.069 0.539
C5 0.099 0.036 0.063 0.494 0.397 1 984
0.4 ■ 
0.35 - 
0.3
MDA Calibration Curve at 8mo
W - 0.1391b - 0.0030
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8.10 8-ISOPROSTANE (8-IP)
8.10.1 Introduction
P h o p / i n f l p J d  In C fia iM ! 
f o a f l  rrrmm trr-mrrm) or 
pi Mam* (I I p o p r o t e i n  J
C H ? - 0  I-ft tty A drl 
C H j - O - A w  ( V i r io n *  I
c h 2-o -p o 3- r *
o , '  *
C H ? - 0 - F « t t y  A cad  
C H j - O P « f O K y  A c a d  - 
C H 2 - 0 - P 0 r R *
«  -  (CH2)2N(CH3)3
Wa a r r a n g a m a n t
C H j - O - F a t t y  A c id  
G H j - O - E n d o p e f Q K i d *  
G H j - O - P O j - R *  
B a J u g tf a B  try
»-r p m u iik a n
C H j - O - F a t t y  A cad  
C K j - O - l s o p r a j U i v a a
C H j - O - P O j - R *
4 -ny<*-OKY nooanal 
ottxjr aJdofiyttas
Figure 13 The metabolic pathway for the formation of 8-IP.
8.10.2 Principle
This ELISA procedure is based on the competition between 8-IP in the sample and an 8- 
IP-acetylchoIinesterase (AChE) conjugate (8-IP tracer) for a limited number of 8-IP- 
specific rabbit antiserum binding sites. Because the concentration of the 8-IP tracer is held 
constant while the concentration of 8-IP varies, the amount of the 8-IP tracer that is able to 
bind to the rabbit antiserum will be inversely proportional to the concentration of 8-IP in 
the well. The rabbit antiserum-8-IP complex (either free or tracer) binds to the mouse 
monoclonal anti-rabbit IgG antibody that has been previously attached to the well. The 
plate is then washed to remove all unbound reagents and the Ellman’s reagent (which 
contains the substrate to AChE) is added to the well. The product of this enzymatic
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reaction has a distinct yellow colour that is measured spectrophotometrically at 412 nm. 
The absorbance is directly proportional to the [bound 8-IP Tracer] and inversely 
proportional to [8-IP],
8.10.3 Reagents in Kit
8-IP kit (Cayman Chemicals, USA) was used and the manufacturer’s instructions followed 
accordingly. The kit contained the following:
1. Mouse anti-rabbit IgG coated plate
2. 8-IP EIA antisera
3. 8-IP AChE tracer
4. 8-IP EIA standard
5. EIA buffer concentrate
6. Wash buffer concentrate
7. Tween 20
8. Ellman’s Reagent
8.10.4 Assay Procedure
Reconstitution of reagents was done according to the manufacturer’s instructions 
using Ultra Pure water (from Cayman). In addition, mapping of the plate was 
designed as recommended by the manufacturer. Wells to cater for blanks, “Non­
specific binding” (NSB), “minimum binding” (B0) and “total activity or maximum 
binding” (TA) were incorporated. Assay was performed in triplicates.
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50 pi of standards and samples were added to the appropriate wells.
50 pi of 8-IP AChE Tracer was again added to each well except the TA and the 
blank wells.
50 pi 8-IP antiserum was added to each well except the TA, NSB and blank wells. 
The plate was covered with a plastic film and incubated for 18 hrs at room temp. 
Wells were emptied and washed 5x with the wash solution.
200 pi of Ellman’s solution was added to each well.
5 pi of Tracer was then added to the TA wells.
Plate was again covered with a plastic film and kept in the dark for 60 to 90 min for 
the colour to develop.
The colour typically developed when B0 read 0.3 to 0.8 A.U at 405 nm.
8.10.5 Example of Calibration Curve and Spreadsheet
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Raw Raw Raw Average Corrected
Data Data Data
mU mU
Blk 0.003 -0.003 0
NSB 0.009 0.012 0.0115
Bo 650 665 657.5
TA 313 331 A B
Abs1(mU) Abs2(mU) Corrected Corrected %Abs/Abs(max) Mean A&B 8-IP Dose x DF 0.9 x2 =
8-IP /g
m il mU (-Av.NSB) [%B/Bo] [%B/Bo] (%B/Bo) Cone. (pg/ml) liver
(-0.005)
S1 118 115 129.5 126.5 19.7 19.2 19.5 62.50
S2 140 144 151.5 155.5 23.0 23.7 23.3 31.30
S3 206 197 217.5 208.5 33.1 31.7 32.4 15.60
S4 274 287 285.5 298.5 43.4 45.4 44.4 7.80
S5 334 333 345.5 344.5 52.5 52.4 52.5 3.90
S6 443 431 454.5 442.5 69.1 67.3 68.2 1.95
S7 540 484 551.5 495.5 83.9 75.4 79.6 0.97
S8 562 584 573.5 595.5 87.2 90.6 88.9 0.49
F1 36 26 47.5 37.5 7.2 5.7 6.5 800 720 2397.60
F2 49 33 60.5 44.5 9.2 6.8 8.0 550 495 1648.35
F3 57 68 68.5 79.5 10.4 12.1 11.3 390 351 1168.83
F4 32 30 43.5 41.5 6.6 6.3 6.5 800 720 2397.60
F5 36 90 47.5 101.5 7.2 15.4 11.3 390 351 1168.83
8.11 DNA EXTRACTION FROM TISSUE BY SALTING OUT METHOD (Miller 
et al., 1988)
8.11.1 Principle
This method involves the use of a high salt concentration to dehydrate and precipitate 
cellular proteins, while DNA remains soluble. The DNA obtained from this simple 
technique yield quantities comparable to those obtained from the phenol chloroform 
method and is suitable for most procedures.
140
Chapter 8: Materials and Methods
8.11.2 Reagents and Preparation
A. Buffer A (pH 8.0)
lOmmoI/lTris 1.21 g/1 }
100 mmol/1 NaCl 5.84 g/1 } autoclaved
10 mmol/1 EDTA 3.72 g/1 }
B Rnase: 20 mg/ml (added fresh before every extraction).
C. Proteinase K: 20 mg/ml Buffer A.
D. 10% SDS: lOg SDS was dissolved in 100 ml ddH20 (not autoclaved).
E. NaCl (6 mol/1): 35 g NaCl was dissolved in 100 ml ddH20.
F. Chloroform / Isoamyl alcohol. This was mixed in the ratio of 24:1
G. Chloroform (MERCK).
H. 70% Ethanol: 70 ml absolute ethanol was made up to 100 ml with ddH20 and kept 
ice cold.
I. TE Buffer (pH 7.4): 10 mmol/1 Tris (1.21 g/1), plus 1 mmol/1 EDTA (0.273 g/1)
8.11.3 Assay Procedure
1. 100 mg of tissue, was sliced very thinly with a scalpel blade and added to 5 ml 
buffer A in a 50 ml NUNC tube.
2. 100 pi proteinase K and 20 pi RNase were added to the tissue / buffer A solution. 4 
ml 10% SDS was finally added. The NUNC tube was tightly screwed and 
incubated at 37°C overnight with gently swirling. Where tissue was not well 
digested a little more proteinase K was added and temperature raised to 50°C.
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3. 2 - 3 ml 6 mol/1 NaCl was added. (Although 1.5 ml had been recommended to give 
a final concentration of 1 mol/1).
4. This was gently shaken by continuous inversion for 10 min at 22°C (room temp). 
Where solution was not milky, a little more of the 6 mol/1 NaCl was added.
5. The mixture was centrifuged at 3500 rpm for 15 min at 22°C. The supernatant was 
then transferred into a polypropylene tube.
6. An equal volume of the chloroform/isoamyl alcohol mixture was added to the 
supernatant and mixed gently by inversion for 5 min.
7. This was centrifuged at 3500 rpm for 10 min at 8°C. The supernatant~was 
transferred to another polypropylene tube.
8. An equal volume of chloroform was added and mixed gently by inversion for 5 
min.
9. This was centrifuged at 3500 rpm for 10 min at 8°C. The supernatant was then 
transferred into a sterile polypropylene test tube.
10. Small quantities of isopropanol were added and inverted gently until DNA strands 
precipitated out of the solution. (Approximately 1 tol.5 ml was added).
11. The DNA was hooked out with a sealed hooked Pasteur pipette. The DNA was 
washed for 2 minutes in cold 70% ethanol by dipping the hooked DNA into it. This 
was then transferred to 200 pi TE buffer.
8.11.4 Verification of DNA
1. 50 ml 1% agarose gel was prepared.
2. 3 pi ethidium bromide was added to the molten gel at about 50°C.
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3. The gel was run in 1% TBE buffer. 5 grl DNA and bromophenol blue dye were used 
alongside a 50 kb ladder.
4. A voltage of 85 V and 56 mA current was applied for about 2 hrs.
5. The gel was viewed under UV to ascertain the presence of the rat liver DNA.
8.12 FLUORIMETRIC ANALYSIS of DNA UNWINDING (FADU)
8.12.1 Introduction
The technique adopted was a combination of the following:
a. Fluorimetric method for rapid detection of DNA strand breaks in human WBC 
produced by low doses of radiation (Birnboim and Jevcak, 1981).
b. Increased unwinding of hepatic double-stranded DNA (dsDNA) in rats with 
chronic dietary iron overload (Edling et al., 1990).
c. Assessment of DNA damage and repair in human peripheral blood mononuclear 
cells (PBMC) using a novel unwinding technique (Kristina Elmendorff- 
Dreikorn, 1999).
8.12.2 Principle
When DNA is exposed to moderate alkali solutions, breaks occur in the phosphodiester
backbone and the two strands unwind. Ethidium bromide (or PicoGreen) will selectively
bind to the double-stranded DNA (dsDNA) in the presence of single-stranded DNA
(ssDNA) when short duplex regions in the ssDNA molecules are solubilized by alkali.
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It has been observed that the rate of unwinding of large DNA molecules in alkali is 
increased by prior exposure of cells to ionizing radiation. This is interpreted to mean that 
radiation induced DNA strand breaks are responsible for the increase in the rate of 
unwinding and, conversely, that increase in the rate of unwinding is a sensitive measure of 
strand breaks.
0.5 g Liver was pressed into 1.5 ml EDTA buffer and gently homogenized. Following 
sedimentation on ice, aliquots of the supernatant were mixed with lysis buffer containing 
PicoGreen and incubated with NaOH to induce unwinding of the DNA. After 1 hr the rate 
of fluorescence was measured at Ex: 480 nm and Em: 520 nm.
8.12.3 Reagents and Preparation
A. TE Buffer: Tris-HCL + EDTA, pH 7.4.
10 mM Tris-HCL and 1 mM EDTA was prepared by weighing the following and 
dissolving into 1L ddH20: 1.576 g Tris-HCL and 0.292 g EDTA (pH = 10.0).
B. Stock lysis solution, pH 10.0
The 9.0 M Urea stock lysis solution was prepared by weighing the following and 
dissolving into 1L double distilled water:
540.54 g Urea 
1 gSDS (0.1% SDS)
58.44 g EDTA (0.2M EDTA)
C. 0.025 M NaOH. This was prepared by dissolving 1 g NaOH in 1L dH20
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D. Lysis-PicoGreen solution:
This was freshly prepared by adding 200 pi of PicoGreen to 10 ml of Stock lysis 
solution. The resulting solution was protected from bright light.
E. Liver homogenate:
0.5 g fresh liver was gently homogenized in 1.5 ml TE buffer using the lowest 
speed (1) of Ultra Turax T8 homogenizer for 30 sec. Samples were allowed to 
sediment for 1 hr on ice.
8.12.4 Assay Procedure 
Table 12 Determination of FADU
Sample and Reagents Micro Macro Remarks
Liver Extract / Blank (TE buffer) 25 pi 250 pi
Lysis-PicoGreen Solution 25 pi 250 pi
Added very slowly 
without mixing or 
shaking
Incubated on 
ice /  in the dark for 
1  hr
0.025 M NaOH Solution 25 pi 2500 pi
Fluorescence Measured at: 
Ex=480 nm; Em=520 nm
Fluorescence was 
measured every 
5 min for 1 hr.
8.12.5 Example of Spreadsheet and Calculation
Sri 10min 25min Sf 5f/min Mean
f1 f2 5f/min
C1 64.7 63.7 1.0 0.067
C2 87.4 86.1 1.3 0.087
C3 84 82.5 1.5 0.100
C4 76.9 75.7 1.2 0.080
C5 69.1 67.9 1.2 0.080 0.083
145
Chapter 8: Materials and Methods
8.13 SUPEROXIDE RADICAL ( 0 2) DETERMINATION BY CHEMI- 
LUMINISCENT TECHNIQUES
8.13.1 Principle
Luminescence is the emission of light by non-thermal processes. In the case of 
luminescence analysis, the light is produced by chemical reactions. Molecules responsible 
for emitting the light absorb free energy released by the chemical reaction and become 
‘excited’. In this state some of the peripheral electrons of the molecule are raised to a 
higher energy level. When these electrons lose energy, they return to a lower energy level 
and the energy lost during this transition is emitted as photons. When the electrons have 
lost all their absorbed energy, the molecule then returns to its stable ground state.
The chemiluminophore used for this research is luminol.
LUMINOL OXIDANT a-AMINOPHTHALATE
The luminol interacts with the oxidizing species to produce larger, more measurable 
amounts of light at a peak wavelength of approximately 425 nm. This was measured by a 
four-channel luminometer interfaced with a computer.
8.13.2 Reagent Preparation
A. 1(T4 M luminol stock solution was prepared by dissolving 0.177 g luminol in 100 
mL of 0.1 M borate buffer.
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B. Borate buffer: 0.1 M, pH 9.0 was prepared by dissolving 9.5 g / 250 ml dH20. The 
pH was adjusted to 9.0.
C. 10‘3 M N-formylmethionylleucinylphenylalanine (fMLP) (stock 10 mM in DMSO).
D. Phenol-free Hank’s balanced salt solution (HBSS) (Sigma).
E. Heparinized whole blood was diluted 1:9 with phenol-free HBSS.
8.13.3 Assay Procedure
Table 13 Superoxide radical determination
Sample and Reagents Volume Remarks
1:9 diluted blood sample 500 pi In luminometer cuvette
10 mM luminol solution 200 pi
Resultant solution was loaded onto 
luminometer
fMLP 300 pi Commencement o f  reaction
Graph: 15 sec / division was used.
Temperature setting: 37°C
Graph was displayed on the screen and ensured that baseline had stabilized halfway 
across the first square.
Gain was adjusted as required so that the luminescence curves were within the 
range on the displayed graph.
Once the gain was established, the test was performed at that particular gain setting. 
The peak luminescence was recorded in mV from the point of fMLP addition to the 
end of the graph.
The results were computerized.
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8.13.4 Example of Spreadsheet and Calculation
Sri. Neutrophil T (max) Tmax/ Mean Integral Integr/ Mean Max. 02 Max. 02 Mean
Count x10A9 Neutr Tmax/Neutr Neutr Integr/Neutr. (mV) (mV) / Max.
Neutr. 02(mV)/Neutr
A1 0.97 169.00 174 1182.80 1219 1.843 1.90
A2 0.90 169.00 188 1204.29 1338 1.631 1.81
A3 3.07 169.00 55 2580.03 840 4.858 1.58
A4 1.13 169.00 150 3832.83 3392 7.998 7.08
A5 1.05 338.00 322 178 1854.43 1766 1711 2.445 2.33 2.94
8.14 PULSED FIELD GEL ELECTROPHORESIS (PFGE)
8.14.1 Introduction
Pulse Field Gel Electrophoresis (PFGE) is a technique for resolving chromosome-sized 
DNA molecules. By alternating the electric field between spatially distinct pairs of 
electrodes, megabase (mb) sized molecules are able to reorient and move at different 
speeds through the pores of an agarose gel. PFGE is used to estimate the number of DNA 
double-strand breaks induced by ionizing radiation and other external agencies. It is 
believed that iron overload leads to oxidative stress, which in-tum induces DNA strand- 
breaks through complex processes.
8.14.2 Principle
The CHEF-DR II system (Clamped Homogenous Electric Fields) provides highly uniform, 
or homogenous, electric fields within the gel. This is accomplished using an array of 24 
electrodes that are “clamped,” or held to intermediate potentials to eliminate lane 
distortion.
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Additionally, CHEF generates a 120° reorientation (field) angle because of the hexagonal 
geometry of the electrode array, which is the optimal angle for separating DNA molecules 
ranging from 100 kb to 6 mb in size. Finally the CHEF-DR II system maintains 
homogenous electric fields using patented dynamic regulation (DR). With DR, the 
electrodes not only generate the electric field, but also sense changes in local buffer 
conductivity as a result of buffer breakdown, change in buffer type, gel thickness, or 
temperature. Voltage potentials are readjusted immediately to maintain uniform fields, thus 
ensuring high-resolution separations during runs and between runs.
In this method, pulsed, alternating orthogonal electrical fields are applied to the gel. Large 
DNA molecules become trapped in their reptation tubes every time the direction of the 
electric field is altered and can make no further progress through the gel until they have 
reoriented themselves along the new axis of the electrical field. The larger the DNA 
molecule, the longer the time required for this alignment. Molecules of DNA whose 
reorientation times are less than the period of the electrical pulse will therefore be 
fractionated according to size. The limit of resolution of PFGE depends on several factors 
including the:
* degree of uniformity of the two electric fields
* absolute lengths of the electrical pulses
* ratio of the lengths of the electric pulses used to generate the two electric fields
* angles of the two electric fields
* relative strengths of the two electric fields
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8.14.3 Reagents and Preparation
Tris
Boric acid 
EDTA
Ethidium bromide
1. 150 ml 0.9% agarose gel was prepared by the addition of 150 ml ddEEO to 13.5 g 
agarose and heated in a microwave the resultant mixture. 5 pi of ethidium bromide was 
added to the molten gel at 60°C.
2. Stock IX TBE buffer (pH 7.0) was prepared as follows: Tris-base 21.6 g/1, EDTA 1.86 
g/1, Boric acid 11.0 g/1. This was diluted to obtain 2L 0.5X TBE (IX TBE is 89 mM Tris 
pH = 7.0, 89 mM boric acid, and 2 mM EDTA) running buffer.
8.14.4 Instrumentation
The basic component of a pulsed field gel system consist of: 
gel box with temp, regulation 
switch unit for controlling the electrical fields 
power supply
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8.14.5 Assay Conditions:
CHEF-DR II parameters
- Block used = b-1
- Voltage = 4.5 V
- Time = 17 hrs
- Initial switch time = 0.1 s
- Final switch time 200 s
- Current = 180 mA
- Pump rate = 75
- Temperature = 17-22°C
8.14.6 Assay procedure
Gel was run for 17 hrs on the CHEF-DR II using DNA extracted from the various groups. 
Two from each group was loaded together with a 50 kb marker (marker XV, Boehringer 
Mannhem, USA). A photograph of the gel was then taken after the run.
8.15 8-HYDROXY-2’DEOXYGUANOSINE (80HdG) DETERMINATION
8.15.1 Principle
The 80HdG test is a competitive in vitro ELISA for the quantitative measurements of the 
DNA adduct, 8-hydroxy-2’-deoxyguanosine (80HdG) in tissue, serum and plasma. 
80HdG monoclonal antibody and the sample (liver tissue homogenate) are added to a 
microtiter plate that has been pre-coated with 80HdG. The 80HdG monoclonal antibody
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reacts competitively with the 80HdG in the tissue and 8GHdG immobilized on the 
microtiter plate. Therefore, higher concentrations of 80HdG in the tissue sample will lead 
to a reduced binding of the antibody to the 80HdG on the plate. Antibodies that are bound 
to the 80HdG in the tissue sample are washed away from the antibodies that are bound to 
the 80HdG on the microtiter plate.
An enzyme-labeled secondary antibody that is added to the plate, binds to the monoclonal 
antibody that is bound to the 80HdG coated on the plate. Unbound enzyme-labeled 
secondary antibody is removed by a wash step and the addition of a chromatic substrate 
results in colour development in proportion to the amount of antibody bound to the plate. 
Finally, the reaction is terminated by the addition of 1M phosphoric acid and the 
absorbance read at 450 nm on a microplate plate reader.
o
Figure 14 Structure of 8-hydroxy-2’-deoxyguanosine
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8.15.2 Reagent Preparation
8-OHdG kit (Genox USA) was used. The kit contained the following:
1. 8-OHdG Microtiter plate : precoated with 8-OHdG (8x12 wells, split type).
2. Primary antibody : monoclonal antibody specific for 8-OHdG.
3. Primary antibody solution : phosphate buffered saline.
4. Secondary antibody : horseradish peroxidase-conjugated antibody
5. Secondary antibody solution : phosphate buffered saline.
6. Chromatic solution : 3,3 ’, 5,5 ’ -Tetramethylbenzid ine.
7. Diluting solution : H2O2 / citrate-phosphate-buffered saline.
8. Wash solution (5 times) : 5 times concentrated phosphate buffered saline.
9. Reaction terminating solution : 1M phosphoric acid
10. 8-OHdG standards : 0.5, 2.0, 8.0, 20.0, 80.0, 200.0 ng/ml
8.15.3 Assay Procedure:
The assay procedure is represented by a flow chart on the next page.
Well A1 was designated blank. The primary antibody was not added to this well
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8.15.4 Example of Spreadsheet and Calculation
A standard curve of absorbance against Log10 concentration was plotted as shown below.
Pubs 80HdG levels at 20 months age / Iron overloading
Sri Abs Log 10 Cone Anti-L x 1.5 (DF) Conc/g Liver
S1 2.200 -0.301 0.500
S2 2.210 0.301 2.000
S3 1.980 0.903 7.998
S4 1.570 1.301 19.999
S5 0.850 1.903 79.983
S6 0.470 2.301 199.986
F1 0.749 1.942 87.506 131 263
F2 0.677 2.017 104.032 156 312
F3 0.814 1.884 76.644 115 230
F4 0.701 1.991 97.875 147 294
F5 0.740 1.951 89.276 134 268
Mean 8-OHdG (ng/g)
273
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Calibration Curve A Calibration Curve B
In order to make 'y ’ the subject o f the equation for easy calculation o f ‘x ’ values from 
calibration curve A, logI0 values were plotted on the on the y-axis and absorbance on the 
x-axis (calibration curve B).
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8.16 AMES MUTAGENICITY TEST (Maron and Ames, 1983).
8.16.1 Introduction
Normal metabolism produces oxidants that are by-products. These oxidants such as *“02 
and H2O2, are the same mutagens produced by irradiation that cause damage to DNA, 
proteins and lipids. Two factors are critical for the formation of these mutagens: lesions in 
DNA, formed when DNA is damaged, and cell division that converts DNA lesions to 
mutagens.
8.16.2 Principle
A test for determining if a chemical is a mutagen is the Ames Mutagenicity Test named 
after Bruce N Ames. The Ames test is based on the assumption that any substance that is 
mutagenic (for the bacteria used in this test) may also turn out to be a carcinogen. 
However, some substances that cause cancer in laboratory animals do not give a positive 
Ames test (and vice-versa). The low cost of the test makes it invaluable for screening 
substances.
The bacterium used in the test is a strain of Salmonella typhimurium that carries a defective 
(mutant) gene, making it unable to synthesize the amino acid histidine (His) from the 
ingredient in its culture medium. However, some types of mutations (including this one) 
can be reversed, (a back mutation) with the gene regaining its function. These ‘revertants’ 
are able to grow in a medium lacking histidine. Many chemicals are not mutagenic (or 
carcinogenic) by themselves, but become converted to mutagens (and carcinogens) as they 
are metabolized in the body. For this reason, the Ames test incorporates a mixture of liver 
enzymes.
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8.16.3 The Bacteria Tester Strain
A set of histidine-requiring strains is used for mutagenicity testing. Each tester strain 
contains a different type of mutation in the histidine operon. In addition to the histidine 
mutation, the standard tester strains contain other mutations that greatly increase their 
ability to detect mutagens. One mutation (rfa) causes partial loss of the lipopolysaccharide 
barrier that coats the bacteria and increases permeability to large molecules that do not 
penetrate the normal cell wall. The other mutation (uvrB) is a deletion of a gene coding for 
the DNA excision repair system, resulting in greatly increased sensitivity in detecting 
many mutagens. The deletion excising the uvrB gene extends through the bio-gefie and 
consequently, these bacteria also require biotin for growth. The standard tester strains 
mostly used are TA97, TA98, TA100 and TA102. TA97, TA98 and TA100 contain R- 
factor plasmid, pKM 101. This increases chemical and spontaneous mutagenesis by 
enhancing an error-prone DNA repair system. TA102 contains multicopy plasmid pAQl 
that carries the /iAG428 mutation and the tetracycline resistant gene. In addition, TA100 
contains the hisG46 mutation. The normal gene hisG gene codes for the first enzyme of 
histidine biosynthesis. This mutation substitutes proline f°r leucine ’.cxc'.". Therefore 
TA100, detects mutagens that cause base-pair substitutions primarily at one of these G-C 
pairs.
TA98 contains the /»sD3052 mutation. The normal gene hisD gene codes for histidinol 
dehydrogenase and detects various frame-shift (FS) mutations. These FS mutations can 
stabilize the shifted pairing that often occurs in repetitive sequences or ‘hot spots’ of the 
DNA, resulting in a frame-shift mutation that restores the correct reading frame for
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histidine synthesis. The his D3052 has the seq u en ce^ gcgcgo, 8 repetitive -GC-residues 
near the site of a FS mutation in the hisD gene. The mutation is reverted by i.e. 2- 
nitrosofluorene, daunomycin. TA97 contains the hisD66\0 mutation, plus a second ‘hot 
spot’ of alternating -GC- base pairs near the run of the cytosines. It is sensitive to some of 
the mutagens that revert TA98. TA102 contains the hisG gene that contains the ochre 
mutation 'Jftf;, This strain detects efficiently a variety of mutagens such as formaldehyde, 
glyoxal, hydroperoxides, bleomycin, X-rays, UV light.
8.16.4 Reagent List and Preparation
Oxoid Nutrient Broth No. 2
Bacto Difco Agar
NaCl
L-Histidine
D-Biotin
KC1
MgCl2.6H20
NaH2P04
Na2HP04
NADP
G-6-P04
MgS04.7H20
K2HP04
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NaHNH4P 04.4H20  
Citric acid monohydrate 
Glucose 
Daunomycin 
Ampicillin 
Crystal Violet 
Aroclor -1254 
DMSO
Nutrient broth (autoclaved)
Oxoid nutrient broth 1.25 g
ddH20 50 ml
Nutrient agar plates (contains histidine) (autoclaved)
Oxoid nutrient broth 4.8 g
Bacto agar 9.0 g
ddH20
Top agar (autoclaved)
600 ml
Bacto agar 0.6 g
NaCl 0.5 g
ddH20 100 ml
Vogel-Bonner medium E (VB medium) (autoclaved)
ddH20 670 ml
MgS04.7H20 5g
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Citric acid monohydrate 50 g
K2HPO4 or K2HPO4.5H2O - 250 g or 327.59 g
NaHNH4P04.4H20  
were added in the above order.
78.5 g
were added after each compound had dissolved. 
Minimum glucose plates
Bacto agar 15 g
ddH20
The above-mentioned was autoclaved.
910 ml
added 25X VB medium E 40 ml
added 40% glucose
Histidine / Biotine Solfi (autoclaved)
Per 250 ml
50 ml
D-Biotin (FW 247.3) 30.9 mg
L-Histidine
0.1 M Hitidine soF (autoclaved)
24.0 mg
L-Histidine
0.5 mM Biotin soF (autoclaved)
1.55 g/ 100 ml
D-Biotin
0.1% Crystal violet soF
0.012 g/ 100 ml
Crystal violet 0.01 g
ddH20 10 ml
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Daunomycin
Glucose-6-phosphate (G-6-P)
1 mg / ml
G-6-P - 2.82 g/ 10 ml
Nicotinamide adenine dinucleotide phosphate (NADP) sol2
NADP(FW 765.4) - 383 m g /5  ml
1.65 M KC1 / 0.4 M MgCl2 salt sol2 (Per 100 ml)
KC1 12.3 g
MgCl2.6H20 8.14 g
0.2 M Sodium phosphate buffer (60 ml A + 440 ml B)
0.2M NaH2P 04.H20 13.8 g / 500 ml........... A
0.2M Na2HP04 14.2 g / 500 ml........... B
S9 Mix (rat liver microsomal enzymes + co-factors) for 50 ml
Rat liver S9 (Aroclor-1254-induced) 2.0 ml
KC1 / MgCl2 Salt sol" 1.0 ml
1 M G-6-P 0.25 ml
0.1 M NADP 2.0 ml
0.2 M phosphate buffer 25.0 ml (pH 7.4)
ddH20 19.75ml
S9 was donated by MRC Unit, Tygerberg, Cape Town.
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8.16.5 Characterization of TA97, TA98, TA100, TA102 strains (donated by Ames Lab, 
USA).
A. Upon receipt of discs impregnated with the Salmonella strains, each disc was 
dropped into separate tubes containing 10 ml nutrient broth. This was incubated at 
37°C overnight with shaking.
B. The overnight culture was plated on nutrient agar plates to obtain single colonies 
and incubated at 37°C overnight. (This is referred to as the master plate.)
C. Six culture tubes were filled with 10 ml nutrient broth. Single colonies were 
transferred into each of the tubes and incubated overnight at 37°C with shaking.
D The various markers were performed on each of the tubes and the tube that satisfied 
all criteria was selected. Where none was suitable, a repeat was carried out using 
single colonies from step B.
8.16.5.1 Test for Histidine Requirement
Requirement - Minimum glucose plates
0.1 M Histidine 
0.5 M Biotin 
ddH20  (autoclaved)
Two circles were marked on the bottom of the culture plates and labeled H20  & 
H/B. (Figures 15 and 16a-d, pages 162-165).
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A sterile loop was dipped into autoclaved ddH20  and plated within the H20  circle. 
Similarly, a loop-full of 0.1 M Histidine was plated within the H/B circle followed 
by a loop-full o f  0.5 M  Biotin.
Finally, a loop-full i.e. TA97 from one o f the 6 tubes was plated within the ddthO  
circle and another within the H/B circle.
The a/m procedure was repeated for two other minimum glucose plates. Thus, 
triplicates were produced for each of the 6 tubes.
The whole procedure for each of the 6 tubes of TA98, TA100 & TA102 was 
repeated.
The minimum glucose plates were incubated at 37°C overnight.
8.16.5.2 rfa (Permeability) Test
Requirement - Nutrient agar plates (NA)
Top agar
0.1% Crystal violet soF
The Top agar was placed in a water bath at 45°C.
2.5 ml of Top agar was dispensed into culture tubes and capped.
0.1 ml i.e. TA98 was added to each tube and vortexed for about 5 sec.
This was quickly poured onto the NA plate. The plate was gently swirled to allow 
even distribution.
Work was done in triplicate.
The above procedure was repeated for the other Salmonella strains.
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An HPLC syringe was rinsed with HPLC MeOH. Using the syringe, 10 |ul of the 
crystal violet solution was drawn onto an autoclaved filter paper disc.
The crystal violet-soaked disc was placed in the center of the plate (i.e. TA98 
plate).
For all 6 tubes of TA97, TA98, TA100, TA102, the above-mentioned procedure 
was repeated. Flamed forceps was used to handle sterile filter paper discs.
The Nutrient agar plates were incubated at 37°C for 24 hr. (Figures 15 and 16e-h, 
pages 162-165).
8.16.5.3 uvf5 Mutation Test
Requirement - NA plates.
Work was done in triplicates and plates labeled TA98, TA100 etc.
A line was drawn under each plate (demarcating it into two halves).
A loop-full of i.e. TA 97 from tube 1 was streaked across the plate. In all, 4-6 
parallel streaks were made. Two streaks were made from each tube. In addition, 
streaks were made at right angles to the dividing line. Samples from all 6 tubes of 
i.e. TA97 were treated in a similar manner.
A piece of sterile cardboard or paper towel (sprayed with 70% EtOH) was placed 
across the plate along the vertical line that divided the plate.
The plates were irradiated by a 15W UV lamp for 6 sec at a vertical distance of 
about 33 cm from above (Figures 15 and 16n-p, pages 162-165).
Finally, the plates were incubated at 37°C for 12-24 hrs.
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8.16.5.4 R-factor Test
Requirement - Minimum glucose plates
Top agar
0.5 mM His/Bio soln
10 ml of His/Bio Sola was added to the Top agar held at 45°C.
2.0 ml of the Top agar (with His/Bio) was added to culture tubes (incubating at 
37°C).
0.1 ml of i.e. TA98 (tube 1) was then added to each of the tubes containing the Top 
agar.
This was vortexed for 3 sec and quickly poured onto the Minimum glucose plate. 
The plate was swirled gently and the Top agar allowed settling.
Ampicillin discs (Bacto - sensitivity disc 10 pg 6363-33 DIFCO) was gently 
dropped onto the plates.
The procedure was repeated for all 6 tubes of i.e. TA98, TA100, TA102 & TA97. 
Plates were incubated at 37°C for 48 hr (Figures 15 and 16z-/, pages 162-165).
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Figure 15 Characterization o f Salmonella typhimurium strains using the various markers.
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8.16.5.5 Spontaneous Revertant Test
Requirement - Nutrient agar plates
Top agar
0.5 mM Histidine/Biotin SolQ
Five plates were prepared for each of the 6 tubes from a particular strain i.e. 
TA97(1), TA97(2)......... TA97(6).
The Top agar was incubated at 45°C and the culture tubes at 37°C.
2.5 ml Top agar was dispensed into each (cupped) culture tube under sterile 
conditions.
0.6 ml of the tester strain i.e. TA97(1) was quickly pipetted and 0.1 ml was 
dispensed into the 5 culture tubes.
The culture tube was vortexed for 3 sec and quickly poured onto the Nutrient agar 
plate.
The labeled culture plate was gently swirled on a flat top and allowed to settle.
The above procedure was repeated for all samples and culture plates were 
incubated at 37°C for 48 hrs undisturbed.
Colonies (‘revertants’ against the background lawn) were counted (i.e. Figure 16/, 
page 164).
For TA97, the acceptable range is: 90-180 colonies
TA98, ii 30-50
TA100, a 120-200 “
TA102, a 240-360 “
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Finally, one sample tube from each Salmonella typhimurium strain that strictly passed all 5 
conditions was selected. The selected tube was referred to as “master copies”. Master 
copies were stored at 4°C and used over the next few days. Master plates however, (first 
culture, see 8.16.5 section B) were stored at -70°C for some few months. For long term 
storage the following procedure was followed:
50 ml of Nutrient broth was prepared and autoclaved for each strain.
The Nutrient broth was allowed to partially cool down. This was incubated for 30 
min with continuous shaking at 37°C.
The 50 ml Nutrient broth was inoculated with 1ml of the cultured bacteria from the 
selected tube and incubated for 12 hrs, with continuous shaking at 37°C.
0.09 ml DMSO (filtered through a 0.22 pm filter) was added per 1 ml of culture 
and gently mixed. 1 ml was then aliquot into ‘Nunc’ tubes. This was stored at - 
70°C for years.
8.15.5.6 Mutagenicity Test
The same procedure as that described for the Spontaneous revertant test was used. 
However, 0.1 ml of the suspected mutagenic substance was first added to the 2.0 ml 
Top agar, followed by 0.1 ml of the tester strain i.e. TA97.
Test samples were challenged with 0.1 ml S9 mix. This was added to the Top agar. 
However, in the present study, the addition of S9 mix did not make any significant 
change.
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Figure 17 Summary of the steps involved in the characterization of the Salmonella 
typhimurium tester strains.
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8.17 DETECTIONOF 8-OHdG IN RAT LIVER SECTIONS BY IMMUNO- 
HISTOCHEMICAL TECHNIQUES
8.17.1 Introduction
Free radical species have been shown to play a role in a variety of pathological and 
physiological processes. ROS, such as 02~ *, H2O2, 'OH, '02, can oxidize various tissue 
components leading to the formation of toxic metabolites. Methods have been developed to 
monitor oxidative damage in tissues, and these are based on the qualitative or quantitative 
detection of the secondary products of free radical reactions. Oxidative stress markers 
include oxidized proteins or DNA adducts, or peroxidized lipids. The advantage of 
detecting these secondary products is that, they are less reactive and more stable than the 
free radical species. They are therefore suitable markers for the assessment of the long­
term effects of ROS.
8.17.2 Principle
A specific monoclonal antibody, N45.1 has been used in several immunohistological 
investigations to demonstrate the presence of increased levels of 80HdG in various cell 
types (Hatori et al., 1995; Toyokuni et al., 1997, 1999). Direct photodyanamic activity 
(Kasai et al., 1992), and the actions of ‘0 2 (Devasagayam et al., 1991) and 'OH (Kasai and 
Nishimura, 1984) have been implicated in the hydroxylation of the C8 position of 2- 
deoxyguanosine, to form 80HdG. Methods have been developed to detect 80HdG DNA 
adducts in paraffin sections.
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8.17.3 Reagents
Phosphate buffered saline (PBS), pH 7.4
Xylene
Ethanol
Bovine serum albumin (BSA)
Specific anti-80HdG antibodies (rabbits) 
Biotinylated rabbit IgG (Sigma) 
ExtrAvidin peroxidase (Sigma)
Diamino benzidine (DAB) substrate 
Mayer’s haematoxylin solution 
Entellan mounting medium
8.17.4 Assay Procedure
Rat liver specimens were obtained from rats that were sacrificed at various time points 
after being fed various diet regimens. Paraffin embedded sections were prepared and 
picked up onto slides. Slides were placed in an oven at 56-60°C (but not more than 60°C) 
for 15 min, for antigen retrieval. Sections were immersed in two changes of xylene (5 min 
each) and then into two changes of absolute ethanol (3 min each). They were then rinsed 
briefly with water.
After incubation in PBS for 15 min sections were blocked, for monospecific binding of the 
antibody, by incubation in 5% BSA for 15 min at room temperature. They were then 
covered in a humidified chamber with 300-500 pi of the primary antibody,
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([anti-8-OHdG] = 5 pg/ml) in PBS overnight at room temperature. PBS without primary 
antibody was used as negative control. Slides were then gently rinsed with PBS from a 
wash bottle, and left in the buffer for 5 min. 300 pi of biotinylated secondary antibody 
diluted in PBS (1/300) was applied onto the sections for at least 30 min at room 
temperature. Slides were washed with PBS as above.
Slides were allowed to drain and then covered with 300 pi of ExtrAvidin peroxidase 
diluted in PBS (1:100), and incubated for at least 30 min at room temperature. After 
rinsing briefly with PBS and shaking off excess fluid, the area around the sections was 
carefully wiped. Freshly prepared diaminobenzidine (DAB) substrate mixture was applied 
to cover the sections, and incubated for 5-10 min. Slides were gently rinsed under running 
tap water and after drying they were mounted with the aqueous medium Entellan. They 
were then observed microscopically using 10X and 40X objectives.
8.18 DETECTION OF 4-HNE IN RAT LIVER SECTIONS BY IMMUNOHISTO- 
CHEMICAL TECHNIQUES
8.18.1 Introduction
Selective biochemical methods have been used in qualitative and quantitative 
determination of free radical-induced oxidative stress in various pathophysiologic 
conditions. This has enabled detection of oxidative modifications in tissue homogenates, 
sub-cellular fractions and reconstituted systems. Application of immunohistochemical 
procedures in detecting various biomarkers of oxidative modifications has allowed
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determination of the in vivo distribution of oxidative stress. These methods are based on 
the use of specific antibodies against secondary products of oxidative modification, lipids, 
proteins and DNA adducts formed by these products.
4-HNE is one of the major LPO products generated by free radical attack on o>6 PUFAs. 
The toxic effects of 4-HNE are as a result of interactions with proteins. 4-HNE reacts with 
histidine, lysine or cystein residues of proteins resulting in the formation of stable 
hemiacetal Michaelis addition adducts (Uchida and Stadtman, 1992). 4-HNE protein 
adducts are relatively stable and have been used as markers of free radical-mediated 
damage. 4-HNE shows genotoxic as well as mutagenic effects on cell proliferation 
(Esterbauer and Cheeseman, 1990). Previous studies have demonstrated by 
immunohistochemical methods, the accumulation of 4-HNE-modified proteins in the 
cytoplasm of hepatocytes from the livers of Long-Evans Cinnamon rats (Ma et al., 1997). 
Semi-quantitative analyses of 4-HNE-protein adduct and Fe intensities in histological 
sections have indicated significant positive correlation (Ohhira et al., 1998). Also in the 
above-mentioned study, an increase in 4-HNE-protein adducts was demonstrated in 
sections of human alcoholic liver disease.
8.18.2 Reagents and Equipment
Phosphate buffered saline (PBS), pH 7.4
Xylene
Ethanol
Bovine serum albumin (BSA)
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Specific anti-HNE antibodies (rabbits)
Biotinylated rabbit IgG (Sigma)
ExtrAvidin peroxidase (Sigma)
Diamino benzidine (DAB) substrate 
Mayer’s haematoxylin solution 
Entellan mounting medium
8.18.3 Assay Procedure
The assay procedure is the same as that used for 80HdG (see section 8.17.4). However, 
2 pg/ml anti-HNE primary antibody was used instead.
8.19 LIVER IRON HISTOLOGY
Formalin-fixed liver specimens for histology were embedded in paraffin wax. 1 pm 
sections were stained with haematoxylin-eosin (H & E) and Peris’ Prussian blue stain for 
iron. The degree of iron loading was assessed histologically in coded sections and graded 
on a scale of 0 - 4. Iron-free foci were confirmed by glutathione-sulfhydryl-transferase-7i 
(GST-ti stain).
8.20 ALPHA FETO PROTEIN (AFP)
AFP was determined using an auto-analyser (Advia Centaur) and kits from Bayer 
(Tarrytown, USA).
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8.21 AST / ALT DETERMINATION
AST and ALT were determined using an auto-analyser (Cobas Integra 400) and kits from 
Roche Diagnostics (Indianapolis, USA).
8.22 SERUM COPPER DETERMINATION
8.22.1 Introduction
Cu is an essential trace element in human nutrition and a component of many 
metalloenzymes. Cu is important for the function of ceruloplasmin and for the synthesis of 
melanin and collagen. Cu deficiency is characterized by growth failure and hypochromic- 
microcytic anaemia. Acute Cu toxicity can cause gastroenteritis and acute renal failure.
8.22.2 Principle
At pH 4.7, Cu that bound to ceruloplasmin is released by a reducing agent. Cu then reacts 
with a specific colour reagent, 4-(-3,5-Dibromo-2-pyridylozo)-N-ethyI-N-(3- 
sulphopropyl)- analine, to form a stable colour chelate. The intensity of the colour is 
directly proportional to the amount of Cu in the sample.
8.22.3 Assay Procedure
Cu kit from Randox Laboratories was used. The manufacturer’s instructions were followed 
accordingly.
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8.23 STATISTICAL ANALYSES
The SAS statistical package was used. All data was expressed as + SEM. Statistical 
analysis was performed by independent Student’s t test at the level of 0.05 for paired and 
unpaired data. A probability value of p<0.05 was considered statistically significant. For 
multiple groups, analysis of variance was performed by Bonferroni (Dunn) Multiple 
comparison t Test. Pearson’s correlation coefficient was determined within groups. 
Multiple regression analysis was performed to determine predictive indicators of oxidative 
stress.
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9.0 RESULTS
Results o f analyses are presented in Figures 18-54 (pages 226-246). Colour codes for 
curves in graphs represent the ff:
.^Control group 
jFe + V group 
•Fe + ASA group
9.0. 1 Serum Iron
Figure 18 shows serum iron levels o f iron-overloaded Wistar rats. The curve for the control 
group remained the lowest with a maximum value o f 56.8 + 14.0 pmol/1 at 8 mo and a 
minimum o f 45.7 + 10.3 p mo 1/1 at 24 mo. Curves for all other groups increased and 
remained high with a minor peak at 4 mo followed by a decrease at 8 mo and a sharp 
increase from 8 mo to 16 mo. A plateau was observed after 16 mo. The curve o f the Fe gp 
obtained a maximum serum iron concentration o f 118.4 + 13.3 pmol/1 at 20 mo, the Fe + V 
gp was 123.9 + 12.0 pmol/1 at 24 mo, the Fe -V  gp was 133.6 + 14.2 pmol/1 at 16 mo, the 
Fe + ASA gp was 134.4 + 4.4 pmol at 24 mo and Fe + Cu gp was 129.5 + 41.4 pmol/1 at 
20 mo. The minor peak at 4 mo was not statistically significant. However, the peak 
observed at 16 mo was statistically significant (p=0.05).
9.0. 2 Superoxide free radical (* O2)
Figure 19 shows superoxide radical (* O2 ) levels in iron-overloaded Wistar rats. The curve 
of the control group showed little change and remained the lowest with a maximum o f  
0.402 mV at 2 mo. Thereafter it declined gradually until 20 mo with a minimum o f 0.280 ± 
0.110 mV. The curves o f  the Fe, Fe + V, Fe -  V and Fe + ASA groups were more
Fe group 
Fe -  V group 
Fe + Cu group
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prominent, having peak values of 0.944 + 0.878 mV, 0.880 + 730 mV, 1.220 + 0.650 mV 
and 1.230mV, respectively, at 12 mo. The curve of the Fe + Cu gp on the other hand was 
different with an early peak at 2 mo (0.929mV) and a second peak at 16 mo (0.520 + 0.31 
mV). At 12 mo, the Fe + Cu gp had a low ’“02 value of 0.200mV.
9.0. 3 Glutathione peroxidase (GPx)
Figure 20 shows glutathione peroxidase levels of iron-overloaded Wistar rats. The curves 
of all the groups except the Fe -  V gp had a similar undulating nature. The C and Fe + Cu 
curves remained the highest up to about 10 mo and later the C and Fe + V groups 
continued to be the highest from 14 mo to the end. Peak values occurred at 4 and 16 mo 
and declined between 8 and 12 mo. Differences between 2-4, 4-8 and 12-16 mo were 
statistically significant (p=0.05 ea). Peak GPx values in the various groups were as 
follows: C gp = 214 + 11.9 U/g Hb (4 mo), Fe gp = 179.1 + 16.1 U/g Hb (20 mo), Fe + V 
gp = 228.8 ± 17.6 U/g Hb (16 mo), Fe -  V = 176.9 ± 24.9 U/g Hb (24 mo), Fe + ASA =
189.2 + 30.8 U/g Hb (16 mo), Fe + Cu = 233.8 + 39.6 U/g Hb (4 mo). GPx level of the Fe 
-  V gp declined from 4 mo, reaching its the lowest at 12 mo and increased gradually to a 
maximum at 24 mo. However, it was the lowest at several time points.
9.0. 4 SOD
Figure 21 shows SOD level of iron-overloaded Wistar rats. Curves for all the groups 
including the control group showed an undulating pattern. The C gp remained the highest 
throughout and the Fe -  V gp, the lowest. SOD levels for the Fe + Cu and Fe + V gps were 
directly below the C gp until 16 mo when they declined and were below the Fe + ASA and
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Fe gps. Peak values observed between 12 and 16 mo were as follows: C gp = 2165 + 444 
U/g Hb (12 mo), Fe gp = 1584 ± 360 U/g Hb (16 mo), Fe + V = 1626 ± 199 U/g Hb (12 
mo), Fe -  V = 1242 ± 201 U/g Hb (16 mo), Fe + ASA = 1546 ± 442 U/g Hb (12 mo), and 
Fe + Cu = 1747 + 162 (12 mo). Significant differences were observed between 8 and 12 
mo (p=0.05) and 12 and 20 mo (p=0.05). In addition, significant differences were observed 
between the control and the various groups.
9.0. 5 Catalase
Figure 22 shows catalase levels of iron-overloaded Wistar rats. Generally, curves showed 
increased values at 2 and 8 mo followed by decreased values. The pattern was very close to 
the SOD curves in Figure 21. The control group was the highest throughout with the Fe + 
Cu and Fe -  V gps the lowest. The levels of the Fe + V gp were below that of the C gp, 
and the Fe gp was in the middle of the levels of the other groups. Peak catalase levels were 
as follows: C gp = 66.9 + 7.9 Units x 103/min (8 mo), Fe = 61.0 + 3.7 Units x 10‘3/min (8 
mo), Fe + V gp = 65.2 + 10.7 Units x 10'3/min (8 mo), Fe -  V gp = 48.7 + 4.4 Units x 10" 
3/min (12 mo), Fe + ASA = 51.3 + 2.2 Units x 10"3/min (12 mo), Fe + Cu = 48.8 + 4.8 
Units x 10"3/min (12 mo). The various groups were significantly different for the period 4 - 
8 and 8 - 20 mo (p=0.05; p=0.05, respectively).
9.0. 6 Vitamin C
Figure 23 shows vitamin C levels of iron-overloaded Wistar rats. There was a general 
increase from about 1 p.mol/1 to about 6.5 pmol/1 over 24 mo. Vitamin C levels for the Fe 
and Fe + V gps were mostly the highest, and the Fe + Cu and Fe gps, the lowest. Vitamin
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C levels of the other groups were in-between. These seemingly straight lines declined at 4, 
12 and 20 mo but the decline was statistically insignificant. Significant differences were 
observed between the Fe + V gp & Fe gp, Fe + V gp & Fe -  V gp and Fe + V gp & 
Fe + Cu gp with p=0.05 each.
9.0. 7 TAS
Figure 24 shows Total Antioxidant Status (TAS) of iron-overloaded Wistar rats. TAS level 
for the control group remained the highest before 12 mo and well separated from the rest 
from 10-24 mo. This difference was statistically significant (p=0.05). Between 12 and 16 
mo TAS levels for the Fe gp were below that of the C gp, however, between 16 and 24 mo, 
TAS levels for the Fe + V gp were below the C gp. Furthermore, between 2-4 and 8-16 mo 
TAS levels for the Fe + Cu gp were the lowest. At 24 mo the TAS level for the Fe -  V gp 
was the lowest. Peak values for most groups occurred at 20 mo and were as follows: C gp 
= 0.87 + 0.08 mmol/1, Fe gp = 0.67 + 0.08 mmol/1 (16 mo), Fe + V gp = 0.76 + 0.07 
mmol/1, Fe -  V gp = 0.73 + 0.03 mmol/1, Fe + ASA gp = 0.68 + 0.04 mmol/1, Fe + Cu gp = 
0.73 + 0.05 mmol/1.
9.0. 8 ORAC
Figure 25 shows ORAC of water- and lipid-soluble fractions of iron-overloaded Wister 
rat’s liver homogenate. ORAC-A and ORAC-L were in the ratio of about 4:1. Curves for 
ORAC-A showed peaks at 12 mo whilst ORAC-L showed peaks at 20 mo. Differences 
between the various groups appeared after 12 mo. In both cases, the curve for the control 
group was the lowest and the Fe + Cu gp the highest except at 12 mo when the curve for
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the Fe gp of the ORAC-A fraction was the highest. In addition, both curves (ORAC-A and 
ORAC-L) appeared to operate in an inverse relationship. When ORAC-A curves were at 
peak values, ORAC-L curves were low. Conversely when ORAC-L curves were at peak 
values, ORAC-A curves were low. The correlation analysis showed a negative correlation 
between ORAC-L and ORAC-A in the C and Fe + ASA groups (r= - 0.39, p=0.0412; r= - 
0.42, p=0.0235, respectively).
9.0. 9 MDA
Figure 26 shows MDA levels of iron-overloaded Wistar rats. Generally MDA valueswvere 
low from 2-12 mo. All other groups apart from the C gp showed increases after 12 mo. 
MDA level for the C gp was the lowest and fairly straight with a maximum value of 6.1 +
1.5 pM. The steepest curve was seen in the Fe gp with a maximum MDA value of 55.5 +
39.8 pM (24 mo). Curves for the Fe + ASA and Fe + Cu gps clustered with maximum 
MDA values of 42.5 + 23.5 pM and 39.5 + 1.4 pM, respectively, at 24 mo. Similarly, the 
curves of the Fe + V and Fe - V gps also clustered with maximum values of 25.3 + 8.0 pM 
and 28.4 + 21.7 pM, respectively.
9.0. 10 8-IP
Figure 27 shows 8-IP level of iron-overloaded Wistar rats. The curve for the C gp was the 
lowest and relatively straight. The maximum value for the C gp was 590 + 194 ng/g liver 
wt. 8-IP levels for all other groups were well above the C gp. 8-IP levels of the Fe + Cu gp 
were far above the rest with a hyperbolic curve. A maximum value of 12940 + 4173 ng/g 
liver wt was obtained at 16 mo. This value compared to the C gp was statistically
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significant (p=0.05). 8-IP levels for the rest of the groups were between the two extremes 
with relatively no differences up to 12 mo and beyond 20 mo. Differences seen between 12 
and 20 mo were statistically significant (p=0.05). Peak values of the Fe gp and Fe + ASA 
gp were 4102 + 2464 ng/g and 2280 + 1172 ng/g liver wt., respectively.
9.0. 11 FADU
Figure 28 shows Fluorimetric Analysis of DNA Unwinding of liver homogenate of iron- 
overloaded Wistar rats. Generally there was relatively no difference amongst the various 
groups up to 12 mo. Thereafter the rate of DNA unwinding of the various groups increased 
sharply apart from the control group. The rate of DNA unwinding of the control group 
remained the lowest with a maximum value of 0.096 + 0.062 units / min. DNA unwinding 
of the Fe + Cu gp was the highest with a maximum value of 0.268 + 0.062 unit / min. The 
rate of DNA unwinding for all other groups were in-between with maximum values as 
follows: F gp = 0.210 + 0.033 unit/min, V gp = 0.198 + 0.071 unit/min, Fe -  V gp = 0.178 
+ 0.027 unit/min, Fe + ASA gp = 0.226 + 0.069 unit/min. The rates of DNA unwinding 
between 12 and 20 mo for all groups were statistically significant (P=0.05).
9.0. 12 LPO
Figure 29 shows Lipid hydroperoxides (LOOH) of iron-overloaded Wistar rats. There was 
virtually no difference in serum LOOH values amongst the various groups for the first 
twelve months. Thereafter LOOH levels for all groups apart from the C gp increased 
sharply and attained peak values at 20 mo. LOOH levels for the C gp were the lowest and 
did not show any peak value. The maximum LOOH value of the C gp was 44.8 + 8.4 pM
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(24 mo). The Fe + Cu gp was the highest with a peak value of 133.3 + 33.2 pM. LOOH 
levels for the various groups were between the C and Fe + Cu gps with peak values as 
follows: Fe gp = 102.2 + 34.3 pM, Fe + V gp = 95.2 + 40.7 pM, Fe -  V gp = 78.2 + 17.9 
pM, Fe + ASA gp = 113.9 + 36.0 pM. Differences between the various groups compared 
to the C gp were statistically significant (p=0.05).
9.0.13 80HdG
Figure 30 shows liver 80HdG levels of iron- overloaded Wistar rats. The curves for all 
groups had a winding pattern with low values at 8 mo. 80HdG level of the C gp was the 
lowest with a first peak at 4 mo. A second peak was seen at 12 mo with liver 80HdG 
concentration of 170 + 64.8 ng/g liver wt. The curve of the C gp was fairly flat after 16 mo. 
The curve of the Fe gp (immediately above that of the C gp) increased from 8 mo and 
attained a maximum value of 370 + 32 ng/g liver wt at 24 mo. 80HdG level for the Fe + V 
gp was high after 8 mo and had a peak value of 346 + 117 ng/g wt at 20 mo. Curves for the 
Fe -V  and Fe + ASA gps, clustered. However, the former showed a peak 80HdG value at 
16 mo (504 + 25 ng/g wt) and the latter, at 20 mo (523 ± 208 ng/g wt). Both curves 
showed a sharp decline thereafter. 80HdG levels of the Fe + Cu gp showed an early peak 
at 4 mo (80HdG = 376 + 70 ng/g wt). This declined sharply at 8 mo and increased again to 
a second peak value of 562 + 180 ng/g wt at 20 mo and gradually declined until 24 mo. 
80HdG levels of most time-points between 12 and 20 mo were statistically significant 
(p=0.05).
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9.0. 14 AMES mutagenicity test
Figure 31 shows Ames mutagenesis test, using fractionated Wistar rat liver homogenate on 
Salmonella typhimurium strain TA 102. The level for the C gp was fairly straight with a 
maximum value of 365 revertant colonies. The curve for the Fe + Cu gp showed a steady 
increase from 2 mo to a peak value of 588 revertant colonies at 20 mo. The rest of the 
curves for the various groups clustered until 16mo, and showed peak values at 20 mo. Peak 
values were as follows: Fe = 662 - ,  Fe + V = 665 - ,  Fe -  V = 643 -  and Fe + ASA= 582 
revertant colonies. Significant differences occurred between 16 and 24 mo (p=0.05).
9.0. 15 AST
Figure 32 shows serum AST levels of Fe-overloaded Wister rats. AST levels of the C gp 
remained the lowest with values in the region of 100 IU. AST levels for the other groups 
showed a gradual increase after 12 mo. The curve for the Fe + V gp was next to that of the 
C gp with a maximum value of 117 + 22 IU (20 mo). The Fe + Cu gp remained the highest 
with a maximum value of 537 + 138 (20 mo). Curves for the Fe + ASA, Fe -  V and Fe gps 
had maximum serum AST values of 364 + 96 IU, 329 + 49 IU, 310 + 61 IU, respectively, 
and clustered in-between the curves of the Fe + Cu and Fe + V groups. Significant 
differences (p=0.05) occurred between 12 and 20 mo. The spotted data (Table 8y, 
Appendix F) show some AST (and ALT) values above 4000 IU.
9.0.16 ALT
Figure 33 shows serum ALT levels of Fe- overloaded Wistar rats. The curve for the C gp 
was fairly straight and the lowest with a maximum ALT value of 65 IU. ALT levels of the
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other groups increased slightly until 12 mo, and thereafter increased sharply. ALT levels 
for the Fe + Cu and Fe + ASA gps continued to increase, whilst that of the rest of the 
groups showed a decline after 16 mo. The curve for the Fe + V gp, lying next and above to 
the C gp had a maximum ALT value of 163 + 21 IU at 16 mo. ALT levels of the Fe + Cu 
gp were above that of the Fe + V gp. In addition, serum ALT value of the former was 250 
+ 73 IU at 20 mo. ALT levels of the Fe gp declined sharply from a peak of 234 + 114 IU 
(16 mo) to 140 + 23 IU (20 mo). ALT level of the Fe + ASA gp increased to 235 + 87 IU 
at 20 mo. From 8 to about 18 mo, ALT level of the Fe -  V gp was the highest with a 
maximum value of 252 + 45 IU at 16 mo and then declined to 202 + 51 IU at 2ft-mo. 
Significant differences occurred after 12 mo (p=0.05).
9.0.17 Cu
Figure 34 shows serum Cu levels of iron-overloaded Wistar rats. All curves showed an 
initial increase in serum Cu from 2-4 mo, followed by a decline between 4 and 8 mo, and 
then another increase up to 16 mo. Thereafter, serum Cu values of all groups apart from the 
Fe + ASA gp remained relatively constant. The serum Cu level of the Fe + ASA gp 
continued to increase to 46.6 + 7.3 pmol/1 (24 mo). The curve for the C gp was initially in 
the middle of the other curves and attained a peak value of 30.4 + 3.4 p.mol/1 (12 mo). 
However, the curve remained constant and the lowest after 16 mo (25.0 + 11.2 pmol/1). 
The curve for the Fe -  V gp was the lowest up to 16 mo (36.1 + 4.0 pmol/1) and then 
showed increased values above the C gp. Peak Cu values of the other groups were as 
follows: Fe gp = 34.9 + 4.6 pmol/1 (16 mo), Fe -  V gp = 33.9 + 4.0 pmol/1 (16 mo),
188
Chapter 9: Results
Fe + Cu gp = 34.1 + 13.9 prnol/1 (16 mo). Significant differences (p=0.05) occurred 
between 8 and 16 mo.
9.0. 18 80HdG Immunohistochemistry
Figures 35-39 on pages 229-233 are slides of 80HdG immunohistochemistry. There was 
hardly any brown visible immuno-staining in the control livers [Figure 35 (a) & (b) to 
Figure 39 (a) & (6)]. Lots of brown stains indicating positive labelling of 80HdG, were 
observed throughout the livers of the Fe + V gp. Intense labelling was observed in several 
aggregates found in these sections, and there was also granular labelling within the' Cells. 
Similar intense labelling in aggregates was observed in the livers of the Fe -  V and Fe + 
Cu gps. This granular labelling was also observed within cells in the liver sections of the 
Fe + ASA gp. Immuno-staining was concentrated in the nuclei, appearing as dark brown 
spots in the liver sections of the Fe + ASA gp.
9.0. 19 4-HNE Immunohistochemistry
In the liver sections of the control [Figure 40 (a) & (b) to Figure 44 (a) & (b), pages 234- 
238] there was hardly any brown labelling observed after exposure to the anti-HNE 
antibodies. Intense brown cytoplasmic granular immuno-staining was observed in the 
hepatocytes of the Fe + ASA, Fe and the Fe + Cu gps. Similar but less intense immuno- 
staining in the liver sections of the Fe -  V gp was seen. Intense brown immuno-staining of 
4-HNE aggregates was also seen in the liver sections of the Fe + V gp especially around 
the vessels.
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9.0. 20 Liver Iron Content (LIC) (see appendix F, spotted data)
LIC at 32 months was: C gp = 0.6 ± 0.2, F gp = 16.4 + 5.6, Fe + V gp = 21.9 ± 6.9, Fe -  V 
gp = 21.6 + 8.4, Fe + ASA gp = 18.7 + 7.5, Fe + Cu gp = 17.2 + 6.8 (units = mg/g w.wt).
9.0. 21 Liver Histology
Data presented in Table 46x (see appendix E) show a gradual hepatic Fe overload over 32 
months. At 4 months, all Fe-loading groups had grade 1+ Fe overload. At 8, 12 and 16 
months, this progressed into 2+, 2+ and 4+ respectively, and remained at 4+ until the end 
of the study (Figure 45, page 239). The control group had grade 0 Fe load throughout, 
except at 24-28 months when traces and 2+ of iron were seen in a few. Kupffer cell Fe on 
the other hand was 2+ at 16 months when hepatic Fe was 4+. Fe load in the Kupffer cells 
increased to 3+ at 20 months and most of them stained 4+ at 24 months. At 28 and 32 
months, all Kupffer cells were 4+. The portal tract was also loaded with Fe but not the bile 
ductular cells. Early signs of iron-free foci (IFF) were seen after 20 months (Figure 46, 
page 240). Of the 25 (iron-overloaded) samples presented for histological examination at 
20 months, 5 (20%) had IFF and 1 was indeterminate (borderline case). Two of the 5 
occurred in the Fe group, 2 in the Fe -  V group, and 1 in the Fe + V group. The borderline 
case IFF belonged to the Fe + V group. At 24 months, 4 out of 34 (12%) Fe-overloaded 
livers had IFF, with 2 from the Fe group being very prominent. The remaining 2 belonged 
to the Fe -  V and Fe + V groups. Of the 54 iron-loaded samples presented for histological 
examination at 28 months, 16 had IFF (30%). Twelve out of 26 iron-overloaded samples 
(46%) submitted to histological examination at 32 months had IFF and 2 were borderline 
cases. Two livers with IFF were found in the Fe group, 5 in the Fe + V group, 5 in the
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Fe + ASA group and the 2 borderline cases belonged to the Fe group. Out of the 144 Fe- 
overloaded samples examined between 20 and 32 months, 37 (26%) had IFF. The 
breakdown is as follows: F group = 10, Fe + V group = 12, Fe -  V group = 6, Fe + ASA 
group = 8 and Fe + Cu group = 1. Inclusions resembling Mallory bodies (MB)(Figure 49, 
page 242) were first identified at 20 months in association with IFF in the Fe group and 
again at 28 months in association with IFF, fat and stem cells in the Fe + V group. Fat and 
fatty foci were also identified and mostly associated with IFF. Microsteatosis was present 
at 28 months in 4 samples. Of the 4 cases, 2 were found in the Fe + V group and 1 in the 
Fe group. However, this was not peculiar to the Fe-loaded groups as 1 case was seen in the 
control group. Hamartoma was found in one of the 12 Fe group livers taken at 28 months. 
Within the same sample size of 12, one liver had microsteatosis, and another, Gandy- 
Gamma bodies. An inconclusive adenoma was seen in one sample belonging to the Fe 
group at 32 months. Von Meyenburg complexes (VMCs) were also identified. Large liver 
cell dysplasia was also observed at 28 months in the Fe group (Figure 49, page 242). 
Hepatocellular adenoma (HCA) was seen in one sample from the Fe group at 28 months. 
HCC was a borderline case in one of the 6 samples from the Fe + V group at 32 months. 
However, HCC developed in one out of the 8 rats that survived up to 32 months in the Fe 
group. The HCC was 2 cm in diameter (Figures 51-54, pages 244-246). Of the remaining 7 
rat livers, 3 with IFF were confirmed malignant by GST-71 stain (Figure 48, page 241). In 
addition, fibrosis and cirrhosis were not present (Figure 52, page 245).
9.0.22 AFP and Comet assays
AFP values remained within the normal reference range with time-increasing trend
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(see Table 8y, appendix F). The comet assay did not give satisfactory results.
9.1 CORRELATION ANALYSIS (Appendix A)
Letters used for the correlation analysis represents the ff groups: C=C group, F = Fe group, 
V = Fe + V group, N = Fe -  V group, A = Fe + ASA group, Cu = Fe + Cu group.
9.2 CORRELATION ANALYSIS OF TEST PARAMETERS WITHIN GROUPS
9.2.1 Control Group (C gp)
9.2.1.1 ALT
The correlation analysis in the Table 20x shows that for group C, ALT and AST (r=0.53, 
p=0.0032), ALT and TAS (r=0.57, p=0012), ALT and LPO (r=0.64, p=0.0002), ALT and 
FADU (r=0.52, p=0.0041), ALT and Vit C (r=0.53, p=0.0029), ALT and 8-IP (r=0.49, 
p=0.0142) are significantly positively correlated.
9.2.1.2 AST
The correlation matrix in Table 20x shows that for group C, AST and TAS (r=0.56, 
p=0.0016), AST and LPO (r=0.59, p=0.0007), AST and ORAC-L (r=0.46, p=0.0225 are 
significantly positively correlated.
9.2.1.3 * Oz
The correlation analysis in Table 20x shows that for group C, *“02 and TAS (r= -0.44,
p=0.0496), *”0 2 and FADU (r= - 0.45, p=0.0445) are significantly negatively correlated.
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9.2.1.4 GPx
The correlation matrix in Table 20x shows that for the C group, GPx and LPO (r=0.45, 
p=0.0069) are significantly positively correlated. However, GPx and CAT (r= -0.45, p= 
0.0082) are significantly negatively correlated.
9.2.1.5 TAS
The correlation matrix in Table 20x shows that for group C, TAS and LPO (r=0.67, 
p<0.0001), TAS and FADU (r=0.60, p=0.0002), TAS and Vit C (r=0.76, p<0.0001), TAS 
and MDA (r=0.73, p<0.0001), TAS and ORAC-L (r=0.77, p<0.0001), TAS and'8-IP 
(r=0.38, p=0.0405), TAS and Cu (r=0.50,p=0.0028) are significantly positively correlated.
9.2.1.6 CAT
The correlation matrix in Table 20x shows that for group C, CAT and ORAC-A (r=0.55, 
p=0.0018) are significantly positively correlated. However, CAT and LPO (r= -0.34, 
p=0.0490), are significantly negatively correlated.
9.2.1.7 LPO
The correlation matrix in Table 20x shows that for group C, LPO and FADU (r=0.50, 
p=0.0024), LPO and Vit C (r=0.65, p<0.0001), LPO and MDA (r=0.68, p<0.0001), LPO 
and 8 IP (r=0.59, p=0.0007), LPO and ORAC-L (r=0.55, p=0.0019), are significantly 
positively correlated. However, LPO and ORAC-A (r= -0.59, p=0.0008) are significantly 
negatively correlated.
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9.2.1.8 80HdG
The correlation matrix in table lOx shows that for group C, 80HdG and Vit C (r=0.39, 
p=0.0211), 80HdG and Cu (r=0.48, p=0.0038) are significantly positively correlated.
9.2.1.9 FADU
The correlation matrix in Table lOx shows that for group C, FADU and Vit C (r=0.54, 
p=0.0009), FADU and MDA (r=0.69, pO.OOOl), FADU and ORAC-L (r=0.64, p=0.0002), 
FADU and 8-IP (r=0.65, p=0.0001), FADU and Cu (r=0.47, p=0.0051) are positively 
correlated. However, FADU and ORAC-A (r= -0.39, p=0.0381) are negatively correlated.
9.2.1.10 Vit C
The correlation matrix in Table lOx shows that for group C, Vit C and MDA (r=0.70, 
pO.OOOl), Vit C and ORAC-L (r=0.52, p=0041), Vit C and 8-IP (r=0.56, p=0.0015), Vit C 
and Cu (r=0.37, p=0.0300) are significantly positively correlated.
9.2.1.11 MDA
The correlation matrix in Table lOx shows that for group C, MDA and ORAC-L (r=0.62, 
p=0.0012), MDA and 8-IP (r=0.66, p=0.0005) were significantly positively correlated.
9.2.1.12 ORAC-L
The correlation matrix in Table lOx also shows that for group C, ORAC-L and 8-IP
(r=0.38, p=0.0412) are significantly positively correlated. However, ORAC-L and ORAC-
A (r= -0.39, p=0.0391) are significantly negatively correlated.
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9.2.2 F Group (Fe gp)
9.2.2.1 Fe
The correlation matrix in Table 22x shows that for group F, serum iron (Fe) and ALT 
(r=0.56, p=0.0014), Fe and AST (r=0.76, p<0.0001), Fe and GPx (r=0.44, p=0.0099), Fe 
and SOD (r=0.40, p=0.0178), Fe and LPO (r=0.78, p<0.0001), Fe and 80HdG (is 0.62, 
p<0.0001), Fe and FADU (r=0.61, p=0.0001), Fe and Vit C (r=0.69, p<0.0001), Fe and 
MDA (r=0.62, p=0.0005), Fe and AMES test (r=0.55, p=0.0023), Fe and ORAC-L (r=0.72, 
p<0.0001), Fe and 8-IP (r=0.47, p=0101), Fe and Cu (r=0.69, p<0.0001) are significantly 
positively correlated.
9.2.2.2 ALT
The correlation matrix in Table 22x shows that for group F, ALT and AST (r=0.75, 
p<0.0001), ALT and GPx (r=0.44, p=0.0158), ALT and SOD (r=0.58, p=0.0009), ALT and 
TAS (r=0.36, p=0.0480), ALT and LPO (r=0.63, p=0.0002), ALT and FADU (r=0.52, 
p=0.0030), ALT and Vit C (r=0.57, p=0.0009), ALT and MDA (r=0.85, p<0.0001), ALT 
and ORAC-L (r=0.61, p=0.0012), ALT and Cu (r=0.53, p=0.0024) are significantly 
positively correlated.
9.2.1.13 ORAC-A
The correlation matrix in table lOx shows that for group C, ORAC-A and ORAC-L (r= -
0.39, p=0.0391) are significantly negatively correlated.
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The correlation matrix in table 22x shows that for group F, AST and GPx (r=0.46, 
p=0.0113), AST and SOD (r=0.51, p=0.0042), AST and TAS (r=0.41, p=0.0229), AST and 
LPO (r=0.71, p<0.0001), AST and 80HdG (r=0.41, p=0.0252), AST and FADU (r=0.70, 
p<0.0001), AST and Vit C (r=0.62, p=0.0003), AST and MDA (r=0.86, p<0.0001), AST 
and AMES test (r=0.49, p=0.0147), AST and ORAC-L (r=0.83, p<0.001), AST and CU 
(r=0.52, p=0.0032) are significantly positively correlated.
9.2.2.3 AST
9.2.2.4 * 0 2
The correlation matrix in table 22x shows that for group F, *“02 and ORAC-A (r=0.49, 
p=0.0277) are significantly positively correlated. However, *“02 GPx (r= -0.45, p=0.0488), 
*“02 and LPO (r= - 0.45, p=0.0466) are significantly negatively correlated.
9.2.2.5 GPx
The correlation matrix in the Table 22x shows that for group F, GPx and LPO (r=0,49, 
p=0.0030), GPx and 80HdG (r=0.47, p=0.0046), GPx and FADU (r=0.44, p=0.0091), GPx 
and AMES test (r=0.39, p=0.0429), GPx and ORAC-L (r=0.49, p=0.0068), GPx and Cu 
(r= 0.57, p=0.0005) are significantly positively correlated. However, GPx and ORAC-A 
(r= -0.42, p=0.0242) are significantly negatively correlated.
9.2.2.6 SOD
The correlation matrix in table 22x shows that for group F, SOD and ORAC-L (r=0.57,
p=0.0013), SOD and Cu (r=0.44, p=0.0093) are significantly positively correlated.
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9.2.2.8 CAT
The correlation matrix in Table 22x shows that for group F, CAT and ORAC-A (r=0.48, 
p=0.0078), are significantly positively correlated. However, CAT and LPO (r= -0.46, 
p=0.0059), CAT and FADU (r= -0.40, p=0.0178), CAT and ORAC-L (r= -0.51, 
p=0.0048), CAT and Cu (r= -0.49, p=0.0030) are significantly negatively correlated.
9.2.2.9 LPO
The correlation matrix in table 22x shows that for group F, LPO and 80HdG (r=0.55, 
p=0.0008), LPO and FADU (r=0.57, p=0.0004), LPO and Vit C (r=0.71, p<0.0001, LPO 
and MDA (r=0.55, p=0.0024), LPO and AMES test (r=0.47, p=0.0120), LPO and ORAC-L 
(r=0.79, p<0.0001), LPO and 8-IP (r=0.50, p=0.0062), LPO and Cu (r=0.63, p<0.0001) are 
significantly positively correlated. However, LPO and ORAC-A (r= -0.50, p=0.0053) are 
significantly negatively correlated.
9.2.2.10 80HdG
The correlation matrix in Table 22x shows that for group F, FADU and Vit C (r=0.71, 
p<0.0001), FADU and MDA (r=0.62, p=0.0005), FADU and AMES test (r=0.64, 
p=0.0002), FADU and ORAC-L (r=0.75, p<0.0001), FADU and Cu (r=0.64, p<0.0001) are
9 2 .2.1 TAS
The correlation matrix in Table 22x shows that for group F, TAS and FADU (r=0.46,
p=0.0058), TAS and Vit C (r=0.43, p=0.0115), TAS and ORAC-A (r=0.38, p=0.0402),
TAS and Cu (r=0.35, p=0.0411) are significantly positively correlated.
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significantly positively correlated. However, FADU and ORAC-A (r= -0.40, p=0.0326) are 
significantly negatively correlated.
9.2.2.11 VitC
The correlation matrix in Table 22x shows that for group F, Vit C and MDA (r=0.64, 
p=0.0002), Vit C and AMES test (r=0.44, p=0.0191), Vit C and ORAC-L (r=0.60, 
p=0.0006), Vit C and Cu (r=0.67, p<0.0001), are significantly positively correlated.
9.2.2.12 MDA
The correlation matix in Table 22x shows that for group F, MDA and AMES test (r=0.67, 
p=0.0004), MDA and ORAC-L r=0.44, p0.0316), MDA and 8-IP (r=0.64, p=0.0008), 
MDA and Cu (r=0.54, p=0.0030) are significantly positively correlated. However, MDA 
and ORAC-A (r= -0.41, p=0.0444) are significantly negatively correlated.
9.2.2.13 AMES
The correlation matrix in Table 22x shows that for group F, AMES test and ORAC-L 
(r=0.63, p=0.0004), AMES test and Cu (r=0.40, p=0.0326) are significantly positively 
correlated. However, AMES test and ORAC-A (r= -0.51, p=0.0057) are significantly 
negatively correlated.
9.2.2.14 ORAC-L
The correlation matrix in Table 22x shows that for group F, ORAC-L and Cu (r=0.60, 
p=0.0007) are significantly positively correlated.
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9.2.3 V group (Fe + V gp)
9.2.3.1 Fe
The correlation matrix in table 24x shows that for group V, Fe and ALT (r=0.61, 
p=0.0008), Fe and AST (r=0.61, p=0.0011), Fe and GPx (r=0.43, p=0.0191), Fe and TAS 
(rO.48, p=0.0067), Fe and LPO (rO.66, pO.OOOl), Fe and 80HdG (r=0.72, pO.OOOl), 
Fe and FADU (r=0.66, pO.OOOl), Fe and Vit C (r=0.60, p=0.0005), Fe and MDA (r=0.64, 
p=0.0005), Fe and AMES test (r=0.44, p=0.0207), Fe and ORAC-L (r=0.56, p=0020), Fe 
and Cu (r=0.57, p=0.0011) are significantly positively correlated.
9.2.2.15 ORAC-A
The correlation matrix in table 22x shows that for group F, ORAC-A and 8-IP (r= -0.39,
pO.0348) are significantly negatively correlated.
9.2.3.2 ALT
The correlation matrix in Table 24x shows that for group V, ALT and AST (r=0.61, 
p=0.0008), ALT and GPx (r=0.69, pO.OOOl), ALT and TAS (r=0.52, p=0.0053), ALT and 
LPO (r=0.82, pO.OOOl), ALT and 80HdG (r=0.67, pO.OOOl), ALT and FADU (r=0.48, 
p=0.0105), ALT and Vit C (r=0.72, pO.OOOl), ALT and MDA (rO.85, pO.OOOl), ALT 
and ORAC-L (rO.70, pO.OOOl), ALT and 8-IP (rO.59, p0.0019), ALT and Cu (r=0.61, 
p0.0007) are significantly positively correlated.
9.2.3.3 AST
The correlation matrix in Table 24x shows that for group V, AST and GPx (r50.61,
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p=0.0010), AST and TAS (r=0.75, pO.OOOl), AST and LPO (r=0.58, p=0.0017), AST and 
80HdG (r=0.56, p=0.0023), AST and FADU (r=0.71, p<0.0001), AST and Vit C (r=0.64, 
p=0.0003), AST and MDA (r=0.71, pO.OOOl), AST and ORAC-L (r=0.77, pO.OOOl), 
AST and 8-IP (r=0.52, p=0.0078), AST and Cu (r=0.43, p=0.0271) are significantly 
positively correlated.
9.2.3.4 GPx
The correlation matrix in Table 24x shows that for group V, GPx and TAS (r=0.57, 
p=0.0011), GPx and LPO (r=0.65, pO.OOOl), GPx and 80HdG (r=0.48, p=0.0066)7GPx 
and Vit C (r=0.38, p=0.0410), GPx and ORAC-L (r=0.64, p=0.0003), GPx and 8-IP 
(r=0.44, p=0.0184), GPx and Cu (r=0.47, p=0.0088) are significantly positively correlated. 
However, GPx and CAT (r= -0.52, p=0.0034) are significantly negatively correlated.
9.2.3.5 SOD
The correlation matrix in Table 24x shows that for group V, SOD and ORAC-A (r=0.42, 
p=0.0238), SOD and 8-IP (r=0.39, p=0.0361) are significantly positively correlated.
9.2.3.6 TAS
The correlation matrix in Table 24x shows that for group V, TAS and 80HdG (r=0.36, 
p=0.0468), TAS and Vit C (r=0.36, p=0.0450), TAS and ORAC-L (r=0.63, p=0.0003), 
TAS and 8-IP (r=0.51, p=0047) are significantly positively correlated.
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9.2.3.7 CAT
The correlation matrix in Table 24x shows that for group V, CAT and LPO (r= -0.64, 
p=0.0001), CAT and 80HdG (r= -0.51, p=0.0031), CAT and FADU (r= -0.39, p=0.0293), 
CAT and Vit C (r= -0.37, p=0.0398), CAT and ORAC-L (r= -0.52, p=0.0036), CAT and 
Cu (r= -0.44, p=0124) are significantly negatively correlated.
9.2.3.8 LPO
The correlation matrix in Table 24x shows that for group V, LPO and 80HdG (r=0.79, 
p<0.0001), LPO and FADU (r=0.56, p=0.0011), LPO and Vit C (r=0.53, p=0.0020)rLPO 
and MDA (r=0.71, p<0.0001), LPO and ORAC-L (r=0.72, p<0.0001), LPO and Cu 
(r=0.70, p<0.0001) are significantly positively correlated.
9.2.3.9 80HdG
The correlation matrix in Table 24x shows that for group V, 80HdG and FADU (r=0.75, 
p<0.0001), 80HdG and Vit C (r=0.60, p=0.0004), 80HdG and MDA (r=0.89, p<0.0001), 
80HdG and AMES test (r=0.70, p<0.0001), 80HdG and ORAC-L (r=0.77, p<0.0001), 
80HdG and 8-IP (r=0.40, p=0.0322), 80HdG and Cu (r=0.69, p<0.0001) are significantly 
positively correlated.
9.2.3.10 FADU
The correlation matrix in Table 24x shows that for group V, FADU and Vit C (r=0.63, 
p=0.0001), FADU and MDA (r=0.85, p<0.0001), FADU and AMES test (r=0.78, 
p<0.0001), FADU and ORAC-L (r=0.70, p<0.0001), FADU and Cu (r=0.58, p=0.0007) are
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significantly positively correlated.
9.2.3.11 VitC
The correlation matrix in Table 24x shows that for group V, Vit C and MDA (r=0.70, 
p<0.0001), Vit C and AMES test (r=0.57, p=0.0012), Vit C and ORAC-L (r=0.52, 
p=0.0035), Vit C and Cu (r=0.40, p=0.0242) are significantly positively correlated.
9.2.3.12 MDA
The correlation matrix in table 24x shows that for group V, MDA and AMES test (r^0.75, 
p<0.001), MDA and ORAC-L (r=0.67, p=0.0004), MDA and Cu (r=0.74, pO.OOOl) are 
significantly positively correlated.
9.2.3.13 AMES test
The correlation matrix in Table 24x shows that group V, AMES test and ORAC-L (r=0.59, 
p=0.0007), AMES test and 8-IP (r=0.42, p=0.0242), AMES test and Cu (r=0.44, p=0.0171) 
are significantly positively correlated. However, AMES test and ORAC-A (r= -0.39, 
p=0.0373) are significantly but weakly, negatively correlated.
9.2.3.14 ORAC-L
The correlation matrix in table 24x shows that for group V, ORAC-L and 8-IP (r=0.55, 
p=0.0019), ORAC-L and Cu (r=0.61, p=0.0005) are significantly positively correlated.
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9.2.4.1 Fe
The correlation matrix in Table 23x shows that for group N, Fe and ALT (r=0.89, 
pO.OOOl), Fe and AST (r=0.85, pO.OOOl), Fe and SOD (r=0.52, p=0.0017), Fe and TAS 
(r=0.49, p=0031), Fe and LPO (r=0.78, p<0.0001), Fe and 80FldG (r=0.72, p<0.0001), Fe 
and FADU (r=0.75, p<0.0001), Fe and Vit C (r=0.76, pO.OOOl), Fe and MDA (r=0.68, 
pO.OOOl), Fe and ORAC-L (r=0.81, pO.OOOl), Fe and Cu (r=0.79, pO.OOOl) are 
significantly positively correlated.
9.2.4 N Group (Fe-V)
9.2.4.2 ALT
The correlation matrix in Table 23x shows that for group N, ALT and AST (rO.84, 
pO.OOOl), ALT and SOD (r=0.72, pO.OOOl), ALT and TAS (r=0.57, p=0.0013) ALT and 
LPO (r=0.87, pO.OOOl), ALT and 80HdG (r=0.80, pO.OOOl), ALT and FADU (r=0.72, 
pO.OOOl), ALT and Vit C (rO.74, pO.OOOl), ALT and MDA (rO.96, pO.OOOl), ALT 
and ORAC-L (r=0.81, pO.OOOl), ALT and Cu (r=0.84, pO.OOOl) are significantly 
positive correlated. However, ALT and *“02 (r= -0.56, p=0.0128), ALT and CAT (r= -0.40, 
p=0.0319) are significantly negatively correlated.
9.2.4.3 AST
The correlation matrix in Table 23x shows that for group N, AST and SOD (rO.67, 
pO.OOOl), AST and TAS (r=0.64, p0.0002), AST and LPO (r=0.71, pO.OOOl), AST and 
80HdG (r=0.74, pO.OOOl), AST and FADU (r=0.65, pO.OOOl), AST and Vit C (rO.76, 
pO.OOOl), AST and MDA (rO.81, pO.OOOl), AST and Cu (rO .75, pO.OOOl) are
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significantly positively correlated.
9.2A.4 * 0 2
The correlation matrix in Table 23x shows that for group N, ‘”02 and CAT (r=0.68, 
p=0.0009), * '02 and ORAC-A (r=0.60, p=0.0055) are significantly positively correlated. 
However, *”0 2 and LPO (r= -0.64, p=0.0024), *”0 2 and 80HdG (r= -0.66, p=0.0015), *”0 2 
and FADU (r= -0.47, p=0.0350), *”0 2 and AMES test (r= -0.45, p=0.0468), *”0 2 and 
ORAC-L (r= -0.56, p=0.0096), *”0 2 and Cu (r= -0.74, p=0.0002) are significantly 
negatively correlated.
9.2.4.5 GPx
The correlation matrix in the table 23x shows that for group N, GPx and CAT (r= -0.36, 
p=0.0390), GPx and ORAC-A (r= -0.41, p=0.0279) are significantly negatively correlated.
9.2.4.6 SOD
The correlation matrix in Table 23x shows that for group N, SOD and TAS (r=0.46, 
p=0.0059), SOD and LPO (r=0.34, p=0.0469), SOD and Vit C (r=0.39, p=0.0208), SOD 
and ORAC-L (r=0.49, p=0.0065), SOD and ORAC-A (r=0.039, p=0.0385), SOD and Cu 
(r=0.35, p=0.0400) are significantly positively correlated.
9.2.4.7 TAS
The correlation matrix in table 23x shows that for group N, TAS and LPO (r=0.36,
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p=0.0385), TAS and 80HdG (r=0.44, p=0.0090), TAS and Vit C (r=0.57, p=0.0005), TAS 
and ORAC-L (r=0.54, p=0.0024), TAS and ORAC-A (r=0.48, p=0.0091), TAS and Cu 
(r=0.34, p=0.0490) are significantly positively correlated.
9.2.4.8 CAT
The correlation matrix in Table 23x shows that for group N, CAT and ORAC-A (r=0.45, 
p=0.0152), are significantly positively correlated. However, CAT and LPO (r= -0.54, 
p=0.0010), CAT and 80HdG (r= -0.46, p=0.0068), CAT and FADU (r= -0.40, p=0.0176), 
CAT and ORAC-L (r= -0.43, p=0.0215), CAT and Cu (r= -0.55, p=0.0007J are 
significantly negatively correlated.
9.2.4.9 LPO
The correlation matrix in Table 23x shows that for group N, LPO and 80HdG (r=0.78, 
p<0.0001), LPO and FADU (r=0.77, p<0.0001), LPO and Vit C (r=0.69, p<0.0001), LPO 
and MDA (r=0.59, p=0.0007), LPO and AMES (r=0.38, p=0.0448), LPO and ORAC-L 
(r=0.79, p<0.0001), LPO and Cu (r=0.84, p<0.0001) are significantly positively correlated.
9.2.4.10 80HdG
The correlation matrix in Table 23x shows that for group N, 80HdG and FADU (r=0.59, 
p=0.0002), 80HdG and Vit C (r=0.57, p=0.0004), 80HdG and MDA (r=0.51, p=0.0050), 
80HdG and AMES test (r=0.53, p=0.0029), 80HdG and ORAC-L (r=0.76, p<0.0001), 
80HdG and Cu (r=0.72, p<0.0001) are significantly positively correlated.
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9.2.4.11 FADU
The correlation matrix in Table 23x shows that for group N, FADU and Vit C (r=0.75, 
pO.OOOl), FADU and MDA (r=0.63, p=0.0003), FADU and AMES test (r=0.52, 
p=0.0038, FADU and ORAC-L (r=0.78, p<0.0001), FADU and 8-IP (r=0.52, p=0.0042), 
FADU and Cu (r=0.76, p<0.0001) are significantly positively correlated.
9.2.4.12 Vit C
The correlation matrix in Table 23x shows that for group N, Vit C and MDA (r=0.59, 
p=0.0008), Vit C and AMES test (r=0.48, p=0.0085), Vit C and ORAC-L (r=0:64, 
p=0.0002), Vit C and 8-IP (r=0.40, p0.0303), Vit C and Cu (r=0.73, p<0.0001) are 
significantly positively correlated.
9.2.4.13 MDA
The correlation matrix in Table 23x shows that for the group N, MDA and AMES test 
(i=0.74, pO.OOOl), MDA and ORAC-L (r=0.54, p=0.0062). MDA and Cu (r=0.70, 
pO.OOOl) are significantly positively correlated.
9.2.4.14 AMES test
The correlation matrix in Table 23x shows that for group N, AMES test and ORAC-L 
(r=0.52, p=0.0037), AMES test and 8-IP (r=0.57, p=0.0012), AMES test and Cu (r=0.54, 
p=0.0025) are significantly positively correlated. However, AMES test and ORAC-A (r= - 
0.51, p=0.0050) are significantly negatively correlated.
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9.2.4.15 ORAC-L
The correlation matrix in Table 23x shows that for group N, ORAC-L and Cu (r=0.76, 
pO.OOOl) are significantly positively correlated.
9.2.4.16 ORAC-A
The correlation matrix in Table 23x shows that for group N, ORAC-A and 8-IP (r= -0.50, 
p=0.0053), ORAC-A and Cu (r= -0.51, p=0.0049) are significantly negatively correlated.
9.2.5 A Group (Fe+ASA gp)
9.2.5.1 Fe
The correlation matrix in Table 19x shows that for group A, Fe and ALT (r=0.69, 
pO.OOOl) Fe and AST (r=0.60, p=0.0008), Fe and TAS (r=0.43, p=0.0150), Fe and LPO 
(r=0.71, pO.OOOl), Fe and 80HdG (r=0.63, pO.OOOl), Fe and FADU (rO.68, pO.OOOl), 
Fe and Vit C (rO.79, pO.OOOl), Fe and MDA (rO.64, p0.0003), Fe and AMES test 
(rO.39, pO.0417), Fe and ORAC-L (rO.57, p0.0016), Fe and Cu (rO.68, pO.OOOl) 
are significantly positively correlated.
9.2.5.2 ALT
The correlation matrix in Table 19x shows that for group A, ALT and AST (rO.66, 
pO.OOOl), ALT and TAS (rO.48, pO084), ALT and LPO (rO.84, pO.OOOl), ALT and 
80HdG (rO.78, pO.OOOl), ALT and FADU (rO.79, pO.OOl), ALT and Vit C (rO.74, 
pO.OOOl), ALT and MDA (rO.89, pO.OOOl), ALT and AMES test (rO.46, p0.0200), 
ALT and ORAC-L (rO.86, pO.OOOl), ALT and 8-IP (rO.47, pO.0187), ALT and Cu
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(r=0.63, p=0.0003) are significantly positively correlated. However, ALT and CAT (r= - 
0.48, p=0.0085), ALT and ORAC-A (r= -0.41, p=0.0395), are significantly negatively 
correlated.
9.2.5.3 AST
The correlation matrix in Table 19x shows that for group A, AST and TAS (r=0.63, 
p=0.0002), AST and LPO (r=0.70, p<0.0001), AST and 80HdG (r=0.83, p<0.0001), AST 
and FADU (r=0.84, p<0.0001), AST and Vit C (r=0.76, p<0.0001), AST and MDA 
(r=0.69, p=0.0002), AST and AMES test (r=0.77, p<0.0001), AST and ORAC-L (r=0.86, 
p<0.0001), AST and CU (r=0.59, p=0.0007) are significantly positively correlated.
9.2.5.4 * 0 2
The correlation matrix in Table 19x shows that for group A, *“02 and CAT (r=0.57, 
p=0.0089), ’”02 and ORAC-A (r=0.65, p=0.0020), are significantly positively correlated. 
However, ’~02 and LPO (r= -0.51,p=0.0214), *~02 and 80HdG (r=0.52, p=0.0174), *T>2 
and FADU (r= -0.53, p=0.0159), ’~02 and AMES test (r= -0.48, p=0.0315), *T>2 and 
ORAC-L (r= -0.49, p=0.0280) are significantly negatively correlated.
9.2.5.5 GPx
The correlation matrix in Table 19x shows that for group A, GPx and TAS (r=0.41, 
p=0.0186), GPx and LPO (r=0.40, p=0.0216), are significantly positively correlated.
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9.2.5.6 TAS
The correlation matrix in table 19x shows that for group A, TAS and LPO (r=0.42, 
p=0.0151), TAS and 80HdG (r=0.39, p=0.0236), TAS and FADU (r=0.37, p=0.0356), 
TAS and Vit C (r=0.55, p=0.0009), TAS and ORAC-L (r=0.40, p=0312) are significantly 
positively correlated.
9.2.5.7 CAT
The correlation matrix in table 19x shows that for group A, CAT and ORAC-A (r=0.84, 
p<0.0001) are significantly positively correlated. However, CAT and LPO (r= ';t).54, 
p=0.0013), CAT and 80HdG (r= -0.39, p=0.0236), CAT and FADU (r= -0.45, p=0.0080), 
CAT and ORAC-L (r= -0.42, p=0.0245), CAT and Cu (r= -0.42, p=0.016) are significantly 
negatively correlated.
9.2.5.8 LPO
The correlation matrix in table 19x shows that for group A, LPO and 80HdG (r=0.77, 
p<0.0001), LPO and FADU (r=0.75, p<0.0001), LPO and Vit C (r=0.69, p<0.0001), LPO 
and MDA (r=0.69, p<0.0001), LPO and AMES test (r=0.53, p=0.0024), LPO and ORAC-L 
(r=0.81, p<0.0001), LPO and 8-IP (r=0.45, p=0.0140), LPO and Cu (r=0.65, p<0.0001) are 
significantly positive correlated. However, LPO and ORAC-A (r= -0.59, p=0.0007) are 
significantly negatively correlated.
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9.2.5.9 FADU
The correlation matrix in table 19x shows that for group A, FADU and Vit C (r=0.73, 
p<0.0001), FADU and MDA (r=0.77, pO.OOOl), FADU and AMES test (r=0.83, 
pO.OOOl), FADU and ORAC-L (r=0.75, pO.OOOl), FADU and Cu (r=0.68, p<0.0001) are 
significantly positively correlated. However, FADU and ORAC-A (r= -0.56, p=0.0016) are 
significantly negatively correlated.
9.2.5.10 Vit C
The correlation matrix in table 19x shows that for group A, Vit C and MDA (pO.67, 
p=0.0001), Vit C and AMES test (r=0.57, p=0.0014), Vit C and ORAC-L (r=0.59, 
p=0.0007, Vit C and 8-IP (0.56, p=0.0016), Vit C and Cu (r=0.64, p<0.0001) are 
significantly negatively correlated.
9.2.5.11 MDA
The correlation matrix in table 19x shows that for group A, MDA and AMES test (r=0.84,
pO.OOOl), MDA and ORAC-L (r=0.48, p=0.0180). MDA and Cu (r=0.73, pO.OOOl), are 
significantly positively correlated. However, MDA and ORAC-A (r= -0.47, p=0.0210) are 
significantly negatively correlated.
9.2.5.12 AMES test
The correlation matrix in table 19x shows that for group A, AMES test and ORAC-L 
(r=0.64, p=0.0005), AMES test and Cu (r=0.63, p=0.0002) are significantly positively 
correlated. However, AMES test and ORAC-A (r= -0.47, p=0.0101) are significantly
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negatively correlated.
9.2.5.13 ORAC-L
The correlation matrix in table 19x shows that for group A, ORAC-L and Cu (r=0.51, 
p=0.0047) are significantly positively correlated. However, ORAC-L and ORAC-A (r= - 
0.42, p=0.0235) are significantly negatively correlated.
9.2.5.14 ORAC-A
The correlation matrix in table 19x shows that for group A, ORAC-A and Cu (r=A).52, 
p=0.0034) were significantly negatively correlated.
9.2.6 Cu Group (Fe + Cu gp)
9.2.6.1 Fe
The correlation matrix in Table 21x shows that for group Cu, Fe and ALT (r=0.57, 
p=0.0014), Fe and AST (r=0.48, p=0.0086), Fe and TAS (r=0.49, p=0.0037), Fe and LPO 
(r=0.62, p=0.0001), Fe and 80HdG (r=0.53, p=0.0015), Fe and FADU (r=0.68, p<0.0001), 
Fe and Vit C (r=0.62, p=0.0001), Fe and MDA (r=0.56, p=0.0019). Fe and AMES test 
(r=0.63, p=0.0003), Fe and ORAC-L (r=0.66, p=0.0001), Fe and 8-IP (r=0.52, p=0.0046), 
Fe and Cu (r=0.47, p=0.0058) are significantly positively correlated. However, Fe and "TL 
(r= -0.46, p=0.0490) are significantly negatively correlated.
9.2.6.2 ALT
The correlation m atrix in Table 2 lx  shows that for group Cu, ALT and AST
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(1=0.84, pO.OOOl), ALT and TAS (r=0.56, p=0.0012), ALT and LPO (r=0.86, p<0.0001), 
ALT and 80HdG (r=0.70, p<0.0001), ALT and FADU (r=0.83, p<0.0001), ALT and Vit C 
(r=0.77, pO.OOOl), ALT and MDA (r=0.92, pO.OOOl), AST and AMES test (r=0.55, 
p=0.0043), ALT and ORAC-L (r=0.91, p<0.0001), ALT and 8-IP (r=0.56, p=0.0035), ALT 
and Cu (r=0.49, p=0.0061), are significantly positively correlated.
9.2.6.3 AST
The correlation matrix in Table 21x shows that for group Cu, AST and TAS (r=0.55, 
p=0.0018), AST and LPO (r=0.65, p<0.0001), AST and 80HdG (r=0.62, p=0.0003),'AST 
and FADU (r=0.66, p<0.0001), AST and Vit C (r=0.54, p=0.0021), AST and MDA 
(r=0.58, p=0.0026), AST and AMES test (r=0.56, p=0.0034), AST and ORAC-L (r=0.84, 
p<0.0001), AST and Cu (r=0.42, p=0.0195), are significantly positively correlated. 
However, AST and ORAC-A (r= -0.45, p=0240) are significantly negatively correlated.
9.2.6.4 * 0 2
The correlation matrix in Table 21x shows that for group Cu, *”02 and GPx (r=0.63, 
p=0.0036) are significantly positively correlated. However, *”02 and TAS (r= -0.60, 
p=0.0049), * '02 and Vit C (r= -0.51, p=0.0202), *~02 and AMES test (r= -0.53, p=0.0152), 
"~02 and 8-IP (r= -0.49, p=0.0271) are significantly  negatively  correlated.
9.2.6.5 GPx
The correlation matrix in Table 2 lx shows that for group Cu, GPx and LPO (r=0.34, 
p=0.0493), GPx and 80HdG (r=0.47, p=0053), GPx and Cu (r=0.38, p=0.0298) were
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significantly positively correlated. However, GPx and SOD (r= -0.34, p=0.0499), GPx and 
CAT (r= -0.34, p=0.0493), GPx and ORAC-A (r= -0.48, p=0.0095) are significantly 
negatively correlated.
9.2.6.6 SOD
The correlation matrix in Table 21x shows that for group Cu, SOD and CAT (r=0.40, 
p=0.0200), SOD and ORAC-A (r=0.51, p=0.0044), SOD and 8-IP (r=0.59, p=0.0007) are 
significantly positively correlated.
9.2.6.7 TAS
The correlation matrix in Table 21x shows that for group Cu, TAS and LPO (r=0.53, 
p=0.0012), TAS and 80HdG (r=0.42, p=0.0127), TAS and FADU (r=0.49, p=0.0032), 
TAS and Vit C (r=0.55, p=0.0007), TAS and AMES test (r=0.41, p=0.0257), TAS and 
ORAC-L (r=0.67, p<0.0001), TAS and 8-IP (r=0.38, p=0.0432), TAS and Cu (r=0.56, 
p=0.0006) are significantly positively correlated.
9.2.6.8 CAT
The correlation matrix in Table 19x shows that for group Cu, CAT and ORAC-A (r=0.80, 
pO.OOOl) are significantly positively correlated. However, CAT and LPO (r= -0.35, 
p=0.0395), CAT and 80HdG (r= -0.37, p=0.0295), CAT and FADU (r= -0.37, p=0.0331), 
CAT and MDA (r= -0.49, p=0061) are significantly negatively correlated.
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9.2.6.9 LPO
The correlation matrix in Table 19x shows that for group Cu, LPO and 80HdG (r=0.87, 
pO.OOOl), LPO and FADU (r=0.82, pO.OOOl), LPO and Vit C (r=0.75, p<0.0001), LPO 
and MDA (r=0.81, p<0.0001), LPO and AMES test (r=0.46, p=0.0115), LPO and ORAC-L 
(r==0.81, p<0.0001), LPO and 8-IP (r=0.40, p=0.0338), LPO and Cu (r=0.64, p<0.0001), 
are significantly positive correlated. However, LPO and ORAC-A (r= -0.57, p=0.0013) are 
significantly negatively correlated.
9.2.6.10 80HdG
The correlation matrix in Table 19x shows that for group Cu, 80HdG and FADU (r=0.70, 
pO.OOOl), 80HdG and Vit C (r=0.62, p<0.0001), 80HdG and MDA (r=0.79, p<0.0001), 
80HdG and ORAC-L (r=0.68, p<0.0001), 80HdG and Cu (r=0.64, p<0.0001) are 
significantly positively correlated. However, 80HdG and ORAC-A (r= - 0.69, p<0.0001) 
are significantly negatively correlated.
9.2.6.11 FADU
The correlation matrix in Table 19x shows that for group Cu, FADU and Vit C (r=0.76, 
pO.OOOl), FADU and MDA (rO.87, pO.OOOl), FADU and AMES test (r=0.69, 
pO.OOOl), FADU and ORAC-L (r=0.73, pO.OOOl), FADU and Cu (r=0.68, pO.OOOl) are 
significantly positively correlated. However, FADU and ORAC-A (r= -0.49, p=0.0076) 
were significantly negatively correlated.
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9.2.6.12 Vit C
The correlation matrix in Table 19x shows that for group Cu, Vit C and MDA (r=0.81, 
pO.OOOl), Vit C and AMES test (r=0.58, p=0.0010), Vit C and ORAC-L (r=0.58, 
p=0.0011), Vit C and 8-IP (r=0.45, p=0.0137), Vit C and Cu (r=0.53, p=0.0014), are 
significantly positively correlated.
9.2.6.13 MDA
The correlation matrix in Table 19x shows that for group Cu, MDA and AMES test 
(r=0.54, p=0.0059), MDA and ORAC-L (r=0.54, p=0.0059), MDA and Cu (r=0:54, 
p=0.0023), are significantly positively correlated. However, MDA and ORAC-A (r= -0.62, 
p=0.0014) are significantly negatively correlated.
9.2.6.14 AMES test
The correlation matrix in Table 19x shows that for group Cu, AMES test and ORAC-L 
(r=0.58, p=0.0009), AMES test and 8-IP (r=0.40, p=0.325), AMES test and Cu (r=0.39, 
p=0.0368) are significantly positively correlated.
9.2.6.15 ORAC-L
The correlation matrix in Table 19x shows that for group Cu, ORAC-L and 8-IP 
(r=0.52, p=0.0042), ORAC-L and Cu (r=0.59, p=0.0007) are significantly positively 
correlated.
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9.2.6.16 ORAC-A
The correlation matrix in Table 19x shows that for group Cu, ORAC-A and Cu (r= - 0.41, 
p=0.0272) are significantly negatively correlated.
9.3 ANALYSIS OF VARIANCE (ANOVA)
9.3.1 Group and Time effect on Iron
Table 25x shows that both time and treatment and their interaction had significant effects 
on serum iron (p<0.0001, pO.OOOl, respectively). The multiple comparison test results in 
Table 26x show that:
i) Significant differences (p<0.0001) are as a result of experiments carried out for 
12 months and less and those that lasted 16 months and above.
ii) With regard to treatment differences, it is noticed in Table 26x that significant 
differences (p<0.0001) occurred between the control group and all other groups. 
Groups other than the control group had significantly higher mean values than 
the control group.
9.3.2 Group and Time effect on ALT
Table 25x shows that both time and treatment and their interaction had significant effects 
on ALT (pO.OOOl, pO.OOOl, respectively). The multiple comparison test results in Table 
27x show that:
i) Significant differences (p<0.0001) are as a result of experiments carried out for 
4-16 months. This time frame showed maximum differences between the means 
of the various groups.
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ii) With regard to treatment differences, it is noticed in Table 27x that significant 
differences (pO.OOOl) occurred between the control group and all other groups. 
Groups other than the control group had significantly higher mean values than 
the control group.
9.3.3 Group and Time effect on AST
Table 25x shows that both time and treatment and their interaction had significant effects 
on AST (pO.OOOl, pO.OOOl, respectively). The multiple comparison test results in Table 
28x show that:
i) Significant differences (p<0.0001) are as a result of experiments carried out 
from 2-20 months.
ii) With regard to treatment differences, it is noticed in Table 28x that significant 
differences (p<0.0001) occurred between the control group and all other groups. 
Groups other than the control group had significantly higher mean values than 
the control group. In addition, significant differences (p<0.0001) occurred 
between Cu & V and Cu & F.
9.3.4 Group and Time effect on * O2
Table 25x shows that time had significant effects on blood '”02 (pO.OOOl). There was no 
significant difference as a result of the diverse treatment to the various groups (p=0.4203). 
However, it was noticed that a combination of time and treatment type had significant 
differences between the groups (pO.OOOl). The multiple comparison test results in Table 
29x show that:
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i) Significant differences (p<0.0001) are as a result of experiments carried out for 
12 and 20 months. This time frame had the highest difference between means.
9.3.5 Group and Time effect on GPx
Table 25x shows that both time and treatment and their interaction had significant effects 
on GPx (pO.OOOl, p<0.0001, respectively). The multiple comparison test results in Table 
3Ox show that:
i) Significant differences (p<0.0001) are as a result of experiments carried out for 
4-12 and 12-20 months.
ii) With regard to treatment differences, it is noticed in Table 30x that significant 
differences (p<0.0001) occurred between groups C & F, and C & N. V & N, Cu 
& N, and A & N also showed significant differences at p=0.05 level. Groups 
other than the control group had significantly higher mean values than the 
control group.
9.3.6 Group and Time effect on SOD
Table 25x shows that both time and treatment had significant effects on SOD (p<0.0001, 
p<0.0001, respectively). However, the interaction of both did not have any significant 
effect (p=0.4125). The multiple comparison test results in Table 3 lx show that:
i) Significant difference between means (pO.OOOl) is maximum between 12 and 
24 months.
ii) With regard to treatment differences, it is noticed in Table 3lx  that significant 
differences (pO.OOOl) occurred between the control group and all other groups.
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In addition, significant differences occurred between Cu & N and V & N 
(p<0.05). Groups other than the control group had significantly higher mean 
values than the control group.
9.3.7 Group and Time effect on TAS
Table 25x shows that both time and treatment and their interaction had significant effects 
on TAS (pO.OOOl, pO.OOOl, respectively). The multiple comparison test results in Table 
32x show that:
i) Significant differences (p<0.0001) are as a result of experiments carried out for 
24 months at almost all time points.
ii) With regard to treatment differences, it is noticed in Table 32x that significant 
differences (pO.OOOl) occurred between the control group and all other groups 
except the V group. In addition, V & N & V & Cu groups, were significantly 
different. Groups other than the control group had significantly higher mean 
values than the control group.
9.3.8 Group and Time effect on CAT
Table 25x shows that both time and treatment had significant effects on CAT (pO.OOOl, 
pO.OOOl, respectively) and the interaction of the two was also significant (p=0.0228). The 
multiple comparison test results in Table 33x show that:
i) Significant differences (pO.05) are as a result of experiments carried out for 8
months and above.
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ii) With regard to treatment differences, it is noticed in Table 33x that significant 
differences (p<0.05) occurred between the control group and all other groups. 
In addition, V & F, V & N, V & A, V & Cu and F & Cu groups were 
significantly different at the p=0.05 level. Groups other than the control group 
had significantly higher mean values than the control group.
9.3.9 Group and Time effect on Vitamin C
Table 25x shows that both time and treatment had significant effects on Vitamin C 
(pO.OOOl, p<0.0167, respectively). However, their interaction showed no significant
effect (p=0.9598). The multiple comparison test results in Table 34x show that:
i) Significant differences (p<0.05) are observed at all time-points except 16-20 
months, 8-12 months and 2-4 months.
ii) With regard to treatment differences, it is noticed in Table 34x that significant 
differences (p<0.05) occurred between V & F, V & N and V & Cu groups. 
Groups other than the control group had significantly higher mean values than 
the control group.
9.3.10 Group and Time effect on LPO
Table 25x shows that both time and treatment and their interaction had significant effects 
on LPO (pO.OOOl, pO.OOOl, respectively). The multiple comparison test results in Table 
36x show that:
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i) Significant differences (p<0.05) are as a result of experiments carried out after 
12 months and less and those that lasted 20months.
ii) With regard to treatment differences, it is noticed in Table 36x that significant 
differences (p<0.05) occurred between the control group and all other groups. 
In addition, significant differences (p=0.05) occurred between V & N, A & N, 
Cu & F, Cu & N and Cu & V groups. Groups other than the control group had 
significantly higher mean values than the control group.
9.3.11 Group and Time effect on Cu
Table 25x shows that both time and treatment had significant effects serum Cu (pO.OOOl, 
pO.OOOl, respectively). In addition, the interaction of both parameters was also significant 
(p=0.0002). The multiple comparison test results in Table 35x show that:
i) Significant differences (p<0.05) are as a result of experiments carried out for 24 
months and can be seen for most time-points.
ii) With regard to treatment differences, it is noticed in Table 35x that significant 
differences (p<0.05) occurred between C & N ,  V&N,  F &N,  A & N  and Cu & 
N groups. Groups other than the control group had significantly higher mean 
values than the control group.
9.3.12 Group and Time effect on FADU
Table 25x shows that both time and treatment had significant effects on FADU (pO.OOOl, 
pO.OOOl, respectively). In addition, the interactive effect of both parameters was also 
significant (p=0.0033). The multiple comparison test results in Table 37x show that:
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i) Significant differences (p<0.05) are as a result of experiments carried out for 24 
months can be seen for most time-points after 12 months.
ii) With regard to treatment differences, it is noticed in Table 37x that significant 
differences (p<0.05) occurred between C & F, C & N, C & A, and C & Cu 
groups. There was no significant difference between C & V groups. However, 
there was significant difference between V & Cu (p=0.05).
9.3.13 Group and Time effect on MDA
Table 25x shows that both time and treatment had significant effects on MDA (pOrOOOl, 
pO.OOOl respectively) and the interaction of both parameters was also significant 
(pO.OOOl). The multiple comparison test results in 38x show that:
i) Significant differences (p<0.05) are as a result of experiments carried out for 24 
months can only be seen after 12 months.
ii) It is noticed in Table 38x that significant differences (p<0.05) occurred between 
C & F, C & A and C & Cu groups but not C & V and C & N groups.
9.3.14 Group and Time effect on AMES test
Table 25x shows that both time and treatment had significant effects on mutagenicity as 
determined by the AMES test (pO.OOOl, pO.OOOl, respectively) In addition the 
interaction of both parameters was also significant (pO.OOOl). The multiple comparison 
test results in Table 39x show that:
i) Significant differences (pO.05) are as a result of experiments carried out for
longer periods i.e. 4-20 months or 4-24months. Shorter periods before 16
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months did no have any significant effect.
ii) With regard to treatment differences, it is noticed in Table 39x that significant 
differences (p<0.05) occurred between the control group and all other groups.
9.3.15 Group and Time effect on 80HdG
Table 25x shows that both time and treatment had significant effects 80HdG (p<0.0001, 
pO.OOOl, respectively) and the interaction of both parameters was also significant 
(pO.OOOl). The multiple comparison test results in Table 40x show that:
i) Significant differences (p<0.05) are as a result of experiments carried out for 24 
months. These differences were significant at most time-points.
ii) With regard to treatment differences it is noticed in 40x that significant 
differences (p<0.05) occurred between the control group and all other groups. 
In addition, Cu & F, Cu & N, Cu & A, Cu & V, N & F, N & V as well as A & 
V groups, were significantly different at p=0.05 level. Groups other than the 
control group had significantly higher mean values than the control group.
9.3.16 Group and Time effect on ORAC-L
Table 25x shows that both time and treatment had significant effects on ORAC-L 
(pO.OOOl, pO.OOOl, respectively). In addition, the interaction of both parameters was 
also significant (pO.OOOl). The multiple comparison test results in Table 41x show that:
i) Significant differences (pO.05) are as a result of experiments carried out for 24
months. These differences were significant at most time-points.
223
Chapter 9: Results
ii) With regard to treatment differences, it is noticed in Table 41 x that significant 
differences (p<0.05) occurred between the control group and all other groups. 
In addition, groups A & N were significantly different (p<0.05).
9.3.17 Group and Time effect on ORAC-A
Table 25x shows that both time and treatment had significant effects on ORAC-A 
(pO.OOOl, pO.OOOl, respectively). In addition, the interaction of both parameters was 
also significant (p<0.0001). The multiple comparison test results in Table 42x show that:
i) Significant differences (p<0.05) are as a result of experiments carried outfor 24 
months. These differences were significant at most time-points.
ii) It is noticed in Table 42x that significant differences (p<0.05) occurred between 
the control group and all other groups except V. In addition, V & A, V & F, V 
& N and V & Cu were significantly different (p<0.05).
9.3.18 Group and Time effect on 8-IP
Table 25x shows that both time and treatment had significant effects on 8-IP (pO.OOOl, 
pO.OOOl, respectively). In addition, the interaction of both parameters was also significant 
(pO.OOOl). The multiple comparison test results in Table 43x show that:
i) Significant differences (pO.05) are as a result of experiments carried out for 24 
months. These differences were significant for intervals after 4 months.
ii) It is noticed in Table 43x that significant differences (pO.05) occurred between 
the control group and all other groups. In addition, Cu & A, Cu & F, Cu & N 
and Cu & V groups were significantly different (pO.05).
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9.4 REGRESSION ANALYSIS
A summary of the regression analysis is shown in the Table 44x. For the Fe group, Fe and 
*"02 significantly affected lipid and DNA destruction. Subsequently, MDA, 8-IP and 
80HdG adducts that were formed significantly contributed to liver damage. For the Fe + V 
group, *“02 and Cu significantly influence LPO. Lipid-soluble antioxidants and MDA 
influenced the formation of DNA adducts. In addition, 8-IP significantly affected the Ames 
mutagenicity test. The lipid-soluble antioxidants and DNA adducts affected liver damage. 
For the Fe -  V group, Cu significantly influenced *”02 production. Furthermore, Cu and Fe 
affected LPO and MDA, respectively. LPO and the lipid-soluble antioxidants significantly 
influenced 80FIdG production. For the Fe + ASA group, Cu and ' ”02 significantly 
influenced LPO. Fe and *“02 influenced MDA production. Furthermore, MDA and ORAC- 
L significantly influenced 80HdG formation and this significantly affected mutagenesis. 
For the Fe + Cu group, Fe influenced *~02 production, and both Fe and *”02 significantly 
influenced DNA destruction and 80HdG production. Mutagenesis was significantly 
influenced by GPx and FADU. ALT levels were influenced by Cu, ORAC-L and MDA.
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■Cgp — 1<  Fegp ---- *  Fe + V gp
Fe - V gp -  ♦  Fe + ASA gp •  Fe + Cu gp
Figure 18. Interaction Plot o f Time and Group: Serum Iron 
levels o f iron over-loaded Wistar rats.
Figure 19. Interaction Plot o f Time and Group: Super Oxide
radical levels o f iron-overloaded Wistar rats.
— +■— c  gp ---- ■ ----Fegp — ---- Fe + V gp
Fe - V gp *  Fe + ASA qp •  Fe + Cu gp
Figure 20. Interaction Plot o f Time and Group: Glutathione 
Peroxidase levels o f iron-overloaded Wistar rats.
• Cgp  • — F « 3 P  — *  F e * V u p
F*  V gp ----- •  f t  • ^SA gp — F# » Cuf l P
Figure 21. Interaction Plot of Time and Group: SOD levels 
o f iron-overloaded Wistar rats.
■Cgp >  Fe gp -----*  Fe + V gp
F e-V gp ---- m  Fe + ASA gp — • —  Fe + Cu gp
Figure 22. Interaction Plot o f Time and Group: Blood Catalase
levels o f iron-overloaded Wistar rats.
Figure 23. Interaction Plot o f Time and Group: Serum 
Vitamin C levels o f iron-overloaded Wistar rats.
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Cgp - " * * • — Fegp A  Fe + V gp
Fe - V gp -----Fe + ASAgp -F a  + Cugp
Figure 24  Interaction plot o f Time and Group: Sreum Total 
Antioxidant Status o f iron-overloaded Wistar rats
Figure 25. Interaction Plot of Tome and Group: ORAC of 
aqueous- and lipid-soluble fractions of iron-overloaded 
Wistar rat liver homogenate.
Figure 26. Interaction Plot of Time and Group: Serum MDA 
levels of iron-overloaded Wistar rats.
-C g p  ■  Fe gp -----A Fe + Vgp
F e -V g p  -----■-----Fe+ASAgp - •  Fe+Cugp
Figure 27. Interaction Plot of Time and Group: Liver 
8-isoprostane levels of iron-overloaded Wistar rats.
Figure 28. Interaction Plot of Time and Group: Fluorimetric 
Analysis of DNA Unwinding, of iron-overloaded Wistar rat 
liver homogenate.
C gp ----- Fe gp - — A —  Fe + V gp
F e -V g p  -— ■----- Fe + ASA •  ■ Fe + Cu
Figure 29. Interaction Plot o f Time and Group: Serum
Lipid hydroperoxides levels o f iron-overloaded Wistar
rats using the FOX II assay.
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Time (mo)
— Cg p  — ■ —  Fegp — * — Fe + Vgp
Fe - V gp Fe + ASA gp — • ---- Fe «• Cu gp
Figure 30. Interaction Plot of Time and Group: Liver 80HdG 
levels of iron-overloaded Wistar rats.
Figure 31. Interaction Plot of Time and Group: AMES 
mutagenicity test using S a lm o n e lla  ty p h im u riu m  s tra in  
TA 102 on iron-overloaded Wister rat liver homogenate.
Figure 32. Interaction Plot of Time and Group: AST levels of 
iron-overloaded Wistar rats.
Figure 33. Interaction Plot of Time and Group: ALT levels 
of iron-overloaded Wistar rats.
•Cgp — Fegp ---- * — Fe + Vgp
Fe - V gp m  Fe + ASA gp ♦  Fe *  Cu gp
Figure 34. Interaction Plot of Time and Group: Serum copper
levels o f iron-overloaded Wistar rats.
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Figure 35
RatLiv C3.4 anti8-OHdG 10c RatLiv C3.4 anti8-OHdG 40b
RatLiv F3.3 anti8-OHdG 10a RatLiv F3.3 anti 8-OHdG 40a
Immunohistochemical detection of SOHdG adducts in normal and iron-overloaded
livers. Photomicrographs (a) and (b) are negative for 80HdG (control group, normal
liver); (c) and (d) are positive (Fe group, iron-overloaded liver).
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Figure 36
RatLiv C3.4 anti8-OHdG 10c RatLiv C3.4 anti8-OHdG 40b
Immunohistochemical detection of 80H dG  adducts in normal and iron-overloaded
livers. Photomicrographs (a) and (b) are negative for 80H dG  (control group, normal
liver); (c) and (d) are positive (Fe + V group, iron-overloaded liver).
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Figure 37
RatLiv C3.4 anti8-OHdG 10c RatLiv C3.4 anti8-OHdG 40b
RatLiv N3.1 anti8-OHdG 10a RatLiv N3.1 anti8-OHdG 40a
Immunohistochemical detection of 80HdG adducts in normal and iron-overloaded
livers. Photomicrographs (a) and (b) are negative for 80HdG (control group, normal
liver); (c) and (d) are positive (Fe - V group, iron-overloaded liver).
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Figure 38
RatLiv C3.4 anti8-OHdG 10c RatLiv C3.4 anti8-OHdG 40b
RatLiv A3.5 anti8-OHdG 10b RatLiv A3.5 anti8-OHdG 40a
Immunohistochemical detection of 80HdG adducts in normal and iron-overloaded
livers. Photomicrographs (a) and (b) are negative for 80H dG  (control group, normal
liver); (c) and (d) are positive (Fe + ASA group, iron-overloaded liver).
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Figure 39
RatLiv C3.4 anti8-OHdG 10c RatLiv C3.4 anti8-OHdG 40b
RatLiv Cu3.1 anti8-OHdG 10c RatLiv Cu3.1 anti8-OHdG 40c
Immunohistochemical detection of 80H dG  adducts in normal and iron-overloaded
livers. Photomicrographs (a) and (b) are negative for 80HdG (control group, normal
liver); (c) and (d) are positive (Fe + Cu group, iron-overloaded liver).
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Figure 40
RatLiv Anti-HNE 3 C.7 RatLiv Anti-HNE 3 C.7.1 40b
a b
RatLiv Anti-HNE 3 F.7.10 10c RatLiv Anti-HNE 3 F.7.10 40a
c d
Immunohistochemical detection of 4-HNE adducts in normal and iron-overloaded
livers. Photomicrographs (a) and (b) are negative for 4-HNE (control group, normal
liver); (c) and (d) are positive (Fe group, iron-overloaded liver).
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Figure 41
RatLiv Anti-HNE 3 C.7 RatLiv Anti-HNE 3 C.7.1 40b
a
RatLiv Anti-HNE 3 V.7.8 10c RatLiv Anti-HNE 3 V.7.8 40c
c d
Immunohistochemical detection of 4-HNE adducts in normal and iron-overloaded
livers. Photomicrographs (a) and (b) are negative for 4-HNE (control group, normal
liver); (c) and (d) are positive (Fe + V group, iron-overloaded liver).
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Figure 42
RatLiv Anti-HNE 3 C.7 RatLiv AntiHNE 3 C.7.1 40b
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RatLiv Anti-HNE 3 N.7.1 lOd RatLivAnti-HNE 3N.7.1 40a
c d
Immunohistochemical detection of 4-HNE adducts in normal and iron-overloaded
livers. Photomicrographs (a) and (b) are negative for 4-HNE (control group, normal
liver); (c) and (d) are positive (Fe - V group, iron-overloaded liver).
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Figure 43
RatLiv Anti-HNE 3 C.7 RatLiv Anti-HNE 3 C.7.1 40b
RatLiv Anti-HNE 3 A.7.9 10a RatLiv Anti-HNE 3 A.7.9 40b
c d
Immunohistochemical detection of 4-HNE adducts in normal and iron-overloaded
livers. Photomicrographs {a) and (b) are negative for 4-HNE (control group, normal
liver); (c) and (d) are positive (Fe + ASA group, iron-overloaded liver).
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Figure 44
RatLiv Anti-HNE 3 C.7 RatLiv Anti-HNE 3 C.7.1 40b
RatLiv Anti-HNE 3 Cu.7.5 10b RatLiv Anti-HNE 3 Cu.7.5 40b
c d
Immunohistochemical detection of 4-HNE adducts in normal and iron-overloaded
livers. Photomicrographs (a) and (b) are negative for 4-HNE (control group, normal
liver); (c) and (d) are positive (Fe + Cu group, iron-overloaded liver).
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Figure 45a : F2.3 Rat Peris' Grade I
Figure 45b : F3.1 Rat Peris' Grade II
Figure 45: The photomicrographs show hepatic iron deposition as a result of 
dietary iron overload indicated by Peris ' Prussian blue stain, (a) Demonstrates 
iron deposition confined to periportal (zone 1) hepatocytes at 8 months, but 
subsequently progressed to zone 2 at 12 months and by 28 months, no gradient was 
observed (c). Iron deposition was massive with grade 4 hepatic iron (c). Kupffer 
cell iron storage also progressed with time. [1 = zone 1,2 = zone 2,3 = zone 3, PT = 
Portal Tract, HV = Hepatic Vein, KC = Kupffer cell, X = Pericanalicular Iron]
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Figure 46a : F7.3 Rat IFF H&E
Figure 46b : F7.3 Rat IFF Peris'
F ig u re  46 : This figure shows dietary iron overload in the liver with an iron-free focus 
(arrowed). Photomicrograph (a) shows the nodule and surrounding hepatic parenchyma 
on an H & E stain. In photomicrograph (b) iron deposition is indicated by Peris' Prussian 
blue stain. The iron free nodule with no or very little iron and iron in scattered Kupffer cells 
is evident and contrasts with the remaining hepatocytes that contain large amounts of iron. 
Arrows surround iron free focus, KC = Kupffer cells]
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Figure 47 : V7.1 Rat IFF H&E
Figure 47 : Another example of the contrast between the heavily iron laden 
hepatocytes at 28 months in an iron-free focus showing little if any iron in the 
hepatocytes (H&Estain)
Figure 48 : V7.7 Rat GST-tt
Figure 48 : Counterstaining with GST-n shows the iron-free foci to be positive for 
this stain, indicating (pre)neoplasia. [Arrows denote iron-free foci]
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Figure 49a : ZV7.1 Rat IFF MB H&E
Figure 49b : ZV7.1 Rat IFF MB Peris'
Figure 49: This figure shows a higher power view of an iron-free focus.
Amphophilic (purple) intracytoplasmic 'rope-like' inclusions resembling Mallory 
bodies (MB) are evident (arrowed). Large dysplastic nuclei (DN) are also seen 
(arrowed) [ H & E  stain (a), Peris' Prussian blue stain (b), HS = Aggregates of 
haemosiderin in Kupffer Cells]
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Figure 50a : ZF7.5 Rat IFF Globules H&E
Figure 50b : ZF7.5 Rat IFF Globules Peris'
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Figure 50: Photomicrograph (H&E stain) demonstrates the presence of globules 
(arrowed) within hepatocytes of the iron-free focus (a). Similarly, globules are 
relieved by Peris' Prussian blue stain (b). [DN = Large Dysplastic Nuclei]
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Figure 51a : F8.8 Rat HCC wholemount H&E
Figure 51b : F8.8 Rat HCC wholemount Peris'
Figure 51: Hepatocellular carcinoma (2cm wholemount) arising in a rat's liver 
and seen at 32 months [H&E stain (a) and Peris' Prussian blue stain (b)].
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Figure 52 : F8.8 Rat HCC Peris'
Figure 52 : This figure shows a higher power view of the area blocked in Fig 51b 
demonstrating small areas of normal liver tissue (X1), seen contiguous with the 
tumours (T). Additionally, there was no fibrosis or cirrhosis (Peris' Prussian blue
Figure 53 : F8.8 Rat HCC (pseudoglandular) H & E
Figure 53 : Photomicrograph (H & E stain) showing pseudoglandular HCC after 
32 months of iron loading.
Figure 54 : F8.8 Rat HCC (pseudoglandular) Peris'
Figure 54 : Peris' Prussian blue stain of photomicrograph shows pseudoglandular 
HCC with iron at the canalicular pole (arrowed).
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Figure 55. Pulsed Field Gel Electrophoresis (PFGE). Lane 1 = 50 kb marker, 
Lanes 3 & 4 = C group DNA, lanes 6 & 7 = Fe group DNA, lanes 8 & 9 = Fe + V 
group DNA, lanes 10 & 11 = F e - V  group DNA, lanes 1 2 & 1 3  = Fe + ASA 
group DNA, lanes 14 & 15 = Fe + Cu group DNA. PFGE was run for 17 hrs 
under the following conditions: 0.9% agarose gel, v = 4.5V, initial switch time 
= 0.1s, final switch time = 200s, current = 180 mA, pump rate = 75, temp « 20°C. 
DNA was obtained from W istar rats after 4 months iron loading. The figure 
demonstrates that DNA strand breaks occur as an early event o f iron-overloaded- 
induced oxidative stress.
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10.0 DISCUSSION
10.1 AN ANIMAL MODEL FOR DIETARY IRON OVERLOAD
Animal models of dietary iron overload have been studied repeatedly but not 
systematically. To date, no study has been done on different species of a particular animal 
using one type of dietary iron. Conversely, different types of dietary iron on one particular 
species of animal have also not been studied. The different animal models and different 
iron preparations, as well as different routes of drug administration, have yielded various 
histological representations of haemochromatosis. Nevertheless, animal models of dietary 
iron administration have provided important information about the mechanisms involved in 
pathophysiology of excess iron.
Park et al. (1987) achieved mild fibrosis and histological iron grading of 3 - 4 after feeding 
SD rats with 3% carbonyl iron (Cl) for 12 months. Iancu et al. (1987) fed SD rats 2% Cl 
for 15 months. A hepatic iron concentration of 1060 pg/g dry wt. was attained, in contrast 
to 8000 pg/g reported by Park et al. (1987). Plummer et al. (1997) fed Poton rats 2% Cl 
and by 32 weeks, grade 3 -4  hepatic iron concentration had been achieved. No fibrosis was 
apparent in any of the livers. Olynyk et al. (1995) fed lactating Wistar Furth rats 3% 
carbonyl iron. Pups continued on a 0.6% Cl liquid diet. By 26 weeks all rats had grade 4 
siderosis. Focal fibrosis was seen around Fe-laden periportal macrophages only. Oates et 
al. (2000) studied excretion in Fe-loaded rats following the change from an Fe-loaded to an 
Fe deficient diet. Wistar rats were fed 3% Cl for 9 weeks. This resulted in a 20-fold 
increase in liver non-haem Fe (2110 + 0.32 pg/g dry wt.). Fe-loading of hepatocytes was 
most prominent in the periportal region (zone I and II). Pietrangelo et al. (1990) analysed
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the level of gene expression in Wistar albino rats during chronic Fe overload. Rats were 
fed 3% Cl for 30 weeks. The liver Fe content was 2110 + 345 pg/g dry wt. No histological 
signs of liver damage were evident.
Recent reports of the use of a more organic iron, ferrocene, to feed Wistar albino rats show 
promise of an experimental approach to characterizing the histopathological similarities to 
chronic hepatic Fe overload observed in humans. For example, Ward et al. (1991) fed 
Wistar rats 5 mg/day ferrocene for 6 weeks. Histologically, there were striking similarities 
to the livers of HH patients with grade 3 Fe overload. Dullman et al. (1992) also reported 
mild signs of fibrosis after 34 weeks of feeding Wistar rats 0.5% ferrocene. Stainable 
hepatic Fe at 39 weeks was grade 3 - 4 .  Nielsen et al. (1993) observed necrosis and mild 
fibrosis when Wistar rats were fed 0.5% ferrocene. The liver Fe concentration was 14.7 +
1.4 mg /g dry wt. at 39 weeks. In the present study, the Wistar albino rat attained a 
maximum of grade 2 hepatic iron overload after 12 months on 2.5% Cl. After switching 
over to 0.5% ferrocene (w/w) hepatic Fe reached grade 4 within 4 months. The serum Fe 
level of the control group was lowest and remained fairly unchanged until 20 months when 
it declined. Mean liver iron concentration of all Fe-loaded groups was 19.8 + 6.9 mg/g 
w. wt (33 times above control value) at 32 months.
Ahluwalia et al. (2000) reported a decline of serum Fe in Lewis rats after 22 months. The 
reduced level of serum Fe in older rats therefore, may be a normal event. In the present 
study, all other groups remained prominently high after 8 months (Figure 18, page 226). 
Furthermore, the initial poor Fe loading up to 8 months could be the result of the 2% Cl
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administered at that time, although Olynyk et al. (1995) reported 3-4+ hepatic iron grading 
after feeding Wistar Furth rats on a 0.6% Cl liquid diet for 8 weeks (after weaning from 
mothers that were fed 3% Cl supplemented diet). In the present study, when Cl was 
increased to 2.5%, a sharp increase in serum Fe was observed up to 12 months. 
Nevertheless, hepatic Fe was still grade 2. Although other researchers reported good initial 
hepatic Fe loading with 2-3% Cl, this may be attributed to the different rats species used 
(Plummer et al., 1997; Park et al., 1987; Iancu et al., 1987).
In the present study, 0.5% ferrocene was introduced after 12 months to replace the 2.5% 
Cl. The increase between 12 and 16 months resulted largely from ferrocene administration 
and not the effect of ferrocene superimposed on Cl. This was proved by feeding two new 
sets of Wistar rats with 2.5% Cl and 0.5% ferrocene, respectively, for 17 months. The 
serum Fe concentration of the Cl-fed group was almost the same as that obtained at 12 
months in the previous experiment, but slightly below levels at 16 months. The ferrocene- 
fed group however, had higher values corresponding to that obtained at 16 months in the 
initial experiment. In addition, the histological grading of hepatic Fe was still 2+ in the CI- 
fed group and 4+ in the ferrocene-fed group. The plateau seen after 16 months could be the 
result of Tf saturation. The Fe groups obtained a maximum serum Fe concentration from 
118 to 134 p.mol/1 between 16 and 24 months. The minor peak at 4 months was not 
statistically significant. Moreover, hepatic Fe loading was 1+ at that time-point. The peak 
seen at 16 months was statistically significant (p=0.05), however. The sharp decrease in 
serum Fe concentration of the Fe + Cu group between 20 and 24 months cannot be 
explained.
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Furthermore, the analysis of variance shows that both time and treatment and their joint 
interaction had significant effects on serum iron (see section 9.3.1, page 216). It was noted 
that significant differences (p<0.0001) across the groups resulted from experiments carried 
out for periods <12 and >16 month. Hepatic Fe that was 4+ at 16 months and beyond also 
accompanied this significant difference after 16 months. In the Fe group, serum iron 
concentration was a predictive indicator of LPO and its by-product MDA (Table 44x). In 
the Fe -  V and Fe + ASA groups, serum Fe was a predictive indicator of MDA 
concentration. In the Fe + Cu group, serum iron significantly predicted ’“O2 production and 
80HdG formation.
Although Fe overload diseases are generally regarded as examples of diseases involving 
oxidative stress, one study has suggested that Fe deficiency is associated with increased 
production of ROS. Rao and Jagadeesen (1996) showed that on feeding rats carcinogens, 
Fe deficiency rendered the rat more susceptible to tumourigenesis by a mechanism 
involving oxidative stress. On the contrary, Lemmer et al. (1999) reported that dietary Fe 
loading appeared to offer protection against the cancer-promoting properties of the 
mycotoxin fumonisin Bj.
In the published animal studies on haemochromatosis by other researchers, successful Fe 
loading was variously achieved. However, the Fe overload never resulted in HCC. The 
present study is the first to produce an animal model of haemochromatosis that progressed 
to the development of HCC. In addition and, of great significance, hepatic Fe loading of 
grade 4 and HCC developed in the absence of cirrhosis or fibrosis.
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Fe may act as a genotoxic substance (Deugnier et al., 1992), as a mitostimulatory agent 
(Crane et al., 1985), as a promoter (Fellows et al., 1988) or as a cofactor that enhances 
tumour formation induced by other carcinogens (Blumberg et al., 1988). Furthermore, Fe 
stimulates growth of preneoplastic cells in vitro (Rotstein et al., 1986), and Fe deprivation 
decreases cell growth of cultured hepatoma cells (Solt and Farber, 1976). On the contrary, 
studies conducted by Stal et al. (1995, 1999) suggest that Fe does not promote growth of 
initiated cells, and does not enhance progression of these into HCC. However, the present 
study has shown that Fe was involved in the initiation, promotion and progression of liver 
cells into HCC.
10.2 DIETARY IRON OVERLOAD AND HCC
An animal model of dietary Fe overload leading to HCC has hitherto not been produced. 
Attempts made by several researchers have resulted in haemochromatosis without HCC 
(Bacon et al., 1983; Goddard and Sweeney, 1983; Park et al., 1987; Iancu et al., 
1987,1988; Ward et al., 1991; Pietrangelo et al., 1995a, 1995b; Onylyk et al., 1995; 
Plummer et al., 1997; Valerio and Peterson, 2000; Arezzini et al., 2003). The present study 
is the first in which dietary exposure to iron has produced Fe overload that was 
complicated by HCC development. Data presented in Table 46x (see appendix E) show a 
gradual hepatic Fe overload over 32 months. At 4 months, all Fe-loading groups had grade 
1+ Fe overload. At 8, 12 and 16 months, this progressed into 2+, 2+ and 4+ respectively, 
and remained at 4+ until the end of the study (Figure 45, page 239). The control group had 
grade 0 Fe load throughout, except at 24-28 months when traces of iron were seen in a few, 
and surprisingly at 32 months about half of the surviving control rats had hepatocyte Fe
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grade 2+ and the other half, 0. Kupffer cell Fe on the other hand was 2+ at 16 months when 
hepatic Fe was 4+. Fe load in the Kupffer cells increased to 3+ at 20 months and most of 
them stained 4+ at 24 months. At 28 and 32 months, all Kupffer cells were 4+. The portal 
tract was also loaded with Fe but not the bile ductular cells.
The main cellular elements of the liver involved in Fe uptake are the hepatocytes, Kupffer 
cells and sinus-lining endothelial cells. The distribution of Fe in these cells depends on the 
mode of application. Intravenously administered Fe is first taken up and stored by the 
Kupffer and sinus-lining endothelial cells and accumulates in parenchymal cells at a later 
stage only (Kuchta et al., 1982). In contrast, orally given compounds at first induce a 
predominantly hepatocellular Fe accumulation. The distribution seen in the present study 
was predominantly hepatocellular at first, followed by Kupffer cell Fe loading. This 
preferential location is similar to that described by Park et al. (1987) and Iancu et al. 
(1987). In HH, the excess Fe reaches the liver via the enteral route, which leads to primary 
parenchymal Fe deposition (Stal et al., 1990), in contrast to the reticuloendothelial 
(Kupffer) cells Fe overload seen after parenteral injections with Fe-dextran (Carthew et al., 
1991). In the present study, antioxidant vitamins and Cu did not interfere with the level of 
hepatic Fe loading or with the pattern of preferential Fe loading, mainly in the hepatocytes 
and Kupffer cells at first, and then fully saturated in the hepatocytes at 16 months, 
followed by saturation in the Kupffer cells between 24 and 28 months.
Early signs of iron-free foci (IFF), which are nodules of hepatocytes found in HH 
(Williams and Yamamoto, 1972; Powell and Kerr, 1975; Deugnier et al., 1993a), with
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significantly less or no Fe in the foci compared with the surrounding parenchyma, were 
seen after 20 months (Figure 46, page 240). IFF may be single or multiple, and are 
considered to be preneoplastic in nature. Of the 25 (iron-overloaded) samples presented for 
histological examination at 20 months, 5 (20%) had IFF and 1 was indeterminate 
(borderline case). Two of the 5 occurred in the Fe group, 2 in the Fe -  V group, and 1 in 
the Fe + V group. The borderline case IFF belonged to the Fe + V group. At 24 months, 4 
out of 34 (12%) Fe-overloaded livers had IFF, with 2 from the Fe group being very 
prominent. The remaining 2 belonged to the Fe -  V and Fe + V groups. However, the 
number of samples with borderline IFF increased to 7. Furthermore, none of the samples 
(at 24 months) from the Fe + ASA and Fe + Cu groups showed signs of IFF. IFF were only 
noticed in those groups after 28 months. Of the 54 iron-loaded samples presented for 
histological examination at 28 months, 16 had IFF (30%). Twelve out of 26 iron- 
overloaded samples (46%) submitted to histological examination at 32 months had IFF and 
2 were borderline cases. Two livers with IFF were found in the Fe group, 5 in the Fe + V 
group, 5 in the Fe + ASA group and the 2 borderline cases belonged to the Fe group. Out 
of the 144 Fe-overloaded samples examined between 20 and 32 months, 37 (26%) had IFF. 
The breakdown is as follows: F group = 10, Fe + V group = 12, Fe -  V group = 6, Fe + 
ASA group = 8 and Fe + Cu group = 1. In comparison, Deugnier et al. (1993a) reported 
that 7.6% of 185 patients with uncomplicated HH had IFF in their livers. A later study by 
(Deugnier et al., 1993b) revealed that IFF were present in 83% of the livers of HH patients 
with HCC. In this study, multiple IFF occurred in one sample from the Fe + V group and 
both small and large IFF were observed (Figure 48, page 241). Multiple IFF have been 
reported in HH (Deugnier et al., 1993a). In their study IFF found in patients with untreated
254
Chapter 10: Discussion
HH and HCC, were always numerous and ranged in size from 1 to 7/cm2. It was also 
observed that the distribution of IFF in HH was similar to that of foci with altered 
hepatocytes in chemically induced cancer, suggesting that IFF are proliferative lesions that 
may progress to HCC, as hypothesized in experimental carcinogenesis (Terada and 
Nakanuma, 1989a, 1989b; Deugnier et al., 1993b). In HH patients with IFF studied by 
Deugnier et al. (1993b), more than 50% developed HCC compared with 8% of control 
patients without IFF. IFF in the livers in the present study appear to be a preneoplastic 
change. Furthermore, it has been shown that in iron-overloaded rats with chemically 
induced liver cancer, early nodules of altered hepatocytes thought to be involved in cancer 
development did not stain for iron (Stal et al., 1995, 1999). Iron depletion was regarded as 
one of the earliest criteria for the identification of putative preneoplastic foci (Williams and 
Yamamoto, 1972; Hirota et al., 1979). A later review by Williams (1989) suggested that 
only a few of these foci developed into neoplasms. Furthermore, the author reported that 
the rate of transformation from foci to cancer nodules has been estimated to be 1 in 1,000 
to 1 in 2,500.
Inclusions resembling Mallory bodies (MB) [an accumulation of intermediate filaments of 
prekeratin (cytokeratin) in the cytoplasm of some damaged hepatocytes, seen in association 
with microtubular failure, vitamin A deficiency or as a marker of preneoplasia] were 
observed. MB was first identified at 20 months in association with IFF in the Fe group and 
again at 28 months in association with IFF, fat and stem cells in the Fe + V group (Figure 
49, page 242). MBs are characteristically associated with alcoholic and non-alcoholic 
steatohepatitis (NASH), but are also present in benign and malignant hepatocellular
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neoplasms, and a diversity of metabolic, toxic and chronic cholestatic liver disorders. MB 
formation in animal models of alcoholic steatohepatitis (ASH) and NASH has been 
demonstrated repeatedly (Denk et al., 1979; Tsunoo et al., 1987; Lieber et al., 1989). In the 
present study, the presence of MB was thought to be an indication of preneoplasia. Fat and 
fatty foci were also identified and mostly associated with IFF. Fat accumulation may have 
resulted from defective fat metabolism. Microsteatosis was present at 28 months in 4 
samples. Of the 4 cases, 2 were found in the Fe + V group and 1 in the Fe group. However, 
this was not peculiar to the Fe-loaded groups as 1 case was seen in the control group.
Hamartoma (a tumour-like but non-neoplastic aggregation of cells) was found in one of the 
12 Fe group livers taken at 28 months. Within the same sample size of 12, one liver had 
microsteatosis, Gandy-Gamma bodies (deposits of hemosiderin and calcium) and an 
inconclusive adenoma was seen in one sample belonging to the Fe group at 32 months. 
Liver tissue frequently showed bile duct proliferation and occasional Von Meyenburg 
complexes (VMCs) were also identified. As reported in isolated cases in literature (Yaziji 
et al., 1997; Balnc et ah, 2000; Morcos et al., 2001), VMCs (and to lesser extent bile duct 
adenomas) are relatively common in liver diseases of people with HH. Although it has 
been suggested that a putative carcinogenic effect of iron on biliary cells may explain the 
occurrence of cholangiocarcinoma (Morcos et al., 2001; Jain et al., 2000), no such 
observation was seen in the present study. Furthermore, VMCs also occurred in 2 samples 
from the control group. The bile ductules did not show any accumulation of iron 
throughout.
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Liver cell dysplasia was also observed at 28 months in the Fe group (Figure 49, page 242). 
Anthony et al. (1973), who first described liver cell dysplasia, suggested a possible 
chronological progression from cirrhosis to dysplasia to HCC. The progression is similar to 
the cellular evolution from initiated preneoplastic hepatocytes to HCC seen in 
experimental carcinogenesis. In another study, however, it was reported that the frequency 
of dysplasia in southern African HCC patients was high whether cirrhosis was present or 
not, implying that this progression was not constant (Cohen et al., 1979). Furthermore, 
Kew et al. (1980) showed no statistically significant difference in the frequency of liver 
cell dysplasia between cirrhotic and noncirrhotic patients with HCC. Howevdrr the 
frequency of liver cell dysplasia in patients with HCC is 49.7% in Uganda (Anthony et al., 
1973), 19.4% and 23% in Japan (Sakuria, 1978; Nakashima et al., 1983), 80% and 48% in 
southern Africa (Kew et al., 1980; Cohen et al., 1979). This suggests that liver cell 
dysplasia is a major risk factor for HCC (Paterson et al., 1989; Borzio et al., 1995). Liver 
cell dysplasia could be large or small. Large liver cell dysplasia (LLCD) refers to the 
presence of groups of hepatocytes with nuclear and cellular enlargement, normal 
nucleocytoplasmic ratio, nuclear pleomorphism, multinucleation and prominent nucleoli 
(Anthony et al., 1973; Anthony, 1976, 1979). Small liver cell dysplasia (SLCD) was 
defined according to Watanabe et al. (1983) as groups of hepatocytes with decreased 
cytoplasm, slight nuclear pleomorphism and an increased nucleocytoplasmic ratio, leading 
to the impression of nuclear crowding. Previous studies have shown the LLCD is a risk 
factor for HCC in patients with cirrhosis of various and unknown aetiology (Borzio et al., 
1995; Ganne-Carrie et al., 1996). Furthermore, Libbrecht et al. (2000) have shown that the 
presence of LLCD in patients with non-cirrhotic chronic viral hepatitis is an important
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independent factor for the development of HCC. In addition, a study by Grand-Lemaire et 
al. (1999) showed that patients with HCC in the absence of cirrhosis had pathological 
changes, especially iron overload and LLCD in the non-tumourous liver tissue. The 
researchers suggested that HCC could originate even in non-cirrhotic livers. Deugnier et al. 
(1993a) reported of 10 patients with LLCD in IFF and of the 10, 50% developed HCC. In 
the present study, LLCD was seen at 28 months in the absence of cirrhosis and was 
associated with IFF.
Hepatocellular adenoma (HCA) was seen in one sample from the Fe group at 28 months. 
Benign hepatic tumours, such as HCA and adenomatous hyperplasia (AH), result from a 
variety of neoplastic and regenerative proliferative processes. HCA is an uncommon 
benign tumour of the liver, most frequently occurring in women with longstanding 
contraceptive steroid use. HCA in men is usually associated with glycogen storage disease, 
diabetics, and the use of androgenic anabolic steroids. Malignant transformation of HCA is 
rare, but it may be difficult to differentiate a benign tumour from a well-differentiated 
HCC (Brunt, 2001). The frequent occurrence of HCA in liver may lead to hepatocellular 
adenomatosis, which is a rare disease (Radhi et al., 2000). However, HCA in a young 
woman with P-thalassemia associated and secondary iron overload has been reported 
(Cannon et al., 1981). In addition, HCA in a non-cirrhotic HBV-related chronic liver 
disease has recently been reported (Hsu et al., 2003). HCA in experimental iron overload, 
apart from the present study, has so far not been reported.
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HCC was a borderline case in one of the 6 samples from the Fe + V group at 32 months. 
However, HCC developed in one out of the 8 rats that survived up to 32 months in the Fe 
group. The HCC was 2 cm in diameter (Figures 51, page 244). Of the remaining 7 rats, 3 
with IFF were confirmed malignant by glutathione-sulfhydryl-transferase-Ti (GST-n) stain 
(Figure 48, page 241). This is the first time HCC has been shown in an experimental rat 
model of haemochromatosis (Figures 53 & 54, page 246). In addition, fibrosis and 
cirrhosis, which are often present when HCC develops in HH, were not present (Figure 52, 
page 245). Other Fe overload animal studies did not observe fibrosis (Iancu et al., 1987; 
Plummer et al., 1997; Pigeon et al., 1999) while others reported mild fibrosis (Parle et al., 
1987; Valerio et al., 2000; Arezzini et al., 2003). The link between oxidative stress and 
experimental animal models of fibrogenesis has not been firmly established (Pietrangelo, 
1996). It is argued that during experimental Fe overload in rats, levels of oxidative damage 
remain below a theoretical threshold at which stimulation of fibrosis occurs. Data from 
Brown et al. (2003) suggests that Fe induced oxidative stress elicits an adaptive response 
involving thiol metabolism that effectively limits the accumulation of oxidative (lipid) 
damage and that may protect against fibrosis. Similarly, HCC occurring in non-fibrotic 
livers have been reported in humans (Bralet et al., 2000).
Cirrhosis originally was thought to be the cause of HCC in patients with HH. However, 
patients with HH are also at high risk for developing HCC in the absence of cirrhosis. 
Furthermore, a number of studies have confirmed that cirrhosis is not an absolute 
prerequisite for the development of HCC in the haemochromatotic liver (Deugnier et al., 
1993a; Fellows, 1990; Blumberg et al., 1988). It has recently been reported that the C282Y
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and H63D mutations found in HH do not appear to be associated with an increased risk of 
HCC in patients with cirrhosis (Boige et al., 2003). In addition, HCC associated with 
secondary haemochromatosis in a non-cirrhotic liver of a 40-year-old multiply transfused 
patient, has been reported (Chung et al., 2003). This is similar to the present finding of 
HCC in a non-cirrhotic animal model of haemochromatosis. Furthermore, HCC has been 
reported to be more aggressive in Fe-overloaded patients without cirrhosis than in those 
with cirrhosis (Choong et al., 2003). In the present study, AFP levels were within the 
normal range up to 24 months, although values increased with time as shown in the dotted 
data (see Table 8y, Appendix F).
The major risk factors for the development of HCC are now well recognised and models of 
neoplastic transformation have been used to identify a multiple step pathway. Three stages 
involved in hepatocarcinogenesis have been identified in a number of animal studies 
including initiation, promotion and progression (Dragan and Pitot, 1992). Studies of age- 
dependent tumour formation in rats suggest that as many 5 or 6 steps may be involved 
(Okuda, 1992). Initiation of cellular transformation involves the formation of abnormal 
cells containing an irreversible genetic change, occurring either spontaneously or as a 
result of exposure to chemical or biological agents. During the promotion stage, selected 
cells clonally expand into foci of altered hepatocytes. This promotion step may be 
reversible (Solt et al., 1980); it is greatly influenced by the continuous presence of a 
promoter agent and for an extended period (Laconi et al., 1993). In the progression stage, 
subsets (1% to 5%) of these foci eventually progress through a process of neoplastic 
transformation into frank malignancy. Androgens and estrogens, the ornithine
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decarboxylase activity and growth factors are thought to influence tumour-promotion. This 
process involves additional genetic alterations that include activation of oncogenes and/ or 
inactivation of tumour suppressor genes (Cote at al., 1985; Hsu et al., 1991). The way in 
which the possible mechanisms of hepatic oncogenesis operate at the molecular level is 
still incompletely understood. However, possible biochemical explanation for the role of 
Fe and oxidative stress in the development of HCC in the present study is further 
discussed.
10.3 DIETARY IRON OVERLOAD AND OXIDATIVE STRESS
Cellular damage arising from an imbalance between ROS- generating and -scavenging 
systems has been implicated in the pathogenesis of a diverse range of human disorders, 
including liver diseases. With regard to the latter, the most widely studied areas include the 
toxic reactions to acute and chronic ethanol ingestion. The involvement of ROS in 
alcoholic liver disease is not, of course, exclusive in terms of tissue damaging agents. Free 
radicals are also thought to play a role in liver damage caused by viral hepatitis, Wilson 
disease, drug-induced liver damage and haemochromatosis, to mention just a few.
10.3.1 *”02 Production
The level of involvement of the ‘”02 radical in the Fe-induced liver damage in the present 
study was investigated. Superoxide radical (*~02) levels in Fe-overloaded rats are shown in 
Figure 19 (page 226). The control group showed little change, and had the lowest ’“O2 
level. This steady state suggests that other agents of oxidative stress did not exacerbate the 
effect of the Fenton reaction. The Fe, Fe + V, Fe -  V and Fe + ASA groups showed more
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impressive changes, having peak values at 12 months. However, differences between the 
Fe-supplemented groups and the control group were not statistically significant. Although 
the Fe + Cu group had an early peak at 4 months, the pattern of the curve did not correlate 
with the others and was not significantly different. A significantly positive correlation was 
found between the Fe and Fe + ASA, Fe and Fe -  V, Fe -  V and Fe + ASA, Fe -  V and Fe 
+ V groups. The analysis of variance on *”02 in this study showed that treatment type (i.e. 
the addition or omission of antioxidants) did not have any significant effect on *“02 
production (see section 9.3.4). However, the regression analyses of the various animal 
models showed that in the Fe, Fe + V and Fe + ASA groups, the *”02 levels significantly 
predicted LPO. In the Fe -  V group, Cu was significantly predictive of *”02 production 
(p=0.0002) and in the Fe + Cu group, serum Fe influenced *”02 production.
Aruoma et al. (1991) examined the production of 'OH during oxidative stress by 
confirming the pattern of damage to the purine and pyrimidine bases of DNA exposed to 
Cu ions and H2O2, and showing that the pattern was characteristic of *0H attack. Kamp et 
al. (1995) also demonstrated that asbestos-induced alveolar epithelial cell injury in vitro is 
the result of Fe-catalyzed *OH-like free radical generation, which in turn causes DNA 
strand breaks. Furthermore, cell-associated reactive Fe is more prone than extracellular Fe 
to induce 'OH generation (Demougeot et al., 2000). In addition, Bruck et al. (2001) 
prevented cirrhosis in rats by *OH scavengers. Although in vitro studies have demonstrated 
the production and quenching of *”02 by antioxidants (Jovanovic et al., 2000), ’”02 was 
not the ultimate reactive free radical produced in the present study because the levels
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generated were not significant. Thus, the *OH free radical remains the more likely ROS 
produced during Fe-induced oxidative stress.
10.4 DIETARY IRON OVERLOAD AND ANTIOXIDANTS
Primary and secondary Fe overload disorders are characterized by, the accumulation of Fe 
in mononuclear phygocytes and parenchymal cells of the liver and other organs. Fe is a 
catalyst in the Habar-Weiss reaction and is involved in the initiation and propagation of 
LPO. Considering the role of Fe in Fe reactions, the question is whether antioxidant 
compounds may have additional therapeutic value in supporting the antioxidant defence at 
the cellular level and, if so, which antioxidants are of importance in haemochromatosis.
10.4.1 GPx
Glutathione peroxidase (GPx) reduces GSH (reduced glutathione) to GSSG (oxidized 
glutathione) and in the process converts H2O2 to H2O and O2, and LPO into lipid alcohol. 
GPx levels of Fe-overloaded rats are shown in Figure 20. All groups except Fe -  V group 
had a similar undulating nature. The curves of the control and Fe + Cu groups remained the 
highest up to 10 months. The control and Fe + V groups continued to be above the others 
from 14 months to the end. In the case of the control group, the absence of oxidative stress 
did not pose a challenge to the antioxidant defence system in the normal rat, hence the high 
GPx values. Similarly, Vitamins A and E reduced the impact of ROS on GPx. Hence the 
high GPx level in the Fe + V group, especially in the second half of the Wistar rat’s life, 
even though hepatic Fe overload was 4+. Similarly, Hamilton et al. (2000) showed that
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vitamin E supplementation increased GPx activity and the authors suggested a homeostatic 
control of antioxidants. The reverse is seen in the Fe -  V group where GPx was low 
throughout. In this same group, GPx & catalase and GPx & ORAC-A, were significantly 
negatively correlated (see section 9.2.4.5, page 205). Thus, catalase, which plays a similar 
role in breaking down H2O2 to H2O and O2, may have augmented the function of GPx. In 
the regression analysis, GPx was not predictive of most of the other parameters. Because 
H2O2 itself is a minor ROS with less potency in liver oxidative stress, GPx may not be an 
important antioxidant in Fe-induced oxidative stress. Fletcher et al. (1989) measured the 
activity of GPx in the livers of iron-loaded rats fed 1.0% - 2.5% Cl, and reported no 
significant differences in the GSH and GPx activity, although there was a trend of 
increased GPx activity in the rats receiving 2.5% Cl. Similarly, other researchers (Selden et 
al., 1980; Young et al., 1994) found no statistical difference between hepatic GPx 
concentration of HH patients and controls. These results also suggest that GPx may not be 
an important antioxidant in Fe-induced oxidative stress. However, significant differences 
were found between GPx of the control group and the Fe group, as well as the control and 
Fe-V groups in the present study, suggesting some importance of GPx in oxidative stress. 
Furthermore, in the Fe group only, GPx significantly affected 80HdG levels (p=0.0121). 
The discrepancy between this GPx levels in this study and that of others, may be attributed 
to the particular period when GPx was measured in any of the above experiments. For 
example GPx levels of the control and Fe groups were statistically significant between 12 
and 16 months, but not 16 and 20 months (Table 30x).
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10.4.2 SOD
SOD (a CuZn- or Mn- containing enzyme) removes *”02 by converting it into H2O2 that is 
then removed by GPx. During this process the Fe-transporting protein, Tf, is normally kept 
around 30% Fe saturation to ensure that no Fe is available to catalyse the formation of 
dangerous radicals such as *OH (Halliwell and Gutteridge, 1992).
SOD levels of Fe-overloaded Wistar rats are given in Figure 21. All the groups including 
the control exhibit an undulating pattern. The control group remained the highest and the 
Fe -  V group the lowest, implying that oxidative stress reduces the level of SOD in Fe 
loading conditions. This observation is contrary to that of Broide et al. (2000) (who noted a 
significant increase in liver SOD activities in children with cholestastic liver disease), but 
similar to that of Irshad et al. (2002), who observed a reduction in SOD in various forms of 
liver diseases. Significant differences were observed between 8 and 12 months (p=0.05) 
and, 12 and 20 months (p=0.05). This may be attributed to the period when Cl was 
increased from 2 to 2.5% (after 8 months) and when ferrocene was introduced (after 12 
months). SOD levels in all groups declined after 12 months. This decline is normal and 
associated with age (Glass and Gershon, 1981). In addition, significant differences were 
observed between the control and the various groups. Comparison between the control and 
the Fe groups (8-12 months) shows that dietary iron reduced the erythrocyte SOD 
concentration by about 60%. Contrary to the observations of Yasa et al. (1999) and Cristol 
et al. (1999), in the present study oxidative stress reduced SOD activity at all time points 
throughout the study (Figure 21, page 226).
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Fletcher et al. (1989) reported a 75% reduction in liver SOD level after feeding rats with 
Cl for 28 days. The researchers speculated that the loss of antioxidant protection provided 
by SOD relatively early in the process of hepatic Fe deposition, may be an important factor 
contributing to LPO, which was later observed in that work as well as in the present study. 
However, a different observation between SOD and LPO (measured as TBARs) was made 
by Cristol et al. (1999), who noted that the antioxidant defence mechanism in elderly 
women was impaired without markers of oxidative stress, when compared with healthy 
volunteers. SOD activity was significantly decreased. However, no corresponding increase 
in TBARs levels was observed. Similarly, Yasa et al. (1999) also noted SOD differences 
were statistically significant in cirrhotic patients and controls, but not TBARs. 
Furthermore, no correlation between SOD and TBARs was found in that study. In the 
present study, a weak correlation between SOD and the products of LPO was found, except 
in the Fe + Cu group where a strong correlation occurred between SOD and 8-IP (r=0.59, 
p=0.0007) (Table 2 lx). This association cannot be explained. In conclusion, SOD is an 
important enzyme in Fe-induced hepatic oxidative stress, but may not directly influence 
LPO.
10.4.3 Catalase
Catalase and GPx in the erythrocyte are not compartmentalized and therefore studies 
performed on the hemolysate are a reflection of similar conditions within the erythrocyte. 
Furthermore, catalase is the major H2O2 decomposing enzyme in normal erythrocyte. It 
decomposes H2O2 without generation of free radicals by minimizing one-electron- 
transfers. Hence, the protective role against free radicals may be its main physiological
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function within the cell.
Catalase levels of Fe-overloaded Wistar rats are shown in Figure 22 (page 226). Generally, 
an increase was observed at 2 and 8 months. The control group remained the highest 
throughout with the Fe -  V group the lowest. The pattern seen here is very close to the 
SOD curve in Figure 21. This suggests that the intracellular antioxidant enzymes play an 
important role in cellular antioxidant defences.
Soltys et al. (2001) observed that the administration of 100 units of vitamin E/kg by 
gavage for 2 days before sacrifice, improved the catalase activity in oxidatively stressed 
obese rats compared with the level seen in lean rats. In this study, catalase decreased from 
the 8 month peak to its lowest at 16 months, when liver Fe had attained a maximum of 4+. 
It is believed that there is interplay of the lipid-soluble antioxidants and water-soluble 
antioxidants in maintaining the overall antioxidant balance in the host. For example, in 
Figures 20-24 the values of the control group were higher than the other groups at almost 
all time-points. This was closely followed by the Fe + V group, whiles the Fe - V group 
was almost always the lowest. However, in Figure 25, the control group is the lowest (12- 
24 months) and the Fe - V group the highest as seen in the curves of aqueous-soluble phase 
(ORAC-A) between 14 and 22 months.
10.4.4 Vitamin C
Vitamin C is considered as one of the most important and least toxic of the natural 
antioxidants (Weber et al., 1996). It is water-soluble and found in high concentrations in
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many tissues. Additionally, vitamin C accounts for 10-15% of the antioxidant capacity in 
fasting plasma (Benzie and Strain, 1997).
Vitamin C levels of Fe-overloaded Wistar rats are shown in Figure 23 (page 226). There 
was a general increase from about 1 pmol/1 to about 6.5 pmol/1 over 24 months. The 
control and Fe + V groups were mostly the highest, with the Fe + Cu and Fe groups being 
the lowest. All other groups were in between. The increase in vitamin C status after 
supplementation with a-tocopherol might be linked to increased absorption and or 
decreased plasma clearance of ascorbic acid. This rate of increase depicted in Figure 23 
decreased at 4, 12 and 20 months. However, these decreases were statistically insignificant. 
A study conducted by Hamilton et al. (2000) showed that supplementation with a- 
tocopherol (7.35mg/d) in humans (for 6 weeks) was associated with increased plasma 
ascorbic acid concentration, as well as improved vitamin E status, even though the latter 
was relatively small. Lenton et al. (2000) demonstrated that seasonal changes account for 
the undulating nature of curves of vitamin C concentration with time in humans. 
Furthermore, this undulating nature was also associated with age. Under the experimental 
conditions of controlled daylight, humidity and temperature in this study, this was not 
expected in the Wistar rats, unless the animal has its own body clock irrespective of its 
immediate environmental factors.
Zolch and Ginter (1995) showed that in guinea pigs deficient in vitamin C, ethanol 
administration caused greater depletion in vitamin C. However, in rats, daily consumption 
of ethanol resulted in an increase in the body stores of vitamin C as a result of its enhanced
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biosynthesis. Suresh et al. (1999) obtained similar results of a lower hepatic but a higher 
plasma vitamin C level upon ethanol administration. Ethanol administration creates 
oxidative stress, and perhaps the increase in oxidative stress in this study may account for 
the rise in vitamin C levels.
Significant differences in vitamin C levels were observed between the Fe + V and Fe 
groups, Fe + V and Fe -  V groups, and, Fe + V and Fe + Cu groups (Table 34x). Thus, 
antioxidant supplementation significantly affected vitamin C levels in the Fe-fed groups. 
However, there was no significant difference between vitamin C in the control group and 
other groups. Similarly, Solty et al. (2001) working with Zucker rats under oxidative stress 
noted that the liver vitamin C level of the obese rats (oxidatively stressed group) was not 
significantly different from those of the lean group (without oxidative stress). Furthermore, 
Figure 23 shows an increase in vitamin C throughout the period with little differences in 
rate of increase between the groups. One possible reason for this unexpected behaviour 
might be related to the ability of the adult rat to easily synthesize vitamin C and thus resist 
the effect of scorbutic conditions (Meister, 1994).
It is noted from Figure 23 that between 16 and 24 months vitamin C in the control group 
did not increase above 5.6 pmol/l. However, at 24 months all other groups were above this 
value. It is assumed that oxidative stress was maximal after 16 months when hepatic iron 
was 4+. Under such conditions, plasma vitamin C increased whereas hepatic vitamin C 
decreased, as inferred from ORAC studies in Figure 25 (page 227), where the water- 
soluble antioxidants decreased after 12 months and declined further between 16 and 24
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months. This apparently low vitamin C level in the control group (Figure 23) may have 
contributed to an increase in lipid peroxidation, as observed later (Figure 29, page 227) and 
also suggested by Halliwell and Gutteridge (1989). The interaction of vitamin C with other 
parameters was examined by correlation analysis. A strong positive correlation between 
vitamin C and DNA damage (estimated by 80HdG measurements) for all Fe-fed groups 
was observed. However, the weakest correlation between vitamin C and 80HdG was 
found in the control group. It is possible that vitamin C in the Wistar rat seems to have a 
pro-oxidant tendency that is aggravated under oxidative stress.
The present study showed that a decrease in dietary vitamins in the Fe -  V group did not 
affect serum vitamin C levels (Figure 23, page 226). Furthermore, no correlation between 
GPx and vitamin C was observed in all groups except for a weak correlation seen in the Fe 
+ V group. On the contrary, Lykkesfeldt el al., (1998) demonstrated that the increase in the 
antioxidant glutathione was accompanied by increased vitamin C after the injection of 
lipoic acid. Lastly, there was no correlation between vitamin C and FADU in all groups.
10.4.5 TAS/ORAC
Figures 24 and 25 (page 227) relate to the total antioxidant status of the plasma and liver, 
respectively. The trolox equivalent antioxidant capacity (TEAC) assay of Miller et al. 
(1993) is based on the inhibition of the absorbance of the radical cation, 2,2'-azinobis(3- 
ethylbenzthiazoline 6-sulphonate) [ABTS(+)], by antioxidants (Figure 24). ORAC (Figure 
25) on the other hand depends on the unique properties of phycoerythrin (PE). It relates a 
lag phase or a rate constant of PE florescence decay to antioxidant capacity of an added
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antioxidant sample. To date, it is the only method that takes the reactive species to 
completion and uses an "area under the curve" technique for quantification, thus combining 
both inhibition time and inhibition percentage of the reactive species action by antioxidants 
into a single quantity.
In Figure 24, the control group is the lowest before 12 months. Similar observations were 
made by Irshad et al. (2002), who noted that TAS was in some cases higher in patients 
with liver diseases than in matching controls. The high TAS level in the various test groups 
compared to the control group suggests that oxidative stress in various tissues leads to an 
enhanced expression of antioxidant enzymes, as observed by Venkatraman et al. (1994). 
However, the control group in the present attained the highest level, well separated from 
the rest between 10 and 24 months. This is an indication of a compromised antioxidant 
defence system in the Fe-fed groups after 12 months, when hepatic Fe increased 
significantly.
Whereas Figure 24 is a reflection of plasma total antioxidant capacity, Figure 25 is a 
refection of the total antioxidant capacity in the liver assessed by a different method. In 
Figure 24, the peak occurred at 20 months whereas in Figure 25, it occurred at 12 months. 
Thus, the antioxidant capacity of the liver was long saturated before it became evident in 
the plasma. This correlates well with the immunohistological findings that as early as 12 
months LPO and DNA oxidative damage could not be attenuated by antioxidants in the 
liver. Khan et al. (2002) also observed the presence of HNE and MDA adducts in the liver, 
after 6 weeks of feeding SD rats 2.5% CL In Figure 25, the control group is the highest up
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to 8 months and thereafter falls below the rest of the groups. However, in Figure 24 the 
control group is the highest after 8 months with all other groups below the control group. 
An inverse relationship between the plasma and liver total antioxidant capacities appear to 
exist.
The analysis of variance shows that both time and treatment had significant effects on TAS 
(pO.OOOl, pO.OOOl, respectively). The interaction of time and treatment also had a 
significant effect on TAS (p=0.0002) (Table 25x). The multiple comparison test results in 
Table 32x show that significant differences (pO.OOOl) resulted from experiments carried 
out for 24 months at almost all time points. With regard to treatment differences it is noted 
in Table 32x that significant differences (pO.OOOl) occurred between the control group 
and all other groups except the V group. Thus, the addition of antioxidant vitamins to the 
diet of the Fe + V group, appeared to have cancelled out the effects of oxidative stress on 
the antioxidant defense system of that group to some extent, which closely resembled that 
of the control group.
In Figure 25, the total antioxidant capacity is separated into two groups. The upper part of 
the graph relates to the water-soluble liver antioxidants and the lower part, the lipid-soluble 
liver antioxidants. Notably, the amount of lipid-soluble antioxidant was about 4-5 times 
less than the amount of water-soluble antioxidants (Figure 25). The lipid- and water- 
soluble antioxidants operated in an inverse relationship until 20 months. At 12 months the 
water-soluble antioxidants attained a peak level. However, this level declined between 16 
and 20 months. On the contrary, the level of the lipid-soluble antioxidants was lowest at 12
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months and peaked between 16 and 20 months. There was virtually no difference at all 
time points between the antioxidant levels of the various groups. However, the water- 
soluble antioxidants showed significant differences between 8 and 16 months.
Figure 25 suggests that a possible inverse relationship exist between the water- and the 
lipid-soluble antioxidants. Between 8 and 16 months, the water-soluble antioxidants in the 
liver were at a peak. Over the same period, the lipid-soluble antioxidants were low. At 12 
months the Fe + V group had the lowest level of water-soluble antioxidants compared to 
the rest. This again is suggestive of the operation of a compensatory mechanism of water- 
and lipid-soluble antioxidants, perhaps in an attempt to maintain equilibrium. This concept 
of a compensatory mechanism amongst the various antioxidants can be seen when Figures 
20-23 are examined. GPx peak values occurred at 4 months (Figure 20), catalase peak 
values at 8 months (Figure 22), SOD at 12 months (Figure 21), GPx again at 16 months, 
TAS at 20 months, and vitamin C at 24 months (Figure 23). It is believed that the 
dynamics of the various antioxidants was an attempt to “scavenge” the continuous 
production of free radicals in the rat liver. In addition, Brown et al. (2003) have shown an 
up-regulation of antioxidant defences involving thiol metabolism in hepatic iron overload.
In a clinical study of SOD, TAS and liver diseases, a similar conclusion was drawn. In that 
study, SOD was found to be significantly lower in all patients compared to the control 
group (Irshad et al., 2002). Moreover, the degree of reduction was found to be nearly the 
same in all types of liver diseases. However, TAS was found to be comparable to that of 
the control group and independent of the type and aetiology of liver disease. In several 
cases, the TAS level was higher in patients than the matched control. The view of the
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possibility of some adaptive or compensatory rise in some other antioxidants that were not 
measured was postulated and the concept tested. A rise in uric acid was observed in all 
types of liver diseases, irrespective of their aetiology (Irshad et al., 2002).
In conclusion, even though the liver has ample resources to dispose of ROS, i.e. SOD, 
catalase, glutathione, and vitamin E, these ROS scavenging systems are mainly 
compartmentalized in specific organelles like peroxisomes (catalase) and mitochondria 
(MnSOD) and can not effectively scavenge ROS in hepatocytes.
10.5 DIETARY IRON OVERLOAD AND BIO-MARKERS OF LIPID 
PEROXIDATION.
In Fe overload diseases such as HH, organ damage has been attributed mostly to Fe- 
induced peroxidation of PUFAs of membrane lipids, which can lead to the breakdown of 
biomembrane functions and finally cell death. Fe is involved in the initiation of this free 
radical chain reaction (LPO) by decomposition of hydrogen peroxide to form the highly 
reactive *OH in the Fenton reaction and by activation of oxygen by ferrous and ferric 
complexes. LPO processes may be studied by monitoring the resulting secondary reaction 
products, which include lipid LOOH, MDA, 4-HNE and 8-IP.
10.5.1 Lipid Hydroperoxides (LOOH)
LOOH of Fe-overloaded Wistar rats is seen in Figure 29 (page 227). There was virtually 
no difference in serum LOOH among the various groups for the first 12 months. Thereafter
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LOOH in all groups, apart from the control group, increased sharply, attaining a peak at 20 
months. Thus, little or no LPO took place within the first 12 months. This can be attributed 
to poor Fe loading over the same period. In Figure 29, the control group has the lowest 
serum LOOH and does not show any peak value. It is inferred that in the absence of iron 
overload, oxidative stress is virtually absent and LPO is minimal and insignificant. In 
Figure 29, differences between the various groups compared to the control group were 
statistically significant. Furthermore, the analysis of variance indicated that both time and 
treatment and their interaction had significant effects on LPO (p<0.0001, pO.OOOl, 
respectively). The multiple comparison test results in Table 25x show that significant 
differences resulted from experiments carried out between 12 and 20 months. With regard 
to treatment differences, Table 36x shows that significant differences occurred between the 
control group and all other groups.
From the afore-mentioned and Figure 29, all other groups receiving Fe supplementation 
showed significant signs of LPO. The greatest effect was seen in the Fe + Cu group. The 
presence of a possible co-carcinogen may be attributed to this as seen in the Long Evans 
Cinnamon rat an animal model of Wilson disease (Kato et al., 1996; Ebara et al., 1999). 
Multiple regression analysis showed that serum Cu levels in the Fe + V, Fe -  V, Fe + ASA 
groups significantly predicted LPO (p=0.0001; p=0.0002; p=0.0046, respectively). Serum 
Fe also predicted LPO in the Fe group. However, there was no group in which both serum 
Fe and Cu could predict LPO.
In Figure 29, the Fe -  V group is the lowest suggesting the presence of less LPO. This was 
unexpected and contrary to what other researchers observed (Huang et al., 2002).
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However, Meagher et al. (2001) administered a-tocopherol supplements at doses of 200, 
400, 800, 1200, or 2000 IU to healthy persons for 8 weeks and found no benefit of a- 
tocopherol on LPO. In Figure 29, the curve for the Fe + V group lies above the Fe -  V 
group, suggesting that more LOOH was produced as a result of vitamin supplementation. 
This was again unexpected. It is possible that the high LPO observed in the vitamin- 
supplemented group (Fe + V) may be attributed to vitamin A (50mg/kg diet). Vitamin A 
may have behaved as a pro-oxidant more than an antioxidant. For example, a recent report 
by Graffin et al. (2002) showed that P-carotene (pro-vitamin A) induced hepatic fibrosis in 
a 66-yr-old woman. In this study, vitamin antioxidants did not make a significant impact in 
reducing LOOH, as seen in Figure 29. Similarly, acetyl salicylic acid (ASA), used as an 
antioxidant, made less impact in reducing LPO (Figure 29). In Figure 29, the decline in 
LOOH in all the iron-supplemented groups after 20 months is an indication of a decline in 
LPO, although the by-products (i.e. 4-HNE) were detected immunohistochemically in the 
livers at that time-point. Benedetti et al. (1984) demonstrated in rats that the loss of cellular 
capacity to undergo LPO may be an early event in hepatocarcinogenesis and may therefore 
represent an early preneoplastic marker. In this study, histopathological evidence of 
neoplastic transformation commenced at 28 months. Unfortunately, immunohistochemistry 
of LPO by-products was not performed after 20 months as a result of technical difficulties.
10.5.2 MDA
Increased LPO is an important expression of both chronic and acute Fe toxicity. Evidence 
supporting increased LPO in chronic Fe overload includes the demonstration of increased 
concentrations of MDA (a by-product of LPO) in organs obtained from thalassaemic
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patients and Fe-loaded experimental animals (Bacon et al., 1983).
MDA levels of iron-overloaded rats are shown in Figure 26 (page 227). There was 
relatively no activity among the various groups from 2-12 months. This is attributed to the 
poor Fe loading using Cl over that period. All other groups, apart from the control group, 
show an increase after 12 months. The control group remained a roughly straight line but at 
a low level with a maximum value of 6.1 pM. Thus, LPO resulting from oxidative stress 
did not occur in the control group. At 24 months, MDA in the Fe group was 9 times higher 
than the value in the control group. Brown et al. (1997) studied fibrogenesis in 2.5-3‘%~CT- 
fed SD rats and observed a 3- 5 fold increase in TBARs of the Cl-fed rats over the controls 
at all time points over 14 months. A 2.5-5 fold MDA increase in the Fe-fed groups was 
observed in the present study at 14 months and this increased to 4-9 fold at the end of 24 
months. Furthermore, Valerio and Petersen (2000) examined whether DBA/2Ibg mice fed 
a ferrocene-enriched diet for 16 weeks would develop hepatic LPO and if liver microsomes 
would contain adducts of MDA. Chronic Fe feeding of the mice resulted in a severe 
hepatic Fe overload with hepatic stores 12-fold greater than those measured in control mice 
and a 3-fold increase in hepatic MDA concentrations. In addition, 10 liver microsomal 
MDA adducts conjugated to proteins in Fe-overloaded mice were detected. Similarly, 
Sochaski et al. (2002) studied LPO and protein modification in a mouse model of chronic 
Fe overload and observed a 2-3 fold plasma increase in aldehydes and a 6-fold increase in 
MDA after 3 weeks of intraperitoneal administration of Fe dextran. Furthermore, Arezzini 
et al. (2003) fed C3H male mice 3% Cl for 12 weeks and observed a 3-fold increase in 
MDA levels in the livers of the mice. A significant increase in MDA was observed in mice
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receiving Fe and those treated with Fe and CC14. On the contrary, no significant difference 
with respect to controls was observed in mice treated with CCU alone. These results 
support the observation in the present study that MDA production was mainly the result of 
excess hepatic Fe.
Lastly, the association between excess hepatic Fe, hepatic TBARs and the co-localization 
of MDA-lysine adducts in selected hepatocytes of 3% Cl-fed SD rats also suggests that 
intracellular LPO is enhanced by excess Fe, leading to the formation of aldehydes 
(Houglum et al., 1990). In support of a hepatocellular origin for aldehyde protein adducts, 
the stable presence of 4-FINE and MDA protein adducts found in the circulation of animals 
did not disappear despite the withdrawal of the 3% Cl diet (Houglum et al., 1990). These 
observations provide direct evidence of the contribution of ROS, LPO and reactive 
carbonyl intermediates to the pathogenesis of Fe-overload diseases. In the present study, 
MDA levels in the Fe + V group, statistically did not differ significantly from the control 
group, suggesting some degree of intervention by vitamins in LPO (Table 38x). Similar 
results were obtained by Brown et al. (1997). Aspirin however, was not as effective as 
vitamin E in reducing the MDA levels in the Fe + ASA group. The Fe -  V group also had 
MDA levels that were statistically different compared to the control group. LPO appears 
therefore to be a key step in the hepatocarcinogenic process.
10.5.3 8-IP
Enzymatic oxidation of arachidonic acid by way of the cyclooxygenase pathway leads to 
the formation of prostaglandins (Samuelsson et al., 1975). Several pro-inhibitory stimuli
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induce cyclooxygenase-2, an isoform of cyclooxygenase, in macrophages, epithelial cells 
and fibroblasts leading to the release of prostaglandins. Major metabolites of the primary 
prostaglandin F2a, 15-keto-13,14-dihydro-prostaglandin F2a (15-K-DH-PGF 2a), and 8-IP 
can be used as an index of inflammation and enzymatic LPO via cyclooxygenase-catalyzed 
oxidation of arachidonic acid. In addition, levels of both 8-IP and 15-K-DH-PGF2a in 
plasma and urine have been shown to increase in an animal model of CCU-induced 
hepatotoxicity (Basu, 1999).
Liver 8-IP levels of Fe-overloaded Wistar rats are shown in Figure 27. The control group 
has the lowest level in a relatively straight line. Thus, oxidative stress was virtually absent 
in the control group and neither did 8-IP increase with time. The maximum value for the 
control group was 590 ng/g liver wt. This value is 4-8x less that of the groups receiving 
iron, except the Fe + Cu group. All other groups were significantly higher than the control 
group. 8-IP in the Fe + Cu group increased in a hyperbolic manner, significantly higher 
than the rest and reaching a maximum value of 12940 + 4173 ng/g liver wt at 16 months. 
This value was 22x that of the control and statistically significant. 8-IP levels for the rest of 
the groups were in between the two extremes, with relatively no difference up to 12 
months and beyond 20 months.
The effect of antioxidant vitamins and aspirin on liver 8-IP was minimal. In fact, aspirins 
seem to have increased 8-IP levels between 12 and 20 months. This increase was however, 
statistically insignificant when compared to the control group [p<0.05 (12-20 months), 
Table 43x], Similarly, Meagher et al. (1999) investigating alcohol-induced generation of
279
Chapter 10: Discussion
LPO products in humans observed that vitamin C, but not aspirin, reduced urinary 
isoprostanes. The difference between the control group and the Fe + V group was 
statistically significant. However, the difference between the Fe group and the Fe + V 
group was not statistically significant. Vitamins A and E were therefore not effective in 
lowering the level of liver 8-IP. Similarly, when Van den Berg et al. (2001) fed 22 male 
smokers on a high fruit and vegetable concentrate diet with high antioxidant capacity for 3 
weeks, no effect of 8-IP as a marker of oxidative lipid damage was observed. On the 
contrary, Sodergren et al. (2001), reported that rats supplemented with vitamin E prior to 
CCU-induced oxidative injury had lower levels of urinary 8-IP compared with rats treated 
with C C I 4  alone. Hepatic levels of 8-IP were also lower in the vitamin E-supplemented 
CCU-treated rats compared to rats treated with C C I 4  alone. However, plasma 8-IP levels 
did not differ between CCU-treated rats with or without vitamin E supplementation. The 
present study, however, showed that vitamin or vitamin-free diet (in combination with 
iron) did not affect liver 8-IP (Table 43x). However, it cannot be explained why serum 
vitamin C correlated positively with 8-IP in the groups that were not supplemented with 
antioxidant (i.e. the C, Fe, Fe-V and Fe + Cu groups), which is different from the negative 
correlation observed between vitamin C and 8-IP by Meagher et al. (1999) in a study on 
alcohol-induced oxidative stress.
A positive correlation was observed between 8-IP and ALT in the following groups: Fe + 
ASA, Fe + Cu and Fe + V. Thus, LPO of arachidonic acid by way of the cyclooxygenase 
pathway contributed to liver damage after 12 months when ALT levels were significantly 
raised in these groups. In the multiple regression analysis, Fe in the Fe group significantly
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predicted 8-IP (p=0.0084). In the Fe + V group 8-IP significantly predicted mutagenicity 
by the Ames mutagenicity test (p=0.0292). Finally, in the Fe + Cu group 8-IP predicted 
80HdG levels. It can be explained for the Fe + Cu group that in the presence of two 
possible carcinogens (Fe, Cu), oxidative stress led to increased 8-IP levels. However, it is 
difficult to explain why this was not applicable to all the other Fe-receiving groups. 8-IP as 
a marker of oxidative stress may be far more complex than it is now known. Other studies 
attempting to correlate antioxidant levels (ascorbate, tocopherols, p-carotene, etc.) with 
plasma or urinary 8-IP are not available. This may indicate that none of the isoprostanes 
correlate with antioxidant insufficiency, or that simply, the isoprostane responsible for 
LPO is another untested isomer.
10.5.4 4-HNE Immunohistochemistry
In the 3C.7 sections (control group) there was hardly any brown immuno-labelling 
observed after exposure to the anti-HNE antibodies [Figures 40 (a) & (b) -  44 (a) & (b), 
pages 234-238]. Intense brown cytoplasmic granular immuno-staining was observed in the 
hepatocytes in the Fe + ASA [Figure 43 (c) & (<7)], Fe + V [Figure 41 (c) & (d)\, Fe 
[Figure 40 (c) & (<7)], and Fe + Cu [Figure 44 (c) & (<7)] groups of the rat liver. Similar but 
less intense immuno-staining in the Fe -  V group liver sections, was observed [Figure 42 
(c) & (<f)]. Intense immuno-staining of brown aggregates was also observed in the 3V7.8 
sections, especially around the vessels (Figure 41).
From the afore-mentioned, it may be concluded that there was virtually no LPO activity in 
the livers of the control group. Thus, with the normal RDA of Fe, little “free Fe” was
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available to generate substantial amounts of free radicals. However, the small amount of 
free radicals produced was effectively scavenged by the body’s antioxidant system with 
virtually little left for LPO. Alternatively, because LPO, a free radical-mediated 
mechanism, leads to oxidative destruction of PUFAs constitutive of cellular membranes, 
the process of LPO in the control group was effectively abolished by antioxidants with 
very little or no 4-HNE formed. On the other hand, the intense brown immuno-staining of 
4-HNE was observed in all the Fe-overloaded groups irrespective of vitamin levels. In 
addition, Cu supplementation in the Fe + Cu group did not increase the intensity of 4-HNE 
microscopically. Similar findings of 4-HNE adducts have been reported in liver tissues 
from patients with different chronic liver diseases, including alcoholic liver injury (Paradis 
et al., 1997a) chronic viral hepatitis (Paradis et al., 1997b) and HH (Niemela et al., 1999). 
Furthermore, 4-HNE adducts were mainly found in the cytoplasm of all iron-overloaded 
groups. Similar findings of cytoplasmic localization of 4-HNE adducts resulting from iron 
overload was observed by Seki et al. (2002).
Immunohistochemical staining for 4-FINE was not examined before 12 months. However, 
by 12 months, liver samples already had 4-HNE deposits. Biochemical results (Figures 26 
and 27) of MDA and 8-IP, respectively, showed very little activity at 12 months. LOOH 
determined by the FOX II assay showed that LPO was just beginning at 12 months (Figure 
29). Although serum Fe levels at 12 months were fairly raised, hepatic Fe was still mild 
(2+) at this time-point. LPO on the other hand was adequately detectable at 12 months. 
LPO may therefore occur as an early event in the hepatocarcinogenic process induced by 
excess Fe and has profound effects on the liver, although it may not be adequately detected
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at the serum level. In addition, it is likely that the process of LPO commences from within 
the liver, and the spill over of adducts is then evident in the serum. Finally, it was noted 
that low hepatic Fe levels are adequate to commence this chain reaction, which was never 
attenuated by high doses of vitamin and aspirin antioxidants.
Although it still remains to be clarified whether LPO is the cause or consequences of liver 
damage, ALT and AST values of all Fe-loaded groups obtained at 12 months were not 
statistically significant when compared to the control group. Therefore, if LPO is part of 
the hepatocarcinogenic process it does so in the absence of overt hepatic damage as 
evidenced by significantly raised serum transaminase levels.
10.6 DIETARY IRON OVERLOAD AND OXIDATIVE DNA DAMAGE
Apart from lipids, nucleic acids and proteins are also targets for ROS attack. For example, 
DNA is attacked by 'OH, which results in increased 80HdG production, and can be 
adequately quantified in urine, serum and tissue. Although enzyme repair mechanisms 
operate, it is possible that in the long term, protein expression is impaired following such 
DNA damage. ROS-induced oxidative damage to proteins resulted in a variety of chemical 
modifications, particularly in the introduction of carbonyl groups into amino acid residues 
(especially proline, arginine, lysine and threonine). Kuchino et al. (1987) observed that the 
formation of 80HdG leads to mutations by inducing misreading of the base itself and its 
adjacent bases. The presence of such mutagens can be detected by the Ames mutatgenicity 
test. Furthermore, Hagen et al. (1994) demonstrated that HCC developed as a result of 
sustained accumulation of 80HdG in the hepatic nuclear DNA of hepatitis B virus 
transgenic mice.
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10.6.1 Hepatic 80HdG levels
Hepatic 80HdG levels of Fe-overloaded Wistar rats are shown in Figure 30. All groups 
have winding curves that relate to the level of 80HdG in the liver. The control group is the 
lowest with a first peak at 4 months and a second at 12 months. Although minor peaks 
occurred, the general pattern of the control group’s curve especially from 12 months was 
‘fairly’ flat, as expected of the control group that received the normal chow diet. In Figure 
30 all curves after 20 months were attenuated and this may be attributed to an adaptive 
mechanism (Radak et al., 2000).
Both time and treatment had significant effects on hepatic 80HdG levels in this study 
(p<0.0001, p<0.0001, respectively). In addition, the interactive effect of both parameters 
was significant (p<0.0001)(Table 40x). The control group in this study did not show any 
net 80HdG change at the end of 28 months (Figure 30). Similarly, increase in 80HdG in 
the liver has been reported not to be time dependent (Fraga et al., 1990; Hirano et al., 
1996; Nakae et al., 2000). In summary, 2.5% Cl supplementation made little impact before 
12 months. Thereafter, supplementation with 0.5% ferrocene caused a drastic increase in 
liver 80HdG production. The analysis of variance between 2 and 8 months was not 
statistically significant. However, significant differences amongst the various groups 
occurred at 24 months (p<0.05). On the contrary, Kang et al. (1998) fed SD male rats on 
3% Cl for 8 weeks and obtained 80HdG levels that were statistically significant compared 
to the control group. The Fe + V group had lower 80HdG levels than the other groups 
except for the period 16 to 24 months. The antioxidant vitamins given to the Fe + V group 
appear to have scavenged free radicals generated to by ferrocene and reduced oxidative 
DNA damage up to 16 months.
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The present study shows that vitamins and aspirin antioxidants reduced liver 80HdG by 
17% and 22%, respectively, within the first two months. However, the absence of 
antioxidants led to 34% increase in 80HdG level in the Fe -V  group when compared with 
that of the Fe + V group and 10% increase when compared with the Fe group. Similarly, 
Haegele et al. (2000) showed that in a 14-day fruit and vegetable intervention trial, plasma 
P-cryptoxanthine (a xanthophyll carotenoid) inversely correlated with 80HdG in the 
lymphocyte DNA. Thompson et al. (1999) reported that the concentration of 80HdG in 
lymphocyte DNA was reduced by 21.5% by a 2-week vitamin intervention. Thus, in the 
absence of vitamin antioxidants, the DNA is more prone to oxidative damage by ROS. 
However, not all vitamin intervention studies had corresponding decreases in 80HdG 
levels (Huang et al., 2000).
In Figure 30, aspirin as an antioxidant (Fe + ASA group) was only effective within the first 
12 months. For example aspirin led to 22% reduction in hepatic 80HdG within the first 
two months. However, under increased oxidative stress with time, this antioxidant was no 
longer effective. The hydroxylation of aspirin has been shown in in vitro studies as an ’OH 
scavenger (Richmond et al., 1981). However, in vivo application of aspirin in the present 
study showed efficacy only under low oxidative stress (i.e. up to 12 months). Multiple 
regression analysis in groups receiving antioxidants (Fe + V and Fe + ASA groups) 
showed that ORAC-L or lipid antioxidants in those groups significantly affected 80HdG 
levels (p=0.0000)(TabIe 44x). Denda et al. (1994) fed male Fischer 344 rats a choline- 
deficient, L-amino acid-reactive (CDAA) diets for 30 weeks and reported that aspirin at 
concentrations >0.2% prevented the development of both cirrhosis and preneoplastic
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nodules. Aspirin also prevented hepatocyte proliferation as well as the generation of 
TBARS and 80HdG. In the present study, 20 mg/kg/d aspirin was used. This comes to 
about one-third of the 0.2% Denda (1994) used to prevent 80HdG generation. The 
inability of aspirin to reduce liver 80HdG after 12 months could be related to the high 
oxidative stress (after 12 months as seen in figures 26, 28, 29, 30, 32 and 33) and perhaps 
the low aspirin dose administered.
The administration of Cu induced high hepatic levels of 80HdG from the onset. The 
correlation analysis (in section 9.1.13, page 191) shows that the Fe + Cu group correlated 
very well with all the other groups apart from the control group. The nature of the curve 
can therefore be attributed to the generation of ROS and its oxidative damage to DNA. In 
the present study, a correlation was also established in the Fe + Cu group between 80HdG 
and FADU (r=0.70, p<0.0001)(Table 21x). Similarly, Toyokuni and Sagripanti (1996) 
observed this kind of association. The multiple regression analysis indicates that Fe, O2, 
TAS, ORAC-A, LPO and 8-IP in the Fe + Cu group, significantly predicted 80HdG 
production in this group rather than any other group. The presence of 80HdG has been 
shown in other liver diseases as well (Farinati et al., 1999; Cardin et al., 2001; Ichiba et al., 
2003).
10.6.2 80HdG Immunohistochemistry
80HdG, a DNA base modified product generated by ROS, can induce G-C to T-A 
transversion at DNA replication (Shebutani et al., 1991). It has been demonstrated that
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80HdG is a good marker of oxidative DNA damage (Kasai, 1997). Previous studies have 
shown that various carcinogens including aflatoxin Bi, psychological stress and ionising 
radiation, increase hepatic 80HdG content. Although increased 80HdG levels in tissue 
extracts from patients with chronic viral hepatitis has been reported (Shimoda et al., 1994), 
little is known about the in situ localization of 80HdG in Fe-overloaded livers.
Photomicrographs of 80HdG immunohistochemistry can be seen on pages 229-233. The 
intrahepatic localization of 80HdG differed from group to group, which may be attributed 
to the differences in the various diet regimens and target(s) of oxidative stress among the 
various groups. The slides show that there was hardly any visible brown immuno-staining 
in the control group liver sections, suggesting that insignificant amounts of 80HdG 
adducts were present in those livers [Figures 35 (a) & (b) -  39 (a) Sc (6)]. A great deal of 
brown immuno-staining, indicating positive labelling of 80HdG, was observed throughout 
the liver sections of the Fe + V group [Figure 36 (c) Sc (<sF)]. Intense labelling was observed 
in several aggregates found in these sections, as well as granular labelling within cells. 
Similar intense labelling in aggregates was observed in the liver sections of the Fe -  V and 
Fe + Cu groups [Figure 37 (c) Sc (d), and 39 (c) & {d) respectively]. This granular labelling 
was also observed within cells in the liver sections of the Fe + ASA group, especially 
around blood vessels. In addition, the immuno-staining was concentrated in nuclei, 
appearing as dark brown spots in this group [Figure 38 (c) & (c/)]. 80HdG has also been 
demonstrated to be present in chronic human liver diseases such as hepatitis B and C, 
autoimmune hepatitis, alcoholic liver disease, and primary biliary cirrhosis. Kitada et al. 
(2001) and Ichiba et al. (2003) have suggested a possible link between 80HdG and active
287
Chapter 10: Discussion
inflammation and hepatocarcinogenesis. Seki et al. (2002) also demonstrated the presence 
of 80HdG in non-alcoholic steatohepatitis (NASH). In that study, 65% of the cases 
examined exhibited nuclear expression of 80HdG in hepatocytes and sinusoidal cells in 
areas of active inflammation. Quantitative analysis revealed that 80HdG expression 
significantly correlated with the grade of necro-inflammation but not with the severity of 
steatosis. The association between body Fe stores and 80HdG, was demonstrated by Kato 
et al. (2001). Normalization of elevated hepatic 80HdG levels in chronic hepatitis C was 
achieved in patients by phlebotomy and low Fe diet (Kato et al., 2001).
10.6.3 FADU
Different methods have been used for measuring DNA damage and repair activities. The 
FADU assay which is one of the common methods, is based on the fact that the rate of 
unwinding of large DNA molecules exposed to alkaline is related to increases in strand 
breaks and conversely, strand breaks are responsible for the rate of DNA unwinding 
(Birnboim and Jevcak, 1981).
In the present study, the FADU (in the liver cells) of Fe-overloaded Wistar rats is seen in 
Figure 28. The absence of substantial differences between the various groups up to 12 
months is suggestive of insignificant DNA strand breaks resulting from low ROS attack on 
the DNA. However, FADU values of all groups apart from the control group and the Fe + 
V group increased sharply between 12 and 16 months. Furthermore, at most of the time 
points the rate of DNA unwinding in the control group was lower than that of other groups. 
Similarly, Edling et al. (1990) observed that the unwinding of hepatic double stranded
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DNA (dsDNA) was greater at all time-points in Fe-loaded rats compared to the control 
after 22 weeks of feeding Wistar rats 2.5-3.0% CL
In the present study, DNA unwinding of the Fe + V group increased steeply from 16-20 
months. The interaction plot of time and group in Figure 28 (page 227) suggests that the 
level of DNA strand-breaks in the Fe + V group was lower than the other groups between 
12 and 20 months, further suggesting that ROS release from the neutrophils in the Fe + V 
group was suppressed or delayed compared to the other groups. This effect was also 
noticed during ‘”02 measurement by chemiluminescence. Apart from vitamins suppressing 
the release of ROS they also lowered the level of DNA strand breaks and unwinding by 
scavenging the ROS produced. The Fe + V group’s curve was almost always the lowest of 
all the Fe-receiving groups. The analysis of variance shows that there was no significant 
difference between group C and Fe + V (see section 9.3.12, page 222). Vitamin 
supplem entation therefore significantly reduced the rate o f DNA unwinding.
The oxidative DNA damage led to DNA strand breaks and unwinding and the subsequent 
formation of adducts, such as 80HdG. This is seen by the strong positive correlation (p 
<0.0001- 0.0007) that exists between FADU and 80HdG in all the groups except the 
control group. Toyokuni and Sagripanti (1996) obtained similar results and suggested that 
DNA strand breaks and 80HdG are possibly related through a common chemical 
mechanism. In the present study, the correlation analysis showed that all the groups were 
significantly positively correlated (section 9.1.14, page 192). The analysis of variance 
showed that both time and treatment had significant effects on the rate of liver DNA
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unwinding (section 9.3.12, page 222). Furthermore, the absence of vitamins increased the 
rate of DNA unwinding in the Fe - V group compared to the Fe + V group and antioxidant 
vitamins were more effective than aspirin in reducing DNA strand breaks and unwinding 
by scavenging peroxyl radicals (Niki, 1996). Similarly, Navasumrit et al. (2000) 
demonstrated that the administration of vitamin C or E (400 mg/kg, i.p., 100 mg/kg, i.p., 
respectively, daily for 5 days) prior to administration of ethanol to male Wistar rats 
inhibited the generation of 1-hydroxyethyl-POBN a free radical adduct by 30 and 50% 
respectively, and both agents prevented the increased frequency of DNA single strand 
breaks caused by ethanol. [POBN = a-(4-pyridyl-l-oxide)-n-tert-butylnitrone, is a Spin- 
trapper], In HH, unwinding of hepatic double stranded DNA and the risk of HCC has been 
associated with chronic Fe overload (Nidereau et al., 1985).
In the present study, DNA unwinding in the Fe + Cu group was higher than other groups at 
all time-points after 8 months. Cu, a possible co-carcinogen, may have caused greater 
DNA strand breaks and unwinding and greater hepatic damage (Ebara et al., 1999; 1991; 
Klein et al., 2000) as seen in the Long-Evans cinnamon rat (Hatano et al., 2000).
10.7 DIETARY IRON OVERLOAD AND MUTAGENESIS
Damage to the DNA is likely to be a major cause of cancer. The Ames mutagenicity test 
has been used extensively to screen a variety of substances for mutagenic activity. This test 
measures back-mutation in several specially constructed mutants of Salmonella 
typhimurium. The test strain Salmonella typhimurium TA 102 contains A-T base pairs at 
the site of the mutation (determined by DNA sequence anaylsis) in contrast to the other
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Salmonella tester strains that detect mutagens damaging G-C base pairs. This strain differs 
from previous tester strains in that the mutation has been introduced into a multi-copy 
plasmid, so that * 30 copies of the mutant gene are available for back-mutation. This strain 
detects a variety of oxidative mutagens, including hydrogen peroxide and other 
hydroperoxides, X-rays, a variety of aldehydes (MDA), bleomycin, UV light etc. (Levin et 
al., 1982).
The results of the Ames mutagenicity test, showing the interaction of time with the various 
treatment types and, using fractionated liver homogenate on Salmonella typhimurium strain 
TA 102 are shown in Figure 31 (page 228). In this figure, the curve of the control group is 
fairly straight with a maximum value of 365 ‘revertanf colonies. Using the established cut­
off point of 360 ‘revertant’ colonies for Salmonella typhimurium TA 102, the liver 
homogenate of the control group was considered negative throughout for the Ames 
mutagenicity test. Colony counts o f ‘revertants’ for the negative control ranged from 310- 
330 ‘revertants’ during the same period. The positive control, daunorubicin hydrochloride 
(daunomycin) had colony counts of 510-520 ‘revertants’.
In the Ames mutagenicity test, the control group also showed increase in ‘revertant’ 
colonies. However, this increase was minimal. Spontaneous mutagenesis and aging may be 
accountable for this. Mutation frequencies in the liver have been reported to increase with 
aging (Dolle et al., 1997). The accumulation with age of spontaneous mutation has long 
been considered to play key roles in senescence in experimental animals (Vijg and van 
Steeg, 1998). Thirty to 40% of mutations that occur are detected in the brain and kidney,
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whereas 10 - 20% are in the liver, lung and spleen (Boerrigter, 1998). About one-third of 
such spontaneous mutations arise before birth; about one-third during the growth period of 
youth; and the remainder during the rest of the animal's life (Paashuis-Lew and Heddle, 
1998).
In the present study, colony counts for the Fe + Cu group increased steadily from 2 months 
until 20 months where it attained a peak value of 588 ‘revertant’ colonies and then 
decreased slightly. Mutagenic activity in the Fe + Cu group appears to be the synergetic 
effect of Fe and Cu. By 8 months this group was moderately positive for the AMES 
mutagenicity test. Although liver homogenate was not analysed to determine the active 
mutagenic compound, it is believed that mutagenicity in the liver fractions was caused by 
MDA and 80HdG. These two compounds have been implicated in mutagenesis caused by 
oxidative stress (Niedernhofer et al., 2003; Cheng et al., 1992).
Niedernhofer et al. (2003) reacted MDA with pSP189 shuttle vector DNA and then 
transfected them into human fibroblasts for replication. MDA induced up to 15-fold 
increase in mutation frequency in the supF reporter gene compared to untreated DNA. 
Sequence analysis revealed that the majority of MDA-induced mutations occurred at GC 
base pairs. These experiments provide biological and biochemical evidence for the 
existence of MDA-induced DNA inter-strand cross-links that could result from 
endogenous oxidative stress and are likely to have potent biological effects. Cheng et al. 
(1992) showed that 80HdG is pro-mutagenic. However, it requires DNA replication 
without repair in order to cause mutation by specifically inducing GC-to-TA transversion.
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In Figure 31 (Ames mutagenicity test), values after 16 months were statistically significant 
compared to those before (p=0.05). MDA and 80HdG products at 16 months were also 
statistically significant (Figures 26 and 30, respectively). However, at 16 months, only the 
Fe + Cu group showed very high increases in the Ames test. From Figure 31, colony 
counts as high as 660 ‘revertanf where noted in the Fe, Fe + V and Fe -  V groups, and & 
600 in the Fe + ASA group at 20 months. Therefore, antioxidant vitamins (A and E) and 
aspirin were unable to prevent the formation of mutagens in the Fe + V and Fe + ASA 
groups, respectively. It appears that once excess Fe accumulates in the liver, the process of 
MDA and 80HdG formation to mutagenic levels is inevitable.
Detailed data on the Ames mutagenicity test are shown in Table z (appendix G). It is seen 
from the Table z that mutagens were strongly present in the microsomes and this increased 
with time. In addition, more liver homogenate fractions became positive for the Ames 
mutagenicity test with time. From what has been mentioned previously, it appears that the 
mutagenic levels 80HdG and MDA originated from the microsomes and spread to other 
parts of the liver. Similar observations were made by Levin et al. (1982). Finally, from 
Table z (appendix G), it is noted that by 24 months almost all liver fraction (S9, 
nucleosomes, cytosol, microsomes and whole homogenate) were strongly positive for 
mutagenesis in all groups except the control group.
Mutation frequencies in the liver of a recently developed la d  transgenic rat were 
substantially lower than those of the transgenic mice previously developed, and mutation
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patterns induced by aflatoxin B1 were clearly different in those two animal models (de 
Boer et al., 1996). Mutation events, either spontaneous or induced, are therefore species- 
dependent. In addition, GC-to-AT transitions are the most frequent class among 
spontaneous mutations (Vijg and van Steeg, 1998), and 80HdG specifically induces GC- 
to-TA transversion (Cheng et al., 1992). Furthermore, different forms of oxidative DNA 
damage can induce different types of mutations, including point mutations, transitions, 
deletions, additions, frameshifts or chromosomal translocation (Gille et al., 1994). 
Moreover, environmental toxins may alter the methylation status of DNA. These events 
may lead to potential mutagenic effects (Pogribny et al., 1995) and activation of oncogenes 
and inactivation of tumour suppressor genes.
Tumour suppressor genes suppress malignant transformation. In some types of tumours, 
inactivation of suppressor genes may occur by methylation (Vorce et al., 1989) and may be 
a molecular mechanism underlying cell proliferation that contributes to carcinogenesis 
(Goodman and Counts, 1993). The p53 protein is a multifunctional transcriptional factor 
that orchestrates cellular responses to DNA damage and thus conserves genetic stability. 
Induction of DNA damage activates p53, which in turn induces either cell growth arrest or 
programmed cell death, depending on the cell type or experimental system. Bressac et al. 
(1995) and Hsu et al. (1991) found G:C to T:A mutations in codon 249 of the p53 gene 
leading to a substitution of arginine to serine in tumours and HCC from southern Africa 
and the Qidong area of China, respectively. The mutation frequency of the p53 tumour 
suppressor gene in HH was studied recently. In one study, 60% A:T to G:C and 40% A:T 
to T:A mutations were observed (Vautier et al., 1999). However, 45% G:C to C:G, 33%
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A:T to C:G, 11% G:C to T:A mutations were observed in another (Marrogi et al., 2001). 
This mutation spectrum suggests that etheno-deoxyguanine or etheno-deoxyadenine DNA 
adducts may be responsible for the DNA damage. These DNA modifications are produced 
by the reaction with lipid peroxidation products in the livers of HH patients (Nair et al., 
1998).
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11.0 CONCLUSION
An animal model of dietary Fe overload leading to HCC has hitherto not been produced. 
Attempts made by several researchers have resulted in haemochromatosis without HCC 
(Bacon et al., 1983; Goddard et al., 1983; Park et al., 1987; Iancu et al., 1987, 1988; Ward 
et al., 1991; Pietrangelo et al., 1995b; Onylyk et al., 1995; Plummer et al., 1997; Valerio 
et al., 2000; Arezzini et al., 2003). The present study is the first in which dietary exposure 
to iron has produced Fe overload that was complicated by HCC development. Furthermore, 
HCC occurred in the absence of cirrhosis and fibrosis. A biochemical explanation for the 
pathogenesis of HCC has been shown to involve oxidative stress. Iron overload led to the 
generation of ROS. Although ’”02 free radical was 2-2.5 times higher in the iron-fed 
groups compared to the control, it was not statistically significant. Thus, the *OH free 
radical remains the most likely free radical generated during dietary iron overload.
Antioxidant enzymes operate in a dynamic equilibrium and with a compensatory 
mechanism. The total lipid-soluble antioxidant within the antioxidant defence system was 
25% the total hepatic antioxidants. This explains the ineffectiveness of the antioxidant 
vitamins to attenuate the consequences of oxidative stress such as oxidative lipid and DNA 
damage. LPO occurred as an early event of oxidative stress generating adducts such as 
MDA and 4-HNE of which the latter was massively deposited in the liver at 12 months of 
Fe-loading. DNA modifications such as 80HdG were produced by reactions with LPO 
products in the livers of the Fe-overloaded Wistar rats as seen in HH patients (Nair et al., 
1998). The level of such mutations in the Fe-fed groups was statistically significant
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compared to the control group. Such mutations were accompanied by DNA strand breaks 
and unwinding, and were confirmed by PFGE (Figure 55) and FADU as early events in the 
carcinogenic process. Liver damage estimated by AST and ALT occurred after 16 months 
of Fe loading although this was not histologically visible. However, signs of 
carcinogenesis were histologically noticeable at 20 months when IFF was first noticed. 
IFFs developed to dysplastic nodules by 28 months and progressed to frank HCC in one 
sample from the Fe group. Dietary Fe alone may be carcinogenic through a mechanism 
that involves the generation of ROS, LPO, oxidative DNA damage, DNA strand breaks 
and unwinding, and mutagenesis.
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LIST OF ABBREVIATIONS
- 0 2 Superoxide radical
y-g t Gamma-glutamytranspeptidase
*OH hydroxyl radical
'0 2 Singlet oxygen
4-HNE 4-hydroxy-2 ’ -nonenal
8-IP 8-isoprostane
80HdG 8-hydroxy-2 ’ -deoxyguanosine
AAPH 2,2’-azobis(2-methylpropionamide)-dihydrochloride
ACP Acid phosphatase
ADP Adinosine diphosphate
AFP Alpha-feto protein
AIN American Institute of Nutrition
ALT Alanine aminotransferase
ASA Acetylsalicylic acid
AST Aspartate amonotransferase
ATP Adenosine triphosphate
Cgp
Cl
Control group 
Carbonyl iron
Cu Copper
DNA Deoxyribonucleic acid
dsDNA Double stranded deoxyribonucleic acid
FADU Fluorimetric Analysis of DNA Unwinding
Fe Iron
Fe -  V gp Iron, minus vitamin group
Fe + ASA gp Iron, plus acetyl salicylic acid 
Fe + Cu gp Iron, plus copper
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List of Abbreviations
Fe + V gp Iron, plus vitamins
Fe gp Iron group
FeNTA Iron nitriloacetate
FOX Ferrous Oxidation with Xylenol
GC/MS Gas Chromatography / Mass Spectroscopy
GPx Glutathione peroxidase
GSH Glutathione
GST-tc Glutathione-sulfhydryl-transferase-7i
HCA Hepatocellular adenoma
HCC Hepatocellular carcinoma
HH Hereditary haemochromatosis
HLA Human Lymphocyte Antigen
HMdU 5 -hydroxymethyl-2 ’ -deoxyuridine
IFF Iron free focus (iron free foci)
LEC Long Evans Cinnamon
LIC Liver iron content
LLCD Large liver cell dysplasia
LO* Alkoxyl radical
LOO* Peroxyl radical
LOOH Lipid hydroperoxide
LPO Lipid peroxidation
MDA Malondialdehyde
NADP Nicotinamide adenine dinucleotide phosphate
NADPH Reduced nicotinamide adenine dinucleotide phosphate
NAGA N-acetylglucosamine
NO* Nitric oxide radical
ORAC Oxygen radical absorbance capacity
ORAC A Aqueous phase Oxygen radical absorbance capacity
ORAC L Lipid phase Oxygen radical absorbance capacity
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List of Abbreviations
PFGE Pulse Field Gel Electrophoresis
PUFA Poly Unsaturated Fatty Acid
ROI Reactive Oxygen Intermediate
ROO* Peroxyl free radical
ROS Reactive Oxygen Species
SLCD Small liver cell dysplasia
SD Sprague-Dawley
SeGPx Selenium dependent glutathione peroxidase
SeiGPx Selenium independent glutathione peroxidase
SOD Superoxide dismutase
TAS Total Antioxidant Status
TBARs Thiobarbituric Acid Reactive Substances
Tf Transferrin
TfR Transferrin Receptor
WD Wilson disease
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